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ABSTRACT 
 
Kinetic and Stoichiometric Modeling of the Metabolism of Escherichia coli for the 
Synthesis of Biofuels and Chemicals. 
 
by  
 
Angela Cintolesi 
 
This thesis presents the mathematical modeling of two new Escherichia coli 
platforms with economical potential for the production of biofuels and chemicals, namely 
glycerol fermentation and the reversal of the β-oxidation cycle. With the increase in 
traditional fuel prices, alternative renewable energy sources are needed, and the efficient 
production of biofuels becomes imperative. So far studies have focused on using glucose 
as feedstock for the production of ethanol and other fuels, but a recent increase in 
glycerol availability and its consequent decrease in price make it an attractive feedstock. 
Furthermore, the reversed β-oxidation cycle is a highly efficient mechanism for the 
synthesis of long-chain products. These two platforms have been reported experimentally 
in E. coli but their mathematical modeling is presented for the first time here. 
Because mathematical models have proved to be useful in the optimization of 
microbial metabolism, two complementary models were used in this study: kinetic and 
stoichiometric. Kinetic models can identify the control structure within a specific 
pathway, but they require highly detailed information, making them applicable to small 
sets of reactions. In contrast, stoichiometric models require only mass balance 
information, making them suitable for genome-scale modeling to study the effect of 
adding or removing reactions for the optimization of the synthesis of desired products. 
To study glycerol fermentation, a kinetic model was implemented, allowing 
prediction of the limiting enzymes of this process: glycerol dehydrogenase and di-
hydroxyacetone kinase. This prediction was experimentally validated by increasing their 
enzymatic activities, resulting in a two-fold increase in the rate of ethanol production. 
Additionally, a stoichiometric genome-scale model (GEM) was modified to represent the 
fermentative metabolism of glycerol, identifying key metabolic pathways for glycerol 
fermentation (including a new glycerol dissimilation pathway). The GEM was used to 
identify genetic modifications that would increase the synthesis of desired products, such 
as succinate and butanol.  
Finally, glucose metabolism using the reversal β-oxidation cycle was modeled 
using a GEM to simulate the synthesis of a variety of medium and long chain products 
(including advanced biofuels). The model was used to design strategies that can lead to 
increase the productivity of target products. 
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1 Introduction 
 
1.1 Motivation and justification 
The current petrochemical industry controls most of the production of 
transportation energy and other petrochemicals; however, this platform has several issues 
that make it necessary to look for alternative sources. The main issues are related to the 
instability of petroleum prices, the uncertainty of its availability in the future, and its 
negative impact in the environment. Although there are renewable sources to produce 
biofuels and biochemicals, which are environmentally friendlier, the price of using these 
alternative sources is not yet competitive with the traditional petrochemical industry. 
Therefore, there is an imperative necessity to continue exploring renewable sources to 
produce fuels and chemicals, as well as to optimize these processes.  
In this thesis, two new platforms for the production of renewable biofuels and 
chemicals in E. coli are studied using mathematical models: glycerol fermentation and 
the reversal of the β-oxidation cycle. Glycerol can be consumed for E. coli in order to 
produce biofuels and biochemicals, and its use is promising when compared to other 
traditional carbon and energy sources for E. coli (glucose, for instance). The reversal of 
the β-oxidation cycle is highly efficient in the synthesis of long chain products, such as 
advanced biofuels. A full study to increase the understanding of glycerol fermentation 
and the use of the reversal β-oxidation cycle in E. coli, as well as to optimize and expand 
these mechanisms, requires mathematical modeling of the metabolism, a task that has not 
been fully explored yet and which is the focus of this thesis.  
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1.1.1 The problem of fuels and chemical production 
Our current society relies on the petrochemical industry for the production of 
transportation energy (fuels) and chemicals. Petrochemical products are those chemicals 
produced from petroleum, also called crude oil and natural gas. Crude oil and natural gas 
are a mixture of hydrocarbons, among them alkanes, cycloalkanes, and aromatic 
hydrocarbons. Petroleum is extracted and processed to obtain two main kinds of 
products: fuels and chemicals. Crude oil is extracted from the earth, and it is processed to 
separate the different components that originate valuable products. Petroleum products 
can be classified into two main groups: fuels and other derivatives (chemicals). Among 
the fuels are ethane, diesel fuel, fuel oils, gasoline, jet fuel, and kerosene. Some 
petroleum derivatives are alkenes, lubricants, wax, sulfuric acid, tar, asphalt, petroleum 
coke, paraffin wax, and aromatic petrochemicals. While petroleum derived fuels 
represent about the 94% of the source for total transportation energy (Reijnders & 
Huijbregts, 2009), derivative chemicals are used in the production of plastic, cosmetic, 
agrochemicals, adhesives, etc. But all this reliance on the petrochemical industry has 
achieved (and it will continue to achieve) unstable and even dangerous levels for society 
and the environment. 
  The first concern is related to economic issues. Petroleum prices have been 
subject to enormous variation in past and present years. Few countries in the world 
produce petroleum, and these countries often have unstable political systems (Soetaert & 
Vandamme, 2009). The crisis in the 1970s, triggered by political issues in the Middle 
East, caused an enormous increase in the price of oil (Figure 1). In more recent years, the 
price of petroleum has continued to suffer huge increases and fluctuations. Before 
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September 2003, the price of crude oil was about $25/barrel (real price), and since then it 
has increased to over $100/barrel in 2011 (BP’s Statistical Review of World’s Energy 
Full Report 2012. Website: http://www.bp.com/statisticalreview. Figure 1 shows 
historical prices. Projections for the future are discouraging as, regardless of political 
issues, crude oil is a limited resource expected to run out in the near future.   
 
 
Figure 1: Crude oil prices 1861-2011. Statistical Review of World Energy June 2012. Website: 
http://www.bp.com/statisticalreview. 
Because petroleum is a non-renewable resource, and because of increasing 
demand, it is estimated that petroleum will run out in 50 years or less (Soetaert & 
Vandamme, 2009). Petroleum was formed by chemical processes that took place during 
millions of years on the earth, and therefore, it is a limited, non-renewable resource. 
Refineries were at first operating in areas of easy access. As easily accessed reserves are 
being exhausted, the process of extracting petroleum becomes more challenging. On the 
other hand, the forecasted demand of crude oil is increasing as a natural consequence of 
increases in population and in development. The U.S. Energy Information Administration 
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(Website: http://www.eia.gov) forecasts a steady projection in the global demand of 
liquid fuel, and an increase in the demand of liquid biofuels (Figure 2). In conclusion, the 
limited capacity of crude oil supply, together with the increase in crude oil price, creates 
an urgent necessity to develop alternative transport fuels.      
 
Figure 2: Forecast of global demand by fuel type (U. S. Energy Information Administration. Independent 
Statistics and Analysis. AEO2013 Early Release Overview. Website: http://www.eia.gov) 
But petroleum does not have just economical and availability issues, it is also 
unsafe to the environment.  The petrochemical industry has been related to CO2 
emissions, air pollution, and acid rain (Union of Concerned Scientists – Clean Energy. 
Website: http://www.ucsusa.org). Carbon dioxide is produced by the combustion of fuels 
and is related to global warming. Although there are multiple sources for carbon dioxide 
emissions, studies reveal that these emissions have increased about 35% when compared 
to pre-industrial times (Environmental Protection Agency. Website: http://www.epa.gov), 
suggesting a relationship with the increased use of fuels. According to the U.S. 
department of energy, CO2 emissions related to energy are connected to over 80% of the 
greenhouse emissions (See Figure 3 for detail of other sources). Air pollution is another 
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negative side effect of using petroleum, causing damage to the health of humans. Burning 
fossil fuel generates several harmful emissions, among them carbon monoxide, nitrogen 
oxides and sulfur oxides. These emissions are related to health issues such as headaches, 
irritation of lungs, bronchitis, and respiratory infections. Finally, some of these emissions 
cause additional damage to the environment, such as acidic rain. Acidic rain has a 
negative impact on water, aquatic animal life, soils, and vegetation.   
 
Figure 3: Greenhouse gas emissions by gas, 2009 (Emission of greenhouse gases in the United States 2009. U.S 
Energy Information Administration, Dec 2009. Website:  ftp://ftp.eia.doe.gov)  
1.1.2 Biofuels 
The expected increase in the price of crude oil, together with the inevitable 
running out of it and the environmental damage associated with this industry, has lead 
several countries to make efforts in incorporating alternatives. Although different kinds 
of renewable energy are being explored, among them nuclear energy, solar energy, wind 
power, and biofuels, the last one is the most appropriate for transportation (Zidansek et 
al., 2009). For instance, solar and wind power are not very reliable as they depend on 
external conditions, and nuclear energy still has some safety issues that would delay any 
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implementation for several years (Zidansek et al., 2009). In contrast, biofuels have 
proven to be appropriate for transport energy and some countries are already 
incorporating them. In addition, biofuels are made from biomass, which can also provide 
substitutes for some derivatives of the petrochemical industry, making biofuels even 
more attractive as a replacement of fossil products. 
 Production of biofuels, and specifically of ethanol and biodiesel, was triggered by 
economic and environmental factors. After the oil crisis of 1973, Brazil decided to 
incorporate ethanol as an energy source for transport, and now it is one of the countries 
with the highest production of ethanol in the world (Leland, 2009; Reijnders & 
Huijbregts, 2009). Following the example of Brazil, the U.S. implemented a program to 
stimulate the use of ethanol in 1978, and is currently the other main producer of ethanol 
in the world (Leland, 2009; Reijnders & Huijbregts, 2009). The U.S. Department of 
Energy expects to quadruple the consumption of renewable biofuels in the coming years, 
from 9 billion gallons in 2008 to 36 billion ethanol-equivalent gallons in 2022 (U.S. 
Department of Energy, 2012), and other countries (such as Canada, South Africa and 
Germany) are also implementing similar strategies to replace part of traditional fuel 
consumptions (Reijnders & Huijbregts, 2009). 
1.1.3 Glycerol and glucose as feedstocks for ethanol and chemicals production 
Traditionally feedstocks for the production of biofuels have been cane and corn, 
for the production of ethanol, and oil crops, for production of biodiesel (Fischer et al., 
2008). Cane and corn contain sucrose and starch respectively, which can be broken down 
into sugars, mainly glucose and fructose, and then be fermented to produce ethanol. 
Sugar fermentation is a relatively simple process that can take place in yeast and other 
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organisms. However, in order to make biofuels economically viable, it is necessary to 
develop new and more efficient processes to use glucose and other less expensive 
biofuels. One way to achieve this is in the use of alternative feedstock, such as cellulose, 
syngas, fatty acids, and glycerol, all of which have been proposed as alternatives to 
reduce cost in the production of biofuels (Dellomonaco et al., 2010; Fischer et al., 2008; 
Yazdani & Gonzalez, 2007). Another way to make biofuels more attractive economically 
is to concentrate on the production of advanced biofuels, which contain higher energy 
density than traditional fuels. In this thesis two approaches are studied: 1) the use of 
glycerol as a cheaper carbon source to produce biofuels and chemicals and 2) the use of a 
newly discovered metabolic pathway, the reversal of the β-oxidation cycle, to produce 
advanced biofuels and other chemicals. The reason for this selection is explained in the 
following two paragraphs. 
Glycerol is a 3-carbon molecule that has two important and promising properties 
for the production of biofuels: low price and a high degree of reduction (Yazdani & 
Gonzalez, 2007). Glycerol is a by-product in the production of biodiesel, and its 
production is 10% (weight) of the biodiesel product. The increase in production of 
biodiesel in recent years has lead to a 10- fold decrease in the price of glycerol between 
2004 and 2006 (Yazdani & Gonzalez, 2007), and its current price is even lower ($0.005 
per pound. 01/2013; www.thejacobsen.com). The low price of glycerol makes it 
competitive when compared to sugars. Furthermore, the highly reduced nature of carbon 
atoms in glycerol (higher than sugars) makes it even more attractive for the production of 
biofuels. For instance, glycerol presents a maximum theoretical yield twice as large as the 
one produced when glucose is used as the carbon source in the anaerobic fermentation in 
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E. coli (Dharmadi et al., 2006). Regardless of experimental efforts that have been 
conducted to improve the utilization by E. coli of glycerol for the productions of 
biofuels and chemicals, no mathematical modeling has been conducted previous to 
this thesis, a task that is imperative for further understanding and optimization of 
this process.   
The reversal of the β-oxidation cycle is a newly engineered process that results in 
the efficient synthesis of long chain chemicals, including advanced biofuels. While the β-
oxidation cycle is the most commonly used metabolic pathway for the utilization of fatty 
acids as energy and carbon sources, the reversal of this process is possible by 
metabolically engineering the pathway. It experimental implementation in E. coli using 
glucose as carbon and energy source was demonstrated in 2011 by Dellomonaco and 
collaborators (Dellomonaco et al., 2011). The implementation of this pathway resulted in 
the production of long chain linear alcohols and fatty acids at higher yields than those 
reported using other pathways, a highly the attractive aspect of this pathway 
(Dellomonaco et al., 2011). In order to increase the understanding of the reversal of 
the β-oxidation cycle in E. coli as well as to explore its capabilities to enhance the 
optimal production of a variety of long chain chemicals, the implementation of 
mathematical model is essential, a task that has been undertaken in this thesis.  
1.2 Selection of microorganism: E. coli as platform 
The production of biofuels requires a platform capable of transforming the 
feedstock into the desired product. The complexity of this operation, together with the 
high efficiency that biological systems provide when compared to chemical catalysts, 
resulted in the decision to use biological microorganisms, which have proven to be able 
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to synthesize biochemicals. In addition, several tools have been developed in the field of 
biotechnology during the last 40 years (starting with the discovery of restriction enzymes 
in the 1970s), focused on the modification of wild strains in order to improve their 
original properties. Biotechnological tools allow, for instance, modifying the tolerance of 
cells to external conditions, adding or removing reactions from the original pathway in 
order to increase the production of the desired product, overexpressing or 
underexpressing native genes, and modifing proteins characteristics (reversibility, 
activity, among others).  
Although different microorganisms are able to produce biofuels, this study 
focuses on one in particular: Escherichia coli. E. coli is a gram negative bacterium that 
has been widely studied for applications in biotechnology. Several properties make E. 
coli an ideal organism for the production of biochemicals on an industrial scale. First, E. 
coli can easily grow in attractive industrial conditions. It can grow with and without 
oxygen, use several substrates, and use inexpensive media components (Clomburg & 
Gonzalez, 2010). Second, the large amount of information on the metabolism of these 
bacteria allows efficient manipulation of it using gene transformation, regulation of gene 
expression, and protein engineering (Stephanopoulos, 2007). Furthermore, the 
development of “omics” technology (genomics, transcriptomics, and proteomics) has 
been applied extensively to E. coli, allowing an increase in the understanding of this 
bacterium. This accumulated knowledge has allowed mathematical modeling of part of 
the metabolism of E. coli, the remarkable examples being the central carbon metabolism 
for glucose utilization (Chassagnole et al., 2002) and genome-scale modeling (Orth et al., 
2011).   
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Most importantly, recent studies confirm that E. coli is able to ferment glycerol in 
the absence of external electron acceptors, an ability shared only by a few organisms 
(Dharmadi et al., 2006), which can lead to the production of ethanol other products. In 
addition, E. coli can produce long chain chemicals (including advanced biofuels) utilizing 
a newly engineered pathway: the reversal of the β-oxidation cycle (Dellomonaco et al., 
2011).  
1.3 The use of mathematical modeling in the study of biological systems  
Prior to the utilization of mathematical models in biological systems, biological 
parts (genes, proteins, reactions, and metabolites) were studied in a limited way with 
laboratory technology. Most of the experiments consisted of the modification of one 
single element (a gene, for instance) and then the observation of the effect over other 
components of the system. This approach has changed in recent years, and several efforts 
have been made to apply mathematical models to the study of biological systems as a 
whole.    
The use of mathematical models allows a deeper understanding of the roles of 
different parts of the system, and how their manipulation can increase the production of a 
desired product under specific conditions. For example, a mathematical model can allow 
the identification of the limiting steps in a system, while otherwise it would be necessary 
to performance multiple experiments in the laboratory, which are expensive and time 
consuming, to reach the same conclusion. Gombert and Nielsen reviewed the two main 
approaches in modeling metabolic pathways: stoichiometric models and kinetic models 
(Gombert & Nielsen, 2000). Furthermore, some models incorporate the genetic 
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regulatory network in order to represent different conditions that suppose the expression 
of different genes (see for example Ramakrishna et al., 1996 and Moisset et al., 2012).   
1.4 Objectives 
The main goal of this thesis is the development of mathematical models for the 
understanding of microbial utilization of glycerol and the implementation of a 
functional reversal of the β-oxidation in E. coli related to the production of biofuels 
and other valuable chemicals. This was done using two approaches: kinetic modeling 
and genome-scale modeling. In particular, the following tasks were performed: 
 Implementing a kinetic model for the fermentative metabolism of glycerol. 
This model was used to elucidate the control structure in this pathway, to create 
predictions, and to propose genetic modifications for increasing the production of 
biofuels. 
 Implementing a genome-scale (stoichiometric) model (GEM) for the 
fermentative metabolism of glycerol. This model allowed the identification of 
active pathways and engineered pathways for the efficient conversion of glycerol 
into biofuels and other chemicals. 
 Implementing a GEM for the utilization of glucose to produce long chain 
chemicals using the reversal of the β-oxidation cycle. This model allowed for 
the evaluation of different strategies for the production of a variety of advanced 
biofuels and other long chain chemicals. These strategies include the evaluation of 
adding and removing reactions. 
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1.5 Organization of the thesis: Overview of the chapters 
The next section of this thesis is Background and literature review. That 
section starts by reviewing metabolic information available for E. coli, which includes 
detailed studies of pathways related to utilization of glycerol and glucose. Specific 
pathways for the consumption of glycerol and glucose are explained. Different pathways 
that have been proposed to produce advance biofuels and other chemicals are explained, 
including the β-oxidation cycle as well as its engineered reversal for the production of 
long chain products. Then, mathematical models for metabolic pathways are presented, 
including approximate models and applications.  
Two mathematical methods were selected for this study: kinetic modeling and 
GEM. Materials and Methods explains why these methods were selected and gives 
further details of their implementations. Also, detailed experimental protocols are 
presented for the validation of predictions and other relevant findings. 
The next three sections present Results, which consist of 1) a kinetic model for 
glycerol fermentation, 2) a GEM for glycerol fermentation, and 3) a GEM for glucose 
metabolism for the production of medium and long chain products using the reversal of 
the β-oxidation cycle. The kinetic model accounts for the glycerol transport and 
dissimilation, glycolysis, and ethanol synthesis, and it represents correctly the 
experimental data. This model was used to study the control structure of glycerol 
fermentation and predictions were experimentally validated. The GEM for glycerol in E. 
coli accurately represents glycerol fermentation. Implementation of this model allowed 
increasing the understanding of glycerol fermentation, as well as investigating the 
synthesis of additional products using optimal strategies. The GEM for the reversal of the 
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β-oxidation cycle was used to evaluate this pathway as an efficient platform for the 
production of a variety of medium and long chain products, including advanced biofuels, 
and it increases the understanding of redox balance and energy requirements of this 
pathway. In addition, a GEM was used to simulate the use of different platforms for the 
production of medium and long chain products. It was concluded that the reversal of the 
β-oxidation cycle predicts higher productivities based on a higher energetic efficiency.  
To conclude, Final Remarks and Future Directions presents a summary of the 
main findings exposed in this thesis, as well as suggestions about future experimental 
work to corroborate the findings of this work. In future experimental work it is suggested 
that a variety of genetic modifications be implemented, leading to i) corroboration of the 
existence of new unstudied pathways and ii) production of biofuels and chemicals at 
optimal levels. Some future directions in the use of mathematical models in metabolic 
engineering, in particular en the area of production of biofuels and chemicals are also 
suggested.   
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2 Background and literature review 
 This chapter describes fundamentals for building mathematical models for 
glycerol fermentation and respiratory utilization of fatty acids in E. coli. First, the 
metabolism of E. coli is described, with special emphasis on glycerol and glucose 
utilization. The fermentative metabolism of glycerol and glucose includes glycolysis and 
production of fermentative products, among others. The problem of achieving redox 
balance is explained, and how this affects both the cell growth and the maximum 
theoretical yield for biofuels production. Then, the use of mathematical tools to model 
metabolism is explained, including different approaches that have been used. A special 
emphasis is given to models that have been successfully applied to E. coli and to models 
for glycerol fermentation that have been developed in other organisms. Then, the 
advantages and challenges of producing advanced biofuels and other long chain 
chemicals are presented, including the newly reported reversal of the β-oxidation cycle. 
This provide a comprehensive vision of the different efforts to model the metabolism of 
E. coli and the utilization of glycerol and glucose for the synthesis of biofuels and 
chemicals.  
2.1 Metabolism of E. coli 
 The cellular metabolism consists of all reactions that uptake nutrients from the 
environment, and then utilize them for cell function and reproduction. Metabolism can be 
divided into two main processes: catabolism and anabolism. The catabolism includes all 
those reactions that break down large molecules in order to obtain energy and building 
blocks. Building blocks are used in the anabolic pathways in order to produce 
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macromolecules that enable the maintenance and reproduction of cells, such as proteins, 
polynucleotides (DNA and RNA) and lipids. Energy and redox power are two important 
concepts that govern the metabolism, as they are involved in a vast number of pathways.     
2.1.1 E. coli 
 This study utilizes the bacterium E. coli K-12, on whose metabolism a vast 
number of studies have been performed. These studies cover both specific pathways and 
genome scale studies. While studies of the metabolism started from studies of particular 
pathways, such as glycolysis and TCA cycle, genome scale studies attempt to include all 
reactions in the metabolism. This section first explains available genome scale 
information for this microorganism and then it explains specific pathways related to the 
utilization of glycerol and fatty acids. 
Genome scale studies 
Prior to the publication of the genome scale project for E. coli, just 1,853 genes 
had been identified in this organism. In 1997 the genome scale project revealed that E. 
coli has 4,288 ORFs (potential genes) (Blattner et al., 1997), and this number has been 
updated to 4,499 genes (Keseler et al., 2013). ORFs potentially encode information for 
proteins, whose main functional categories are metabolism (enzymes), transportation 
(across cellular membranes), regulation, and structure. The database EcoCyc collects the 
information related to each of these ORFs of E. coli and presents it in a user-friendly and 
integrated way (Keseler et al., 2013). Both sequence analysis and experiments are used to 
assign the biochemical function of a gene product (Karp et al., 2007). By 2006 EcoCyc 
curators finished performing a literature review of each of the ORFs of E. coli, and they 
keep updating the database (Karp et al., 2007; Keseler et al., 2013). Among the genes that 
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E. coli has, 76% of them have a biochemical function assigned, and in most of those 
cases there are experiments that support the function (Karp et al., 2007). In addition, 
EcoCyc present all known metabolic pathways of E. coli, and it also presents related 
information for each enzyme in a reaction, such as activators, inhibitors, and cofactors. 
By 2012, EcoCyc cited 23,909 distinct references, and included 300 metabolic pathways, 
which is considerably more than the 194 metabolic pathways reported by this site in 2007 
(Karp et al., 2007). A classification of these pathways is complicated given the 
complexity of the metabolic network, but a general classification considers biosynthetic 
pathways, degradation pathways, detoxification, generation of precursor metabolites and 
energy, and signal transduction pathways (taken from EcoCyc website).  
The information presented in EcoCyc has been used and compared with the 
metabolic model built by the group of Palsson (Karp et al., 2007). The final result of this 
effort is a GEM, named the iJO1366, that accounts for all known metabolic pathways 
presented in EcoCyc (Orth et al., 2011). In addition, this model includes spontaneous 
reactions that are not catalyzed by enzymes, and therefore they are not part of the EcoCyc 
database. The model includes 2,251 reactions and 1,366 ORFs, representing the effort of 
21 years working on the reconstruction of the complete metabolic network of E. coli 
(Figure 1).  
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Figure 4: Seven milestones efforts in the construction of metabolic network of E. coli (Feist & Palsson, 2008). 
This figure was updated to include the information from the last released GEM for E. coli, the iJO1366 (Orth et 
al., 2011). 
 
Another relevant source of information in the study of the metabolism of E. coli is 
the BRaunschweig ENzyme DAtabase, most commonly referred to as BRE'DA 
(Schomburg et al., 2013). This database collects detailed enzymatic information, such as 
biochemical and molecular information, from nearly 500 organisms. As with EcoCyc, 
BRENDA curators collect information from literature. BRENDA is not specific to any 
organism, but for each enzyme, it offers the option to restrict the displayed information to 
a specific organism, among them E. coli. This database is especially useful for collecting 
kinetic information, as it links to articles that have reported rate law, reversibility, kinetic 
parameters, and possible inhibition of the corresponding reaction.  
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Glycolysis and fermentative pathways 
Pathways in the central metabolism are especially relevant in this study, as they 
allow the utilization of different carbon sources, such as glucose, malate, succinate, and 
acetate. Glucose and other sugars have been widely studied, as they represent an efficient 
cellular growth. Anaerobic fermentation of glucose uses the glycolysis and fermentative 
pathways in order to obtain energy (in the form of ATP), and it results in the production 
of lactate, ethanol, and other fermentative products (Sawers & Clark, 2004). In the case 
of aerobic utilization of glucose, the tricarboxylic acid cycle (TCA cycle) is also 
incorporated, which results in a higher production of ATP and therefore a more efficient 
cell growth. Glycolysis and fermentative pathways are explained in the next paragraphs. 
Glycolysis is for the most part a linear pathway that starts from the metabolite 
glucose-6-phosphate (G6P) and culminates in the production of pyruvate (Figure 5). 
Glucose can be transported and phosphorylated into G6P by the phosphotransferase 
system (PTS), a well studied mechanism that is also related to catabolic repression of the 
utilization of other carbon sources (Romeo & Snoep, 2005). Other carbon sources, such 
as galactose and maltose, are first transformed in an intermediate metabolite, glucose-1-
phosphate (G1P), which is then converted into G6P by the action of a 
phosphoglucomutase (Pgm) (Romeo & Snoep, 2005). The first reaction in glycolysis is 
the conversion of G6P into fructose-6-phosphate (F6P) mediated by phosphoglucose 
isomerase (Pgi). F6P is an essential metabolite that either goes to the pentose phosphate 
pathway (PP pathway) or continues in the glycolytic pathway by adding a second 
phosphorylation that results in fructose-bi-phosphate (FBP). The interconversion of F6P 
and FBP is considered a regulatory step in the glycolysis, as it is catalyzed by two 
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phosphofructokinases (Pfk-1 and Pfk-2) that present allosteric and genetic regulation 
(Romeo & Snoep, 2005). Pfk-1 and Pfk-2, are encoded by the genes pfkA and pfkB 
respectively, the first being responsible for 90% of the enzymatic activity in this step 
(Romeo & Snoep, 2005). FBP is reversibly dissociated into two metabolites, 
glyceraldehyde-3-phosphate (GAP) and di-hydroxyacetone-phosphate (DHAP). DHAP 
can be transformed into GAP by the action of a triosephosphate isomerase (TPI) and 
continue with the glycolytic pathway, or it can be transformed into the toxic metabolite 
methylglyoxal (MG). GAP is interconverted through four successive reactions into 
phosphoenolpyruvate (PEP), resulting in the production of one molecule of ATP and one 
molecule of NADH (equivalent to two reducing equivalent, H) (Romeo & Snoep, 2005). 
The last reaction in glycolysis is the conversion of PEP into pyruvate (PYR), producing 
one ATP. This reaction is catalyzed by the action of two pyruvate kinases (PykF and 
PykA), both subject to genetic and allosteric regulation (Romeo & Snoep, 2005). In the 
case of glucose utilization, glycolysis represents the production of two NADH (four 
reducing equivalents, H) given that one molecule of glucose allows the production of two 
molecules of PYR. These molecules of NADH need to be reoxidized to maintain redox 
poise, which is achieved either by using fermentative pathways or by the action of an 
external electron acceptor.   
In the absence of external electron acceptors, E. coli utilizes fermentative 
pathways to generate products that are more reduced than the starting metabolite, 
resulting in a pathway that oxidizes the reducing equivalents generated during the 
glycolysis. Fermentative pathways can produce a variety of products, such as acetate, 
carbon dioxide, dihydrogen, ethanol, formate, lactate, and succinate (Sawers & Clark, 
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2004). Figure 5 shows how these fermentative pathways connect to the glycolysis, 
starting from either PEP or PYR.   
 
Figure 5: Glycolysis and fermentative pathways for E. coli. Intermediate metabolites are shown in black and 
fermentative products appear in green. (Sawers & Clark, 2004). 
In order to understand how the fermentative pathways allow the cell to achieve 
redox balance, it is necessary to consider the degree of reduction of carbon molecules in 
substrates, products, and biomass production. The degree of reduction per carbon in a 
molecule can be calculated in three steps: 1) define a set of reference compounds with a 
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degree of oxidation equal to zero, 2) calculate the oxidation number of each element in 
the reference system, and 3) calculate the degree of reduction by adding the number of 
oxidation in the molecule and dividing it by the amount of carbons (Ratledge & 
Kristiansen, 2001). Selection of H2O, H
+, HCO3
-, SO4
2-, and H2SO4 as reference 
compounds results in the following oxidation number per element: O = -2, H = 1, C = 4, 
S = 6, and N = -3. Table 1 shows the degree of reduction per carbon in substrates, 
metabolites, products, and biomass. Thus, the 2 molecules of NADH generated in the 
glycolysis during glucose utilization can be reoxidized by transforming PYR into some of 
the products with a higher degree of reduction, such as ethanol or lactate. The amount of 
reducing equivalent that each of the fermentative pathways generates is shown in Figure 
5. 
Table 1: Oxidation state and degree of reduction of various substrates, intermediate, products, biomass and 
reactions. 
Compound Formula Degree of reduction 
Substrates   
   Glucose C6H12O6 4 
   Xylose C5H10O5 4 
   Glycerol C3H8O3 4.67 
Intermediate   
   PYR C3H3O3 3 
Products   
   Acetic Acid C2H4O2 4 
   Ethanol C2H6O 6 
   Formic acid CH2O2 2 
   Lactic acid C3H6O3 4 
   Succinic acid C4H6O4 3.5 
   1,2-PDO C3H8O2 5.33 
   1,3-PDO C3H8O2 5.33 
   Carbon dioxide CO2 0 
Biomass CH1.9O0.5N0.2 4.3 
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Although different fermentative pathways allow achieving redox balance, not all 
of them are efficient in energy production. For instance, one molecule of PYR going to 
ethanol consumes 2 molecules of NADH and does not produce energy; in contrast, 
production of acetate from PYR produces one molecule of ATP, but it does not consume 
any reducing equivalent. Since glucose utilization allows the production of two molecules 
of PYR, producing 50% ethanol and 50% acetate is an option that both achieves redox 
balance and produces ATP.  
So far the analysis of redox balance has been done without including the 
production of biomass. The degree of reduction of reactions can be calculated as the 
difference of degree of reduction of products and substrates, weighted by the 
stoichiometric number and the amount of carbons. Thus, if glucose is used for the 
production of biomass, it results in the consumption of part of the reducing equivalents 
generated during glycolysis. On the other hand, if the carbon source is more reduced than 
the biomass (e.g. glycerol), the fermentative pathways need to be able to reoxidize the 
reducing equivalents generated during glycolysis and biomass production. 
In the presence of an external electron acceptor, such as oxygen, fermentative 
pathways are no longer required to achieve redox balance, and metabolites generated in 
the glycolysis can go to the TCA cycle. This cycle is part of the aerobic respiration 
process, and it generates energy (as ATP) by reducing metabolites and subsequently 
increasing the number of reducing equivalents (Alberts, 2002). The final electron 
acceptor in respiration is oxygen, which allows the reoxidation of reducing equivalents.  
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2.1.2 Glycerol fermentation 
Glycerol fermentation is an attractive system to produce biofuels because of its 
potentially high efficiency. When compared with common sugars such as glucose and 
xylose, the highly reduced nature of glycerol (Table 1) represents a higher theoretical 
yield of ethanol (Dharmadi et al., 2006). This section presents the current knowledge of 
glycerol fermentation in bacteria. 
Glycerol fermentation in bacteria 
Among the few species that are able to ferment glycerol anaerobically, there are 
Klebsiella, Enterobacter, and Citrobacter. The mechanism that allows these bacteria to 
ferment glycerol has been studied for years. In these organisms, the fermentation of 
glycerol is linked to the ability to metabolize glycerol through two pathways: reductive 
and oxidative (Lin, 1976; Zhu et al., 2002). Figure 6 shows the two pathways that allow 
the utilization of glycerol: the oxidative pathway produces DHAP and the reductive 
pathway produces 1,3-propanediol (1,3-PDO). In the oxidative pathway, glycerol is 
dehydrogenated by a NAD-dependent glycerol dehydrogenase (glyDH-I), resulting in the 
formation of dihydroxyacetone (DHA). Then, DHA is phosphorylated by a DHA kinase 
(DHAK), resulting in the formation of DHAP, which is incorporated to the glycolysis. 
DHAK requires either PEP or ATP to donate the phosphate group (Yazdani & Gonzalez, 
2007). Additionally, fermentation of glycerol in these members of the 
Enterobacteriaceae family is linked to their ability to produce 1,3-PDO. Production of 
1,3-PDO starts with the dehydration of glycerol by the coenzyme B12-dependent glycerol 
dehydrogenase (GlyD) resulting in the production of 3-hydroxypropionaldehyde (3-
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HPA). This molecule is then reduced to 1,3-PDO by the action of the NADH-dependent 
1,3-PDO dehydrogenase (1,3-PDODH) (Yazdani & Gonzalez, 2007).  
 
 
Figure 6: Glycerol utilization model for species of the Enterobacteriaceae. 1,3-PDO: 1,3-propanediol, GLYC: 
glycerol, DHA: dihydroxyacetone, 3HPA: hydroxypropionaldehyde, DHAP: di-hydroxyacetone phosphate, 
PYR: pyruvate, DHAK: di-hydroxyacetone kinase (Yazdani & Gonzalez, 2007). 
To understand why glycerol fermentation requires the production of 1,3-PDO in 
members of the Enterobacteriaceae family, it is necessary to understand how to achieve 
redox balance. First, the degree of reduction of glycerol and biomass (shown in Table 1) 
indicates that glycerol is more reduced than biomass (4.67 versus 4.3), which is the 
opposite case than in the utilization of glucose. Consequently, biomass production 
starting from glycerol generates reducing equivalent. In addition, production of ethanol is 
redox balanced when glycerol is the carbon source (Figure 5). Although the ethanol 
fermentation pathway is able to consume the reducing equivalents generated during 
uptake of glycerol and glycolysis, this pathway is not able to consume any of the extra 
reducing equivalents that would be generated during cell growth; therefore, a different 
pathway is necessary. Production of 1,3-PDO allows the reoxidation of reducing 
equivalents but this pathway does not generate energy; consequently, both pathways 
(production of ethanol and 1,3-PDO) need to be combined to enable maintenance and cell 
growth.  
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A few other organisms have been reported to ferment glycerol without producing 
1,3-PDO, such as Propionibacteria freudenreichii and Propionibacteria acidipropionici 
ssp shermanii, (Bories et al., 2004). Nevertheless, the pathways that enable these 
organisms to ferment glycerol have not been well studied. 
Glycerol fermentation in E. coli 
E. coli does not have the ability to produce 1,3-PDO; consequently, it was 
believed that this organism fermented glycerol only in the presence of an external 
electron acceptor. Aerobic utilization of glycerol starts with the transport of glycerol into 
the cell using passive diffusion or facilitated diffusion by the aquaglyceroporin GlpF 
(Heller et al., 1980). The gene encoding this enzyme (glpF) belongs to the same operon 
as the gene glpK. The product of glpK is an ATP-dependent glycerol kinase (GlpK) that 
catalyzes the conversion of glycerol into glycerol-3-phosphate (G3P) (Booth, 2005). Two 
glycerol 3-phosphate dehydrogenases (GlpD and GlpABC, for aerobic and anaerobic 
conditions respectively) allow the oxidation of G3P into DHAP (Booth, 2005). These 
enzymes are membrane-bound flavin-dependent, and the reaction results in the 
production of one reduced ubiquinone (ubiquinol). In the absence of external electron 
acceptors, the second reaction cannot proceed as there are no later steps to reoxidize the 
ubiquinol, resulting in the accumulation of G3P in toxic levels (Booth, 2005). Figure 7 
shows this pathway.  
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Figure 7: Respiratory utilization of glycerol by E. coli. PYR: pyruvate, G3P: glycerol-3-phosphate, DHAP: di-
hydroxyacetone phosphate. G3P: glycerol-3-phosphate, an-G3PDH: anaerobic G3P dehydrogenase, ae-G3PDH: 
aerobic G3P dehydrogenase  (Murarka et al., 2008). 
The discovery that E. coli is able to consume glycerol in the absence of external 
electron acceptors motivated several studies to understand the experimental conditions as 
well as the pathways required in this process, since E. coli is a highly attractive host for 
the production of chemicals and biofuels. The first experiment that showed fermentative 
utilization of glycerol in E. coli utilized a rich medium (Dharmadi et al., 2006), but  later 
experiments were performed in a minimum medium supplemented with tryptone, sodium 
selenite, and Na2HPO4 (Murarka et al., 2008). In these batch experiments, the initial 
concentration of glycerol was 110 mM at 37⁰C. The optimum pH was identified as 6.3, 
although alkaline conditions were tolerable when a supplemented minimum medium was 
used. Fermentation of near 80% of the glycerol took 96 hours, with a maximum specific 
growth rate of 0.04 h-1 (Murarka et al., 2008). Figure 8 shows the utilization of glycerol 
in 96 hours, and the corresponding production of biomass, ethanol and other byproducts. 
Products of this process are 1,2-propanediol (1,2-PDO), acetic acid, succinic acid, formic 
acids (minor amounts), carbon dioxide, hydrogen, and ethanol, the latter corresponding to 
the most abundant (other than hydrogen and carbon dioxide) (Gonzalez et al., 2008; 
Murarka et al., 2008). Ethanol corresponds to nearly 95% of the fermentative products, 
while 1,2-PDO presents a very low concentration (0.5 ±0.15 mM in stationary phase) 
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(Gonzalez et al., 2008). These results contrast with the products of glucose fermentation 
in E. coli, where the main product is lactate (not observed in glycerol fermentation), 
ethanol represents only a 29%, and there is no evidence of 1,2-PDO production (Sawers 
& Clark, 2004). 
 
Figure 8: Glycerol fermentation by E. coli MG1655. Cell density: black squares. Cell density log-linear: white 
squares. Ethanol: black circles. Glycerol: triangles. Succinic acid: rhombus. Formic plus acetic acids: cross. 1 
OD = 0.34 gCDW/L. 
Glycerol fermentation in E. coli starts with the conversion of glycerol into DHA 
catalyzed by the enzyme glycerol dehydrogenase (glyDH), a type two glycerol 
dehydrogenase encoded by the gene gldA (Gonzalez et al., 2008). The existence of this 
gene was known before the discovery of E. coli being able to ferment glycerol, but it was 
considered cryptic (Truniger & Boos, 1994). The discovery that E. coli can express this 
enzyme is key in the fermentation of glycerol, and it constitutes one of the essential 
enzymes of this process (Gonzalez et al., 2008). The next step is the phosphorylation of 
DHA into DHAP by the action of the PEP-dependent di-hydroxyacetone kinase (DHAK). 
This enzyme, likewise glyDH, is essential for the utilization of glycerol in the absence of 
external acceptors (Gonzalez et al., 2008).  
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Studies were conducted to investigate the effect of alternative pathways for the 
breakdown of glycerol, as well as the branches to different products. Disruption of the 
gene glpK (responsible for the conversion of glycerol into G3P) decreased the maximum 
specific growth rate in 17.5% (Murarka et al., 2008), suggesting that although this 
enzyme is not essential, it contributes to the process. In addition, deletion of fermentative 
pathways indicates that ethanol production is essential for glycerol fermentation, while 
disruption of acetate production (deletion of gene pta) resulted in a decrease in the 
maximum specific growth rate of nearly 30% (Murarka et al., 2008). Disruption of the 
enzyme formate-hydrogen lyase (FHL), responsible for the conversion of formate into 
hydrogen (H2) and carbon dioxide (CO2), results in a significant reduction of cell growth, 
a phenomenon than has been attributed to the necessary presence of CO2 in the media and 
the negative effects of H2, as it affects the redox balance (Gonzalez et al., 2008; Murarka 
et al., 2008).   
Given the inability of E. coli to produce 1,3-PDO, and the finding that 1,2-PDO is 
a byproduct of glycerol fermentation, a new model linked to 1,2-PDO production was 
proposed to explain the fermentation of glycerol (Gonzalez et al., 2008). Figure 10 
presents two pathways that could allow the production of 1,2-PDO in E. coli. They both 
start with the conversion of DHAP into MG, a highly toxic compound for E. coli (Booth, 
2005). MG can be converted into 1,2-PDO via production of either hydroxyacetone (HA) 
or lactaldehyde (Lald), both reducing steps that result in the consumption of one NADH 
(or NADPH). Experimental data support the production of 1,2-PDO through HA rather 
than through Lald, as genetic disruption in the first branch decreases the production of 
1,2-PDO to nearly 65% of original values, while disruption in the second branch does not 
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have any effect (Gonzalez et al., 2008). Interestingly, the enzyme that catalyzes the 
reduction of HA to 1,2-PDO is glyDH (encoded by gldA), the same that oxidizes glycerol 
to DHA in the first step of glycerol breakdown under fermentative conditions, which 
highlights the importance of this enzyme.    
 
Figure 9: Metabolic pathways for the production of 1,2-PDO in E. coli, starting form DHAP. Tick lines 
represent the most probably pathway for glycerol fermentation in E. coli (Gonzalez et al., 2008). DHAP: di-
hydroxyacetone phosphate, MG: methylglyoxal, HA: hydroxyacetone, Lald: lactaldehyde, 1,2-PDO: 1,2 
propanediol.  
Figure 10 presents the glycerol uptake pathway, combining with the production of 
fermentative products and 1,2-PDO. The transformation of DHA to DHAP via a PEP-
dependent (DHAK) requires that this reaction combines with the last step in the 
glycolysis, which is responsible for the conversion of PEP into PYR. A simple 
stoichiometric analysis predicts that PEP is converted into PYR at the same rate that 
DHA is converted to DHAP, but this is incompatible with the fact that part of the flux is 
going to the production of 1,2-PDO. One pathway that could partially explain it is the 
conversion of glycerol into DHAP going through G3P, a pathway that requires the 
already mentioned GlpK and GlpABC. Nevertheless, disruption of this pathway only 
results in a decrease in the cell growth, not in a total inability to ferment glycerol. 
Therefore, these experimental findings indicate that additional pathways may play an 
important role in the fermentation of glycerol in E. coli, a fact that emphasizes the 
Lald
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importance of conducting additional studies in glycerol fermentation in order to identify 
all pathways involved in the process. Despite experimental studies of glycerol 
fermentation in E. coli, no mathematical analysis of glycerol fermentation has been 
conducted previous to this thesis. 
  
Figure 10: Proposed model for glycerol fermentation in E. coli. Production of ethanol and 1,2-PDO is essential to 
support cell growth as a combined synthesis of these two products supports the generation of ATP and the 
consumption of reducing equivalents. GldA: glycerol dehydrogenase, DHAK: di-hydroxyacetone kinase, FHL: 
formate hydrogen lyase, PFL: pyruvate formate lyase, AdhE: alcohols/aldehyde dehydrogenase (Gonzalez et al., 
2008).  
 
2.1.3 Glucose utilization and the production of advanced biofuels 
The mechanism that carries the consumption of glucose in E. coli has been well 
documented, as glucose is a preferred substrate by this and many other microorganisms. 
The incorporation of glucose into E. coli utilizes the phosphotransferase system (PTS), 
which results in the transport and phosphorylation of glucose to produce G6P using PEP 
as the phophoryl group-donor (Mayer & Boos, 2005).  The PTS consist of the general 
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component and the sugar-specific component. The general component includes the 
enzyme I (EI), encoded by the gene ptsI, and the histidine protein (HPr), encoded by the 
gene ptsH. The sugar-dependent component includes the enzyme complexes II, 
corresponding to enzymes EIIA, encoded by the gene crr, and EIIBC, encoded by the 
gene ptsG. The phosphoryl group is subsequently transferred from PEP to EI, HPr, EIIB, 
and then to glucose, resulting in the production of G6P. The domain EIIC is responsible 
for the transport of glucose across the membrane into the cell (Mayer & Boos, 2005). 
Once G6P is in the cytoplasmatic compartment, it can be metabolized in the glycolysis as 
explained above (page 18), or go into the pentose phosphate pathway (PPP) to produce 
the essential metabolites ribose-5-phosphate, sedpheptulose-7-phosphate and erythrose-4-
phospthate (Ecocyc website).   
The PTS system is also involved with the gene expression regulation system. In 
the absence of glucose, the predominantly present phosphorylated EIIA causes catabolic 
repression of genes involved in the transport and utilization of sugars. In contrast, the 
presence of glucose increases the concentration of nonpnosphorylated EIIA, which 
prevents the use of other substrates by inhibiting the activity of non-PTS sugar transport 
system (Mayer & Boos, 2005).  
Glucose has been utilized for the production of advanced biofuels in E. coli. 
Advanced biofuels are molecules with a higher energy density than traditional biofuels, 
making them more comparable to traditional fuels. For example, ethanol, the most widely 
used biofuels, only contains 70% of the energy density of gasoline, while butanol, an 
advance biofuel, contains 84% of the energy density of gasoline (Atsumi et al., 2008a; 
Peralta-Yahya & Keasling, 2010). However, for most advanced biofuels there is no 
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natural pathways to produce them (butanol being the exception), but in recent years a 
number of efforts have been made in experimental work to implement the production of 
advanced biofuels in bacteria, and specifically in E. coli. The following paragraphs 
review the most remarkable pathway to convert glucose into advanced biofuels: the fatty 
acid (FA) biosynthesis pathway, the α-keto acid pathway, and the reversal of the β-
oxidation cycle. 
E. coli has been metabolically engineered to produce long chain chemicals using 
the FA biosynthesis pathway and proper termination enzymes (Steen et al., 2010). 
The FA biosynthesis pathway is a well studied process in E. coli, in which one molecule 
of AcCoA is converted into malonyl-ACP (malACP) using energy, and then the malACP 
is utilized to elongate an acyl-ACP molecule (Cronan & Rock, 2008). A diagram of this 
pathway is shown in Figure 11. The mechanisms that converts AcCoA into malACP 
requires the genes accC, accAD, acpH, acpS and fabD, and it uses the energy of one 
phosphoryl group from ATP (Figure 11-A). The molecule malACP can be combined with 
one molecule of AcCoA (using enzyme FabH) to produce acetoacety-ACP, which initiate 
FA synthesis, or it can be used as carbon donor in the elongation cycle (Figure 11-B). 
The elongation cycle for FAs consists of four reactions: reduction (catalyzed by enzyme 
FabG), dehydrogenase (catalyzed by enzyme FabZ), reduction (catalyzed by enzyme 
FabI), and elongation (catalyzed by enzymes FabB and FabF) (Cronan & Rock, 2008).  
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Figure 11: FA biosynthesis pathway. Panel A shows the production of malACP and acetoacetyl-ACP for 
elongation and initiation of the production of fatty acids. Panel B shows the elongation cycle, which incorporates 
the two carbon molecules from mal-ACP to produce acyl-ACP (Cronan & Rock, 2008). 
 
Using the FA biosynthesis pathway and metabolic engineering, Steen and 
collaborators proved the production of a variety of long chain products, such as fatty 
alcohols and fatty esters (Steen et al., 2010). Figure 12 shows a diagram that summarizes 
this pathway and the genetic modifications involved. Synthesis of desired products 
resulted from the overexpresion of thioesterases (TES) and acyl-CoA ligases (ACL) to 
produce AcCoA, and the different products were obtained by overexpressing fatty-acyl-
CoA reductase (FAR) for the production of fatty alcohols, and acyltransferase (AT) for 
the production of esters. Other products were also produced in this study, including 
biodiesels. Production of long chain FAs was obtained at a yield of 6% (w/w), while 
production of long chain fatty alcohols was not reported in yields, a 2% (w/v) of glucose 
was converted into 60 mg/l, which correspond to a yield of 3% (w/w) assuming that all 
the glucose was consumed (not reported) (Steen et al., 2010). 
A B
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Figure 12: Metabolic pathway for the production of long chain products using the FA biosynthesis pathway. 
Figure is an adaptation from Steen and collaborators. TES: Thioesterase,  ACL: Acyl-CoA ligases, FAR: fatty-
acyl-CoA reductase, pdc: pyruvate decarboxylase, adhB: alcohol dehydrogenase, AT: Acyltransferase, Pyr: 
pyruvate, EtOH: ethanol, AcAld: acetaldehyde (Steen et al., 2010). 
 
A different approach that has been implemented for the production of synthesis of 
long chain products is the α-keto acid pathway, which unlike the FA biosynthesis 
pathway, incorporates one molecule of carbon per cycle. This pathway was developed in 
Dr. James Liao's research center, and it modifies an aminoacids biosynthesis pathway for 
the production of linear alcohols. Figure 13 shows a diagram of how this pathway 
converts glucose into butanol. Using this strategy the production of butanol consists of 
using the biosynthesis pathway for the production of threonine, converting this molecule 
into 2-ketobutyrate, and then elongating 2-ketobutyrate incorporating one molecule of 
acyl-CoA and releasing one molecule of CO2 ( utilizing genes leuA, leuCD and leuB), 
resulting in the production of the intermediate 2-ketavalerate. Finally, production of 
butanol is achieved by reducing 2-ketovalerate using genes kivd (from Lactococcus 
lactis) and ADH2 (from Saccharomyces cerevisiae) (Figure 13) (Shen & Liao, 2008). 
Thus, the combination of gene leuA, leuCD and leuB allows the elongation in one 
FAs-derived 
productsGlucose
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molecule of carbon, and it extension to produce hexanol has been proved (Marcheschi et 
al., 2012).  
 
Figure 13: Schematic illustration of the production of propanol and butanol utilizing the threonine biosynthesis 
pathway (Shen & Liao, 2008). Enzymes LeuA, LeuCD and LeuB elongate the intermediate product in one 
carbon, and it can be utilized to produce 1-pentanol and 1-hexanol.  
 
More recently a new promising pathway has been implemented for the synthesis 
of long chain products in E. coli: the reversal β-oxidation cycle. In 2011, Dellomonaco 
and collaborators engineered the β-oxidation cycle, which normally breaks down fatty 
acids into AcCoA molecules, to produce medium and long chain products (includying 
alcohols and fatty acids) starting from glucose (Dellomonaco et al., 2011). The 
implementation of this pathway required the modification of the regulatory pathway in 
wild type E. coli in order to activate this pathway in the absence of natural substrate (i.e., 
fatty acids) and the presence of glucose. The metabolic pathway requires the breakdown 
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of glucose into AcCoA, a molecule that is used both as starting point for the reversal β-
oxidation cycle, and as carbon donor for the elongation step in this cycle (Figure 14). 
 
Figure 14: Illustration of the reversal β-oxidation cycle to synthesize long chain products. Glucose is first break 
down into acetyl-CoA in the glycolysis, a process that results in production of ATP and reducing equivalents. 
Then acetyl-CoA is utilized to produce the primer of the cycle, and also as elongation molecule in the cycle. 
Expression of proper termination enzymes results in the production of alcohols and fatty acids (Dellomonaco et 
al., 2011). 
   
The primer of the reversal β-oxidation cycle is synthesized by the enzyme acetyl-
CoA acetyltransferase (AtoB), which catalyze the conversion of two molecules of acetyl-
CoA into one molecule of acetoacetyl-CoA (a ketoacyl-CoA). The reversal β-oxidation 
cycle has 4 steps in addition to the starting point: elongation, reduction (first), 
dehydration and reduction (second). Ketoacyl-CoA molecule is reduced by the action of 
FadB, producing a molecule of hydroacyl-CoA. The reaction oxidizes one molecule of 
NADH in turn. Hydroacyl-CoA is dehydrated by the action of FadB. A second reduction 
occurs by the action of enoyl-CoA reductase, a reaction that has been proposed to use 
ferredoxins as reducing equivalents, associated to the gene ydiO. The expression of 
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proper termination enzymes resulted in the production of long chain FAs at yields of 28% 
(w/w), and of higher chain liner alcohols (C6-C10) at 8.3% (w/w). These values are 
higher than those reported using other the FA biosynthesis pathway and the α-keto acid 
pathway, which was proposed to be due energetic efficiencies of this pathway 
(Dellomonaco et al., 2011). More recently additional experimental efforts have been done 
using this pathway, especially in order to have a more controllable system for the 
regulatory system (Clomburg et al., 2012), but previous to this thesis no studies have 
been done using mathematical models. The utility of these models, as well as the state of 
art of pertinent mathematical models, is the focus of the following section of this chapter. 
 
2.2 Mathematical modeling of microbial metabolism 
Mathematical modeling of metabolism in microbial organisms consists in 
expressing in mathematical language the interaction between biochemical reactions, 
metabolites, substrates, and products. Biochemical reactions are those reactions that 
interconvert metabolites (or substrates) into other metabolites (or products). Because 
these reactions take place in a microorganism, they are often catalyzed by enzymes. From 
a structural point of view, there are two main categories of mathematical modeling of 
metabolism: stoichiometric models and kinetic models (Gombert & Nielsen, 2000). 
These two models differ in complexity and applicability, and they provide answers to 
questions such as what is the transient answer of the system when an external variable is 
changed, which are the control reactions in a specific pathway, what is the maximum 
theoretical yield of biomass, and what pathways need to be activated or deleted in order 
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to increase product yield. These two kinds of models are complementary to each other as 
they study the metabolism from different points of view.        
2.2.1 Stoichiometric modeling 
 Stoichiometric models require the definition of a set of metabolites and the 
reactions that interconnect these metabolites. Each reaction should keep the law of 
conservation of mass; in other words, there must be a valid stoichiometric relationship in 
each reaction. In addition to this, stoichiometric models assume that the system is in a 
steady state, and therefore there is no accumulation of any internal metabolite. A 
stoichiometric matrix (S) contains all the stoichiometric parameters, in which rows 
represent reactions and columns represent metabolites. Because this matrix is used for 
mathematical calculus, linearly dependent cofactors (such as ATP and ADP) are included 
just once in the stoichiometric matrix in order to avoid having a linearly dependent 
matrix. Figure 15 represent the implementation of stoichiometric modeling for a metabolic 
network. In steady a state, it is valid to say that the net rate of formation of each 
metabolite minus the dilution rate associated with that metabolite (μ ∙ ) is equal to zero 
(Figure 15, c). The dilution term is usually neglected because levels of intracellular 
metabolites are small; therefore, this flux is also small when compared with other fluxes 
of production and consumption of metabolites (Stephanopoulos et al., 1998). This leads 
to an equation system, in which the vector of fluxes v contains the unknown rates (Figure 
15, c). Nevertheless, the system is often underdetermined and additional tools should be 
included.  
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Figure 15: Stoichiometric Modeling. (a) Shows a segment of the structure of a metabolic network that is 
modeled. The metabolic network is translated into a matrix (b) in which rows represent metabolites and 
columns correspond to reactions. Finally, the stoichiometric matrix is used to write a system of equations in 
steady-state (c). 
 
Stoichiometric models are used to find a list of feasible reactions that satisfy 
steady state conditions, but it is necessary to include more information in order to come 
near to realistic solutions. Because of this, stoichiometric models are often combined with 
Metabolic Flux Analysis (MFA), which incorporates measurements of fluxes (external 
and/or internal) in order to reduce the degrees of freedom of the system. The application 
of MFA to a metabolic pathway has been explained by Stephanopoulos et al., and a 
summary of that method is presented here (Stephanopoulos et al., 1998). 
Depending on the system and on the number of measured fluxes, the system 
might be determined, underdetermined, or overdetermined. Suppose that there are K 
metabolites and J fluxes in the system. In the matrix form, this means that the dimension 
of v is Kx1 and the dimension of S is JxK. The second equation in Figure 15, c presents a 
system with a degree of freedom F = J – K. To have a determined system, we need to 
measure F independent fluxes, which will reduce the freedom of the system to zero. 
Mi-2
Mi
Mi+1
Mi-1
ri-2
ri
ri-1
(a) (b)
(c)

 ⋱⋯⋯
⋯ ⋯ ⋯−1     0    1    0 −1    1
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Assume F fluxes were measured and storage in the vector vm, and the vector vc storages 
the remaining unknown fluxes. Then the second equation in Figure 15, c can be re-written 
as: 
0 =  ∙  =  ∙  +   ∙            (1) 
which lead to a unique solution for the unknown fluxes: 
 = − ∙  ∙               (2) 
The matrix  can be inverted since this is a square matrix of dimension KxK, 
and the solution is unique. If the system is overdetermined (the number of measured 
fluxes is greater than J – K) and there is little noise in measurements, the system can be 
determined using the Moore-Penrose pseudo-inverse matrix of , named #, which 
is square matrix. In this case we have: 
 = −# ∙  ∙  ,        (3) 
where  # can be calculated as: 
# =  ∙  ∙  .      (4) 
 If the system is underdetermined, optimization might be combined with MFA in 
order to elucidate the fluxes. In stoichiometric modeling, the system is linear; therefore, 
all theory from linear optimization can be applied. Here is presented a brief description of 
linear optimization, but it will be further explained together with Flux Balance Analysis 
(FBA). A linear optimization problem requires the definition of an objective function and 
a set of constraints. The objective function is usually the optimization of cell growth 
(Stephanopoulos et al., 1998), although other functions have also been proposed, such as 
optimization of product formation. Then, the system is restricted to the space of valid 
solutions that are allowed for each flux rate.  
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MFA requires the incorporation of measured fluxes. There are two ways to do 
this: measurement of external fluxes (without labeling) and measurement of internal 
fluxes (requires labeling). When this information is incorporated, the degrees of freedom 
of the system decrease. Measurement of internal metabolites increases the complexity of 
experiments but it also increases the quality of the calculus. In order to do this, substrates 
are labeled and then the labeled state of internal metabolites is measured. One widely 
used method for the determination of intracellular fluxes is the incorporation of isotopes 
of carbon (13C or 14C) in a specific position of a substrate. This results in an introduction 
of an asymmetry in the distribution of labeled carbon, which can be detected and used to 
calculate internal fluxes (Stephanopoulos et al., 1998). Distribution of internal 
metabolites is measured using either gas chromatography-mass spectrometry (GC-MS) or 
Nuclear Magnetic Resonance (NMR).  
 Stoichiometric modeling has also been used in conjunction with flux balance 
analysis (FBA). This method uses optimization in order to simulate microbial 
metabolism (Kauffman et al., 2003). The fundamental difference between MFA and FBA 
is the scope: while MFA focuses on the determination of metabolic fluxes for one 
experimental condition, the goal of FBA is to predict metabolic fluxes of a system under 
new conditions (Llaneras & Pico, 2008). Optimization of a linear problem requires, as 
was already stated, the definition of an objective function and a set of constraints for the 
unknown fluxes. The objective function is a linear combination of other fluxes in the 
system, and the objective must either maximize or minimize that function. The 
mathematical formulation of this is as follows: 
 !"#  $%&!"#'& = ()*(+  ∑ - ∙ ./     ,    (5) 
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where J is the number of fluxes of the system and αi is the coefficient associated with the 
flux . The objective in FBA is usually the maximization of biomass production, and 
other possible objective functions are the maximization of ATP production and 
maximization of a desired product (Kauffman et al., 2003). The use of Biomass as 
Objective Function (BOF) has been validated experimentally; in fact, FBA applied to E. 
coli using BOF has shown a quantitative prediction of growth in 86% (68 out of 79) of 
mutants examined by Edwards and Palsson (Edwards & Palsson, 2000). Constraints refer 
to the range of valid values that each flux can take. For instance, those reactions that are 
known to be irreversible should be restricted to the range of positive values. In general 
this requirement can be written in the following mathematical form: 
0 ≤   ≤ % 
where 0 and % represent the lower and upper admissible values for flux  . Other 
constraints that can be included are regulatory constraints (which fluxes are allowed 
under specific circumstances) (Covert et al., 2001) and incorporation of thermodynamics 
constraints (Beard et al., 2002). 
 Once the metabolic network has been established in conjunction with the 
stoichiometric relationship, flux constraints, and an objective function, the problem can 
be solved using a mathematical software. Figure 16 represents a hypothetical case in 
which  and 2 are unknown fluxes. Each of these fluxes has been restricted to a 
positive value, and the maximum value is as shown in the figure. Inclusion of additional 
restrictions coming from stoichiometric relationships defines the space of admissible 
solutions, also called solution space (area in color). The objective function is a linear 
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combination of fluxes of the system. Optimization of the objective function finds a 
solution (if possible), but in some cases multiple solutions are found.     
 
Figure 16: Linear optimization in a constraint system. Left figure represent a situation in which the optimum is 
unique, and right figure correspond to a case in which there are multiple optimum solutions (Kauffman et al., 
2003). 
 
Linear optimization is also used to find alternative metabolic fluxes that satisfy a 
desired condition (called flux variability analysis) and to perform flux coupling 
analysis (Zomorrodi et al., 2012). In the first case, flux variability analysis (FVA) 
identifies the minimum and maximum flux values for each reaction that will support 
certain condition of the optimal function (e.g., 95% of maximum specific growth rate). 
The second case uses FVA to identify if two fluxes vary independently of each other or 
not. Two fluxes are coupled if they depend on each other. These two tools are used to 
predict and study possible flux distributions.   
The increase in information on metabolic networks, driven by genome sequencing 
of several organisms and “-omics” technologies, has allowed the implementation of a 
new kind of stoichiometric modeling: Genome Scale Models (GEMs). These models 
represent large scale metabolic networks, and they utilize FBA to predict phenotypes. At 
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present at least 35 organisms have been modeled with this approach, including E. coli 
(Orth et al., 2010). Implementing a GEM requires an extensive literature review and a 
detailed consideration of reactions to be included. Figure 17 represents the four 
fundamental steps to build one of these models: (1) searching metabolic information in 
databases (“-omics), (2) reconstruction of the biochemical network, (3) in silico 
modeling, and (4) experimental validation. The construction of the model is complicated 
due to the large number of reactions that are included. In fact, after a draft metabolic 
network is built, the consistency of it must be checked to ensure that the model is not 
breaking thermodynamic laws (e.g. generation of energy in cycles), and that there are no 
missing reactions that prevent the model from being functional (Durot et al., 2009).  
 
Figure 17: Genome-scale model construction. The scheme shows four steps for the construction a model, which 
include (1) bibliographic search with special focus in “omics” technology, (2) construction of the model, (3) in 
silico modeling and (4) validation and applications (Feist & Palsson, 2008).  
 
 GEMs have multiple applications for the study of microbial organisms and in 
metabolic engineering. The large number of metabolic interconnections included in a 
GEM allows consideration of the multiple requirements of the system. For instance, the 
biomass equation can contain a detailed account of the different building blocks that are 
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necessary. The main use of GEMs is to quantitatively identify physiological states of 
wild-type and mutant microorganisms (Feist & Palsson, 2008). The use of these models 
allows the identification of essential reactions and metabolites in a specific condition 
(Feist & Palsson, 2008). GEMs are also used in metabolic engineering because it can 
identify necessary changes to produce new products. (Feist & Palsson, 2008). In addition, 
GEMs can be used to drive biological discoveries, as these models allows the 
identification of gaps between the computational model and experimental information 
(Feist & Palsson, 2008). For instance, if the experimental data supports the existence of a 
pathway that creates a  metabolite, but computational data does not reflect that, efforts 
can be made to identify the function of unknown ORFs that may be involved in that 
pathway.  
The introduction of GEMs has laid the foundation for the development of 
optimization tools for the synthesis of desired products, remarkable being the OptKnock 
tool, which defines a bilevel linear optimization problem to propose reaction deletions 
that will result in optimizing the synthesis of a desired product and in coupling synthesis 
of the product to cell growth (Burgard et al., 2003). The bilevel problem consists on an 
outer and an inner problem: the outer problem is to find the optimal production rate of a 
desired chemical, and the inner problem is to optimize production of biomass (Figure 18-
a). The expected solution identifies target reactions to knockout in order to optimize the 
synthesis of the desired product, and to couple it to biomass production. This expected 
result is exemplified in mutants A, B and C for the synthesis of succinate in Figure 18-b. 
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Figure 18: Optnock framework. a) The bilevel optimization structure of optKnock consists of two optimization 
problems that are solved simultaneously: optimization of the production of a chemical (vchemical) and 
maximization of biomass (the inner problem). The achievement of these two objectives is facilitated by deleting 
reactions. b) One example of solution shows different mutants that result in the coupled production of succinate 
and biomass after removing reactions (Burgard et al., 2003).   
2.2.2 Kinetic modeling 
 Kinetic Modeling includes, in addition to the stoichiometric balances, the kinetics 
of each of the reactions that are present in the model. Because the system is a 
microorganism, many of the reactions are catalyzed by enzymes. The kinetics of one 
reaction is defined by the rate law of the reaction plus the value of all involved kinetic 
parameters. For example, the most widely used kinetics of enzymes comes from the 
derivation of Michaelis-Menten, which describes an enzymatic kinetic reaction to 
transform irreversibly one substrate into one product. Figure 19 shows a scheme of the 
derivation of this kinetic model. A mass balance for each metabolite (or substrate or 
product) is defined as an ordinary differential equation (ODE) system using the 
stoichiometric relationships and the kinetics of each reaction. Figure 20 schematizes the 
fundamental steps to define a kinetic model: 
Maximize     vchemical
(through gene knockout)
Subject to: • 
• Number of knockouts ≤ limit
Maximize Biomass
(over fluxes)
Subject to: • Fixed substrate uptake
• Mass balance
• Blocked reactions 
identified by outer problem
(a) (b)
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Figure 19: Michaelis-Menten enzymatic reaction. (a) Irreversible enzymatic mechanism. E represent Enzyme, S 
is the substrate and P is the product. ES is an intermediate complex formed by the enzyme and the substrate. (b) 
Rate expression. (c) Plot of reaction rate as a function of substrate concentration. 
 
 
Figure 20: Kinetic Modeling. (a) Shows a segment of the structure of a metabolic network. For each reaction a 
kinetic is associated (b). Finally, a system of ordinary differential equations is writing for each metabolite, which 
represents the dynamic behavior of the system (c). Figure adapted from Gombert and 'ielsen (Gombert & 
'ielsen, 2000). 
 Defining all the kinetic reactions is a complex problem, and it often limits the 
applicability of kinetic models. Each of the rate laws and parameters came from detailed 
experimental studies (in vitro), which are not always available. Nevertheless, some 
organisms and some pathways have been more extensively studied, and kinetic 
information is available in literature. For instance, the central carbon metabolism is of 
great importance, and many of the reactions involved in this pathway have been studied 
in different organisms. But in vitro parameters do not always represent a good fit for in 
r
S
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vivo conditions, and additional adjustments are necessary. A good example of an 
adjustment is the mathematical modeling of the central carbon metabolism of 
Saccharomyces cerevisiae developed by Rizzi et al. (Rizzi et al., 1997). In their paper 
they considered a generic form for each kinetic reaction 7: 
@A = @ABCD ∙ EAF, H ,          (6) 
where 7)* is the maximum rate of the reaction 7 and I=, 6 is a function that depends 
on metabolite concentrations C and on a set of parameters P. For instance, in the example 
of Figure 20, the following equation is valid for metabolite Ci in steady state: 
FAJK = @AL + @AM − @A − μ ∙ FA = N ,      (7) 
where µ is the dilution rate. From this equation the maximum reaction rate (7)* can be 
calculated as: 
7)* = 7# + 7#−1 − μ∙=#I#=,6                (8) 
The next step presented by Rizzi et al. was to perform a glucose pulse experiment, 
and to measure the response of the system within a few minutes. It can be assumed that in 
this time the concentration of enzymes does not change; therefore, the value for the 
maximum reaction rate remains constant. Then the data collected is used to calculate the 
value of maximum reaction rates in sequential steps, starting from the first reaction in the 
pathway. As a result, this method allows calculating values of maximum reaction rates 
when the other kinetic parameters are known, by measuring internal metabolite 
concentrations after a perturbation. 
 A complementary method to improve the quality of parameters in kinetic 
modeling is presented in the paper of Chassagnole et al., who modeled the central carbon 
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metabolism of E. coli using glucose as a carbon source (Chassagnole et al., 2002). In that 
paper, the authors used the approach presented by Rizzi et al. to calculate the maximum 
reaction rates, and they used mathematical optimization for the other kinetic parameters 
using the software packages ACSL and OPTDESX (Parkinson & Balling, 2002). These 
two packages allow modeling, simulation, and optimization of dynamical systems.  
Another software that has been used for the estimation of parameters is a nonlinear least-
square routine from Matlab (lsqnonlin.m), which minimizes the sum-squared error of the 
simulated results versus experimental data  (Tholudur et al., 1999).  
 Kinetic modeling can be combined with Metabolic Control Analysis (MCA) 
theory in order to elucidate the control structure of the pathway. MCA studies the effects 
of perturbations on a system in steady state (Stephanopoulos et al., 1998). Metabolic 
models are complex systems; therefore, it is not obvious which reactions are controlling 
the complete system. It is important to emphasize that this theory only applies to steady 
(or pseudo) state systems (Stephanopoulos et al., 1998). Two important concepts arise 
from MCA theory: flux control coefficients (FCCs) and concentration control coefficients 
(CCCs). FCCs represent the normalized change in the flux, given an infinitesimal change 
in an enzyme, and CCC is the normalized change in the concentration of a metabolite, 
given an infinitesimal change in one enzyme concentration. FCCs and CCCs are 
properties of the metabolic system, and their elucidation establishes the control structure 
of the pathway. Mathematical formulas for each FCC and CCC are as follow: 
$==.O = 3#PQ  RPQR3#               (9) 
===ST = UVST WSTWUV            (10) 
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where Ei refers to enzymatic activity of i-th enzyme, k represents the k-th reaction in the 
pathway J, and Xj is the concentration of the metabolite j. Additional concepts and 
theories must be introduced in order to calculate FCCs and CCCs. 
 The flux-control summation theorem stipulates that the sum of all the FCCs of a 
specific flux Jk is equal to one. The mathematical expression for this theorem is: 
∑ $==.O = 1X/        Q ∈ Z1, 2, … , \]          (11) 
A FCC close to one means that the corresponding enzyme is the rate-limiting of 
the system, although more frequently the control of the flux is distributed among more 
than one enzyme (Fell, 1998). The summation theorem for CCCs establishes that the sum 
of all the CCCs of one metabolite is equal to zero for any metabolite. For a system with 
M metabolites, this expression is as follows: 
∑ ===ST = 0X/         ∈ Z1, 2, … , ]          (12) 
 Calculation of FCCs and CCCs requires the introduction of elasticities. The 
elasticity is defined as the normalized change of a rate ^ (for the enzyme i), given an 
infinitesimal change in the concentration of metabolite j, _`  (Fell, 1992):  
aST =  _^#  R^#R_             (13) 
Many of these elasticities take null values because not all the metabolites are part of the 
kinetics of each enzyme. 
 The connectivity theorem for flux-control and concentration-control relate control 
coefficients to the elasticities (Fell, 1992). For a linear pathway, the connectivity theorem 
for FCCs is as follows (Fell, 1992): 
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∑ $==.O ∙ aST = 1X/        Q ∈ Z1, 2, … , \];   ∈ Z1, 2, … , ]       (14) 
 The connectivity theorem for CCCs takes two different expressions depending on 
weather the metabolite in the CCC is the same or a different one than the metabolite in 
the elasticity. The mathematical expression is as follows (Fell, 1992): 
∑ ===Sc ∙ aSd = 0X/        e ≠ g      e, g ∈ Z1, 2, … , ]       (15) 
∑ ===Sc ∙ aSc = 1X/                                e ∈ Z1, 2, … , ]       (16) 
Connectivity theorems change for pathways that are not linear, such as branches and 
cycles. 
 When MCA is applied to a kinetic model, all the elasticities can be calculated 
analytically from the kinetic expression of each reaction. The use of the connectivity and 
summation theorems allows writing a system of equations, which leads to finding values 
for all the FCCs and CCCs of the system. MCA allows understanding the control steps in 
a metabolic pathway; therefore, it provides essential information to lead metabolic 
engineering efforts to increase the production of a desired product. 
2.2.3 Approximative kinetic models 
 Kinetic modeling has great utility in the study of dynamics, simulation, and 
control structure. Nevertheless, its implementation requires detailed kinetic information 
for each of the reactions, most of them non linear in metabolite concentration. Rate laws 
and kinetic parameters are often not available depending on the microorganism and 
pathway that are being studied. Because of this, several theories have been developed in 
order to obtain similar results to those obtained with a kinetic model, but using less 
information. The simplest case is a linearization of rate law in the proximity of a known 
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solution using Taylor expansion, which results in a simple expression for a rate, but is not 
very useful because the validity of a linear approximation in most metabolic cases is just 
for infinitesimal changes. The main formats that have been applied for metabolic 
modeling are logarithmic-linear (log-linear), power law-Generalize Mass Action 
(GMA-power law), synergistic system (S-systems), thermokinetic, linear-logarithmic 
(lin-log), and structural kinetic. The last format differs from the previous ones because 
this model does not attempt to solve the steady state and dynamic behavior, but it rather 
focuses in the study of stability, oscillation, and existence of chaos (Steuer et al., 2006). 
Heijnen compared most of these formalisms (log-linear, GMA-power law, S-systems, lin-
log, and thermodynamic), and he concluded that the lin-log model is the most powerful 
approximation (in terms of simplicity in amount of kinetic parameters), providing proper 
description of rate behavior, and existence of analytical solution (Heijnen, 2005). 
Nevertheless, all these formats have been proposed for metabolic modeling; therefore, 
here is given a brief description of each of them.  
 Log-linear approximation was developed by Hatzimanikatis and Bailey, and it 
is based on the Taylor expansion of the logarithmic rate expression, using the 
approximation lnj ≈ j − 1 (Hatzimanikatis & Bailey, 1997). Main qualities of this 
approximation are the existence of an analytical solution for dynamic and steady state, 
and for control coefficients of MCA (Hatzimanikatis & Bailey, 1997). Nevertheless, the 
applicability of this approximation is limited to study cases with small changes in 
enzymatic activities (Heijnen, 2005), which do not correspond to most cases of genetic 
engineering where big changes are desired (Heijnen, 2005).  
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 GMA-power law uses power law kinetics to describe each reaction in an 
unbranched metabolic pathway. This form of power law is useful to describe reactions 
with several metabolites. Following this approximation, each reaction 7 can be written as 
a function of metabolite concentrations (:` ) in a power law form: 
7 = Q ∙   ∙ ∏ :`)VT`/ ∙ ∏ !`mVO+n/           (17) 
where Q and   are kinetic parameters and enzymatic activities respectively, and 9` and 
` are exponential factors. The second product in the formula contains factors that are 
independent of concentrations (!` ). GMA-power law applies to cases with small changes 
in metabolite concentration, as the function for kinetic rate is unbounded, contrasting 
with enzymatic reactions that have a limited value for maximum rate (Heijnen, 2005).  
Another limitation of GMA-power law is the applicability to unbranched 
pathways, which is rarely the case in metabolic networks. Modifications to include 
branched pathways resulted in the introduction of S-systems formalism. In this 
formalism, all the reactions that originate a metabolite : are combining in one rate law, 
and the same is valid for all reactions that consume the metabolite. Thus, for any 
metabolite, the differential expression is (Torres & Voit, 2002): 
o*Vop = -# ∙ ∏ :q#8=1 − r# ∙ ∏ :ℎ#Q8Q=1          (18) 
where - and r are kinetic parameters, and q` and ℎn are exponents. The use of this 
formalism allows analytical solutions of the dynamics and steady states, as well as the 
study of sensitivity and stability (Alvarez-Vasquez et al., 2000). A good example of the 
application of this model was developed for citric acid production in Aspergillus niger, in 
which the model was used to develop strategies of optimization (Alvarez-Vasquez et al., 
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2000). As previous approximative models, S-systems model is limited to small changes 
in enzymatic activities, and it cannot simulate deletions of enzymes in one branch as that 
would annul the complete output flux (Heijnen, 2005).  
The thermokinetic format is a linear approximation for kinetic description of 
enzymes based on Gibbs free energy (Nielsen, 1997). By approximating kinetic rates (7) 
to a linear combination of affinities, a general mathematical formulation is obtained 
(Nielsen, 1997): 
7 = 9 ∑ Q` ∙ lnt:` u + `/           (19) 
where 9,  and Q` are kinetic parameters. This generic equation allows the presence of 
effectors, in which case the kinetic parameters need to be calculated empirically (Nielsen, 
1997). In the absence of effectors, the term 9 becomes equal to the slope in the inflection 
point of the rate, and  is minus the product of the slope and the affinity (both evaluated 
in the inflection point) (Nielsen, 1997). Also, the kinetic coefficients Q` should keep the 
stoichiometric relationships. This formalism better approximates enzymatic equations 
than power-law format, exemplified in a simple Michaelis-Menten kinetics (Figure 21). 
MCA can be applied to thermokinetic format in order to obtain the control structure of 
the pathway. 
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Figure 21: Comparison between Michaelis-Menten equation (square points), best fit using power-law kinetics 
(broken line), and best fit using thermokinetic format (solid line) ('ielsen, 1997).   
 The thermokinetic format inspired another format, the lin-log format, in which the 
main change is that the kinetic coefficients Q` do not need to keep stoichiometric 
relationships (Visser & Heijnen, 2003). In addition, the enzymatic activity ( ) is 
explicitly introduced, leading to the following equation (Heijnen, 2005): 
7 =   + ∑ 9` ∙ lnt:` u*`/ + ∑ 9` ∙ lnt!` u`/*       (20) 
where :`  and !`  refer to intracellular and extracellular metabolites, respectively. 
Parameters are found using experimental data (Visser & Heijnen, 2003). This formalism 
retain the good qualities of the thermokinetic format (good adjustment, analytical 
solution, study of control structure), and it adds flexibility in the adjustment of 
parameters. Moreover, it allows finding analytical solutions for steady state and dynamic 
states when there are large changes in enzymatic activities (Heijnen, 2005).  
 Finally, structural kinetic models focuses in the study of the dynamic behavior 
of the system, in terms of stability, oscillations and possibility of chaos (Steuer et al., 
2006). This format focuses in the construction of the Jacobian matrix (referred to the 
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vector of reaction rates) of a metabolic system in the steady state. Elements of the matrix 
can be calculated using experimental data (Steuer et al., 2006).    
2.2.4 Remarkable models for E. coli central carbon metabolism and glycerol 
fermentation 
 
 This section presents models that have been built to represent the metabolism of 
E. coli and glycerol fermentation. E. coli has been the subject of study for several years, 
and a number of mathematical models have been built to describe its metabolism. Among 
the most remarkable are the stoichiometric model for glucose fermentation (Chassagnole 
et al., 2002) and the GEM (Feist et al., 2007). To date there are no kinetic models for the 
glycerol fermentation in E. coli, but a model has been proposed to describe this process in 
Klebsiella pneumonia (Sun et al., 2008), one of the few microbial organisms that is able 
to ferment this carbon source. There is one effort that has been made for the glycerol 
fermentation of E. coli, and it is a stoichiometric model using FBA (Murarka, not 
published). Nevertheless, this model just represents a set of 78 reactions, and in view of 
the recent development of GEMs, it is more useful to describe accurately the 
fermentation of glycerol using a GEM. Furthermore, that stoichiometric model was built 
assuming certain pathways without having experimental confirmation of them.  
2.2.4.1 Kinetic modeling of the central carbon metabolism of E. coli  
A kinetic modeling of central carbon metabolism of E. coli was developed by 
Chassagnole and collaborators in 2002, and it represents the most cited kinetic model for the 
study of central carbon metabolism in E. coli (over 180 citations to date, according to 
Web of Knowledge – Thomson Reuters) (Chassagnole et al., 2002). The goal of this project 
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was to present a dynamical model that allows quantitatively predicting the physiological 
behavior of E. coli when there are changes in the glucose supply. Moreover, the model 
allows the study of stability and control structure (using MCA). 
The experimental conditions consisted in the aerobic growth of E. coli K-12 strain 
W3110, in a continuous culture. The metabolic network included the phosphotransferase 
system (PTS) to uptake glucose, the glycolysis (also known as embden-meyerhof-parnas 
pathway), the pentose-phosphate pathway (PPP), and reactions for the production of 
amino acids and polysaccharides (Figure 22). The PTS is a PEP-dependent system that 
allows E. coli to uptake carbohydrates, such as hexoses and disaccharides. The vast 
number of studies performed to elucidate the mechanisms of enzymes in the central 
carbon metabolism of E. coli allowed the construction of a detailed kinetic model. Most 
of the kinetic rates of glycolysis were taken from analytical experiments reported in the 
literature.  Unknown rates were proposed using Michaelis-Menten kinetics. Some kinetic 
expressions that were utilized are reversible Michaelis-Menten, allosteric regulation, and 
Hill equation.   
58 
 
 
Figure 22: Metabolic network of kinetic model for central carbon metabolism in E. coli. Squares: enzymes, 
circles: regulatory effects (Chassagnole et al., 2002). See 'omenclature for abbreviations (page 214). 
 
Kinetic parameters were adjusted using experimental data and computational 
optimization. Maximum reaction rates were calculated by using experimental data of 
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intracellular metabolite concentrations after a glucose pulse experiment, and by applying 
the methodology presented by Rizzi et al. (Rizzi et al., 1997). Computational softwares 
ACSL and OPTDESX were used to optimize values of other kinetic parameters. 
Unbalanced co-metabolites (energy balance and redox balance) were fitted with 
analytical expression, and they were not part of the ODE system used to solve the 
dynamic state of the system.  
As a result, the kinetic model fits most of the experimental data of intracellular 
metabolite concentrations after a pulse of glucose. The main difference was found for 
PYR, which could be caused by errors in measurements together with wrong assumptions 
in the mechanistic model. The stability of the model was studied by evaluating the 
model’s recovery after a glucose pulse. As a result, the model did not come back to the 
original steady state, but the experiments did not either, indicating that there might be 
instabilities. In addition, the model allowed the calculation of the theoretical natural 
frequency of oscillation (analysis of eigen values of the system), which result was of the 
same order of magnitude than previous studies of oscillation in E. coli.  
The model was used to elucidate the control structure in the pathway by using 
MCA. The result showed that the control of glucose utilization is shared by the PTS 
(FCC=0.42) and, to a lesser extent, by glucose-6-phosphate dehydrogenase, 
phosphofructokinase, and pyruvate dehydrogenase. 
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2.2.4.2 Kinetic modeling of glycerol fermentation in K. pneumonia  
 K. pneumonia is one the few organisms that can ferment glycerol in the absence 
of electron acceptors. As already stated, the utilization of glycerol in this species requires 
the combination of two pathways: oxidative and reductive pathways. Glycerol oxidation 
allows the formation of DHAP, which will later go to the glycolysis pathway, while 
reductive pathway of glycerol produces 1,3-PDO. Sun and collaborators developed a 
kinetic model for this process, which includes the oxidative and reductive pathway 
(Figure 23) (Sun et al., 2008).  
 
Figure 23: Anaerobic pathways for metabolism of glycerol. GlpF: glycerol facilitator, GDH: glycerol 
dehydrogenase, DHA: dihydroxyacetone, DHAP: di-hydroxyacetone phosphate, HAc: acetate, EtOH: ethanol, 
GDHt: glycerol dehydratase, 3-HPA: 3-hydroxypropionaldehyde, PDOR: 1,3-PD oxydoreductase, 1,3-PD: 1,3-
propanediol (Sun et al., 2008). 
 The model represents anaerobic metabolism of glycerol at 37⁰C, and it applies to 
batch and continuous cultures. This is a small kinetic model, in which the emphasis is in 
the reducing pathway that allows the formation of 1,3-PDO. In fact, the model just 
represents four reactions of the reducing pathway (toward formation of 1,3-PDO). 
Among them, one is glycerol transport, two are Michaelis-Menten (proposed in this 
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work), and the last one is diffusion of 1,3-PDO. The oxidative pathway (toward 
formation of DHAP) was considered a black box. In addition, the complexity of the 
model increases for multiple growth inhibitions that affect K. pneumonia under 
fermentative conditions. In particular, K. pneumonia growth is inhibited by glycerol, 1,3-
PDO, ethanol, and acetate.  
 The kinetics of transport of glycerol is a combination of simple diffusion and 
facilitated transport mediated by a permease. Facilitated transport is modeled as 
Michaelis-Menten kinetics, according to studies performed in the equivalent permease in 
E. coli. The two intracellular reactions were modeled as Michaelis-Menten reactions with 
inhibition by 3-HPA (the intermediate metabolite of this pathway) in agreement with 
experimental data. The Monod equation with multiple inhibitions for batch cultures was 
used for the specific growth rate. Kinetic parameters were found using experimental data, 
and utilizing the method of multi-dimensional unconstrained nonlinear minimization 
(Matlab). How the black box was set for the oxidative pathway is not presented in the 
model, nor is the simulated production of acetate and ethanol as fermentative products. 
 Simulations using the model are compared with experiments of batch and 
continuous cultures. The model represents correctly concentrations of biomass, glycerol, 
3-HPA, 1,3-PDO, ethanol, and acetate. In batch cultures, simulation curves of glycerol 
and biomass appear displaced to the right and left, respectively, indicating that the model 
is predicting a slower utilization of glycerol and production of biomass. In addition, the 
model predicts an abrupt consumption of glycerol in the late stage of batch cultures, 
which is in disagreement with experimental data. The authors did not go into the 
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explanation of this phenomenon, but it could be caused by the use of an erroneous 
glycerol transport rate. 
 Finally, the model suggests that 1,3-propanediol oxidoreductase (PDOR) (Figure 
23) may be the limiting step because simulating data shows accumulation of 3-HPA (in 
agreement with experimental data). 
Other models developed to study the dynamics of glycerol fermentation include 
the implementation of an S-system model to study the regulatory and metabolic pathway 
in K. pneumonia (Sun et al., 2012).  
2.2.4.3 Genome-scale metabolic model for E. coli  
In 2011, the last version of a GEM applied to E. coli was released and developed 
within the group of Dr. Bernhard Palsson. This version is an upgrade of the previous 
versions, which were presented in 2000 by Edwards and Palsson, 2003 by Reed et al., 
and 2007 by Feist et al. (Edwards & Palsson, 2000; Feist et al., 2007; Reed et al., 2003). 
By 2008 these three models had been used in more than 60 studies of metabolism (Feist 
& Palsson, 2008), and their utilization has continued in recent years.   
The last version of the GEM for E. coli, named i1366, includes 1,366 functional 
ORFs, 97% of which are experimentally based, and 3% of which present functions 
computationally predicted. Different intracellular compartments were included, and 
transport reactions allowed them to be connected. The model contains 2,251 reactions; 
among them, 1,382 correspond to metabolic reactions catalyzed by enzymes, and 706 
correspond to transport reactions catalyzed by enzymes. As for metabolites, the model 
contains 1,136 unique metabolites (regardless of their intracellular location).     
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The iJO1366 model is an updated version of the previous GEM for E. coli, the 
iAF1260, which was presented in 2007 by Feist et al. The construction of the iJO1366 
model included the metabolic information of E. coli contained in the EcoCyc Database 
and biochemical studies performed over enzymes of this bacterium (Keseler et al., 2009). 
Gene associations were made for each reaction when there was an identified enzyme 
associated with a reaction. Besides, thermodynamic information for each reaction was 
calculated using an intracellular metabolite concentration (of an estimated 1 mM) to 
perform thermodynamic consistence analysis that could ensure feasibility in the 
directionality of each reaction, following the system developed by Feist et al. (Feist et al., 
2007). For instance, the reactions of export and import of ions were considered reversible 
at first, but thermodynamic analysis and literature review confirmed that export of ions is 
a separate mechanism that requires energy. Then, the model was curated by filling gaps 
in pathways for the formation of essential metabolites starting from a minimum medium. 
Finally, the construction of the model used experimental data to propose a reaction for 
biomass production, and also to determine growth associated maintenance energy (GAM) 
and non-growth associated maintenance energy (NGAM). This resulted in a calculated 
NGAM of 3.15 mmol ATP/gCDW/h and a GAM of 53.95 mmol ATP/gCDW/h. 
 FBA was used to perform different studies, and biomass was used as objective 
function. The predicting capability of the iJO1366 model was validated using two 
approaches: first, to study a vast variety of possible substrates using the model, and 
second to study single gene deletions using glucose and glycerol in minimal media. Both 
approaches proved the highly accurate in predicting phenotypes using the iJO1366 (Orth 
et al., 2011).    
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3 Materials and methods 
 The present project consists of mathematical modeling of E. coli using two 
recently developed platforms: glycerol fermentation and the reversal β-oxidation cycle 
utilizing glucose. These two approaches have recently been reported experimentally and 
this study expands their capabilities as platforms to produce biofuels (including advanced 
biofuels) and biochemicals. Mathematical models need to be validated experimentally; 
therefore, a section for experimental conditions is also included. Finally, the workflow 
will be explained.  
3.1 Modeling 
In the previous section, different mathematical models of metabolism were 
explained. The present project uses two of them: kinetic modeling and GEM.  
Kinetic modeling allows the detailed study of one pathway, and it can be 
implemented as long as the pathway has been identified and kinetic information has been 
determined. Given the fact that the main pathways in glycerol and in fatty acids 
metabolisms have been well characterized in E. coli, it is possible to implement this kind 
of model for glycerol fermentation. This approach allows a dynamic study of the system 
and the elucidation of the control structure of the pathway by applying MCA. 
GEM, a stoichiometric model, gives a global vision of the complete metabolic 
network. The use of FBA together with this model allows finding the maximum 
theoretical growth under a given condition, and which pathways should be used to 
achieve such state. Identification of active pathways that allow the fermentative 
utilization of glycerol and the use of the reversal of the β-oxidation cycle is fundamental 
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for a deeper understanding of these processes. Predictions presented using GEMs can 
lead experimental efforts in metabolic engineering. The vast amount of studies performed 
in E. coli has allowed the construction of a GEM for this organism(Orth et al., 2011). 
This model is available online and it can be modified to represent different conditions, 
such as adding or deleting pathways, or changing the chemical composition of the 
medium. 
Both kinds of models are used to study the metabolism of E. coli from different 
perspectives, two fundamental tasks for understanding glycerol fermentation and the 
reversal of the β-oxidation cycle, and to engineer this microorganism for the efficient 
production of biofuels.   
3.1.1 Kinetic modeling and MCA 
This section explains the steps in the construction of a kinetic model without 
going into details of the specific pathways that are studied. Further details are part of 
results (chapters 4, 5 and 6). 
3.1.1.1 Kinetic modeling 
The fundamental steps in the construction of kinetic modeling are: 
1. Set computational system. Use of Matlab v7.11.0 (R2010b, The Mathworks, 
Inc.).  
2. Define metabolic network. This step defines which metabolites and reactions 
are part of the model. This information is available and it was presented in the 
previous section (Background and Literature Review). 
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3. Define kinetics of each reaction. This information is available for all the 
reaction.  
4. Define system of ODE. The system is obtained by applying a mass balance in 
each substrate, metabolite, product, and biomass.  
5. Define initial conditions. It is necessary to define initial concentrations of 
substrates, internal metabolites, products, and biomass. The substrates, 
products, and the biomass concentrations are known for these experiments. In 
contrast, values of internal metabolites need to be obtained experimentally or 
estimated. In many cases, estimated values can be obtained from the literature, 
and the mathematical model is not sensitive to these values after the first few 
seconds. This is because the mathematical solution of the system quickly 
adjusts values of the internal metabolites.  
6. Parameter optimization. In vitro kinetic parameters can be obtained from the 
literature for most of cases, and they can be estimated in the other cases. These 
values were used as an initial estimate of the real values. An analysis of 
sensitivity was performed over all parameters of the system. Sensitive 
parameters were optimized using Matlab and simulations. 
7. Solve the system. The program Matlab was used to write the ODE system that 
needs to be solved. 
3.1.1.2 MCA 
MCA theory applied to cycles represents some variations with respect to linear 
pathways, which will be explained below.  
 
67 
 
Construction of matrix method for MCA 
FCCs and CCCs can be calculated when elasticities are known. The system of 
equations is linear and allows the construction of a matrix equation. Since a metabolic 
pathway may be linear, branched or cyclic, the system of equations will vary for the 
different cases. Matrix method for linear and branched pathways were developed by 
Sauro and Fell (Sauro et al., 1987). Extension of this method to conserved cycles requires 
to apply the principles presented by Fell and Sauro, and Hofmeyr et al. (Fell & Sauro, 
1985; Hofmeyr et al., 1986). 
Linear pathways (Sauro et al., 1987) 
 For a linear pathway of 3 reactions and 4 metabolites (Figure 24), equation 21 
presents the system of equations that apply.  
 _v Uw→ _ Ux→ _y Uz→ _{ 
Figure 24: Linear pathway 
 
| 1 1 1a ay 00 ayy ay{} ∙ ~
$= ==Sw ==Sx$=y ==ySw ==ySx$={ =={Sw =={Sx = 
1 0 00 ̵1 00 0 ̵1        (21) 
 Extension of this system to bigger systems is intuitive. The first matrix, named M, 
present a first row with just ones, coming from the summation theorem for FCCs and for 
CCCs. The following rows in M contain the elasticities with respect to the metabolites 
(rows) and enzymes (columns), which come from the connectivity relationships between 
FCCs and elasticities, and connectivity relationships between CCCs and elasticities. 
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Branched pathways (Sauro et al., 1987) 
 Equation 22 applies for a branch point of 3 reactions and 4 metabolites, in which 
the branches take fluxes of aJ and (1-a)J as shown in Figure 25. ===), ===y), and ==={) 
correspond to branch distribution coefficients. 
 
Figure 25: branched pathway 
 
 1 1 1a ay a{0 1 − 9 −9 ∙ ~
$== ===Sw ===)$==y ===ySw ===y)$=={ ==={Sw ==={) = 
1 0 00 ̵1 00 0 1 − 9       (22) 
 
Moiety-conserved cycles (Hofmeyr et al., 1986) 
 A cycle in a metabolic pathway is a special case of a branched pathway. Consider 
the case represented in Figure 26.  
 
Figure 26: Cyclic pathway 
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While the summation theorem for FCCs does not change, connectivity theorem equations 
are modified as follows: 
$== ∙ a + $==y ∙ ay = 0          (23) 
$==y ∙ ay +  $=={ a{ − a{ ∙  − $==2 ∙ a2 ∙  = 0        (24) 
$=={ ∙ a{ +  $==2 a2 − a2 ∙  − $==y ∙ ay ∙  = 0       (25) 
$==2 ∙ a2 + $== ∙ a = 0           (26) 
Notice that elasticities with respect to Q and R were combined in one equation, 
the same for elasticities with respect to R and P. The result of combining all these 
equations leads to the following system of equations to calculate the FCCs for the system 
presented in Figure 26: 
 27 
 
The FCC can then be calculated by solving this system of equations. 
3.1.2 Stoichiometric modeling 
As already stated, a GEM is available for E. coli to represent the metabolism of 
glucose under aerobic conditions. The model was modified to represent the conditions 
that are the focus of this study. Below are the steps involved in the modification and use 
1 1 1 1 1 1
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70 
 
of this model to the study of glycerol fermentation, and of the reversal of the β-oxidation 
cycle. 
1. Set computational system. The COBRA toolbox v2.0 was used, which is a 
toolbox for Matlab that has been developed specifically to manipulate genome-
scale programs (Schellenberger et al., 2011). COBRA stands from “Constraint-
Based Reconstruction and Analysis”, and it provides a friendly platform to 
perform diverse studies in GEM, such as FBA, FVA, addition and deletion of 
reactions, and OptKnock. The latest version of COBRA (v2.0) includes a linear 
programming kit (GLPK), libSBML, SBML toolbox, and glpkmex, all of 
which are necessary for the proper functioning of COBRA. In order to use 
Optknock from COBRA, the solver Gurobi 5.0 was implemented. 
2. Set experimental conditions. For glycerol fermentation, oxygen and glucose 
utilization were set as unavailable, and glycerol was set as available. For the 
glucose fermentation using the reversible β-oxidation cycle, glucose was set as 
available, and oxygen was set as unavailable. In both cases it was assumed 
minimal medium.    
3. Model curation. This was a repetitive process. First, the model was checked to 
ensure that all the reactions in the main pathways are present, and with the right 
directionality. Then, reactions that were not feasible under the current 
conditions were eliminated. Some of these reactions were amino acids 
degradation, nucleotides degradation, and ion exchange. Degradation of amino 
acids and nucleotides does not take place under normal conditions, as these 
processes require the expression of involved enzymes. Ion exchange is subject 
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to thermodynamic restrictions. This process was facilitated by using FBA with 
biomass as the objective function, evaluating if the results are feasible, and 
modifing the model if necessary.  
4. Perform Flux Balance Analysis (FBA) and Flux Variability Analysis 
(FVA) of base case. Biomass was used as the objective function (BOF), and 
FBA was used to identifying the main pathways that are predicted for the 
production of maximal theoretical cell growth. FVA was used to identify 
alternative optimal solutions and to generate solution spaces, which represent 
productivity versus biomass production. 
5. Perform FBA of additional pathways. In addition to simulate flux 
distribution of the base case (wild type E. coli for glycerol fermentation, and a 
modified E. coli containing the reversal β-oxidation cycle for glucose 
fermentation), additional pathways are incorporated as a way to optimize the 
synthesis of desired products.  
6. Perform OptKnock to optimize synthesis of desired products. This tool was 
used to identify possible reactions to knockout that would result in the coupling 
production of biomass and a desired product. In each case, up to 8 reactions 
were permitted as target to knockout, and the minimal specific growth rate was 
set as 0.07 h-1. The solver Gurobi 5.0 was used in combination with the 
COBRA toolbox. 
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3.2 Experimental work 
Experimental validation is a fundamental step in the construction and adaptation 
of mathematical models to predict cellular phenotypes. In particular, the results from 
MCA for glycerol fermentation were used to predict changes in the metabolic network 
when enzymatic activities are modified, and experiments were conducted to corroborate 
the predictions. Below are the protocols for strain and genetic methods, culture medium 
and cultivation, analytical methods and enzymatic activities. The protocol for glycerol 
fermentation was taken from the experiments performed by Dharmadi et al. (Dharmadi et 
al., 2006) and Gonzalez et al. (Gonzalez et al., 2008) unless otherwise is indicated. All 
the experimental work of this thesis was performed by James Clomburg. 
Glycerol fermentation – strains, plasmids and genetic methods 
Wild-type strains E. coli K12 strain MG1655 was used as wild type, and mutants 
were constructed using the transposon-mediated mutagenesis method (Kang et al., 2004). 
Table 2 shows the strain and plasmids used in this study. The protocols for the 
contraction of plasmids pZSBlank (Yazdani & Gonzalez, 2008), pZSKLMgldA (Yazdani 
& Gonzalez, 2008), pZSKLM (Bachler et al., 2005), pZSgldA (Yazdani & Gonzalez, 
2008), and pZSadhE (Clomburg & Gonzalez, 2011) have been previously described. For 
construction of plasmids pZSpflB, pZStpiA, and pZSglpF, the genes pflB, tpiA, and glpF 
were PCR amplified from MG1655 genomic DNA. The resulting products were then 
cloned into pZSKLMgldA (Yazdani & Gonzalez, 2008) digested with KpnI and MluI 
using the InFusion PCR cloning kit (Clontech Laboratories, Inc., Mountain View, CA).  
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Table 2: Strains and plasmids used in this study. 
Manufacturer protocols and standard methods (Miller, 1972; Sambrook et al., 
1989) were followed for DNA purification (Qiagen, Valencia, CA), restriction 
endonuclease digestion (New England Biolabs, Ipswich, MA), and DNA amplification 
(Stratagene, La Jolla, CA and Invitrogen, Carlsbad, CA). The strains were kept in 32.5% 
glycerol stocks at -80°C. Plates were prepared using LB medium containing 1.5% agar, 
and when appropriate chloramphenicol was included at 34 µg/mL.  
Glycerol fermentation – culture medium and cultivation conditions 
Culture conditions of strains were minimal medium (Neidhard.Fc et al., 1974) 
supplemented with 10 g/L tryptone (Difco, USA), 10 g/L glycerol, 5 g/L yeast extract, 
and 1.32 mM Na2HPO4 in place of K2HPO4. Pre-culture medium was supplemented 
with MOPS. Chemicals were obtained from Fisher Scientific (Pittsburg, PA) and Sigma-
Aldrich Co. (St. Louis, MO).  
Anaerobic conditions as well as 37ºC will be kept. The pH was maintained at 6.3 
(optimum) using NaOH and H2SO4. Fermentations were conducted in a SixFors multi-
Strain/Plasmid/ 
Primer 
Description/Genotype/Sequence Source 
MG1655 F- λ- ilvG- rfb-50 rph-1 (Kang et al., 2004) 
pZSblank oriR pSC101*, tetR, cat, contains PLtetO-1 (Yazdani & Gonzalez, 2008) 
pZSKLMgldA 
E. coli dhaKLM and gldA genes under 
control of PLtetO-1(tetR, oriR SC101*, cat) 
(Yazdani & Gonzalez, 2008) 
pZSKLM 
E. coli dhaKLM genes under control of 
PLtetO-1(tetR, oriR SC101*, cat) 
(Yazdani & Gonzalez, 2008) 
pZSgldA 
E. coli gldA gene under control of PLtetO-
1(tetR, oriR SC101*, cat) 
(Yazdani & Gonzalez, 2008) 
pZSadhE 
E. coli adhE gene under control of PLtetO-
1(tetR, oriR SC101*, cat) 
(Clomburg & Gonzalez, 
2011) 
pZSglpF 
E. coli glpF gene under control of PLtetO-1 
(tetR, oriR SC101*, cat) 
This Study (James 
Clomburg) 
pZSpflB 
E. coli pflB gene under control of PLtetO-1 
(tetR, oriR SC101*, cat) 
This Study (James 
Clomburg) 
pZStpiA 
E. coli tpiA gene under control of PLtetO-1 
(tetR, oriR SC101*, cat) 
This Study (James 
Clomburg) 
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fermentation system (Infors HT, Bottmingen, Switzerland) with six 500 mL working 
volume fermenters and independent control of temperature, pH, and stirrer speed (200 
rpm). The system will be designed to prevent evaporation and to keep anaerobic 
conditions, as previously reported (Dharmadi et al., 2006). Strains were streaked onto LB 
plates and incubated overnight, and then a single colony was used to inoculate 17.5 
Hungate tubes completely filled with medium (Murarka et al., 2008). The tubes were 
incubated at 37ºC until they achieved an OD550 of 0.4, and washed pellet was used to 
inoculate each of the six fermenters  with the target starting optical density of 0.05 at 550 
nm (Dharmadi et al., 2006). 
Glycerol fermentation – analytical methods and enzyme activities 
The methodology for the analytical methods was presented by Dharmandi et al. 
(Dharmadi et al., 2006). Cell growth, substrate (glycerol) concentration and products 
concentrations were monitored during the experiments. Cell concentration were estimated 
measuring optical density at 550 nm (1 OD = 0.34 g DW/L). Samples were centrifugated 
and the supernatant was stored at -20ºC for further analyses. The substrate (glycerol) and 
products (lactate, acetate, formate, succinate, and ethanol) were measured with ion-
exclusion HPLC as previously reported (Dharmadi et al., 2006). 
The activity of glycerol dehydrogenase on glycerol oxidation was measured as 
described previously (Gonzalez et al., 2008), with potassium carbonate (pH 9.5) as the 
buffer. PEP-dependent dihydroxyacetone kinase activity was assayed using the method 
reported by Kornberg and Reeves (Kornberg & Reeves, 1972), with minor modifications 
as previously described (Yazdani & Gonzalez, 2008). 
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3.3 Workflow  
Figure 27 shows the workflow diagram that was followed to implement the 
mathematical models. The process starts collecting relevant data to the study (literature 
review), and it finishes with a validated model that can be used in metabolic engineering. 
The process is iterative in comparing computational simulations/predictions with 
experimental data, and major differences require to review and to modify the model. 
 
 
Figure 27: Workflow diagram for mathematical model construction.  
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4 Results I: Kinetic modeling and metabolic control analysis 
of the fermentative metabolism of glycerol fermentation.  
This chapter presents the development and results of a kinetic model for the 
fermentative metabolism of glycerol in E. coli, as well as the use of the model for the 
elucidation of the control structure of the associated metabolic pathway. The anaerobic 
fermentation of glycerol was believed for many years to be exclusive to those organisms 
having the ability to produce 1,3-propanediol (1,3-PDO), and the recent discovery that E. 
coli is able to ferment glycerol even though it is unable to produce 1,3-PDO has drawn 
interest from the scientific community as a possible platform for the production of 
biofuels (see for example (Yazdani & Gonzalez, 2007). Despite efforts to establish 
pathways and mechanisms of glycerol fermentation in E. coli, the quantitative analysis of 
this metabolic process had not been performed before this thesis.    
Kinetic models quantitatively describe dynamics and steady state of a metabolic 
network (metabolites, substrates, products, and fluxes) by defining a system of ordinary 
differential equations (ODEs) and using kinetic information for specific enzymatic and 
transport reactions. Once a kinetic model has been established, Metabolic Control 
Analysis (MCA) can be introduced to calculate flux control coefficients (FCCs).  
 The following are sections of this chapter: Model development, Parameter 
estimation, Result of modeling, MCA of glycerol fermentation, Experimental validation 
and Conclusions. Model development presents the metabolic pathway and the kinetic 
equations for each step, together with the system of ODEs. Parameter estimation explains 
in detail the problem of obtaining reliable parameters and the approach used in this work 
77 
 
to optimize those parameters. Once the model has been established and the parameters 
have been defined, results of the model are presented for glycerol, ethanol, biomass and 
internal metabolites, and compared to experimental data. The next section presents MCA 
of the model, which allows elucidating that the first two enzymes (glycerol 
dehydrogenase and di-hydroxyacetone kinase) are controlling the flux through the 
pathway. Experimental verification shows that in fact these two enzymes are responsible 
for the control over this pathway, and overexpression of these two enzymes resulted in 
doubling the rate of glycerol utilization and ethanol synthesis. 
4.1 Model development and simulations 
The model construction focused on the anaerobic fermentation of glycerol at a pH 
of 6.3 (optimum) in a minimum medium supplemented with 10% of tryptone, 5 g/L of 
yeast and 10 g/l of glycerol (see section 3, Material and Methods for further details); 
where negligible amounts of glycerol goes to by-products or biomass (Gonzalez et al., 
2008). The model considered ethanol as the only product of this fermentation since it 
accounts for over 95% of carbon recovery. This metabolic pathway is NADH balanced 
and produces ATP, two essential functions to support cell growth. The model was 
constructed using information from previous publications, the details of which will be 
given later in this section. Kinetic structures and parameters were taken from studies 
conducted in E. coli unless otherwise specified. Figure 28 shows the metabolic pathway 
of the model, which is comprised of 11 reactions starting with the passive transport of 
glycerol across the cell membrane (Heller et al., 1980). Under fermentative conditions, 
intracellular glycerol is converted to the glycolytic intermediate dihydroxyacetone 
phosphate (DHAP) in a two-step pathway involving glycerol dehydrogenase (glyDH) and 
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dihydroxyacetone kinase (DHAK), as previously reported (Gonzalez et al., 2008). The 
native E. coli DHAK is a phosphoenolpyruvate (PEP)-dependent enzyme that utilizes 
PEP as the phosphate group donor for the phosphorylation of dihydroxyacetone (DHA) 
(Gutknecht et al., 2001). The conversion of DHAP into PEP takes place in five steps 
through the action of common glycolytic enzymes (Romeo and Snoep, 2006). While the 
glycolytic enzyme pyruvate kinase converts PEP into pyruvate during metabolism of 
other carbon sources (Romeo & Snoep, 2005), a unique characteristic of glycerol 
metabolism is that the conversion of PEP into pyruvate is coupled to DHA 
phosphorylation (i.e. due to the fact that DHAK uses PEP as the phosphate group donor). 
This coupled reaction is a critical component of glycerol fermentation in E. coli and 
generates a cycle in the metabolic pathway (Figure 28) which for the purpose of the 
model allows the assumption of negligible pyruvate kinase activity.  The synthesis of 
acetyl-CoA (AcCoA) from pyruvate can take place through two different enzymes, the 
pyruvate dehydrogenase complex (PDHC) and pyruvate formate lyase (PFL). However, 
considering the high NADH/NAD+ ratios observed during glycerol fermentation 
(Murarka et al., 2008) and given that NADH negatively regulates PDHC (Sawers & 
Clark, 2004), PFL is expected to play a primary role. The dispensable nature of pyruvate 
dehydrogenase during glycerol fermentation has been verified in our laboratory 
(Clomburg and Gonzalez, unpublished). The final reactions in the model consist of the 
two-step conversion of AcCoA into ethanol through the action of acetaldehyde/alcohol 
dehydrogenase (ALDH/ADH) (Sawers & Clark, 2004). 
The kinetic rate expressions considered for each of the reaction are presented 
below with their sources and justifications. For a given reaction i and metabolite j, the 
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following notation will be used:  7)*   for the maximum rate(mM/s), ;  for the 
equilibrium constant, ;8`  for the Michaelis-Menten constant (mM) and =`  for the 
metabolite concentration (mM). X represents cell concentration (g CDW/L). Other 
notations are presented for some specific reactions, which will be noted later.  
 
Figure 28: Model of Glycerol Fermentation under anaerobic conditions in E. coli. Reactions: ADH, acetaldehyde 
dehydrogenase; ALDH, alcohol dehydrogenase; DHAK, dihydroxyacetone kinase; E'O, enolase; GAPDH, 
glyceraldehyde 3-phosphate dehydrogenase; glyDH, glycerol dehydrogenase; GlpF, glycerol transport; PFL, 
pyruvate formate-lyase; PGM, phosphoglycerate mutase; PGK, phosphoglycerate kinase; TPI, triose phosphate 
isomerase. Metabolites: 2PG, 2-phosphoglycerate; 3PG, 3-phosphoglycerate; AcCoA, acetyl-CoA;  ADP, 
adenosine diphosphate; ATP, adenosine triphosphate; DHA, dihydroxyacetone; DHAP, dihydroxyacetone 
phosphate; GAP glyceraldehyde-3-phosphate; 'ADH, dihydrodiphosphopyridine nucleotide; 'AD+, 
diphosphopyridine nucleotide; PGP, 1,3-diphosphateglycerate; PYR, pyruvate. 
 
Kinetic rate expressions 
 Glycerol Transport: The first step in glycerol fermentation is the transport of 
glycerol, as shown in Figure 28. Transport is possible through passive transport across 
the membrane, aided by the action of the aquoporin GlpF which allows facilitated 
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diffusion of glycerol in both directions of the membrane (Lu et al., 2003). Although flux 
mediated by GlpF has been modeled as Michaelis-Menten (Voegele et al., 1993), those 
studies assume unidirectional transport. Nevertheless, since the next reaction (glycerol 
dehydrogenase) has a high Michaelis-Menten constant comparative to the concentration 
of external glycerol (Table 3), it is most likely that the intracellular concentration of 
glycerol (GLYC in the kinetic equation) will be high compared with the external 
concentration (GLYC_ext in the kinetic equation), and flux in both directions is expected. 
On the other hand, GlpF has also been modeled as diffusion, following a two-parameter 
formalism for this enzyme (Kleinhans, 1998). Therefore, a simple diffusion equation was 
used in this project, where D (s-1) is the diffusivity constant (which includes simple 
diffusion and facilitated diffusion):  
7 =  ∙ t=X_*p − =Xu              (28) 
Oxidation of glycerol: glyDH is one of the key enzymes that allow glycerol 
fermentation, as was previously stated. Reversible Michaelis-Menten reaction is used for 
this step (Subedi et al., 2008): 
7 ¡¢£ = ¤¥¦§
¨©ª«¬
­¥¨©ª«¬®¯°±  ∙ ²®¯°±  ±«¬c­³´¨©ª«¬µ ¶  ±®¯°±­¥¨©ª«¬®¯°±  ¶ ±«¬c­¥¨©ª«¬«¬c           (29)  
Phosphorylation of DHA: DHAK in E. coli is a PEP-dependent kinase. This 
reaction allows the simultaneous conversion of DHA into DHAP, and PEP into PYR, 
creating a cycle in the metabolic pathway (Figure 28). It must be mentioned that there is 
another enzyme, the ATP-dependent pyruvate kinase (PYK), which is also able to 
convert PEP into PYR. However, a simple mass balance indicates that all the flux to 
produce PYR must go through the action of DHAK in this simplified model. The kinetics 
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of DHAK has been modeled as an irreversible Michaelis-Menten (Gutknecht et al., 
2001). This kinetics assumes that DHA is the limiting reactant, and that there is an excess 
of PEP. Other kinetic expressions are available with competitive inhibition from L-D 
glyceraldehyde (Garcia-Alles et al., 2004), but since glyceraldehyde is not part of the 
metabolic pathway the former kinetics was considered to be appropriate: 
7¢£· = ¸¥¦§«¬c­ ∙ «¬c·«¬c­ ¶  «¬c              (30) 
Isomerization of DHAP: The enzyme triose phosphate isomerase (TPI) mediates 
the conversion of DHAP into glyceraldehyde-3-phosphate (GAP). Its kinetics correspond 
to a reversible Michaelis-Menten (Richter et al., 1975): 
7¹ = 7)*¹ ∙ «¬cº  ±®cº­³´»º¼·»º¼«¬cº ∙ ² ¶ ±®cº­¥»º¼®cºµ ¶ «¬cº         (31) 
Oxidation of GAP: The conversion of GAP into 1,3-diphosphoglycerate (PGP) is 
mediated by the enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Its 
kinetics is modeled according to a two-substrate reversible Michaelis-Menten mechanism 
(Chassagnole et al., 2002) and represented by the following expression: 
7¢ = 7)*¢ ∙ ®cº ∙ ½c«  ±º®º ∙ ±½c«¬­³´®cº«²·®cº«®cº ∙²¶ ±º®º­¥®cº«º®º µ¶ ®cºµ∙²·®cº«½c« ∙²¶ ±½c«¬­¥®cº«½c«¬µ¶½c«µ         
(32) 
Phosphorylation of PGP: This reaction allows converting PGP into 3-
phosphoglycerate (3PG), and it is catalyzed by the enzyme phosphoglycerate kinase 
(PGK). The kinetics of this enzyme is modeled according to a two-substrate reversible 
Michaelis-Menten mechanism (Chassagnole et al., 2002). Concentration of ATP and 
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ADP were kept constant, as these metabolites are unbalanced in the modeled pathway. 
Below is the equation for this reaction. 
7· = 7)*· ∙ c«º∙º®º  ±c»º ∙ ±zº®­³´º®­²·º®­ c«º ∙ ² ¶ ±c»º­¥º®­c»º µ ¶ c«ºµ∙²·º®­º®º ∙ ² ¶ ±zº®­¥º®­zº® µ ¶ º®ºµ        (33) 
Isomerization of 3PG: The enzyme phosphoglycerate mutase (PGM) allows the 
conversion of 3PG into 2-phosphoglycerate (2PG), and its kinetics corresponds to a 
reversible Michaelis-Menten (Chassagnole et al., 2002): 
7(  = ¸¥¦§º®¾ ∙ zº¨  ±xº®­³´º®¾·º®¾zº®  ∙ ² ¶ ±xº®­¥º®¾xº® µ ¶ zº®            (34) 
Dehydration of 2PG: The enzyme enolase (ENO) allows the interconversion of 
2PG and PEP, and its kinetics is modeled as a reversible Michaelis-Menten (Chassagnole 
et al., 2002):  
7U¿À = 789:3Á ∙ =26Â − =636; 3Á;83Á26Â  ∙ Ã1 + =636;83Á636 Ä + =26Â           (35) 
PYR cleavage: PYR can be converted into AcCoA using two different enzymes: 
Pyruvate dehydrogenase complex (PDHC) or Pyruvate formate lyase (PFL). The first one 
is associated with an oxidative process, which generates one molecule of NADH, while 
PFL is activated under anaerobic conditions and does not produce NADH. In addition, 
PDHC is negatively regulated by NADH, which makes this enzyme inactive under 
fermentative conditions (Sawers & Clark, 2004). Therefore, PFL is expected to be the 
only active enzyme that performs this step under fermentative conditions. The kinetics of 
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PFL has been modeled as a ping-pong mechanism by Knappe et al. (Knappe et al., 1974), 
which expression is given below:  
7X =  7I89:6$\  ∙ =6Å ∙ =='e=6Å∙=='e+;86$\6j7 ∙=='e+;86$\='e∙=6Å − 7789:6$\  ∙ =e!='e ∙ =$'78=e!='e∙=$'78+;86$\e!='e∙ =$'78+;86$\$'78∙=e!='e     
(36) 
Under anaerobic fermentation of glycerol, formate was not detected (Dharmadi et 
al., 2006) causing the second term  to be negligible. 
Reduction of AcCoA: Alcohol dehydrogenase, encoded by adhE, is able to 
catalyze the conversion of AcCoA into acetaldehyde (ACALD), and then ACALD into 
ethanol. This first reaction, acetaldehyde dehydrogenase (ALDH), has been modeled as a 
bi-uni-uni-uni ping-pong mechanism (Shone & Fromm, 1981). While an explicit 
expression of the reverse reaction is presented in this paper, the forward reaction is 
obtained from Segel (Segel, 1975). Both reactions are simplifications from the original 
mechanism, assuming absence of products or absence of substrates, respectively. All 
kinetic parameters are obtained from Shone and Fromm (Shone & Fromm, 1981), except 
for the case of Kia, a kinetic constant of this mechanism (see details in Segel, 1975). 
Concentration of Coenzyme-A (CoA) was also considered as a constant. The kinetic 
expression results having the following equation: 
7X¢£
= 7)*X¢£ ∙ =Æ;8X¢£Æ + =Æ ∙ 1 + ;8X¢£¿¢£=¿¢£ + ;8X¢£¿¢£ ∙ =X¢;) ∙ =¿¢£  −
7)*X¢£; X¢£
∙ =X¢ ∙ =¿¢ ∙ =À;) ∙ ;¿¢ ∙ =Æ + ;À ∙ =X¢ ∙ =¿¢ + ;¿¢ ∙ =X¢ ∙ =Æ + ; X¢ ∙ =¿¢ ∙ =Æ + =X¢ ∙ =¿¢ ∙ =Æ  (37) 
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Reduction of acetaldehyde: ACALD is reduced into ethanol by the enzyme 
alcohol dehydrogenase (ADH), which has been modeled as reversible Michaelis Menten 
(Membrillo-Hernandez et al., 2000): 
 7¢£ =  ¸¥¦§c«¬·c«¬c±c¯« ∙ c±c¯« ±ÇÈÉ¬­³´c«¬¶ ±c±c¯«­¥c«¬c±c¯«¶ ±ÇÈÉ¬­¥c«¬ÇÈÉ¬     (38) 
Cell growth: The specific growth rate ( Ê ) was adjusted using Monod equation 
(see equation 39), where Ê)* is the maximum specific rate and ;8 ¡¸ÆËpÌis the Monod 
coefficient. Biomass production was calculated from the specific growth rate according to 
equation 40: 
Ê = Í¥¦§∙®¯°± ³§È·®¯°±®¤ÎÏÈÐ¶®¯°± ³§È              (39) 
Ê = 1_ ∙ >_>"                                (40) 
Mass Balances: ODE 
Once all the kinetic equations are defined, these rates are integrated in a system of 
ODEs. The ODEs for a batch system are listed below. Equations for substrates and 
products are divided by the density, as they are presented in different units than internal 
metabolites.  
 
Ñ ÒÓÔÕÖ ×ØÙÑÚ  = -rGlpF · X/density          -- Substrate        (41)  
Ñ ÒÓÔÕÖÑÚ  = rGlpF – rglyDH - µ · CGLYC    (42) 
Ñ ÒÛÜÝÑÚ  = rglyDH - rDHAK - µ  · CDHA    (43) 
Ñ ÒÛÜÝÞÑÚ  = rDHAK – rTPI - µ · CDHAP    (44)  
Ñ ÒÓÝÞÑÚ  = rTPI - rGAPDH - µ · CGAP    (45) 
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Ñ ÒÞÓÞÑÚ  = rGAPDH – rPGK - µ · CPGP    (46) 
Ñ ÒzÞÓÑÚ  = rPGK - rPGM - µ · C3PG     (47) 
Ñ ÒxÞÓÑÚ  = rPGM – rENO - µ · C2PG     (48) 
Ñ ÒÞßÞÑÚ  = rENO – rDHAK - µ · CPEP     (49) 
Ñ ÒÞÕàÑÚ  = rDHAK – rPFL - µ · CPYR    (50) 
Ñ ÒÝáÖâÝÑÚ  = rPFL – rALDH - µ · CAcCoA    (51) 
Ñ ÒÝÖÝÔÛÑÚ  = rALDH - rADH - µ · CACALD    (52) 
Ñ ÒßÙãÜÑÚ  = (rADH) · X/density             --Product  (53) 
Ñ äÑÚ  = µ · X                                        --Biomass  (54) 
This system of ODEs was solved using Matlab v7.11.0 (R2010b, The Mathworks, 
Inc.), using function ode23t (suitable for moderately stiff problems). Concentration of 
ATP and ADP were kept constant as these metabolites are unbalanced in the modeled 
pathway. Concentrations of ATP, ADP, NADH and NAD were taken from the model of 
glucose metabolism, with values of 4.27 mM, 0.595 mM, 0.1 mM, and 1.47 mM, 
respectively  (Chassagnole et al., 2002). Concentration of the coenzyme-A (CoA) was 
assumed constant and equal to 0.1 mM. Initial concentrations of other metabolites were 
assumed to be 0.1 mM, although this assumption does not affect the response of the 
system after one minute of simulation. The total time of simulation was 100 hours. See 
Appendix 0 for details. 
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4.2 Parameters estimation: In vitro, in silico and optimization 
 The problem of finding reliable parameters for the model is non-trivial. While it is 
desirable to know the in vivo parameters, in practice there is no sufficient technology that 
allows do that, and in vitro or in silico experiments approach the real values. In vitro 
parameters are obtained in three defined steps: 1) assignments of a rate law, 2) 
measurements of involved molecules, and 3) parameter calibration (Dreger et al., 2009). 
Since this procedure requires studying an isolated part of the system, and also assuming 
one specific rate law, differences with respect to the in vivo parameters are expected. To 
obtain the maximum rate using in vivo information, data of internal metabolites 
concentration together with the kinetic expressions are used (Rizzi et al., 1997). On the 
other hand, parameters can be calculated by defining a model, and then finding the 
parameter values that allow representation of experimental observations in the best 
possible way (optimization). Different strategies have been proposed to solve the problem 
of the optimization, among them Monte Carlo methods (random optimization) and 
Evolutionary Algorithms (Dreger et al., 2009). Different models differ in complexity and 
performance and, depending on the system to be modeled, one or another method may be 
more convenient (Dreger et al., 2009). Whereas in vitro parameters and optimization 
attempt to solve the same problem, often differences are found, and optimized parameters 
differ even in several orders of magnitude with respect to in vitro parameters 
(Chassagnole et al., 2002; Teusink et al., 2000). In this work, I combined both approaches 
to find parameters for the glycerol fermentation model. 
Values from literature were used as an initial approach, followed by sensitivity 
analysis and optimization of relevant parameters. For Michaelis –Menten parameters, the 
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approach was to use in vitro information from E. coli when available. For maximum rate 
parameters there were two main strategies: 1) for glycolytic enzymes shared with glucose 
fermentation, parameters from Chassagnole et al. were used (Chassagnole et al., 2002), 
which were calculated using measurements of metabolites in addition to the kinetic rate 
laws and optimization; 2) for others enzymes, which are specific to glycerol utilization 
(glyDH and DHAK) and ethanol synthesis (ALDH and ADH), information of specific 
activity in vitro from experiments in our group was used.  
A sensitivity analysis was performed over all the parameters in order to increase 
the quality of these, using a Matlab program (Garcia, 2002). Some parameters have been 
shown to have a different value in modeling optimization (Chassagnole et al., 2002), 
others were obtained in different experimental conditions, and a third group was 
proposed in this paper. The sensitivity analysis allowed identifying the parameters that 
have an influence over the three measured variables (glycerol, ethanol, and biomass). As 
a result of this, the following parameters were identified:  7)* ¡¢£ , ;8 ¡¢£¢£  , ;  ¡¢£ , 
7)*¢£·, ;8¢£· , Ê)*, and ;8 ¡¸ÆËpÌ. Among these parameters, the Michaelis-Menten 
constants were considered more reliable than the maximum rates. In addition, Ê)* has 
been calculated from the anaerobic fermentation of glycerol (Murarka et al., 2008), while 
in contrast there is no reliable data for ;8 ¡¸ÆËpÌ. Therefore, an optimization was 
performed over 7)* ¡¢£, 7)*¢£·, ;8 ¡¸ÆËpÌ. First, random parameters were generated in 
order to identify the range of best fit for these three parameters. Then, a grid was 
prepared in order to find the values of these three parameters that minimized the error 
(difference between simulated and experimental concentrations of glycerol, ethanol and 
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biomass). The resulting parameters are presented in Table 3, along with all the other 
kinetic parameters used in this model and their sources. 
Table 3: Kinetic parameters for glycerol fermentation in E. coli. 
 
Reaction Parameters Source 
GlpF D = 1 This study.  
glyDH 7)* ¡¢£ = 1.33 mM/s ;8 ¡¢£ ¡ = 56 8 ;8 ¡¢£¢£ = 0.3 8 ;  ¡¢£ = 0.006977a 
This study. 
(Subedi et al., 2008). 
 (Subedi et al., 2008). 
(Subedi et al., 2008).  
DHAP
K 
7)*¢£· = 0.72 mM/s ;8¢£ = 45 ∙ 10{8 This study.  (Gutknecht et al., 2001). 
TPI 7)*¹ = 68.7 8/ê ; ¹ = 0.04 ;8¹¢£· = 2.8 8 ;8¹ = 0.3 8 
(Chassagnole et al., 2002). 
(Babul et al., 1993). 
(Babul et al., 1993). 
(Babul et al., 1993) 
GAPD
H 
7)*¢£ = 921.6 8/ê ; ¢£ = 0.67  ;8¢£ = 0.15 8 ;8¢£  = 0.1 8 ;8¢£¿¢ = 0.45 8 ;8¢£¿¢£ = 0.02 8 
(Chassagnole et al., 2002) 
(Bakker et al., 1997). 
(Bakker et al., 1997). 
(Bakker et al., 1997). 
(Bakker et al., 1997). 
(Bakker et al., 1997). 
PGK 7)*· = 3021.778/ê ; · = 1800 ;8·¢ = 0.18 ;8· = 0.24 8 ;8·  = 0.006 ;8·{  = 0.17 
(Chassagnole et al., 2002). 
(Ni & Savageau, 1996). 
(Molnar & Vas, 1993).  
(Fifis & Scopes, 1978).  
(Lavoinne et al., 1983).  
(Schmidt et al., 1995).  
PGAM 7)*( = 89.0497 8/ê ; ( = 0.1 ;8({  = 0.2 mM ;8(y  = 0.369 8 
(Chassagnole et al., 2002). 
(Pettersson, 1990). 
(Britton et al., 1972). 
(Grana et al., 1989).  
ENO 7)*U¿À = 330.448 8/ê ; U¿À =6.7 ;8U¿Ày  = 0.1 8 ;8U¿ÀU = 0.135 8 
(Chassagnole et al., 2002). 
(Bakker et al., 1997).  
(Spring & Wold, 1971). 
(Duggleby, 1994). 
PFL 7¸ )*X =656 mM 
 7ë)*X = 0.46 ∙ 7¸ )*X /1.33  ;8X¡¸ = 2.05 8 ;8XÆ = 0.0068 8 ;8XÆ¸ = 24.5 8 ;8XÆ = 0.051 8 
Calculated from Zhu and Shimizu (Zhu & Shimizu, 
2004)  
Calculated from data presented in Knappe et al. 
(Knappe et al., 1974). 
(Knappe et al., 1974). 
(Knappe et al., 1974). 
(Knappe et al., 1974). 
(Knappe et al., 1974). 
ALDH 7)*¢£ = 2311 8 ; ¢£ = 1 ;8¢£Æ = 0.007 8 ;8¢£¿¢£ = 0.025 8 ;) = 1 
This study. 
(Hoefnagel et al., 2002). 
(Shone & Fromm, 1981). 
(Shone & Fromm, 1981). 
This study. 
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;8¢£¿¢ = 0.080 8 ;8¢£Æ = 0.008 8 ;8¢£p) = 10.0 8 
(Shone & Fromm, 1981). 
(Shone & Fromm, 1981). 
(Shone & Fromm, 1981). 
ADH 7)*¢£ = 2311 8/ê ; ¢£ = 12354.9  ;8¢£p) = 5.4 8 ;8¢£UpÀ£ = 2.4 8 
This study. 
(Hoefnagel et al., 2002) 
(Membrillo-Hernandez et al., 2000). 
(Membrillo-Hernandez et al., 2000). 
Bioma
ss 
µmax= 0.04/3600 s
-1 ;8 ¡¸ÆËpÌ= 159.2 mM 
Density = 476.762
b
 
(Murarka et al., 2008) 
This study 
(Sundararaj et al., 2004) 
a
 By deﬁnition, KeqglyDH = (CDHA eq/Cgly eq) = (7ìíî _ë ¡¢£ / 7ìíî _¸ ¡¢£ ) (;8 ¡¢£¢£ / ;8 ¡¢£ ¡ ). Here KeqglyDH was 
calculated as (kcat f /kcat r) (;8 ¡¢£¢£ / ;8 ¡¢£ ¡ ) given that kcat = rmax /[E], where [E] is the enzymatic 
concentration. 
b
Density appears in Equations (41) and (53) as a conversion factor to use biomass in proper units. It 
was calculated using data from CyberCell Database (CCDB) (Sundararaj et al., 2004). Density ¼ 
cell-dry-weight/cell-cytoplasm-vol = 3*10
-13
 g / 6.7*10
-6
 L. 
 
4.3 Results of modeling 
Figure 29 shows the solution to the system of ODEs for glycerol, ethanol, and 
biomass, and compares them to experimental data. Data at time zero was not included to 
adjust the curves, and predictions of biomass in the interval zero to 12 hours are an 
extrapolation using the model. The model is able to describe correctly glycerol 
metabolism, ethanol production, and biomass. Also, simulated glycerol utilization shows 
a smooth curve in the late stages in agreement with experimental data, being it a direct 
consequence of using simple diffusion in the kinetic expression for glycerol transport. In 
contrast, when a Michaelis-Menten kinetics was tested for the transport of glycerol (in 
accordance with report from Voegele et al. (1993)), there was an abrupt decrease in 
glycerol concentration at later stage of fermentation (results not shown), which is in 
disagreement with experimental data. The fact that the simulated curve for ethanol is 
above experimental data in late stages can be attributed to evaporation of ethanol in 
experimental measurements and exclusion of by-products.  
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Figure 29: Glycerol fermentation by E. coli. Experimental concentration of glycerol (blue circles), ethanol (red 
squares) and cells (green triangles). Simulated concentration of glycerol (blue dashed line), ethanol (red 
continuous line) and biomass (green dotted line).  
   
Figure 30 presents predictions for internal metabolite concentrations. The internal 
metabolite concentrations can be classified into two main groups based on their 
concentrations similarities throughout the fermentation. The first group, which includes 
3PG, PEP and AcCoA (dashed lines in Figure 30), corresponds to metabolites that 
experience an almost step-increase in concentration at the beginning of the fermentation, 
and then their concentration exponentially decreases converging to a value close to 1 
mM. However, it is noteworthy that the most dramatic decreases in the concentrations of 
these intracellular metabolites takes place within the first 24 hours, during which the cells 
have not reached the exponential growth phase.  Once exponential growth has been 
reached, these metabolites appear to be in quasi-steady state as the change in their 
concentrations is small compared to that of the extracellular metabolites (Figure 30).  
Interestingly, the concentrations of these metabolites were also reported to change in a 
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coordinated manner in response to changes in the metabolism of glucose (Schaub & 
Reuss, 2008). The second group of metabolites, which includes DHA, DHAP, 2PG, 
ACALD, PYR, GAP and PGP (continuous lines in Figure 30), corresponds to metabolites 
that are not predicted to have dramatic changes in their concentrations throughout the 
fermentation period. Overall, after 24 hours all internal metabolites are considered to 
have achieved a quasi-steady state, as the change in their concentrations is less than 2% 
the change in concentrations of external metabolites (glycerol and ethanol). Internal 
concentration of glycerol was not included in Figure 30 because it has the same behavior 
(and values) of external glycerol concentration, which is caused by the high value of the 
Michaelis-Menten constant of the enzyme glyDH. 
 
Figure 30: Prediction of changes in the concentration of intracellular metabolites. Two groups of intracellular 
metabolites are distinguished for the behavior: group 1 (3PG, AcCoA and PEP), dashed lines, have the greater 
variation during first 24 hours, and group 2 (DHA, DHAP, GAP, PGP, 2PG, PYR and ACALD), continuous 
lines, have lower concentrations and they remain in quasi-steady state during the fermentation. Reactions: 
ADH, acetaldehyde dehydrogenase; ALDH, alcohol dehydrogenase; DHAK, dihydroxyacetone kinase; E'O, 
enolase; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; glyDH, glycerol dehydrogenase; GlpF, glycerol 
transport; PFL, pyruvate formate-lyase; PGM, phosphoglycerate mutase; PGK, phosphoglycerate kinase; TPI, 
triose phosphate isomerase. 
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4.4 Metabolic control analysis of the fermentative utilization of glycerol  
 MCA is a theory developed to elucidate the control structure of a metabolic 
pathway. The main concept that arises from this theory is the Flux Control Coefficients 
(FCCs), as they represent the normalized change in each flux given an infinitesimal 
change in an enzyme concentration. The flux-control summation theorem stipulates that 
the sum of all the FCCs of one flux J is equal to one. Because of this, a FCC close to one 
means that the corresponding enzyme is the rate-limiting of the system, although more 
frequently the control of the flux is distributed among more than one enzyme (Fell, 
1998). FCCs are properties of the metabolic system. 
The cyclic pathway in the glycerol fermentation pathway presented in Figure 28 
falls into the classification of conserved cycle, because the total concentration of its 
components does not change. This cycle can be treated as a mioetyc cycle because there 
is a conserved component in the cycle (the three carbon chain with one aldehyde group) 
that is neither synthesize nor breakdown (Sauro, 1994) For a system where moiety-
conserved cycles are present, Hofmeyr et al. presented the theories that allow calculating 
FCCs using a matrix system. See Material and methods (chapter 3) for the theory and 
Appendix 10.1 for the matrix system applied to the glycerol fermentation pathway. 
Elasticities were calculated using the kinetic expressions for each reaction, and using 
predicted values of internal metabolites from quasi-steady state, at time equal to 50 hrs 
(Figure 30). This point was considered quasi-steady state because the concentration of 
intracellular metabolites changes at a rate that is less than 2% of that of external 
metabolites. The resulting FCCs calculated using this approach are shown in Figure 31. 
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Figure 31: Calculated Flux Control Coefficients (FCCj, where j represents the reaction specified by the listed 
enzyme) for the glycerol fermentation pathway represented in Figure 28. Reactions: ADH, acetaldehyde 
dehydrogenase; ALDH, alcohol dehydrogenase; DHAK, dihydroxyacetone kinase; E'O, enolase; GAPDH, 
glyceraldehyde 3-phosphate dehydrogenase; glyDH, glycerol dehydrogenase; GlpF, glycerol transport; PFL, 
pyruvate formate-lyase; PGM, phosphoglycerate mutase; PGK, phosphoglycerate kinase; TPI, triose phosphate 
isomerase. 
 
 
Discussion of limiting steps 
Values of FCCs reveal that the control of the flux in the glycerol fermentation 
pathway is shared by two steps: glyDH and DHAK, with values of FCC 0.44 and 0.56, 
respectively. All other FCCs have null (or near to null) values, meaning that no control is 
performed by the corresponding enzymes. These findings reveal a very different control 
structure than found for similar analyses of glucose metabolism.  For example, using a 
kinetic model Chassagnole and collaborators calculate the FCCs of glucose respiration in 
E. coli, and they reported that for glucose metabolism the control of the flux through the 
pathway is mainly in the phosphotransferase system (PTS), with an FCC of 0.4, and in a 
smaller but still significan degree in the enzymes phosphofructokinase (PFK), glucose-6-
phosphate dehydrogenase (G6PDH), and pyruvate dehydrogenase (PDH), due to their 
inhibtory effects on the PTS (Chassagnole et al., 2002).  In addition, Koebmann and 
collaborators used an experimental approach to study the control structure of E. coli in 
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glucose respiration, and they have postulated that the majority of control of the glycolytic 
flux resides outside of the pathway, with the enzymes that hydrolyze ATP, as the authors 
were able to significantly increase the glycolytic flux through the specific induction of 
ATP hydrolysis (Koebmann et al., 2002).  Both of these findings using glucose contrast 
the control structure elucidated for glycerol metabolism, as the transport reaction for 
glycerol (GlpF) was found to have very little control on the overall flux, and two key 
pathways enzymes, glyDH and DHAK, were found to have nearly total control of the 
overall pathway flux. 
Based on the results of the MCA for glycerol fermentation in E. coli (Figure 31), 
it is predicted that changes in the enzymes glyDH and DHAK will reduce the time of 
glycerol fermentation toward the production of ethanol in E. coli, while overexpression of 
other enzymes involved in the pathway will have no effect in this metabolic process.  
4.5 Experimental verification  
The purpose of this section is to corroborate the predictions performed using the 
MCA, in which it was proposed that overexpression of the enzymes glyDH and DHAK 
should accelerate the fermentation of glycerol toward ethanol, and overexpression of 
other enzymes of this pathway should not affect the rate of glycerol consumption and 
ethanol production.    
Experiments were performed by collaborator James Clomburg in order to 
corroborate the effect of overexpressing DHAK, glyDH, and both. Figure 32 shows the 
effect in glycerol consumption and ethanol production when the enzymes glyDH and 
DHAK were overexpressed. It is clear that both enzymes have a noticeable effect in 
reducing the time to ferment glycerol. The effect of increasing DHAK is bigger than 
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increasing glyDH, in agreement with values of FCCs of these two enzymes. In addition, 
overexpression of both enzymes has a synergistic effect over this process, as the time to 
ferment glycerol decrease more than the simple addition of time reduction in the 
overexpression of these enzymes separately. Table 4 shows the measured enzyme 
activities and metabolic fluxes for strains for the control strain (MG1655 pZSblank), and 
for strains overexpressing glyDH (MG1655 pZSgldA), DHAK (MG1655 pZSKLM), or 
both (MG1655 pZSKLMgldA). The increase of metabolic fluxes for glycerol 
consumption and for ethanol production is maximal for the overexpression of glyDH and 
DHAK. 
 
 Figure 32: Effect of overexpressing enzymes glyDH, DHAK, and both (glyDH_DHAK) in the fermentation of 
glycerol in E. coli. Concentrations of glycerol (circles) and ethanol (squares) are shown. Results are compared to 
wild type (WT). Experiments were performed by James Clomburg. 
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Table 4: Enzyme activities and glycerol-utilization and ethanol-synthesis fluxes for wild-type MG1655 and 
strains overexpressing glycerol-utilization enzymes. Experiments and calculations were performed by James 
Clomburg. 
Strain 
 
Enzyme activity
a
 Metabolic fluxes
b
 
glyDH DHAK 
Glycerol 
utilization 
Ethanol 
synthesis 
MG1655 
(pZSblank) 
0.114±0.002 0.0157±0.001 4.6±0.7 4.1±0.5 
MG1655 
(pZSgldA) 
0.62±0.03 NM 4.3±0.9 3.9±0.8 
MG1655 
(pZSKLM) 
NM 0.028±0.03 6.4±0.9 6±2 
MG1655 
(pZSKLMgldA) 
0.41±0.01 0.037±0.001 10.7±0.8 10±1 
a
 Activities (µmol/mg protein/min) were measured during active growth as described in Materials 
and Methods. 'M: not measured. 
b
 Fluxes (mmol/g CDW/h) represent average values for fluxes calculated during the active growth 
phase. 
 
Finally, to further demonstrate that the control of the metabolic pathway is not 
shared with the other enzymes that were predicted to have FCCs close to zero, 
experiments increasing expression of genes tpiA, adhE and glpF (separately) were 
performed, resulting in no apparent change after 72 hours of fermentation. These results 
confirmed that these enzymes do not have participation in the control structure of 
glycerol fermentation (Figure 33). 
   
Figure 33: Effect of overexpression of enzymes/proteins involved in glycerol metabolism. Overexpression of 
genes glpF, tpiA, pflB and adhE. Concentrations of glycerol (circle) and ethanol (square) are shown. 
Experiments were performed by James Clomburg. 
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4.6 Conclusions 
A kinetic model for glycerol fermentation in E. coli was developed. The model 
includes the main 11 reactions that allow the conversion of glycerol into ethanol, a 
process that is NADH balanced and generates ATP. One interesting property of this 
metabolic pathway is the appearance of a cycle, as the second reaction, phosphorylation 
of DHA to produce DHAP, is catalyzed by a PEP-dependent kinase that also converts 
PEP into PYR.  
The model is able to correctly represent the utilization of glycerol and synthesis of 
ethanol and biomass. In addition, the model was used to identify the control structure of 
the pathway, indicating that reactions glyDH and DHAP are the limiting steps in glycerol 
fermentation in E. coli. Experiments were conducted to corroborate these results. It was 
found that separate overexpression of glyDH and DHAK accelerate the fermentation of 
glycerol, being DHAK the one that has a bigger impact in accordance with the FCCs 
values. The combined overexpression of both enzymes has a higher impact in increasing 
the fermentation rate of glycerol than the mere addition of overexpressing enzymes 
glyDH and DHAK separately. In addition, overexpression of other enzymes in the 
pathways did not affect the kinetics of glycerol fermentation, which further corroborates 
the predictions of the model. 
In conclusion, the use of metabolic control analysis combined with kinetic 
modeling is a powerful tool to guide rational strain design to optimize the synthesis of 
desired products. For example, the kinetic model presented in this chapter was developed 
using only kinetic equations from the literature and measurements of the external 
concentrations of glycerol, ethanol and biomass. This information was later used to 
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optimize the kinetic parameters, predict internal metabolite concentrations, and calculate 
flux control coefficients, which were used to decide which genes needed to be 
overexpressed in order to reduce the fermentation time for glycerol conversion to ethanol. 
Thus, the implementation of a kinetic model is useful in saving time and resources in 
experimental work. 
In summary, the main results and findings presented in this chapter are: 
• Implementation of a kinetic model of the fermentative metabolism of 
glycerol in E. coli. The model consists of 11 reactions that represent the 
conversion of glycerol into ethanol, the main product of this process. 
• Optimization of parameters in the model, by using sensitivity analysis and 
minimizing the error between predictions and experimental data for 
external variables (glycerol, ethanol and biomass). 
• Predict internal metabolite concentrations. 
• Identification of the control structure of the fermentation of glycerol, by 
calculating flux control coefficients, which identified that the enzymes 
glyDH and DHAK share the control of the flux through the pathway. Use 
of these results to predict changes in the production of ethanol after 
overexpressing key genes. 
• The results were experimentally validated by a collaborator, and the 
experimental production rate of ethanol doubled its original value after 
overexpressing genes associated with glyDH (gldA) and DhaK (dhaKLM). 
Overexpression of other genes was tested and, as predicted, it did not have 
an impact on the production rate of ethanol.   
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5 Results II: Genome-scale modeling of the fermentative 
metabolism of glycerol and assessment of its potential as a 
platform for fuel and chemical production 
This chapter presents the study of glycerol fermentation in E. coli using a genome 
-scale model (GEM) as a mean to study the metabolism from a comprehensive approach. 
The most recent GEM model for E. coli, named iJO1366, was used as a base to model 
fermentative metabolism of glycerol in this organism (Orth et al., 2011). Flux Balance 
Analysis (FBA) was used to predict flux distribution and cell growth by maximizing 
biomass production (called Biomass Objective Function, of BOF). The use of a GEM to 
study glycerol in E. coli has two main purposes: 1) to understand which products and 
reactions are important in this metabolic process, and 2) to develop strategies for the 
production of desired fuels and chemicals.  It was of special interest to identify which 
secondary pathways would allow the production of 1,2-PDO, a product that has been 
suggested as essential to achieve redox balance when biomass is produced and whose 
production pathway is not well established (Gonzalez et al., 2008). Unlike the kinetic 
model presented in the previous section, in which one of the assumptions was that 
glycerol is used exclusively to produce ethanol (the scenario using rich medium), in this 
analysis I used a GEM to simulate the use of minimal medium. It is important to note that 
experimental efforts for using minimal medium for glycerol fermentation have been 
unsuccessful in wild-type E. coli, although two strategies had led to ferment glycerol in 
minimal medium: engineering a strain to overproduces 1,2-PDO or modifying the 
medium by adding acetol, which leads to the synthesis of 1,2-PDO(Gonzalez et al., 
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2008). These results suggest that there is a correlation between the capacity to ferment 
glycerol in minimal medium and the capacity to produce 1,2-PDO. Thus, this analysis 
used a GEM to elucidate which pathways are associated with production of 1,2-PDO in 
order to achieve redox balance when biomass is produced. In addition, the GEM was 
used to determine the effect of deleting products and reactions, and to identify the 
function associated with key reactions. 
Another objective in the use of a GEM was to develop strategies for the 
production of desired fuels and chemicals from glycerol, besides ethanol. Products that 
were targeted in this analysis included native products (lactate, 1,2-PDO and succinate), 
and non-native products (1,3-PDO, butanol, propionic acid, and propanol). In all cases, 
the GEM model was used to evaluate the introduction and/or deletion of reactions that 
would result in an increased productivity yield of the desired products. The development 
of the strategies incorporated knowledge of pathways that would increase the yield of the 
desired products, as well as the utilization of mathematical optimization tools that would 
identify efficiently reactions that need to be removed. 
The following are sections of this chapter: 1) model implementation, 2) results A: 
understanding glycerol fermentation, 3) results B: assessing the capabilities of glycerol 
fermentation as a platform for the synthesis of fuels and chemicals, and 4) conclusions. 
Model implementation defines the external conditions that were simulated in the model, 
as well as its curation in order to model glycerol fermentation properly. Results I 
describes the predicted pathways for glycerol fermentation using a GEM, in good 
agreement with the experimental data, it proposes a pathway for the production of 1,2-
PDO, and it reviews the role of different reactions.  Results II describes simulations and 
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development of strategies for the production of 1,2-PDO, 1,3-PDO, succinate, lactate, 
butanol, propionic acid, and propanol. Finally, the conclusions discuss the implications of 
using this kind of model to increase the understanding of glycerol fermentation and to 
simulate genetic modifications. 
5.1 Model Implementation 
 
The implementation of the GEM to represent glycerol fermentation in E. coli 
requires three steps: 1) defining a starting GEM, 2) defining external conditions, and 3) 
curating the model. Below I elaborate in each of these points. 
5.1.1 Define a starting GEM.  
The genome scale iJO1366 for E. coli K-12 MG1655 was used as starting point, 
as it represents the most updated GEM for this bacterium (Orth et al., 2011). Table 5 
presents some of the properties of iJO1366. The model includes 1,366 genes; among 
them 1,328 have an experimentally based function and 38 have a computationally 
predicted function. These genes represent 91% of total genes/ORF with an assigned 
enzymatic function (Serres et al., 2004) (http://genprotec.mbl.edu/overview.html, updated 
on Aug 2007).  These genes support the production of 1,254 unique functional proteins, 
including complex enzymes and isoenzymes. The system has 2,251 reactions, which can 
occur in the cytoplasm, periplasm, or extracellular compartment. The presence of 
different cellular compartments requires the inclusion of transport reactions. In addition 
to protein-associated reactions, some reactions occur spontaneously. The correlation 
between experimental data and in silico results allowes the establishment of a growth 
associated maintenance (GAM) of 53.95 mmol ATP/gCDW/h and a non-growth 
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associated maintenance (NGAM) of 3.15 mmol ATP/gCDW/h. It is interesting to note 
that the previous model, named iAF1260, contains a higher value of GAM and NGAM, 
which indicates that different sets of experimental data may result in different 
calculations of these parameters. However, from a modeling point of view, the values 
used in the model iJO1366 were considered sufficient for the purpose of this section, 
while it is acknowledged that a more accurate set of these values (specific for glycerol 
fermentation) would increase the quantitative prediction power of the model. 
Table 5: Main properties of the GEM iJO1366 (Orth et al., 2011). 
Included genes 1366 
      Experimentally based function 1328 
      Computationally predicted function 38 
Unique functional proteins 1254 
Reactions 2251 
      Metabolic reactions 1473 
      Transport reactions 778 
      Exchange reactions 330 
Unique metabolites 1136 
 
5.1.2 Definition of External Conditions. 
In order to properly use this model to represent glycerol fermentation, it is 
necessary to adjust the external conditions and to curate the model. The external 
conditions were set to represent minimal medium under anaerobic conditions (no external 
electron acceptor). In a GEM, external conditions are defined by changing the lower 
bound limit of the corresponding exchange reaction, usually setting the value to -1000 
mmol/gCDW/h for non limiting nutrients. Table 6 shows a list of the nutrients that were 
considered as part of the minimal medium, with the corresponding exchange reaction and 
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lower bound, as defined elsewhere (Feist et al., 2007; Orth et al., 2011). Glycerol was the 
only limiting nutrient, and its value was set to -20 mmol/gCDW/h.   
Table 6: External conditions for the GEM to represent glycerol fermentation. All reactions correspond to 
“exchange” reactions, which represent the presence of these molecules in the medium. 
 
Exchange Reaction Lower bound 
(mmol/gCDW/h) 
Exchange Reaction Lower bound 
(mmol/gCDW/h) 
Calcium exchange -1000 Sodium exchange -1000 
Chloride exchange -1000 Ammonia exchange -1000 
Co2+ exchange -1000 Ni2+ exchange -1000 
Cu2+ exchange -1000 Phosphate exchange -1000 
Fe2+ exchange -1000 Selenate exchange -1000 
Fe3+ exchange -1000 selenite exchange -1000 
H+ exchange -1000 Sulfate exchange -1000 
H2O exchange -1000 tungstate exchange -1000 
K+ exchange -1000 Zinc exchange -1000 
Mg exchange -1000 Glycerol exchange -20 
Mn2+ exchange -1000 Cob(I)alamin exchange -0.01 
Molybdate exchange -1000   
 
5.1.3 Model curation 
Initially, no additional modifications were made to the model. However, the 
preliminary predictions of flux distribution and cell growth (using FBA) did not match 
experimental data at the redox balance level. Therefore, the model iJO1366 was curated 
to represent glycerol fermentation properly.  
As already discussed in the introduction of this thesis, the fermentation of 
glycerol by E. coli is particularly challenging because of the highly reduced nature of 
glycerol. The ethanol-1,2-PDO model has been proposed to explain glycerol fermentation 
in E. coli. The synthesis of ethanol from glycerol is NADH-balanced and hence supports 
generation of ATP through substrate-level phosphorylation in the glycolytic pathway. 
Conversion of glycerol to 1,2-PDO results in the consumption of the extra reducing 
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equivalents generated during cell growth on glycerol (Gonzalez et al., 2008). However, 
the initial use of FBA identified ethanol as the only essential fermentative product, and a 
non-permissible pathway under the simulated conditions was consuming the reducing 
equivalents generated during cell growth. A recursive process of identifying non-
permissible sinks for reducing equivalents and then eliminating them from the model 
resulted in the identification of the following pathways: 
a) Amino acid degradation and nucleotide degradation. 
b) Sulfate reduction. 
c) Iron reduction. 
d) Spermidine and 5-methylthio-D-ribose production. 
In addition to these modifications, other modifications were introduced to account 
for changes specific to the use of glycerol, or changes that were overseen by the starting 
model iJO1366. These modifications correspond to: 
e) Activation of formate hydrogen-lyase (FHL) toward formation of CO2. 
f) Irreversibility of reaction NADP-dependent glycerol-3-phosphate 
dehydrogenase. 
g) Removal of pyruvate synthase reaction linked to oxidation of flavodoxin. 
h) Modification of pyridine nucleotide transhydrogenase (PntAB). 
i) Essentiality of DHAK in glycerol fermentation. 
  
Modifications a) through d) were made to remove non-permissible electron sinks 
under the current conditions from the model. Below these modifications are explained in 
detail. 
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a) The first non-permissible pathway identified in the consumption of 
reducing equivalents was the simultaneous production and degradation of amino acids 
and nucleotides. Amino acids and nucleotides are essential cellular components, and 
therefore their production is required when a minimal medium is used. However, the 
simultaneous activation of synthesis and degradation pathways of these building blocks 
would be energetically expensive. In fact, the activation of enzymes involved in amino 
acids degradation is highly regulated (Reitzer, 2005) and degradation of nucleotides is 
also subject to regulation (Jensen et al., 2008). Therefore, the model was curated to 
eliminate all reactions catalyzed by enzymes unique to amino acid degradation and to 
nucleotide degradation. It is interesting to note that although FBA assumes that 
optimization of the production of biomass allows the prediction of flux distribution and 
cell growth, FBA uses linear optimization and cannot incorporate the non-linear effect 
that would result in incorporating specific enzyme production for each reaction. Inclusion 
of these non-linear factors would help to reject a solution that includes inefficiencies 
associated with the simultaneous production of enzymes for the synthesis and 
degradation of molecules. In other words, if a non-linear optimization model was used 
(which incorporates a burden associated with the production of enzymes in each active 
reaction), then the model would likely exclude the simultaneous use of biosynthetic and 
degradation pathways for amino acids and nucleotides, as it is inefficient. However, a 
non-linear problem would greatly increase the complexity of the system and finding a 
solution for a GEM would be impracticable.  
b) After removing the degradation of amino acids and nucleotides, in silico 
simulations using FBA used sulfate as an electron acceptor. While some organisms are 
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known to use sulfate as an electron acceptor for anaerobic respiration (Klenk et al., 1997; 
Matias et al., 2005), E. coli has not been reported to use sulfate as an electron acceptor. 
However, in silico results using FBA indicated that E. coli assimilate sulfur by converting 
sulfate into hydrogen sulfide. Therefore, in order to ensure fermentative conditions, the 
export of hydrogen sulfide was deleted as a way to prevent the respiratory utilization of 
sulfate. 
c) The presence of iron is intended as a nutrient in the minimal medium, 
although some organisms (including E. coli) are capable of using iron as an electron 
acceptor by oxidizing Fe(III) to Fe(II) (Appenzeller et al., 2005; Sugio et al., 1987). I 
modified the GEM to prevent the export of Fe(II), and therefore Fe(II) would be used 
only as a nutrient. 
d) Finally, simultaneous production of spermidine and 5-methylthio-D-ribose 
consumed reducing equivalents in some of the situations simulated using FBA, in a 
pathway that involves production of methionine, an essential amino acid. Experimental 
data support that spermidine is toxic and consequently E. coli does not accumulate it 
(Limsuwun & Jones, 2000). In addition, there is no experimental evidence that indicate 
production and accumulation of 5-methylthio-D-ribose in wild type E. coli for glycerol 
fermentation. Therefore, I decided to remove the exchange reactions of spermidine and 5-
methylthio-D-ribose, thus still allowing their production for other intracellular processes, 
but preventing their production as an end product.   
Modifications e) to h) were made to specific reactions in order to represent proper 
regulation under glycerol fermentation.  
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e) The reaction formate hydrogen-lyase (FHL) was considered unfeasible 
toward formation of CO2 and H in the original model (Feist et al., 2007; Orth et al., 
2011). However, this enzyme is active under acidic conditions and, in particular, it has 
been experimentally shown to be active in glycerol fermentation under optimal (acidic) 
conditions (Bagramyan et al., 2002; Murarka et al., 2008). Therefore, this reaction was 
modified in the model in order to allow conversion of formate into carbon dioxide and 
molecular hydrogen.  
f) The reaction NADP-dependent glycerol-3-phosphate dehydrogenase was 
considered as reversible in the iJO1366 GEM, but when glycerol is fermented this 
reaction is expected to be inhibited by glycerol-3-P (G3P), and for that reason the flux 
was modified to be irreversible toward production of G3P (Edgar & Bell, 1978).  
g) The pyruvate synthase reaction was included in the iJO1366 GEM 
associated with the oxidation of flavodoxin. However, experimental evidence associates 
this reaction with the oxidation of ferredoxin (and not flavodoxin) (Charon et al., 1999), a 
molecule that is not part of the GEM. Since there is no purpose in adding this reaction as 
this is the only reaction that uses ferredoxins, this reaction was eliminated from the 
model.  
h) The reaction pyridine nucleotide transhydrogenase (PntAB) converts 
NADH into NADPH using a proton exchange pump, was modified to do the conversion 
using transport of only one proton, and not two as included in the original GEM. 
Modification of PntAB was made to represent the reaction as it is more widely accepted 
(Fjellstrom et al., 1997; Pedersen et al., 2008).  
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i) Experimental information for the dissimilation of glycerol into DHAP was 
incorporated. Preliminary predictions of flux distribution using FBA and FVA identified 
two optimal pathways to metabolize glycerol into the glycolytic intermediate 
dihydroxyacetone phosphate (DHAP). Figure 34 shows the flux distribution in two 
scenarios for optimal solutions. The first pathway consisted of two steps, using a glycerol 
dehydrogenase and then converting the dihydroxyacetone (DHA) into DHAP by the 
action of the enzyme PEP-dependent DHAK. This pathway has been experimentally 
shown to have a key role in glycerol fermentation (Gonzalez et al., 2008).  The second 
pathway, which will be called the “fructose phosphate bypass” from here on, converts 
glycerol into DHAP in three steps that start with consuming glyceraldehydes-3-P and end 
with producing it again. The first reaction of the fructose phosphate bypass converts 
DHA and glyceraldehyde-3-P into fructose-6-P (F6P) by the action of a fructose-6-P 
aldolase (fsaA, fsaB). F6P is then phosphorylated into fluctose-1,6-bisphosphate (FDP) 
by a ATP-dependent phosphofructokinase (pfkA, pfkB) and FDP splits into DHAP and 
glyceraldehyde-3-P by the action of a fructose-bisphosphate aldolase (fbaA, fbaB). Both 
pathways achieve the conversion of DHA into DHAP with the same ATP efficiency, but 
the first pathway does it in one step through the PEP-dependent DHAK, while the 
fructose phosphate bypass does it in three steps in a PEP-independent manner, allowing 
more flexibility in lower stages of the glycolytic pathway. Preliminary results using FBA 
showed that DHAK was not essential (see fluxes in Figure 34), although experimental 
data have proven the importance of these enzymes (Gonzalez et al., 2008). Therefore, the 
model was modified to restrict the flux through the fructose phosphate bypass to up to 4 
mmol/gCDW/hr, wherein DHAK and glyDH become essential. This modification is also 
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supported by the fact that the control flux of the glycerol fermentation pathway is in 
reactions DHAK and glyDH, and overexpression of those enzymes results in increasing 
the flux of the overall pathway, indicating that the glyDH-DHAK is the main pathway 
(Cintolesi et al., 2012).   
 
Figure 34: Alternative optimal flux distributions in preliminary results for the conversion of glycerol into 
DAHP. Optimal solution 1 is marked in bold, and optimal solution 2 is underlined. Optimal solution 1 converts 
DHA into DHAP using mainly enzyme DHAK, while optimal solution 2 converts DHA into DHAP using only 
fructose phosphate bypass pathway. See 'omenclature for details (page 214). 
 
j) Finally, using Flux Variability Analysis (FVA) I identified three 
alternative pathways for the conversion of fructose-6-P (F6P) into DHAP and 
glyceraldehydes-3-P (GAP), as shown in Figure 35.  
• Pathway A converts F6P into DHA and GAP is catalyzed by the 
enzyme F6P aldolase (F6PA), and then DHA is phosphorylated to produce DHAP 
by the enzyme DHA phosphotransferase (DHAK), which is finally converted into 
GAP by the action of TPI.  
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• Pathway B phosphorylates F6P into fructose diphosphate (FDP) by 
the action of a phosphofructokinase (PFK), and FDP is converted into DHAP and 
GAP by the enzyme fructose bi-phosphate aldolase (FBPA) and finally DHAP is 
converted to GAP by TPI.  
• Pathway C combines erythrose 4-phosphate (e4p) and F6P to 
produce sedoheptulose 7-phosphate (S7P) and GAP by the action of the enzyme 
transaldolase, and then S7P is phosphorylated by phosphofructokinase (PFK_3) 
into sedoheptulose 1,7-bisphosphate (S17BP), which is then split into DHAP and 
e4p by the enzyme S17BP glyceraldehyde-3-phosphate-lyase (FBPA3). Finally, 
DHAP is converted into GAP by the action of TPI.  
These three pathways were identified with simulations of glucose fermentation 
(and hence the three pathways start from F6P, and intermediate of that metabolism), and 
their possible relevance for glycerol fermentation are analyzed below. The three 
pathways have the same net effect of converting F6P into GAP and DHAP, but pathway 
A does it in a PEP-dependent way, while pathways B and C perform this conversion in an 
ATP-dependent way. After analyzing the feasibility of these three pathways, I found that 
pathway A was relevant to this study, as DHAK has shown to be essential. Pathway B 
can combine with pathway A to produce glycolytic intermediates (DHAP and GAP) 
independent of conversion of PEP into PYR, and thus it seems reasonable to keep it. 
Pathway C, however, corresponds to the S7P bypass pathway, which uses some of the 
same enzymes as the traditional central carbon metabolism, and it seems more likely to 
active in the glucose fermentation, but not in glycerol fermentation (Nakahigashi et al., 
111 
 
2009). Therefore, for simplicity pathway C was no longer considered in the simulation 
for glycerol fermentation.  
 
Figure 35: Alternative pathways for the conversion of F6P to GAP. Pathway A goes through DHA, pathway B 
goes through FDP and pathway C goes through S17BP (sedoheptulose bisphosphate bypass). See 'omenclature 
for details (page 214). 
 
Hexanoate production was also removed from the model as this was not a product 
of interest in this study. 
The modifications presented in this section were implemented in the iJO1366 
model by modifying the upper and/or lower boundaries of the corresponding reactions, 
and a detail of these modifications is presented in the Appendix 10.2. The resulting model 
is referred to as glyc-GEM. The model was used to predict cell growth and flux 
distribution, and, when possible, these predictions were contrasted with available 
experimental data. Results generated using the glyc-GEM are also referred to as in silico 
results. The next two sections of this chapter present the results generated by the glyc-
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GEM to increase the understanding of glycerol fermentation, and to evaluate glycerol as a 
platform for the production of valuable chemicals. See Appendix 10.10 for details of the 
Matlab function of the model glyc-GEM. 
 
5.2 Results A: Understanding glycerol fermentation 
 
The glyc-GEM was used in combination with FBA to predict cell growth and 
product synthesis during metabolism of glycerol under fermentative conditions. 
Optimizing cell growth resulted in production of biomass at a specific growth rate of 0.15 
h-1. Table 7 presents a complete list of substrates/products of this simulation; many of 
which are consumed/produced in small amounts to satisfy cell growth requirements. The 
exceptions are consumption of glycerol (fixed at 20 mmol/gCDW/h), production of 
ethanol (15.48 mmol/gCDW/h), production of 1,2-PDO (2.21 mmol/gCDW/h), 
production of carbon dioxide (16.05 mmol/gCDW/h), production of hydrogen (16.12 
mmol/gCDW/h) and production of water.  
Table 7: Substrates and products of glycerol fermentation. Positive values correspond to production rates, and 
negative values correspond to consumption rates. 
 
Reaction Reaction name 
Consumption or production 
rate (mmol/gCDW/h) 
EX_12ppd-R(e) (R)-1,2-PDO exchange 2.210076 
EX_ca2(e) Calcium exchange -0.00078 
EX_cl(e) Chloride exchange -0.00078 
EX_co2(e) CO2 exchange 16.04787 
EX_cobalt2(e) Co2+ exchange -3.7E-06 
EX_cu2(e) Cu2+ exchange -0.00011 
EX_etoh(e) Ethanol exchange 15.48282 
EX_fe2(e) Fe2+ exchange -0.00124 
EX_fe3(e) Fe3+ exchange -0.00117 
EX_glyc(e) Glycerol exchange -20 
EX_glyclt(e) Glycolate exchange 0.0001 
EX_h(e) H+ exchange 1.478851 
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EX_h2(e) H2 exchange 16.11898 
EX_h2o(e) H2O exchange 6.246339 
EX_k(e) K+ exchange -0.02928 
EX_meoh(e) methanol exchange 3E-07 
EX_mg2(e) Mg exchange -0.0013 
EX_mn2(e) Mn2+ exchange -0.0001 
EX_mobd(e) Molybdate exchange -1.9E-05 
EX_nh4(e) Ammonia exchange -1.62002 
EX_ni2(e) Ni2+ exchange -4.8E-05 
EX_pi(e) Phosphate exchange -0.14469 
EX_so4(e) Sulfate exchange -0.03783 
EX_succ(e) Succinate exchange 0.049716 
EX_zn2(e) Zinc exchange -5.1E-05 
 
The in silico results presented in this section were compared with the 
experimental studies that have been done previously in order to understand glycerol 
fermentation in E. coli (Dharmadi et al., 2006; Gonzalez et al., 2008; Murarka et al., 
2008). The main topics that have been studied are glycerol dissimilation pathways, 
essential fermentative products, and the role of FHL. It is important to note that the first 
published study of glycerol fermentation was performed for E. coli K12 strain MG1655 
in rich medium (Dharmadi et al., 2006), and that subsequent studies have been done for 
the same strain in minimal medium supplemented with 2 g/L of tryptone (Gonzalez et al., 
2008; Murarka et al., 2008). In contrast, in silico analysis was done simulating minimal 
medium, and therefore some differences are expected. Here I will discuss how in silico 
results compare to previous experimental studies in terms of glycerol dissimilation, 
essential fermentative products, the role of FHL, and other single deletions that have been 
characterized.  
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5.2.1 Glycerol dissimilation 
Different experimental studies have been conducted to understand glycerol 
dissimilation pathways in E. coli. These studies have shown that the main pathway 
involves two enzymes: glycerol dehydrogenase (glyDH) and DHAK (Gonzalez et al., 
2008), which convert glycerol into DHA, and then DHA into DHAP.  
Figure 36 shows flux distribution of the trunk and auxiliary pathways that were 
simulated using FBA in this study. The trunk pathway is responsible for the conversion 
of glycerol into glycolytic intermediates, and the auxiliary pathways enable glycerol 
fermentation by providing reactions to produce ATP and to achieve redox balance 
(Gonzalez et al., 2008). The enzyme glycerol dehydrogenase (glyDH) converts glycerol 
into DHA, and then DHA is metabolized through two pathways: one that converts 83% 
of DHA into DHAP by the action of the enzyme DHAK, and another branch that 
converts 17% of the flux of DHA into DHAP through two intermediate (F6P and FDP). 
As most of the flux of glycerol dissimilation is incorporated into the glycolytic pathway 
using enzymes glyDH and DHAK, deletion of these enzymes was evaluated using the 
glyc-GEM. Simulation of deletion of any of these two reactions gave no valid solution, 
correlating well with the fact that experimental results have shown the essential role of 
these enzymes and that deletion of either one of them would result in no glycerol 
fermentation (Gonzalez et al., 2008). It is necessary to mention that the enzyme DHAK 
was not essential before restricting the fructose phosphate bypass flux (Figure 34), as that 
pathway could support the same achievement of ATP and conversion of DHA into 
DHAP. 
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Figure 36: Prediction of flux distribution using FBA. Figure includes central carbon metabolism and main 
fermentative products. See 'omenclature for details (page 214). 
 
Also, I explored the possible role of respiratory pathways in the fermentation of 
glycerol by E. coli using the glyc-GEM and I compared my in silico results with previous 
experimental studies. In previous studies the experimental deletion of genes glpA, glpD 
and glpK had been performed to study the role of associated reactions, all of which are 
involved in the respiratory metabolism of glycerol in E. coli (see Figure 7, page 26) 
(Gonzalez et al., 2008; Murarka et al., 2008). Gene glpK encodes enzyme glycerol 
kinase, and genes glpA and glpD encode enzymes glycerol-3-p dehydrogenase, anaerobic 
and aerobic, respectively. My simulations indicate that reactions associated with genes 
glpA (G3PD5, G3PD6, G3PD7) and glpD (G3PD5) and glpK (GLYK) were non-
essential, in agreement with experimental results presented by Murarka and collaborators 
(Murarka et al., 2008).   
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5.2.2 Essential Products 
Gonzalez et al. proposed a metabolic model for glycerol consumption associated 
with the production of ethanol and 1,2-PDO, which are essential products (Gonzalez et 
al., 2008). The results of flux predictions using the glyc-GEM supported their model. In 
fact, single knockout simulation of reactions alcohols dehydrogenase (ALDH, for 
production of ethanol) or methylglyoxal synthase (MGSA, for production of 1,2-PDO) 
resulted in no cell growth. Interestingly, while simulation of knockout of ALDH resulted 
in an unfeasible case, simulation of knockout of MGSA still allowed the model to find a 
solution in which production of ethanol was 20 mmol/gCDW/h (equal to the maximal 
theoretical yield) with no cell growth associated. These results indicated differences in 
the functional role of the production of ethanol and 1,2-PDO. While ethanol production is 
essential to satisfy minimal energetic requirements of the model in a redox balance 
manner, the role of 1,2-PDO production seems to be strictly associated with the 
consumption of the reducing equivalent generated during cell growth. This situation is 
shown in Figure 37, which shows the solution space associated with the production of 
ethanol, 1,2-PDO and biomass. The optimal solution (identified using FBA) corresponds 
to the highest production of biomass and lower biomass productions allow to produce 
ethanol and 1,2-PDO at different rates. The solution space shows graphically that 
production of ethanol is always essential, even if the specific growth rate is equal to zero 
(stationary phase), while production of 1,2-PDO is essential for optimal cell growth, but 
it is not necessary for cell growth. 
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Figure 37: Predicted solution space for the production of 1,2-PDO, ethanol and biomass in wild type E. coli. 
Continuous line corresponds to the simulated solution space of ethanol production, and dashed line corresponds 
to the simulated solution space of 1,2-PDO. 
 
FBA predicts production of ethanol at a yield of 0.77 mol/mol, and production of 
1,2-PDO at a yield of 0.11 mol/mol. In contrast, experimental data show production of 
ethanol at a rate of 0.92 mol/mol (19% higher than the modeled value) and 1,2-PDO at a 
very low yield (not specified) (Murarka et al., 2008). In addition, the model predicted 
specific growth rate of 0.15 1/hr, which is significantly higher than the 0.04 1/hr 
experimental result (Murarka et al., 2008). However, the big difference in the predicted 
specific growth rate is in part explained by the fact that in the model I assumed a different 
glycerol consumption rate (20 mmol/gCDW/h) than the experimentally found (7.8 
mmol/gCDW/h, calculated from Murarka et al., 2008). In fact, the ratio between glycerol 
consumption rate and specific growth rate using the model was 133 mmol 
glycerol/gCDW, versus an experimental value of 194 mmol glycerol/gCDW: only 31% 
smaller than the predicted value. Discrepancies in predicted result for ethanol, 1,2-PDO, 
and biomass were linked to each other. A simulated higher production of biomass 
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resulted in fewer resources to produce ethanol, at the same time that a higher production 
of biomass required a higher production of 1,2-PDO in order to consume the increased 
production of reducing equivalents from biomass. In addition, the glyc-GEM simulated 
growth in minimal condition at a fixed glycerol consumption rate, while experimental 
data correspond to growth under minimal supplemented data at a lower glycerol 
consumption rate. 
While the glyc-GEM successfully predicted the necessity of producing 1,2-PDO, 
the pathway that it used is different from the one that has been experimentally verified 
(Gonzalez et al., 2008). Figure 36 shows the pathway that FBA selected as the most 
efficient (optimal), which consists of two dehydrogenase steps from MG to lactaldehyde, 
and then from lactaldehyde to 1,2-PDO. Each of these steps consumes one molecule of 
NADH. In contrast, experimental evidence shows that the pathway that produces 1,2-
PDO in E. coli goes through hydroxyacetate, consuming one molecule of NADHP in the 
first step, and one molecule of NADH in the second step. Both pathways consume the 
same amount of reducing equivalents, but of different kinds. Deletion of the pathway 
going through lactaldehyde results in using a pathway going through hydroxyacetate with 
a slight reduction in cell growth prediction (3%), and with minimal impact in production 
of ethanol and 1,2-PDO. This result indicates that although a pathway for production of 
1,2-PDO going through lactaldehyde was identified as optimal, both pathways (going 
through lactaldehyde and hydroxyacetate) have a very similar outcome. 
In addition to the synthesis of ethanol and 1,2-PDO, previous experimental 
studies have evaluated the role of other  metabolic products. Deletion of pta and frdA, 
involved in the production of acetate and succinate respectively, were properly predicted 
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as non-essential by the glyc-GEM, in agreement with experimental results (Murarka et 
al., 2008). However, some differences need to be considered. For the case of acetate 
production, the glyc-GEM predicted no acetate production in the original case, and 
therefore no effect was observed in the simulations after deleting reaction PTAr 
(corresponding to gene pta: phosphate acetyltransferase). However, the experimental 
deletion of gene pta caused a reduction in growth rate of 29% (Murarka et al., 2008). In 
the case of gene frdA for production of succinate, in silico results showed that the 
associated reactions, namely FRD2 and FRD3, were not being used, although there was 
experimental evidence that succinate was being produced in small amounts. Surprisingly, 
experimental deletion of frdA resulted in an increase of specific growth rate of 43%, but 
this could be associated with a higher rate of glycerol consumption, which was not 
simulated using the glyc-GEM. While it may be difficult to use glyc-GEM to predict 
differences in specific growth rate if they are associated with changes in glycerol uptake 
rate (the glycerol consumption rate is fixed in the in silico simulations), experimental 
results support the findings that the phenotypes of the mutants with deletion of pta or 
frdA are indistinguishable from the phenotype of the wild-type E. coli (Murarka et al., 
2008). 
5.2.3 Role of FHL 
Simulation results also coincided with experimental data in identifying the 
enzyme formate-hydrogen lyase (FHL) as active in the dissimilation of formate to 
produce hydrogen and carbon dioxide (Dharmadi et al., 2006). It was proposed that the 
role of FHL in glycerol fermentation is to provide an acidic medium by increasing the 
concentration of carbon dioxide, which medium may be required for proper functioning 
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of enzymes or other processes. Interestingly, the in silico predictions indicated that FHL 
may have an energetic role linked to the conservation of protons, which could relate to 
the experimental function of keeping an acidic concentration of protons. Experimental 
deletion of FHL resulted in 70% reduction of glycerol fermentation and a 50% reduction 
in cell growth, while in silico deletion of FHL resulted in a reduction in cell growth of 
27% (using a constant glycerol consumption rate). Deletion of FHL in the glyc-GEM 
predicted an increase in the production of protons (from 1.5 to 12.2 mmol/gCDW/h), 
while formate production appeared at a value of 17.0 mmol/gCDW/h (previously zero). 
The additional protons generated in the glyc-GEM were exported by the model using the 
reaction ATP hydroxylase, which used ATP to export protons at a rate of 4.9 
mmol/gCDW/h (versus a rate of 0.9 mmol/gCDW/h before deletion of this reaction). This 
possitive correlation between energy and FHL has been reported experimentally by 
Akopian and collaborators  (Akopian et al., 2006), although in their experiments the ATP 
hydroxylase worked in the opposite direction (as ATP synthase). 
5.2.4 Production of 3-C intermediate metabolites 
The previous section shows the importance of production of DHAP by converting 
glycerol to DHA, and then DHA to DHAP. However, this pathway imposes a 
stoichiometric constraint as conversion of DHA to DHAP is linked to conversion of PEP 
to PYR, a later step in the glycolytic flux. Therefore, the production of 1,2-PDO as well 
as precursors for the production of biomass require an additional pathway that would 
allow redirection of 3C metabolites between DHAP and PEP (namely DHAP, GAP, Pgp, 
3Pg, 2Pg, and PEP) into other synthetic pathways. While this could be achieved using the 
enzyme PEP synthase that could convert PYR back into PEP using two phosphate groups 
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from ATP (one of them is released and the other one is transfer to PYR to produce PEP), 
in silico results identified a new pathway that could accomplish the generation of 3C 
intermediate metabolites in a more efficient way. This pathway, named the fructose 
phosphate bypass, is presented in Figure 36, and it converts glycerol into DHAP with no 
necessity to tie this conversion to the conversion of PEP into PYR. This new pathway 
converts DHA into DHAP going through F6P and FBP. 
The fructose phosphate bypass consists of three steps and incorporates GAP as a 
pseudo carrier. The first steps binds DHA and GAP to produce F6P by the action of the 
enzyme F6P aldolase, the second step phosphorylates F6P into FDP catalyzed by the 
enzyme phosphofructokinase, and the last step converts FDP into DHAP and GAP by the 
enzyme fructose bisphosphate aldolase. The first step can be performed by one of the two 
enzymes F6P aldolase that have been identified in E. coli: FsaA and FsaB, encoded by 
genes fsaA and fsaB respectively (Schurmann & Sprenger, 2001). It is interesting to note 
that although the physiological role of F6P aldolases in E. coli is unknown (Schurmann & 
Sprenger, 2001), the gene fsaB is encoded in the same transcription unit as gene gldA (see 
Figure 38, taken from Ecocyc website), whose physiological function has recently been 
elucidated as a component of glycerol fermentation (Gonzalez et al., 2008). The fact that 
the gene fsaB is in the same transcription unit as gene gldA indicates that the 
physiological function of fsaB may also be in glycerol fermentation, an option that is now 
supported by the in silico results from the glyc-GEM. It is of further interest that there is 
a third gene in this transcriptional unit, ptsA, which encodes a protein whose function has 
been predicted to be a component of a phosphotransferase system, similar to the system 
that glucose and other sugars need in order to be metabolized (Reizer et al., 1995). Thus, 
122 
 
the role of genes fsaB and ptsA, both encoded in the same transcription unit as gene gldA, 
may be linked to the fermentation of glycerol. Last, the new fructose phosphate bypass 
has the equivalent effect of an ATP-dependent DHAK, such as the one in Citrobacter 
freudii, which converts DHA into DHAP in one direct step that consumes one molecule 
of ATP.       
  
Figure 38: Transcription unit gldA-fsaB-ptsA in E. coli. The inclusion of these three genes in the same 
transcriptional unit suggests that they may be involved in the same process. The operon was taken from the 
Ecocyc website (Keseler et al., 2011). 
 
5.2.5 Study of essential genes/reactions 
In addition to those genes that were mentioned in previous sections, a complete 
study of essential genes of the model was conducted. Using single gene deletion the 
current study found that 15.7% genes were essential for cell viability (218 genes out of 
the 1366, see Appendix 10.4). I then focused on the reactions from the central carbon 
metabolism (Figure 36), and I performed a single reaction deletion (which often includes 
deletion of more than one gene). Results are summarized in Figure 39. As discussed in 
previous sections, reactions glyDH and DHAK were predicted to be essential by the 
model, as was the production of 1,2-PDO and ethanol. In addition to those reactions, all 
reactions involved in the glycolytic pathway for the transformation of DHAP up to 
AcCoA were also predicted to be essential, which is expected given that these reactions 
are required to produce ethanol and other essential intermediates. Deletions in the 
fructose phosphate bypass proved to be non-essential, although the predicted specific 
growth rate decreased by 16% after deletion of this pathway (see insertion in Figure 39), 
gldA ptsAfsaB
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and the reaction PEP synthase became active as a way to produce 3-C intermediates 
(although in a less efficient way, as this reaction consumes two phosphate groups from 
ATP, as oppose to the only one phosphate group that is required in the fructose phosphate 
bypass).  
 
 
Figure 39: Analysis of reaction essentiality of central carbon metabolism of glycerol fermentation using FBA. 
Red crosses correspond to essential reactions for cell growth, and green crosses correspond to non-essential 
reactions. Insert on the left shows effect of removing non-essential reaction over ethanol and 1,2-PDO 
production, and specific growth rate. See 'omenclature for details (page 214). 
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5.2.6 Targets Identified for Experimental Validation 
This section proposes experimental validation for two relevant results identified 
using the glyc-GEM: the fructose phosphate bypass, and the role of gene ptsA.  
In order to validate the potential role of the new fructose phosphate bypass 
proposed in this thesis, I propose the following four steps: 
1.- Measure activity of F6P aldolase.  
2.- Measure activity of F6P aldolase after deleting fsaB gene.  
3.- Delete fsaA/fsaB and perform glycerol fermentation. 
4.- Delete genes fsaA/fsaB and ppsA . Deletion of fsaA/fsaB would prevent the 
fructose phosphate bypass, and deletion of ppsA would prevent PEP synthase. By 
removing these two pathways it is expected that cells cannot grow as at least one of these 
pathways is required. 
The first two steps of this strategy will allow identification of the presence of F6P 
aldolase activity, and whether that activity is linked to the gene fsaB, as suggested in the 
results of this chapter. Step 3 will allow us to determine if genes fsaA and fsaB are 
essential for fermentation of glycerol. If they are not essential step 4 can identify the role 
of gene ppsA in providing a less efficient pathway to generate intermediate 3 carbon 
metabolites, as previously discussed. 
In addition to experimentally validating the fructose phosphate bypass, I suggest 
validating the role of gene ptsA linked to the transport and utilization of glycerol, as part 
of a possible phosphotransferase system (PTS). It has been suggested that the gene ptsA 
encodes a fusion of two components of a PTS: the enzyme I (in the N-terminal) and the 
enzyme EIIA (in the C-terminal) (Reizer et al., 1995), although other genes may be 
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involved in this system as well. These components mediate the transport and 
phosphorylation of other sugars (such as glucose, as it is reviews in section 2.1.3). Since 
this gene is part of the same transcription unit as genes gldA and fsaB (Reizer et al., 
1995), both of them have been proven or predicted to have a role in glycerol 
fermentation, it is now suggested that the product of gene ptsA is involved in the transport 
of glycerol. To prove this theory, construction of a ptsA deficient strain is suggested to 
test if fermentation of glycerol is affected. To further validate this strategy it is proposed 
to express gene ptsA in the strain deficient in this gene and repeat fermentations.  
5.2.7 Other Models 
In addition to the ethanol-1,2-PDO model that explains how wild type E. coli can 
ferment glycerol, other possible models could support glycerol fermentation in E. coli. In 
this section other models are explored by using a logical approach to generate models. 
Table 8 presents a list of possible products that E. coli could produce either as wild type 
or after adding exogenous reactions. Each product in Table 8 has an associated net ATP 
production, a net reducing equivalents production, and a conversion factor that indicates 
how many molecules of the product can be generated from one molecule of glycerol.  
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Table 8: Possible products whose synthesis could enable fermentative metabolism of glycerol by wild type or 
engineered E. coli. 'egative values of ATP production or reducing equivalents production indicate that such 
molecules are being consumed in the pathway that converts glycerol to the associated product. 
Product Stoichiometric reaction ATP 
produced 
Reducing 
equivalent 
(2[H]) 
Conver-
sion 
Factor 
Ethanol  Glycerol  ATP + Ethanol + CO2  1 0 1 
Propanol  Glycerol  + 4[H] Propanol  0 -2 1 
Propanol (PckA*)  Glycerol  + 4[H] Propanol + ATP  1 -2 1 
Butanol Glycerol  ATP + ½ Butanol + CO2  1 0 0.5 
Propionate Glycerol  Propionate  0 0 1 
Propionate 
(PckA*)  
Glycerol  ATP + Propionate  1 0 1 
Lactate Glycerol  ATP + Lactate + 2[H]  1 1 1 
Succinate Glycerol  + CO2 Succinate  0 0 1 
Succinate (PckA*)  Glycerol  + CO2 ATP + Succinate  1 0 1 
1,2-PDO (through 
lactaldehyde)  
Glycerol + ATP  + 2[H]  1,2-PDO  -1 -1 1 
1,2-PDO (through 
acetol)  
Glycerol + ATP  + 2[H]  1,2-PDO  -1 -1 1 
1,2-PDO (glycerol 
directly to 
lactaldehyde)  
Glycerol + 2[H]  1,2-PDO  0 -1 1 
1,3-PDO Glycerol + 2[H]  1,3-PDO  0 -1 1 
Acetate  Glycerol  1,2-PDO + 2ATP + 4[H]  2 2 1 
Acetone  Glycerol + 2[H]  Acetone  0 -1 1 
PckA*: reversible PEP kinase added. 
 
Based on the information presented on Table 8, I calculated the possible 
combination of products that could produce ATP and consume reducing equivalents, as 
these are essential requirements to produce biomass. A total of 47 feasible models were 
predicted using this approach, and results are presented in Table 9. Interestingly, 
production of propanol combined with the addition of reversal PckA can produce ATP 
and consume reducing equivalents, resulting in this being the only product that could 
support production of biomass by itself. This caused production of propanol with the 
addition of reversal PckA to combine with any other products whether or not such a 
product helps in production of ATP and consumption of reducing equivalents.   
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Table 9: Predicted models that could support cell growth in E. coli under anaerobic fermentation of glycerol. 
This prediction table was constructed using the analysis of redox and ATP presented in Table 8. In grey are 
marked redundant models. 
 
The glyc-GEM was then used to validate the predicted models, finding 100% of 
the models envisioned based on redox balance and ATP analysis and 12 new models 
were identified (Table 10), corresponding to models producing 1,2-PDO (using 
conversion of glycerol into 1,2-PDO), 1,3-PDO and acetone. In these three cases biomass 
production was possible due to small amounts of ATP produced in non-substrate level 
phosphorylation reactions, such as the use of the proton pump (ATP synthase), and other 
minor reactions. 
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Ethanol 0 1 1 0 0 0 0 0 0 1 1 1 1 0 1
Propanol 0 1 1 0 1 1 0 1 0 0 0 0 1 0
Propanol (reversible PckA added) 1 1 1 1 1 1 1 1 1 1 1 1 1
Butanol 0 0 0 0 0 0 1 1 1 1 0 1
Propionate 0 0 0 0 0 0 0 0 0 0 0
Propionate (reversible PckA added) 0 0 0 0 1 1 1 1 0 1
Lactate 0 0 0 0 0 1 1 0 1
Succinate 0 0 0 0 0 0 0 0
Succinate (reversible PckA added) 0 1 1 1 1 0 1
1,2-PDO (through Lald) 0 0 0 0 0 0
1,2-PDO (through acetol) 0 0 0 0 0
1,2-PDO (Glyc directly to Lald) 0 0 1 0
1,3-PDO 0 1 0
Acetate 0 1
Acetone 0
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Table 10: Predictions of biomass optimization using glyc-GEM for predicted models that could support cell 
growth in E. coli under anaerobic fermentation of glycerol. Values correspond to specific growth rate predicted 
using FBA. In green are highlighted the models with a predicted specific growth rate greater than 0.15 (wild 
type). In red are highlighted the new predicted models that were identified using the glyc-GEM model, but 
which were not identified by the redox and ATP analysis. In grey are marked redundant models. See Appendix 
10.11 for the Matlab function that was developed to find these models. 
 
Results presented in Table 10 are relevant to guiding efforts in metabolic 
engineering. Furthermore, among the 55 feasible models identified using FBA and the 
glyc-GEM, 16 models are predicted to allow E. coli to growth at a higher specific growth 
rate than in silico predictions of wild type E. coli.    
5.3 Results B: Assessing the capabilities of glycerol fermentation as a platform 
for the synthesis of fuels and chemicals 
 
This section assesses the capabilities of glycerol fermentation as a platform to 
produce valuable products. A number of experimental papers have been published in this 
direction, but previous works have not used mathematical models to support experimental 
strategies. GEMs are ideal to develop strategies for the production of desired products 
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Ethanol 0 0.18 0.21 0 0 0 0 0 0 0.15 0.15 0.18 0.17 0 0.17
Propanol 0 0.08 0.18 0 0.21 0.07 0 0.08 0 0 0.07 0 0.11 0.01
Propanol (reversible PckA added) 0.08 0.21 0.21 0.21 0.15 0.08 0.08 0.08 0.08 0.11 0.08 0.21 0.08
Butanol 0 0 0 0 0 0 0.15 0.15 0.18 0.17 0 0.17
Propionate 0 0 0 0 0 0 0 0.09 0.02 0 0.06
Propionate (reversible PckA added) 0 0 0 0 0.16 0.15 0.21 0.19 0 0.20
Lactate 0 0 0 0 0 0.11 0.05 0 0.08
Succinate 0 0 0 0 0.05 0 0 0.01
Succinate (reversible PckA added) 0 0.05 0.05 0.10 0.06 0 0.06
1,2-PDO (through Lald) 0 0 0.05 0 0 0
1,2-PDO (through acetol) 0 0.05 0 0 0
1,2-PDO (Glyc directly to Lald) 0.05 0.05 0.15 0.05
1,3-PDO 0 0.08 0
Acetate 0 0.12
Acetone 0
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and to improve existing strategies. GEMs allow prediction of the effect of adding and 
removing reactions of an existing metabolic network, without requiring any kind of 
experimental data or kinetic parameters.  
In addition, mathematical optimization strategies have been developed using 
GEMs as a starting point, OptKnock being remarkable among them (Burgard et al., 
2003). OptKnock is an optimization algorithm that identifies target reactions that would 
allow the coupling of cell growth to production of a desired product. Thus, OptKnock 
identifies a strategy that would more likely result in the cell being forced to produce the 
desired product in order to grow and a strategy with this quality can be further optimized 
using directed mutagenesis because growth and product will be optimized together 
(Burgard et al., 2003). Background and literature review (Chapter 3) presents further 
details of this tool. All OptKnock simulations considered a knockout number of up to 8 
reactions, a computation time of up to 48 hours to find a result, and a minimal specific 
growth rate of 0.07 h-1, unless otherwise specified. The solver Gurobi Optimizer 5.0 
(Gurobi Optimization, Inc.) was used in combination with COBRA toolbox v2.0 
(Schellenberger et al., 2011) in Matlab v7.11.0 (R2010b, The Mathworks, Inc.). The 
COBRA toolbox v2.0 includes a function for OptKnock.  
Figure 40 shows the simplified pathways that would allow the production of 8 
products with economical relevance, with 2 [H] representing one reducing equivalent 
(such as NADH) involved in the reaction conversion pathway. Since production and 
optimization of ethanol was already presented in the previous chapter using a kinetic 
model, here I present a mathematically supported strategy for the remaining 7 products, 
namely 1,2-PDO, 1,3-PDO, succinate, D-lactic acid, butanol, propanol, and propionic 
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acid. It is important to note that this list of products is not a complete list, as glycerol 
could be converted into various other products; however, this list represents a good 
sample to study the capabilities of glycerol for products that differ in energy and reducing 
equivalents being generated/consumed.  
 
Figure 40: Glycerol as a platform for the production of biofuels and chemicals. Intermediated from the 
glycolytic pathway are presented in blue boxes, and final products are presented in white boxes. Dashed lines 
represent pathways for the production of each product from a glycolytic intermediate. 2 [H] represents reducing 
equivalents associated with each pathway. See 'omenclature for details (page 214). 
 
In each study case a predicted solution space was generated using the glyc-GEM, 
which space represents the region where possible specific growth rate and product 
production could take place. In a solution space, the optimal solution (found by FBA) 
correspond to the highest specific growth rate, and the lower and higher curves of the 
space are found using Flux Variability Analysis (FVA).  
 
 
2[H]
2[H]
4[H]
2[H]
4[H]4[H]
2[H]
8[H]
8[H] 4[H]
OH
OHHO
HO OH
OHOH
OH
OH
HO
O
O
OH
O
HO
OH
O
HO
OH
131 
 
5.3.1 1,2-PDO 
Although 1,2-PDO is a natural product in the fermentation of glycerol by E. coli, 
it is naturally produced in very small amounts (Gonzalez et al., 2008). A strategy to 
increase the production of 1,2-PDO had already been developed in E. coli by Clomburg 
and collaborators using glycerol as carbon source (Clomburg & Gonzalez, 2011). In order 
to differentiate this and any other previous experimental strategy from experimental 
support that may be part of this thesis, any previous strategy will be referred as “pre-
existing”. In this thesis, the pre-existing strategy was simulated using the glyc-GEM in 
order to contrast how well the glyc-GEM can simulate this condition and also to identify 
if there is space for improvement of the pre-existing strategy.  
Genetic modifications of the pre-existing strategy consisted of deleting key genes 
for the production of competing by-products and pathways, expressing one gene for the 
free production of 1,2-PDO, and overexpressing genes for the conversion of glycerol into 
DHAP, and then DHAP into 1,2-PDO (Clomburg & Gonzalez, 2011). In particular, the 
following genes were deleted: ackA (acetate kinase), pta (phosphate acetyltransferase), 
ldhA (D-lactate dehydrogenase) and dhaK (PEP-dependent DAH kinase). The insertion of 
enzyme ATP-dependent DhaK was simulated in order to allow production of 1,2-PDO 
uncoupled to production of ethanol. Finally, the pre-existing strategy overexpressed 
genes mgsA (methylglyoxal synthase) and gldA (L-1,2-propanediol dehydrogenase / 
glycerol dehydrogenase), both of them directly involved in the conversion of glycerol to 
1,2-PDO. The simulation of this strategy was done by knocking down reactions 
corresponding to the gene knockout (namely ACKr, PTAr, LDH_D and DHAK in the 
glyc-GEM), and adding the reaction ATP-dependent DHAK to the model. 
132 
 
Overexpression of genes cannot be included in a GEM scale model; therefore, that 
information was not included.  
Figure 41 shows the predicted solution space that was generated using the glyc-
GEM for the pre-existing strategy from Clomburg and collaborators and its comparison 
to other in silico results and experimental results. The simulation indicates that 1,2-PDO 
is essential for the cell growth rate, as was already established in the previous section of 
this chapter (Results I). Two scenarios were simulated: wild type with no modifications, 
and wild-type with insertion of ATP-dependent DHAK and deletion of by-products, as 
established by the strategy of Clomburg and collaborators. Both platforms gave similar 
results and additional simulations removing the PEP-dependent DHAK for the second 
option was performed to confirm that the ATP-dependent DHAK was being used in that 
case. Although both scenarios provided a very similar prediction, pre-existing 
experimental results, however, support that adding ATP-dependent DHAK and deleting 
production of by-products is a better option. Discrepancies between experimental results 
and simulated results are likely due to limitations in maximum enzymatic rates that are 
not incorporated into the glyc-GEM. The results of these simulations were compared 
against the experimental yield reported of 0.213 w/w, which after converting to 
comparable units represent 2 mmol/gCDW/h (solid red circle in Figure 41). Details of all 
calculations can be found in Appendix 10.6. 
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Figure 41: Predicted solution space for the production of 1,2-PDO and biomass. Two cases are simulated, which 
results overlap. The blue dotted line corresponds to the simulated solution space simulation of wild type E. coli. 
The green continuous line corresponds to the simulated solution space of adding an ATP-dependent DhaK and 
knocking out production of acetate and lactate (delete reactions ACKr, PTAr and LDH_D) in accordance with 
the pre-existing strategy. The solid red circle corresponds to the reported results using the pre-existing strategy 
(Clomburg & Gonzalez, 2011), in which there cells enter into stationary phase after 12 hours of fermentation (no 
cell growth). 
 
While the experimental data of the pre-existing strategy are promising, the 
simulated solution space shows that it is theoretically possible to achieve a higher yield. 
This in turn motivated the use of OptKnock to identify different reactions whose deletion 
would result in a higher yield and productivity. Using OptKnock the following reactions 
were identified as targets for deletion: acetaldehyde dehydrogenase NADP (ALDD2y), 
malate dehydrogenase NADP (ME2), 6-phosphogluconolactonase (PGL), and two 
transhydrogenase periplasm (THD2pp and PntAB). Four of these deletions resulted in 
preventing the utilization of the cofactor NADP to generate the reducing equivalent 
NADPH, suggesting an important role in the kind of cofactors utilized. The use of this 
strategy, together with adaptive evolution (Fong et al., 2005) could result in an strategy 
leading to productivities close to 4.48 mmol/gCDW/hr of 1,2-PDO (productivity at 
maximal specific growth rate). 
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Figure 42: Predicted solution space for the production of 1,2-PDO and biomass. Green line corresponds to the 
simulated solution space of wild type E. coli. Blue line corresponds to the simulated solution space implementing 
the reduced OptKnock strategy (deletion of ALDD2y, ME2, PGL, THD2pp and PntAB). 
5.3.2 1,3-PDO 
For many years the fermentation of glycerol was linked to microorganisms with 
the capability to produce 1,3-PDO, a compound that could consume the reducing 
equivalents generated by the production of biomass from glycerol. E. coli, however, is 
not capable of producing 1,3-PDO, but metabolic engineering led Tang and collaborators 
to develop a strategy for the production of 1,3-PDO in E. coli (Tang et al., 2009), in 
which they inserted genes dhaB1, dhaB2 and yqhD from Clostridium butyricum, 
mediating the conversion of glycerol into 1,3-PDO. Genes dhaB1, dhaB2 encode a 
glycerol dehydratase enzyme and its activating factor, while gene yqhD encodes a 1,3-
PDO oxidoreductase isoenzymes that can convert glycerol into 1,3-PDO, in the following 
manner: 
Glycerol  3-hydroxypropanal (3HPA) + h2o (glycerol dehydratase) (55) 
3HPA + NADPH + h  1,3-PDO + NADP (Oxidoreductase isoenzymes) (56) 
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In this section the pre-existing strategy developed by Tang and collaborators was 
implemented in the glyc-GEM by adding reactions glycerol dehydrogenase and 1,3-PDO 
oxidoreductase, as described above, and the simulated solution space was compared to 
the pre-existing experimental results. Figure 43, blue line shows the result of this 
comparison. From the experimental results presented by Tang et al. (2009) I calculated 
the estimated specific growth rate as 0.014 h-1, and the production rate of 1,3-PDO as 
1.42 mmol/gCDW/h (see details of calculations in Appendix 10.6). This values fall inside 
the predicted solution space (Figure 43, solid red circle), and it is observed that there is 
theoretically space for the improvement of the strategy. While the experimental 
implementation of this strategy resulted in the production of 1,3-PDO as main product, 
with small amounts of co-products pyruvate, acetate and others (Tang et al.), in the in 
silico results ethanol was the main product and 1,3-PDO was produced in small amounts. 
Deletion of ethanol as co-product resulted in a decrease in the simulated maximal growth 
rate of 50% (from 0.17 h-1 to 0.08 h-1), and a switch to 1,3-PDO being the main product 
(increased from 2.5 mmol/gCDW/h to 12.9 mmol/gCDW/h) for the optimal solution, and 
acetate being the main by-product (Figure 43, green line). The deletion of ethanol presents 
a significant improvement with respect to previous results by providing a required 
coupling between production of 1,3-PDO and cell growth. This strategy needs to be 
evaluated experimentally in order to assess any further modifications, and overexpression 
of genes gldA should be considered as this enzyme is a limiting step in the fermentation 
of glycerol by E. coli. However, overexpression of gene gldA could also increase 
production of 1,2-PDO due to the by-function of the protein associated with this gene; 
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therefore, it may be convenient to knockout out production of 1,2-PDO by knocking out 
gene mgsA and thus also preventing accumulation of the toxic methylglyoxal.  
 
 
Figure 43: Predicted solution space for the production of 1,3-PDO and biomass. Blue line corresponds to the 
simulated solution space of the pre-existing strategy presented by Tang and collaborators (Tang et al., 2009). 
Green line corresponds to the simulated solution space removing ethanol production to the pre-existing strategy.  
The solid red circle corresponds to the reported results using the pre-existing strategy (Tang et al., 2009). 
 
To explore alternative strategies for the production of 1,3-PDO, OptKnock was 
utilized. However, the outcome solution space of this strategy did not differ much from 
the outcome of the strategy deleting only ethanol production (as presented in previous 
paragraph), and the OptKnock strategy had the additional complexity of including 8 
knockouts as opposed to only one knockout in the case of deleting only ethanol 
production. Therefore, the strategy of deleting ethanol production was considered 
sufficient. 
5.3.3 Succinate 
As in the case of previous products of this section, strategies to produce succinate 
in E. coli using glycerol have been implemented experimentally previously, and in this 
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thesis I evaluate two of them. Blankschien and collaborators used an approach using 
microaerobic conditions (Blankschien et al., 2010), and Zhang and collaborators used an 
anaerobic approach (Zhang et al., 2010).  
Microaerobic approach 
The strategy presented by Blankschien and collaborators also required the 
deletion of key genes toward the production of by-products (adhE for ethanol, pta for 
acetate, and ldhA for lactate). In addition to these deletions, the gene poxB (pyruvate 
oxidase) was deleted in order to ensure removal of acetate production. Gene ppc (PEP 
carboxylase) was deleted, and replaced by heterologenous gene pyc (pyruvate 
carboxylase) to drive production of succinate. This strategy also required the addition of 
carbon dioxide to the medium and the use of microaerobic conditions. The former 
condition provided carbon dioxide to be assimilated in the conversion of PEP into 
oxaloacetate (OAA), and the later condition provided a mean to oxidize reducing 
equivalents providing ATP.   
In this thesis the aforementioned strategy was simulated using the glyc-GEM, and 
the in silico results were contrasted with the pre-existing strategy results. Simulation of 
microaerobic conditions was done by allowing oxygen consumption at a rate of 2 
mmol/gCDW/h versus the 18.5 mmol/gCDW/h that has been used in GEMs to represent 
aerobic conditions (see for example (Feist et al., 2007)). The paper from Blankschien and 
collaborators reported a maximum succinate production rate of 3.45 mmol/gCDW/h, and 
the specific growth rate can be estimated as 0.038 h-1 (see Appendix 10.6). Figure 44 
shows the solution space predicted by the use of the glyc-GEM (dotted blue line), and 
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how this space compares to the experimental results reported by the authors (solid red 
circle).  
 
Figure 44: Predicted solution space for the production of succinate and biomass using pre-existing strategy 
simulated in the glyc-GEM. The solid red circle corresponds to the reported results using the pre-existing 
strategy (Blankschien et al., 2010). 
 
The next step was to use OptKnock in order to evaluate possible target reactions 
for deletion, which could result in an increased succinate production coupled to biomass 
production. The OptKnock optimization was done including the same additions as in the 
strategy presented by Blankschien and collaborators, which consisted of addition of 
carbon dioxide to the media, microaerobic conditions, and addition of reaction from L. 
lactis pyruvate carboxylase (pyc). OptKnock identified 8 reactions and this set of 
reactions was further reduced to only three reactions, as their deletions contained the 
most relevant impact. The three reactions corresponded to aldehyde dehydrogenase 
(ALDH), D-lactate dehydrogenase (LDH_D), and pyruvate formate lyase (PFL), and the 
predicted solution space after incorporating these deletions is presented in Figure 45. This 
strategy allowed a prediction of 3-fold increase in productivity (from 3.45 
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mmol/gCDW/h to 10 mmol/gCDW/h) if the specific growth rate is maintained as in 
experimental results from Blankschien and collaborators. It is interesting to note that two 
of the reactions of the reduced OptKnock strategy correspond to deletions of the pre-
existing experimental strategy, namely ALDH and LDH_D, for the production of by-
products ethanol and lactate, respectively, and therefore the main contribution of 
OptKnock is to propose the deletion of PFL, and the non-deletion of POX and PPC.   
 
Figure 45: Predicted solution space for the production of succinate and biomass using OptKnock strategy. Blue 
line corresponds to the full OptKnock strategy (deletion of ACACT3r, ALDH, LDH_D, PFL, PPCSCT, SUCOA, 
THD2pp, and PntAB), and green line corresponds to the reduced OptKnock strategy (deletion of ADH, LDH_D 
and PFL). The solid blue circle corresponds to experimental results using preexisting strategy (Blankschien et 
al., 2010). 
 
I propose validating this strategy by knocking out genes adhE, ldhA and pflB, 
corresponding to reactions ALDH, LDH_D and PFL, and including the additions 
mentioned by Blankschien and collaborators, namely addition of carbon dioxide to the 
media, microaerobic conditions, and addition of reaction pyc from L. lactis. An 
alternative to this strategy could consist of working in the same conditions, addition and 
deletions presented by Blankschien and collaborators, and deleting gene pflB, as this gene 
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represents the only new deletion of the strategy presented in this thesis in comparison to 
the strategy presented by Blankschien and collaborators. 
  
Anaerobic approach 
Zhang and collaborators proposed expressing a reversible PEP carboxykinase  
(PckA) that can convert PEP into OAA producing one molecule of ATP. This enzyme 
exists in E. coli and other organisms, such as Bacillus subtilis, and it performs the 
following reaction: 
ADP + CO2 + PEP <=> ATP + OAA     (57)  
The advantage of introducing the reversible PckA is to produce one molecule of 
ATP, as opposed to dissipating energy by releasing one molecule of phosphate. The 
reversible PckA was incorporated into the glyc-GEM. This strategy also included a 
source of CO2, which was modeled in the glyc-GEM by changing the lower boundary of 
the associated export reaction. In addition, the strategy evaluated different deletions, 
being be most efficient (for productivity) the deletion of genes pflB (pyruvate formate 
lyase) and ptsI (PTS enzyme I). Deletion of the gene pflB was simulated in the glyc-GEM 
by deleting the associated reaction in the model (PFL), as was the deletion of the gene 
ptsI, which was involved in more than 10 reactions (including DHAK), was simulated by 
using the function deleteModelGenes (in COBRA), that simulated the knock out of this 
gene.  
The in silico results of the evaluation of this strategy using the glyc-GEM were 
contrasted with the pre-existing strategy results. Zhang and collaborators reported a 
maximum succinate yield of 0.8 w/w. The estimate a succinate production rate was 
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reported as 2.8 mmol/gCDW/h (see Appendix 10.6), and the specific growth rate was 
very low. The experimental result (represented as a solid red circle) is within the 
predicted solution space (Figure 46), which indicates that the glyc-GEM is simulating the 
implementation of this strategy properly.    
 
Figure 46: Predicted solution space for the production of succinate and biomass using pre-existing anaerobic 
strategy simulated in the glyc-GEM. The blue dotted line represent the simulation of the pre-existing strategy, 
and the green dotted line represent the OptKnock strategy. The solid red circle corresponds to the estimated 
results using the pre-existing strategy (Zhang et al., 2010). 
 
The next step was to use OptKnock in order to evaluate possible target reactions 
for deletion, which could result in an increased succinate production coupled to biomass 
production. The OptKnock optimization was done by including the same additions as in 
the strategy presented by Zhang and collaborators. OptKnock identified 8 reactions, and 
this set of reactions was further reduced to only three reactions, as their deletions 
contained the most relevant impact. The three reactions corresponded to CO2 transporter 
via diffusion (CO2tpp), FBPA, and formate transporter via diffusion (FORtppi). Figure 
44 shows the predicted solution space using this strategy, in which there was an increase 
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in the maximum predicted growth rate, but there was a decrease in the predicted 
production rate of succinate. 
The results using the microaerobic strategy presented more promising number for 
productivity and cell growth (experimental and in silico results), and therefore it is 
recommended that further studies are performed using the microaerobic strategy, as 
already discussed above.   
5.3.4 D-Lactic acid 
Production of lactic acid using glycerol as feedstock in E. coli has been reported 
by Mazumdar and collaborators (Mazumdar et al., 2010). This experimental strategy 
consisted of knocking out genes involved in production of by-products, specifically frdA 
(for succinate), adhE (for ethanol), and pta (for acetate). Deletion of the aerobic D-lactate 
dehydrogenase (ldl) was introduced in order to prevent lactate utilization. In addition, the 
gene pflB was deleted, which corresponds to pyruvate formate dehydrogenase, as deletion 
of this gene has been shown to result in accumulation of lactate (Durnin et al., 2009). 
Furthermore, the respiratory pathway GlpK-GlpD was overexpressed in order to increase 
production of DHAP, and the fermentative lactate dehydrogenase (ldhA) was 
overexpressed in order to increase production of lactate from pyruvate. Microaerobic 
conditions were used in this strategy. This strategy resultedin a maximum lactic acid 
production rate of 13.88 mmol/gCDW/h, and the specific growth rate can be estimated as 
0.048 h-1 (see Appendix 10.6). 
In this section this pre-existing strategy was modeled in the glyc-GEM, as 
explained below. First, the knockout of genes was simulated in the glyc-GEM by 
removing reactions associated with each gene, in the following way: reaction PFL for 
143 
 
gene pflB, reactions FRD2 and FRD3 for gene frdA, reaction ALDH for gene adhE, 
reaction LDH_D2 for gene ldl, and reaction PTAr  for gene pta. Microaerobic conditions 
were simulated by allowing consumption of oxygen at an uptake rate up to 2 
mmol/gCDW/h. Overexpression of genes was not incorporated in the model, as 
stoichiometric models do not incorporate that kind of information. Figure 47 shows the 
solution space corresponding to the modeling of this strategy in the glyc-GEM (dotted 
blue line) compared to the experimental result reported by Mazumdar and collaborators 
(solid red circle) (Mazumdar et al., 2010), and it is observed that the experimental data 
falls above the simulated solution space, with a productivity value 25% higher than the 
one obtained using the optimal solution optimizing biomass. The difference could have 
been caused by a variety of factors, including the use of an underestimated oxygen uptake 
factor in the model, a higher experimental consumption rate of glycerol, or the presence 
of unknown reactions that have not been included in the model. A more accurate 
modeling of this condition could be modeled in future works by performing continuous 
culture experiments, and in steady state conditions measuring glycerol uptake rate and 
oxygen uptake rate, to then be incorporated in the model. Oxygen consumption can be 
calculated by experimentally measuring kla, and then multiply it by dissolved oxygen at 
equilibrium. 
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Figure 47: Predicted solution space for the production of lactate and biomass using the pre-existing strategy 
simulated in the glyc-GEM. The solid red circle corresponds to the reported results using the pre-existing 
strategy (Mazumdar et al., 2010).     
 
The use of OptKnock in this case was unable to identify one solution that would 
satisfy the minimal requirements, even after 64 hours of simulation. The reason for that 
was not being able to satisfy minimal requirements for specific growth rate, which was 
set as 0.07 h-1. However, OptKnock delivered a solution that was under-requirements, 
with a maximal production of biomass of 0.03 h-1 (57% below requirement). For the 
reasons mentioned above, the strategy presented by Mazumdar and collaborators is 
considered satisfactory. 
5.3.5 Butanol 
Production of butanol in E. coli has been done using different pathways, the most 
remarkable being α-keto acid using glucose (Atsumi et al., 2008a) and the reversal of the 
β-oxidation cycle starting from glucose (Dellomonaco et al., 2011). This section presents 
the simulations using one turn of the reversal β-oxidation cycle, as this pathway is more 
energy efficient than the α-keto acid pathway (more details of comparison of these 
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pathways is presented in the next chapter of this thesis). Following the same description 
of this pathway introduced by Dellomonaco and collaborators, reactions acyl-CoA 
dehydrogenase (ferredoxin) and pyruvate ferredoxin oxido reductase (PFOR) were added 
to the glyc-GEM as part of the reversal β-oxidation cycle. In addition, termination 
enzymes acyl-CoA reductase and aldehyde/alcohol dehydrogenase were added to 
produce n-butanol as final product (Dellomonaco et al., 2011). Each of the termination 
enzymes consumes one reducing equivalent of the form of NADH, making the pathway 
for the production of butanol redox balanced. Since ethanol is a natural competing by-
product (same ATP production and redox balance), deletion of ethanol was simulated in 
the model by knocking out reaction aldehyde dehydrogenase (ALDH). Figure 48 shows 
the solution space of this strategy obtained using the glyc-GEM. As expected, production 
of butanol coupled to biomass production, which is a natural result of having removed 
ethanol as possible product, and introduced butanol production instead in a manner that 
produces ATP and is redox balanced, just as the natural product of this fermentation 
process (ethanol).  
Another strategy that was evaluated was introducing knockouts of other by-
products, namely succinate, acetate and lactate, in addition to ethanol. This strategy was 
introduced by Dellomonaco and collaborators when using glucose as carbon source, and 
it is reasonable to consider this as a proper strategy when glycerol is used instead 
(Dellomonaco et al., 2011). For this purpose the following genes were deleted: frdA (for 
succinate), pta (for acetate), adhE (for alcohol) and ldh (for lactate). The simulated 
solution space of this case corresponded exactly to the simulation of the solution space 
deleting only production of ethanol (remove reaction ALDH). 
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The use of OptKnock in this case was not able to identify any better strategy than 
the strategy presented in the previous paragraph, and therefore the aforementioned 
strategy is considered satisfactory.  
 
Figure 48: Predicted solution space for the production of butanol and biomass using one turn of the reversal of 
the β-oxidation cycle. This strategy simulates the deletion of competing by-product ethanol by removing 
reactions ALDH and ADH. 
 
5.3.6 Propionic acid 
This section and next section present the production of propionic acid and 
propanol, two products that have not been produced experimentally in E. coli using 
glycerol.  
Production of propionic acid from glycerol has been reported in other organisms. 
For example, Barbirato and collaborators studied three strains, namely 
Propionibacterium acidipropionici, Propionibacterium acnes, and Clostridium 
propionicum, for this process (Barbirato et al., 1997). According to their results, P. 
acidopropioncini performed the best for the production of propionic acid. In this analysis 
it was hypothesized that E. coli could be genetically modified in order to produce this 
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product by including the reactions from P. acidopropioncini that convert succinate into 
propionic acid.  
The production of propionic acid from the glycolytic intermediate PEP in this 
organism includes 4 steps: 1) conversion of PEP into OAA, 2) conversion of OAA into 
malate using NADH, 3) conversion of malate into succinate using NADH and producing 
ATP, and 4) conversion of succinate into propionate. The glyc-GEM already includes a 
set of equivalent reactions (using different co-factors) for the conversion of PEP into 
propionic acid. The glyc-GEM, however, lacks a transport system to export propionic 
acid, and therefore this reaction was added. 
Another interesting step in this pathway is the conversion of PEP into OAA. Wild 
type E. coli completes this step using the enzyme PEP carboxylase, which fixes one 
molecule of carbon from bicarbonate and releases one phosphate group. In this section it 
is proposed to use a reversible PckA, which converts PEP into OAA and produces one 
molecule of ATP in this process (see reaction 57 in the for succinate production).  The 
reversible PckA was incorporated into the glyc-GEM, and FBA was used to find the 
optimal solution. The initial solution indicated that ethanol was a competing product; 
therefore, the reactions ALDH essential for the production of ethanol was deleted. Figure 
49 shows the solution of this strategy after deleting reaction ALDH (blue line). 
Production of propionic acid became essential after deleting production of the competing 
by-product ethanol. This is because production of propionic acid with the previously 
proposed strategy is redox balanced and produces one molecule of ATP per molecule of 
glycerol, having therefore the same net effect in terms of energy and redox balance as 
production of ethanol.  
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Figure 49: Predicted solution space for the production of propionic acid and biomass. Blue line corresponds to 
results after deleting competing pathway for the production of ethanol (deletion of ALDH). Green line 
corresponds to the solution space deleting the reactions identified by the OptKnock strategy (ALDH, GLYK and 
MDH).  
  
OptKnock was used in order to other possible reactions to target as knockout, and 
that could increase the productivity (Figure 49, green line). Using OptKnock, the 
following three reactions were identified as target for deletion: aldehyde dehydrogenase 
(ALDH), glycerol kinase (GLYK) and malate dehydrogenase (MDH). This strategy can 
be implemented experimentally by knocking out the following genes: adhE (for reaction 
ALDH), glpK (for reaction GLYK) and mdh (for reactions MDH). While deletion of 
ALDH removed ethanol as a by-product, deletion of GLYK resulted in redirecting that 
flux to go through the DHAK reaction, which links phosphorylation of DHA to 
conversion of PEP into PYR, and PYR in turn is converted back to PEP by the action of 
the reaction PEP synthase (PPS in the glyc-GEM) using ATP. In addition, deletion of 
MDH forces the conversion of OAA into malonate to go through reaction malate oxidase 
(MOX), which produces oxygen. 
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In order to experimentally validate this strategy further research will be needed. I 
propose to introduce gene pckA (encoding reversible PEP carboxykinase), and to perform 
the gene knockout identified in the previous paragraph (adhE, glpK and mdh). Transport 
of propionate across the membrane is expected to occur spontaneously, and therefore no 
further genetic modifications are needed for that step.      
5.3.7 Propanol 
Production of propanol has been report in metabolically engineered organisms by 
extending natural pathways from 1,2-PDO (Jain & Yan, 2011) and from propionyl-CoA 
(Deng & Fong, 2011) , and using glucose as feedstock. In this section a strategy to 
produce propanol from glycerol is developed.  
The glyc-GEM was used to simulate addition of both strategies mentioned in 
previous paragraph as follow: 
1,2-PDO + cobamamide  h2o + 1-propanal     (58) 
1-propanal + NADH + h  1-propanol + NAD    (59) 
Propanoyl-CoA (ppcoa) + NADH + h  1-propanal + NAD + CoA (60) 
Introducing both strategies and then using FBA to identify the optimal solution 
allows me to evaluate which one of the aforementioned strategies is expected to be more 
efficient. In addition to these modifications, a reversible PckA was introduced as 
explained in previous section (production of propionic acid).   
FBA was used to predict flux distribution and cell growth after adding reactions 
58-60, and the reversible PckA. The resulting solution space is presented in Figure 50, 
blue line. FBA selected production of propanol through propanoyl-CoA as the optimal 
solution (reactions 59 and 60), as oppose to production of propanol from 12-PDO 
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(reaction 58 and 59). Analysis of flux distribution of the solution identified ethanol as a 
competing by-product, and therefore this product was removed by simulation the deletion 
of reaction ALDH, a case that resulted in a clear coupling of the production of propanol 
and cell growth (Figure 50, red line). The optimal solution produces biomass at a specific 
growth rate of 0.21 h-1, and propanol at a rate of 9.2 mmol/gCDW/h.   
 
Figure 50: Predicted solution space for the production of propanol and biomass. Blue line corresponds to the 
solution before deleting competing by-products, and red line corresponds to the solution after deleting reaction 
ADH for the production of ethanol. Green line corresponds to OptKnock strategy (deletion of ALDH, ACt2rpp, 
D-LACtex, PYRt2rpp). 
 
In order to explore the possibility of producing propanol at a higher yield, 
OptKnock was used. Using OptKnock the following four reactions were identified as 
target for deletion: aldehyde dehydrogenase (ALDH), acetate reversible transport via 
proton symport (ACt2rpp), D-lactate transport via diffusion (D-LACtex) and pyruvate 
reversible transport via proton symport (PYRtrpp). These four reactions are associated 
with production of ethanol, acetate, lactate and pyruvate, respectively. Deletion of these 
four reactions in the glyc-GEM increased production of propanol from 9.2 
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mmol/gCDW/h to a value between 11.7-14.1 mmol/gCDW/h (multiple optimal 
solutions), which represent an increase of 40% (Figure 50, green line).   
The experimental validation of this strategy will require adding genes for the 
conversion of propanoyl-CoA into propanol, add a reversible PckA, and knockout genes 
toward the production of the undesired products identified using OptKnock. Production 
of propanol from propanoyl-CoA is expected to happen after adding the bifunctional 
aldehyde/alcohol dehydrogenase (gene adhE2) from Clostridium acetobutylicum, as 
presented by Deng and Fong (Deng & Fong, 2011). Thus, the associated protein could 
perform reactions 59 and 60. In addition, I propose to increase the expression of pckA 
from E. coli, encoding reversible PEP carboxykinase, using a promoter mutation (Zhang 
et al., 2010). The deletion of reactions identified using OptKnock cannot be implemented 
directly, as three out of the four reactions identified with this methodology do not have a 
specific gene associated. While deletion of reaction ALDH can be performed simply by 
knocking out gene adhE, the three other reactions identified by OptKnock correspond to 
transport reactions that would be difficult to remove. To this end I propose to knockout 
genes pta, and ldhA involved in the production of acetate and lactate respectively, as 
these deletions will have the same (or very similar) effect as deleting the transport 
reactions for acetate and lactate. Export of pyruvate will be more difficult to control, as 
pyruvate is an essential intermediate metabolite, and its transport occurs using generic 
transporters.   
The following table shows a summary of the findings of this section, for the 
synthesis of different products. 
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Table 11: Summary table comparing production rates and specific growth rate for the synthesis of desired 
products using glycerol.  
Product 
Experimental results In silico predictions 
Production rate 
(mmol/gCDW/h) 
Specific 
growth rate 
(1/h) 
Production rate 
(mmol/gCDW/h) 
Specific 
growth rate 
(1/h) 
1,2-PDO 2
a
 0
a
 2.2 0.15 
1,3-PDO 1.4
b
 0.014
b
 12.1 0.08 
Succinate - 
microaerobic 
3.5
c
 0.038
c
 18.31* 0.07* 
Succinate - anaerobic 2.8
d
 0
d
 14.2 0.08 
Lactic acid 13.88
e
 0.038
e
 11.1 0.05 
Butanol   0.15 7.74 
Propionic acid - - 17.2* 0.09* 
Propanol - - 11.7-14.1* 0.08* 
 
* Optimal Strategy identified using OptKnock. a Clomburg & Gonzalez, 2011. b Tang et al., 2009. c Blankschien 
et al., 2010 . d  Zhang et al., 2010. e Mazumdar et al., 2010. 
 
5.4 Conclusions 
This chapter presented the modeling of glycerol fermentation in E. coli using a 
GEM. When available experimental data, the model simulated well the main features 
observed for this microorganism. Further, the use of a comprehensive metabolic network 
of this microorganism allowed exploring new unstudied pathways that appear to have a 
relevant role in glycerol fermentation. Of special interest was the prediction of the 
fructose phosphate bypass, which could support the production of 3C intermediate 
metabolites independently of PEP-dependent DhaK, providing a path for the production 
of 1,2-PDO and biomass. This theory is also supported by fact that the gene fsaB, which 
encodes enzyme F6P aldolase (necessary for the fructose phosphate bypass), belong to 
the same transcription unit as gene  gldA, which has a key role in the fermentation of 
glycerol in E. coli, suggesting that both genes may be involved in the same process. 
Experimental validation of these results will need to be conducted in order to confirm the 
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role of the fructose phosphate bypass. The glyc-GEM validated the ethanol-1,2-PDO 
model for glycerol fermentation in wild type E. coli, by predicting these two products to 
be essential for cell growth. The glyc-GEM was also used to evaluate possible genetic 
modifications that would enable cell growth associated to the synthesis of other products, 
which identified a total of 59 possible models, 18 of them with a predicted maximum 
specific growth rate higher than the value predicted for wild type E. coli.   
After studying fermentation of glycerol using the glyc-GEM, production of a 
variety of fuels and chemicals was addressed using the model. The simplicity of the 
method is remarkable when compare to other options, such as the use of a detailed kinetic 
model, or a purely experimental approach. Further, in most of the cases that were studied 
in this chapter, the simulated solution space generated by the model correlated well with 
pre-existing experimental data (data not used to curate the model), which highlight the 
predictive power of the glyc-GEM presented in this thesis. In most cases the use of the 
mathematical optimization algorithm OptKnock identified possible genetic manipulations 
that could increase the productivity of these desired chemicals. 
 While GEMs are powerful to study flux distributions without using experimental 
data, as well as to identify target genes to incorporate or delete in order to increase 
productivity of a desired product, its limitations can be complemented using kinetic 
models. One lacking aspect in the use of GEMs is the inability to predict the effect 
enzymes overexpression. The overexpression of enzymes plays a significant role in 
metabolic engineering, as it may result in increasing the flux on a desired pathway, or in 
re-directing part of the flux from one pathway to another one. Because of this, 
experimental implementations of strategies identified using GEMs may need to be 
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modified, in order to include possible gene overexpressions. One way to identify target 
genes to be overexpressed is the use of kinetic models, as presented in Chapter 3 of this 
thesis, which make these two kinds of models complimentary for the study and 
optimization in metabolic engineering.  
 In summary, the main results and finding presented in this chapter are: 
• A detailed adaptation and curation of the genome scale model iJO1366 to 
represent glycerol fermentation in E. coli. The resulting model (glyc-
GEM) represents well preexisting experimental data about the proposed 
Ethanol-1,2-PDO metabolic model of glycerol fermentation and 
corresponding essential genes and reactions. 
• The glyc-GEM in conjunction with FBA identified a new possible 
dissimilation pathway to convert glycerol into DHAP independently of 
enzymes glycerol dehydrogenase and glycerol kinases. This pathway is 
potentially more efficient than alternative pathways, and it suggests that 
the physiological function of the gene fsaB (fructose bisphosphate 
alsolase) is to facilitate the anaerobic fermentation of glycerol. This gene 
is part of the same transcriptional unit as gene gldA, which is essential for 
glycerol fermentation in E. coli. 
• The glyc-GEM in conjunction with FBA validated the ethanol-1,2-PDO 
model, which had been suggested to explain the anaerobic fermentation of 
glycerol in E. coli. Additional pathways were simulated in the model, 
using 15 conditions (products/pathways), and the viability of these 
pathways was evaluated. The glyc-GEM and FBA identified a total of 55 
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possible models using combinations of these conditions, 16 which 
predicted maximum specific growth rate higher than the value predicted 
for wild type E. coli. 
• The glyc-GEM in conjunction with OptKnock evaluated and identified 
strategies for the optimal production of succinate, 1,2-PDO, 1,3-PDO, 
lactate, propanol, butanol and propionic acid. 
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6 Results III: Genome scale model for the reversal of 
the β-oxidation cycle 
This chapter presents the in silico evaluation of the recently published reversal of 
the β-oxidation cycle in E. coli for the production of advanced biofuels with long 
hydrocarbon chains. This theoretical research expands upon the experimental work that 
was conducted by Dellomonaco and collaborators for the implementation of a functional 
of a reversal of the β-oxidation cycle (Dellomonaco et al., 2011). In order to produce long 
chain biofuels and biochemicals, it is necessary to elongate of a starting molecule or 
precursor, and to implement appropriate termination enzymes. Remarkable strategies for 
the elongation stage are the use of the fatty acids biosynthesis pathway (Schirmer et al., 
2010; Steen et al., 2010), the engineering of the α-keto acid pathway for the production of 
alcohols (Zhang et al., 2008), and more recently the engineering of a functional reversal 
β-oxidation cycle (Dellomonaco et al., 2011). The latest has been shown to produce 
butanol and longer chain n-alcohols at higher yields than those reported previously, as it 
is energetically more efficient; therefore, it opens the door to a significant improvement 
in the productivity of a wide possibility of products.  
The genome scale model iJO1366 was adapted for the in silico evaluation of the 
reversal β-oxidation cycle in E. coli. The production of several long chain product 
families was evaluated, including production of n-alcohols, alkanes and fatty acids. Flux 
Balance Analysis (FBA) and Flux Variability Analysis (FVA) were applied to the 
resulting genome-scale model (GEM) to generate predictions of flux distribution and 
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solution spaces. The iJO1366 model was also adapted to simulate the use of other 
platforms for the production of these products, and the results are contrasted. 
The following are sections of this chapter: model implementation, results and 
conclusions. The model implementation presents the modifications that were done to the 
iJO1366 model in order to properly simulate the use of the reversal β-oxidation cycle to 
produce a variety of medium and long chain products, including alcohols, alkanes and 
fatty acids in E. coli. The model implementation section also presents the modifications 
that were done to represent alternative platforms for the production of the same products 
(for comparison purposes). Then, the results of the predicted performance of the reversal 
β-oxidation cycle for the production of desired products are presented. Deletions of 
native fermentation products were simulated in order to enhance the yields of desired 
products coupled to biomass growth. The energetic efficiency of this pathway allowed for 
the prediction of production of medium and long chains members of these product 
families, at significant productivities. The results are contrasted with other widely used 
pathways to verify the superiority of the reversal β-oxidation cycle under the 
circumstances evaluated in this project. In addition, the results of simulating the 
production of long chain products with a functionalized side chain are presented. Adding 
further modifications to the metabolic pathway in order to produce hydroxylated and 
carboxylated primers for the reversal β-oxidation cycle, allowed for the identification of 
efficient pathways for the production of diols, dicarboxylic acids and hydroxyacids. 
Finally, the conclusion section discusses the implications of using a GEM to 
quantitatively assess the metabolic capabilities of using the reversal of the β-oxidation 
cycle as an efficient platform for the production of long chain chemicals in E. coli.  
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6.1 Model implementation 
The implementation of the GEM to represent the reversal β-oxidation cycle in E. 
coli for the production of long chain products requires four steps: 1) define a starting 
GEM, 2) define external conditions, 3) curate the model, and 4) add necessary reactions 
for the reversal β-oxidation cycle and termination reactions. The first three steps are 
similar to those presented in the previous chapter for the use of GEM to represent 
glycerol fermentation. The fourth step was implemented in three modules: Module I 
(priming), Module II (elongation, reduction, dehydration, reduction), and Module III 
(termination). Additional modifications to the Modules I, II and III were included for the 
production of chemicals with a functionalized side chains. Each of these points is 
expanded below. 
6.1.1 Define a starting GEM 
The genome scale model iJO1366 for E. coli K-12 1655 was used as starting point 
(Orth et al., 2011). See details of this model in section 5.1.1 (page 101).  
6.1.2 Define External Conditions 
The external conditions were set to represent glucose fermentation in minimal 
medium (no external electron acceptor). As stated in the previous chapter, external 
conditions are defined by changing the lower bound limit of the corresponding exchange 
reactions, usually setting the value to -1000 mmol/gCDW/h for non-limiting nutrients. 
Table 12 shows a list of the nutrients that were considered as part of the minimal 
medium, with the corresponding exchange reaction and lower bound, as defined 
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elsewhere (Feist et al., 2007; Orth et al., 2011).  Glucose is the only limiting nutrient, and 
its value was set to -15 mmol/gCDW/h.   
Table 12: External conditions for the GEM to represent glucose consumption. All reactions correspond to 
“exchange” reactions, which represent the presence of these molecules in the medium. 
 
Exchange Reaction Lower bound 
(mmol/gCDW/h) 
Exchange Reaction Lower bound 
(mmol/gCDW/h) 
Calcium exchange -1000 Sodium exchange -1000 
Chloride exchange -1000 Ammonia exchange -1000 
Co2+ exchange -1000 Ni2+ exchange -1000 
Cu2+ exchange -1000 Phosphate exchange -1000 
Fe2+ exchange -1000 Selenate exchange -1000 
Fe3+ exchange -1000 selenite exchange -1000 
H+ exchange -1000 Sulfate exchange -1000 
H2O exchange -1000 tungstate exchange -1000 
K+ exchange -1000 Zinc exchange -1000 
Mg exchange -1000 Glucose exchange -15 
Mn2+ exchange -1000 Cob(I)alamin exchange -0.01 
Molybdate exchange -1000   
 
6.1.3 Model curation 
The curation of the model was performed in order to represent glucose 
consumption. Some modifications identified in the GEM for glycerol fermentation (glyc-
GEM) were considered as a starting point, as those modifications were done to prevent 
non-permisive pathways for the consumption of reducing equivalents (see section 5.1.3, 
page 103 for details). In particular, the following pathways were restricted to be equal to 
zero: 
a) Amino acid degradation and nucleotide degradation. 
b) Sulfate reduction. 
c) Iron reduction. 
d) Spermidine and 5-methylthio-D-ribose production. 
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Also, following the same rationale as in the curation of model glyc-GEM, 
pathway C for the conversion of fructose-6-phosphate (F6P) into glyceraldehyde-3-
phosphate (GAP) (see Figure 35, page 111) was restricted to allow only the pathways that 
go through di-hydroxyacetone-phosphate (DHAP) (pathways A and B).  
Pyruvate production was also removed from the model as this was not a product 
of interest in this study.  
Finally, the iJO1366 model includes the reaction pyruvate oxidoreductase 
(POR5), which was modified. This reaction, although irrelevant in most of the cases 
studied in this chapter, was generating a non-permisive electron sink in some cases. 
Specifically, this situation was identified in preliminary results for the production of fatty 
acid after deleting competing by-products. An evaluation of this reaction identified that 
this reaction should be associated with ferredoxins, but the iJO1366 model has this 
reaction linked to flavodoxins. Because of this, the reaction was eliminated from the 
model, and instead a new reaction was added (named PFOR for pyruvate ferredoxin 
oxidoreductase), which uses ferredoxins (fd) as electron acceptor to convert pyruvate 
(PYR) into acetyl-CoA (AcCoA). 
The next three subsections (6.1.4 - 6.1.6) present the implementation of the 
reversal β-oxidation cycle, implementation of alternative pathways (for comparison 
purposes), and implementation of termination pathways. The alternative pathways that 
are being considered in this thesis are the fatty acid (FA) biosynthesis pathway and the α-
keto acid pathway, both of which are currently being used for the production of long 
chain products. Termination pathways were implemented to produce alcohols, alkanes, 
and fatty acids. Subsection 6.1.7 presents further modification to the iJO1366 model in 
 order to produce chemicals with a functionalized side chain using
cycle.  
6.1.4 Implementation of 
The production of long chain products using the 
consists of three modules: Module I (priming), Module II (elongation, reduction, 
dehydration, reduction), and Module III (termination). 
reversal β-oxidation cycle for the production of different families of products
modularity system. 
Figure 51: Pathway for reversal 
 
The first module, priming, is already part of the iJO1366, and therefore no further 
modifications are necessary.
reduction, dehydration, and reduction
iJO1366 model with the proper reversibility. 
 the reversal 
the reversal β-oxidation pathway 
reversal of the β
Figure 51 shows a scheme of the 
Β-oxidation cycle. Modularity for the synthesis of different products.
 The second module consists of 4 steps
. Three of these steps already are 
The fourth step, reduction of an enoyl
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was added coupled to the oxidation of a ferredoxin (fd) (see equation 61). Thus, the 
reversal β-oxidation cycle was fully implemented by adding the fourth step.  
fd2- + enoyl-CoA + H+   AcCoA + fd    (61) 
It is necessary to mention that the iJO1366 model already included the acyl-CoA 
dehydrogenase reactions, which were modified as part of this study. The iJO1366 
includes reversible acyl-CoA dehydrogenases linked to the oxidation/reduction of a flavin 
adenine dinucleotide (fad) and to the gene fadE. However, previous evidence suggests 
that these reactions occur only in the direction of oxidation of the acyl-CoA in vivo 
conditions, and therefore this family of reactions was restricted to function only in that 
direction (Clark & Cronan, 2005). 
As previously suggested (Dellomonaco et al., 2011), the redox balance of 
ferredoxins is achieved  by adding the enzyme pyruvate ferredoxins oxidoreductase 
(PFOR), which transforms pyruvate (PYR) into acetyl-CoA (AcCoA) according to the 
following reaction:  
PYR + CoA + fd AcCoA + CO2 + fd2- + h+     (62) 
Finally, the reaction acetyl-CoA carboxylase was restricted to have a flux no 
greater than 0.1 in order to prevent simultaneous activation of the reversal of the β-
oxidation cycle and of the FA biosynthesis pathway.  
6.1.5 Implementation of FA biosynthesis pathway and α-keto acid pathway 
As stated in the introduction of this chapter, two pathways have been used for the 
production of long chain products: the FA biosynthesis pathway and the α-keto acid 
pathway. These two pathways were implemented in the GEM in order to benchmark the 
use of the reversal β-oxidation cycle. 
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The FA biosynthesis pathway is an essential pathway in wild type E. coli, and 
therefore it was already part of the iJO1366 model. This pathway requires malonyl-ACP 
for the production of the precursor acetoacyl-ACP and to act as carbon donor in the 
elongation of the fatty acids. Each cycle of this pathway elongates the four intermediates 
by 2 carbons.    
The α-keto acid pathway is an engineered pathway in E. coli and it was 
implemented in the model for the production of n-butanol and n-hexanol, as reported 
(Atsumi et al., 2008b; Shen & Liao, 2011). To this end, I first verified that the production 
of 2-ketobutyrate using the L-threonine biosynthesis pathway was part of the iJO1366 
model, and then I included the keto acid chain elongation cycle (Atsumi et al., 2008b; 
Shen & Liao, 2008), which consists of three steps: condensation (LeuA), isomerization 
(LeuCD) and oxidation (LeuB). Equations 63-65 show each of these reactions. 
Cn-keto acid + AcCoA + h2o  2-Cn-alkyl-malate + CoA  (63) 
2-Cn-alkyl-malate  3-Cn-alkyl-malate    (64) 
3-Cn-alkyl-malate + NAD  Cn+1-keto acid  + CO2 + NADH (65) 
Unlike the reversal β-oxidation cycle and the FA biosynthesis pathway, in which 
each cycle elongates the intermediate metabolites by 2 carbons, the α-keto acid pathway 
elongates the intermediate product by only one carbon molecule.  
6.1.6 Implementation of termination pathways 
Termination pathways were added for the production of n-alcohols, alkanes and 
fatty acids. These three product families are a sample of advanced fuels and chemicals 
that can be produced using the reversal of the β-oxidation cycle. The starting point for the 
termination steps will be either a fatty acyl-CoA (using the reversal of the β-oxidation 
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cycle), a fatty acyl-ACP (using the FA biosynthesis pathway), or an α-keto acid (using 
the α-keto acid pathway for production of n-butanol and n-hexanol). Acyl-CoA and acyl-
ACP are structurally similar, as are the chemical reactions involved.  
Using the reversal of the β-oxidation cycle, a fatty acyl-CoA can be converted 
into an alcohol by the action of two successive reduction steps catalyzed by an aldehyde-
forming acyl-CoA reductase and an alcohol dehydrogenase (Dellomonaco et al., 2011). 
Likewise, an acyl-ACP (produced in the FA biosynthesis pathway) can be converted into 
an alcohol in two reducing steps catalyzed by an acyl-ACP reductase and an alcohol 
dehydrogenase (Schirmer et al., 2010). These reactions were implemented in the model 
as follows:   
fatty acyl-CoA +h + NADH   CoA + NAD + aldehyde  (66) 
fatty acyl-ACP + h + NADH  ACP + NAD + aldehyde  (67) 
NADH + aldehyde + h  NAD + n-alcohol.    (68) 
Production of medium chain n-alcohols can also result from using the α-keto acid 
elongation pathway. The production of n-butanol and n-hexanol using the α-keto acid 
elongation pathway uses a 2-keto acid as starting point (Shen & Liao, 2011). The 
termination steps of this pathway include the decarboxylation of the 2-keto acid by the 
action of the enzyme 2-ketoisovalerate decarboxylase (KIVD), and dehydrogenation of 
the resulting aldehyde by the action of the enzyme alcohols dehydrogenase as previously 
described (see equation 68). The decarboxylation step is implemented as follows: 
2-ketoacid (Cn)  aldehyde (Cn-1) + CO2.    (69) 
The production of alkanes can be achieved by reducing an acyl-CoA or an acyl-
ACP into an aldehyde as described in equation 66 and 67, followed by decarbonylatinon 
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of the aldehyde using a fatty aldehyde decarbonylase (Schirmer et al., 2010), in the 
following way:  
aldehyde  alkane + CO.      (70) 
Production of fatty acids is achieved by hydrolysis of the thioester group in the 
acyl-CoA molecule (using the reversal of the β-oxidation cycle) or in the acyl-ACP 
molecule (using the FA biosynthesis pathway). E. coli possesses a number of 
thioesterases that can perform this function, and their overexpression has enhanced the 
production of fatty acids. For example, the enzyme TesA has been used to convert acyl-
ACP into fatty acids (Steen et al., 2010) and acyl-CoA into fatty acids (Dellomonaco et 
al., 2011). Other enzymes, such as thioesterases TesB, FadM and YciA, have also been 
overexpressed to convert acyl-CoA into fatty acid (Dellomonaco et al., 2011). 
Accordingly, the hydrolysis of an acyl-CoA or an acyl-ACP is already part of the 
iJO1366 model. However, the original model only included a transport system for two 
molecules of this family: butyrate and hexanoate. Since experimental results suggest that 
E. coli is capable of producing longer chain FAs as final product, the transport reactions 
were added into the GEM as follows: 
Fatty acid[c] + h[c]  fatty acid[p] + h[p].    (71)   
where [c] and [p] indicate the location of the molecules: [c] for cytoplasm, and [p] for 
periplasm. 
After adding the pathways for the production and transport of n-alcohols, alkanes 
and fatty acids, the final step in the model implementation is the addition of exchange 
reactions. In a GEM, the “exchange” reactions provide substrates and remove products to 
and from the media in order to simulate state conditions in the system. The iJO1366 
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model already includes the exchange reactions for fatty acids (as they are part of the 
possible natural substrates of E. coli). Addition of exchange reactions was necessary for 
all the new products, which consist of n-alcohols (C-4 to C-18, even chain length) and 
alkanes (C-3 to C-17, odd chain length), and for the by-product carbon monoxide. All 
these products possess a straight fatty chain and a terminal group, with no functional side 
chains.  
6.1.7 Implementation of pathways for the synthesis of products with a functional side 
chain 
 The reversal β-oxidation cycle can also be used to synthesize products with a 
functional side chain. In the following sections two strategies are presented to this end. 
The first one consists of applying the termination pathways to different intermediates of 
the reversal β-oxidation cycle (beside the acyl-CoA metabolite). The second strategy 
utilizes a primer with a functional group in the omega end, a hydroxyl or a carboxyl, to 
produce 1,n-diols and dicarboxylic acids. The in silico implementation of these two 
strategies is explained next. 
6.1.7.1 Strategy 1: Derive products from intermediate metabolites 
 The termination pathways described in previous sections can be applied to 
different intermediates of the reversal β-oxidation cycle, generating a variety of long 
chain products. This strategy can be experimentally implemented by using termination 
enzymes with different specificities and with the same catalytic function. Dellomonaco 
and collaborators already demonstrated that the use of thioesterases can act upon the 
intermediates β-keto acyl-CoA, trans- β-hydroxyacyl-CoA, and trans-d2-enoyl-CoA. The 
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resulting products of these reactions are β-ketoacids, β-hydroxyacids, and trans-d2-fatty 
acids (Dellomonaco et al., 2011). This experimental work is extended in this chapter, 
using mathematical modeling, to the production of other products using the same or other 
intermediates of the reversal β-oxidation cycle. Figure 52 shows a diagram of the 
products that result from applying the termination pathways presented earlier in this 
chapter to produce n-alcohols, alkanes and fatty acids. Box 1 in Figure 52 shows 
synthesis of products from an acyl-CoA; box 2 shows synthesis of products from a β-keto 
acyl-CoA, box 3 shows synthesis of products from a trans-β-hydroxy acyl-CoA, and box 
4 shows synthesis of products from a trans-∆-enoyl-CoA. 
 
Figure 52: Production of long chain chemicals using the reversal of the β-oxidation cycle, starting from CoA 
intermediates. Four intermediates are used as inputs for the termination pathways: β-ketoacyl-CoA, trans- β-
hydroxyacyl-CoA, trans-d2-fatty enoyl-CoA and acyl-CoA. Three set of termination pathways are implemented, 
each of them classified with a different color: red: alcohols termination, blue: alkane termination, and orange: 
carboxylic acid termination.  
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The mechanisms of the reactions involved in the termination pathways are the 
same mechanisms that were already presented using acyl-CoA as starting point. Thus, for 
the production of β-ketoalcohols, 1,3-diols and trans-d2-fatty alcohols, the termination 
pathway consists of two consecutive reductions performed by dehydrogenases, as 
presented in equations 66 and 68. Production of β-ketones, 3-alcohols and alkenes is 
achieved by the action of a decarbonylase as presented in equation 70. Production of β-
ketoacids, β-hydroxyacids and trans-d2-fatty acids is achieved by hydroxylation of the 
thioester group of the starting metabolite, in the following way: 
h2o + β-ketoacetyl-CoA  CoA + h + β-ketoacid   (72) 
h2o + trans-β-hydroxyaceyl-CoA  CoA + h + β-hydroxyacid (73) 
h2o + trans-2-enoyl-CoA  CoA + h + trans-d2-fatty acid  (74) 
All these modifications were added to the iJO1366 model, and the results of 
adding these pathways are presented in the subsection 6.2.5 (Synthesis of products with 
functionalized side chain). 
6.1.7.2 Strategy 2: Use hydroxylated and carboxylated primers 
 The final set of products that was evaluated using the functional reversal of the β-
oxidation cycle consists of diols, hydroxyacids and dicarboxylic acids. The production of 
these products was simulated using a hydroxylated primer or a carboxylated primer, 
instead of using the original AcCoA as primer. Figure 53 shows a simplified diagram of 
the main reactions and pathways involved in this case, and corresponding reactions were 
added to the iJO1366 model when needed for the termination reactions and for the 
production of the primers.  
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Figure 53: Simplified diagram of the use of hydroxylated and carboxylated primers in the reversal β-oxidation 
cycle to produce diols, hydroxyacids and dicarboxylic acids. Glucose is converted into a hydroxy acid (oxalate, 
malate and succinate) or a carboxy acid (hydroxy propionate and hydroxy propionate), and these molecules are 
activated using one molecule of ATP. The elongation of the molecule occurs using AcCoA. 
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oxalyl-CoA, malonyl-CoA and succinyl-CoA, 4-hydroxybutyryl-CoA, and 3-
hydroxypropionyl-CoA. Production of these primers can be achieved by activation of the 
corresponding hydroxy acid or carboxy acid. To this end, I first identified the primers 
and/or acids that the iJO1366 model can produce, and I found pathways for the 
production of the carboxylated primers oxalyl-CoA, malonyl-CoA, and succinyl-CoA. In 
the iJO1366 model, the production of oxalyl-CoA and succinyl-CoA is mediated by the 
activation of the corresponding acids: oxalate and succinate, respectively. The production 
of the hydroxylated primers 4-hydroxybutyryl-CoA and 3-hydroxypropionyl-CoA was 
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not part of any pathway in the iJO1366; therefore, their production was simulated in the 
model by extending existing pathways of the iJO1366 model.   
The production of 4-hydroxybutyryl-CoA can be achieved by activating the 
hydroxy acid hydroxybutyrate, an intermediate molecule whose production is part of the 
iJO1366, into 3-hydroxypropionyl-CoA. This activation was simulated in the model by 
adding the reaction hydroxybutyryl-CoA synthetase, which is part of the 4-
hydroxybutyrate cycle in some Archea (Berg et al., 2007), in the following way:  
hydroxybutyrate + ATP + CoA  4hydroxybutyryl-CoA + AMP + ppi (75) 
 The production of 3-hydroxypropionyl-CoA can be achieved by adding a 3-
hydroxypropionyl-CoA synthase that converts the hydroxy acid 3-hydroxypropionate into 
the desired molecule. Since production of 3-hydroxypropionate is not part of the iJO1366 
model, two pathways that would produce this molecule were added, following the 
diagram presented in Figure 54. Equations 76-80 show these reactions in detail, which 
correspond to malonyl-CoA reductase (eq. 76), hydroxypropionate:NADP+ 
oxidoreductase (eq. 77), glycerol dehydratase (eq. 78), 3-hydroxypropionaldehyde 
dehydrogenase (eq. 79) and 3-hydroxypropionate:CoA ligase (eq. 80). All of the 
reactions presented in equations 76-80 were added to the iJO1366 model by simulating 
the incorporation of exogenous genes encoding the proteins capable of performing these 
reactions (Berg et al., 2007; Daniel et al., 1998), and by adding the endogenous reaction 
3-hydroxypropionaldehyde dehydrogenase (Jo et al., 2008).  
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Figure 54: Addition of exogenous pathways in the iJO1366 model for the production of 3-hydroxypropionate 
(hydroxylated primer) and 3-hydroxypropionyl-CoA (activated primer) from glucose. 
 
malCoA + NADPH + h  Malonate-semialdehyde + CoA + NADP    (76) 
Malonate-semialdehyde + NADPH + h  3-hydroxypropionate + NADP   (77) 
glyc  3-hydroxypropionaldehyde + h2o       (78) 
3-hydroxypropionaldehyde +NAD +h2o  3-hydroxypropionate + NADH + 2 h (79) 
3-hydroxypropionate + CoA + ATP  3-hydroxypropionyl-CoA  ppi + amp.  (80) 
 The next step consisted of the incorporating these primers into the reversal β-
oxidation cycle reactions, as illustrated in Figure 53. The following equations represent 
the reactions for the incorporation of the primers: 
hydroxyacetyl-CoA + AcCoA --> 4-hydroxyacetoacetyl-CoA + CoA  (81) 
3-hydroxypropionyl-CoA + AcCoA --> 5-hydroxy-3-oxopentanoyl-CoA +CoA (82) 
4-hydroxybutyryl-CoA + AcCoA --> 6-hydroxy-3-oxohexanoyl-CoA + CoA (83) 
oxaloacetyl-CoA + AcCoA --> 3-oxosuccinyl-CoA + CoA   (84) 
malonyl-CoA + AcCoA --> 3-oxoglutaryl-CoA + CoA    (85) 
succinyl-CoA + AcCoA --> 3-oxoadipyl-CoA + CoA.    (86) 
Finally, two termination pathways were incorporated into the model, starting from 
either a hydroxy-acyl-CoA or a carboxy-acyl-CoA (Figure 53). The first termination 
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pathway consists of two dehydrogenation steps toward the production of diols or 
hydroxyacids. The second termination pathway consists of a hydroxylation of the 
thioester group of the starting metabolite, resulting in the production of hydroxyacids or 
carboxyacids. It is important to note that the production of hydroxy acids was 
implemented in the model following two distinct pathways, as shown in Figure 53. The 
first pathway uses a hydroxylated primer to produce a hydroxyacyl-CoA in the reversal 
β-oxidation cycle, and then it converts the hydroxyacyl-CoA into a hydroxy acid by 
hydroxylation of the thioester group. The second pathway uses a carboxylated primer to 
produce a carboxyacyl-CoA in the reversal β-oxidation cycle, and then it converts the 
carboxyl-acyl-CoA into a hydroxy acid by two consecutive reductions. The use of FBA 
will identify the most efficient pathway.  
All these reactions were added to the iJO1366 model in order to simulate the 
production of diols, hydroxyacids and dicarboxylic acids. The integration of both even 
and odd length primers enabled the simulated production of even and odd length chain 
products using the model. For the case of diols, the model was used to simulate 
production of all 1,n-diols from 4 carbon molecules (1,4-butanediol) to 18 carbon 
molecules (1,18-octadecanediol). For the case of hydroxyacids, the model was used to 
simulate all omega-hydroxyacids from 4 carbon molecules (4-hydroxybutyric acid) to 18 
carbon molecules (18-hydroxyoctadecanoic acid). For the case of dicarboxylic acids, the 
model was used to simulate production of all omega dicarboxylic acids, from 4 carbon 
molecules (3-dicarboxylic propionic acid) to 18 carbon molecules (17-dicarboxylic 
heptadecanoic acid).  
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All the modifications presented in this section were added to the iJO1366 model. 
Appendix 10.3 shows a detail of the reactions that were added or removed. The resulting 
model is referred to as lcp-GEM in the rest of this chapter, where “lcp” stands for “long 
chain products”. The following section (Results) shows the results of in silico simulations 
using the lcp-GEM for the production of alcohols, alkanes, FAs, and products with a 
functionalized side chain. Appendix 10.12 shows the Matlab function for the model lcp-
GEM, and Appendices 10.13 and 10.14 show the Matlab functions for the GEM that 
simulates the synthesis of products with a functionalized chain. 
6.2 Results: Production of alcohols, alkanes and fatty acids 
The lcp-GEM was used in combination with FBA and FVA to predict production 
of long chain alcohols, alkanes, and FAs. In each case simulations were performed by 
allowing or deleting fermentative products. The deletion of native fermentation products 
was done to couple production of biomass to the desired product. For this purpose I 
considered the following as possible fermentative products: ethanol, lactate, acetate, 
succinate and acetate. Deletion of key enzymes was simulated by deleting the following 
reactions: ALDH (aldehyde dehydrogenase, AdhE), ADH (alcohol dehydrogenase, 
adhE), LDH_D (D-lactate dehydrogenase, ldhA), PTA2 (Phosphate acetyltransferase, 
pta), PTAr (phosphotransacetylase, pta), FRD2 (fumarate reductase, frdA, frdB, frdC, 
frdD), and FRD3 (fumarate reductase, frdA, frdB, frdC, frdD). In addition to these 
metabolic reactions, the following export reactions were deleted to ensure the 
eliminations of associated products: EX_ac(e) (for acetate), EX_PYR(e) (for pyruvate), 
and EX_hxa(e) (for hexanoate). 
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For the production of n-alcohols, simulations using the reversal β-oxidation cycle 
were contrasted against simulations using the FA biosynthesis pathway or the α-keto acid 
pathway. In a similar manner, for the production of alkanes and FAs, predictions using 
the reversal of the β-oxidation cycle were contrasted with predictions using the FA 
biosynthesis pathway. 
All simulated solution spaces are presented for each product on carbon mole 
basis, in order to make the results comparable. 
6.2.1 Production of alcohol 
This section shows the simulated results for the production of alcohols using the 
reversal of the β-oxidation cycle, as well as the FA biosynthesis pathway and the α-keto 
acid pathway. The predicted performances of these three pathways were compared. In 
each case the solution space was simulated by allowing or deleting possible native 
fermentation products. 
6.2.1.1 Use of the reversal β-oxidation cycle 
Figure 55-A shows the predicted solution space associated with the production of 
alcohols using the reversal of the β-oxidation cycle. In each case the optimal specific 
growth rate was 0.39 h-1, and the main products were acetate (11.7 mmol/gCDW/h) and 
ethanol (12.3 mmol/gCDW/h). Production of butanol and other longer chain alcohols was 
not found in the optimal solution, indicating that the native products (acetate and ethanol 
in this case) support a higher production of biomass than production of longer chain 
alcohols using the reversal of the β-oxidation cycle. Deletion of native fermentation 
products as explained above resulted in production of all alcohols considered in this study 
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coupled to cell growth (Figure 55-B), with an optimal growth rate equal to 0.26 ± 0.2 h-1, 
and an alcohol production rate of 51.9 ± 0.5 mmol-C/gCDW/h (see Table 13 for more 
detailed values). Titers were calculated for all alcohols over a period of 24 hours (Table 
13). See Appendix 10.8 for calculation of titers. 
 
Figure 55: Predicted solution space for the production of alcohols using the reversal of the β-oxidation cycle (A, 
B), the FA biosynthesis pathway (C,D), and the α-keto acid pathway (C). Results are shown before deleting 
native fermentation products (A, C) and after simulating deletion of native fermentation products ethanol, 
acetate, lactate and succinate (B, D). There was no production of alcohols after deleting native fermentation 
products when the α-keto acid pathway was used. 
 
Table 13: Model predictions for specific growth rate, production rate and titers. Production of alcohols using the 
reversal of the β-oxidation cycle, after blocking synthesis of native fermentation products. 
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Flux - Alcohols C-4 C-6 C-8 C-10 C-12 C-14 C-16 C-18
Specific growth rate (1/h) 0.28 0.27 0.26 0.26 0.25 0.25 0.25 0.25
Production rate (mmol C/gDW/h) 51.4 51.8 52.0 52.1 52.2 52.2 52.3 52.3
Titer 24 hr (mol C/L) 152.9 118.0 103.6 95.8 90.9 87.6 85.2 83.3
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Production of alcohols using the reversal of the β-oxidation cycle is redox 
balanced as expected; hence, no additional by-products were predicted as necessary to 
achieve redox balance. The expected amount of ATP produced in association with the 
production of alcohols using this pathway is presented in equation 87 (see details of 
calculations in Appendix 10.7): 
n Glucose  4n/m Alcohol_Cm + 2n ATP,     (87) 
where ‘n’ is the flux of glucose, ‘m’ is the number of carbons in the product, and 
Alcohol_Cm is the product (example: Alcohols_C8 is octanol). Since ATP production is 
independent of the produced alcohol, the model was expected to predict the same optimal 
solution for cell growth and production rate (per unit of carbon). However, although 
simulations in the production of all alcohols produced very similar solution spaces, 
production of shorter chain alcohols were simulated to allow a slightly higher specific 
growth rate (Figure 55-A,B). Analysis of flux distribution indicates that there is a 
connection between these minor differences and changes in flux distribution at the 
pyruvate node. Table 14 shows the flux distribution at the pyruvate node for the 
production of alcohols with different chain length. The longer the alcohol chain, the 
bigger the flux through PFOR and the smaller the flux through pyruvate dehydrogenase 
(PDH). This is because the redox balance is achieved in the two reduction steps of the 
reversal β-oxidation pathway plus the two reduction steps of the termination reactions. 
Consequently, a longer chain alcohol is associated with a smaller production per mole of 
product base and therefore more reducing equivalents are consumed in the cycle than in 
the termination steps. Since half of the reducing equivalents consumed in the β-oxidation 
cycle comes from ferredoxins, a higher consumption of reducing equivalents requires a 
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higher flux of ferredoxins to be oxidazed in the reaction PFOR.  Considering that the 
reaction PFOR results in the generation of one proton (Charon et al., 1999), and that the 
reaction PDH was included in the iJO1366 without production of protons, the different 
flux distributions at the pyruvate node generate different production of protons. These 
protons under fermentative conditions need to be exported in order to maintain proton 
concentration inside the cell, a process that is catalyzed by the enzyme ATPase and that 
consumes energy (Cain & Simoni, 1989). Thus, simulation of the production of longer 
chain alcohols results in a slighter higher requirement of energy, which in turn lowers the 
efficiency in production of biomass. However, this situation may change if the enzyme 
PDH is modeled producing protons, as has been presented elsewhere (Bates et al., 1977), 
in which case both reactions (PFOR and PDH) would produce the same amount of 
protons. 
Table 14: Analysis of flux partitioning at the pyruvate node and corresponding differences in specific growth 
rate during alcohol synthesis through the β-oxidation reversal. Abbreviations: PFOR (pyruvate ferredoxins 
oxidoreductase), PDH (pyruvate dehydrogenase), and PFL (pyruvate formate lyase).   
 
 
 
6.2.1.2 Use of the FA biosynthesis pathway 
Figure 55-C shows the predicted solution space associated with the production of 
alcohols using the FA biosynthesis pathway. In each case the optimal specific growth rate 
was 0.38 h-1, and the main products were acetate (12.2 mmol/gCDW/h) and ethanol (11.9 
mmol/gCDW/h). Production of butanol and other longer chain alcohols was not found in 
the optimal solution, indicating that the native products (acetate and ethanol in this case) 
Pyruvate Node  
(rates normalized with glucose rate) C-4 C-6 C-8 C-10 C-12 C-14 C-16 C-18
PFOR 0.90 1.19 1.34 1.43 1.49 1.53 1.56 1.59
PDH 0.83 0.55 0.41 0.32 0.26 0.22 0.19 0.17
PFL 0.07 0.07 0.06 0.06 0.06 0.06 0.06 0.06
Alcohols
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support a higher production of biomass than production of longer chain alcohols using 
the FA biosynthesis pathway. Deletion of native fermentation products resulted in 
production of only butanol and hexanol coupled to cell growth (Figure 55-D). Values of 
simulated specific growth rate, production rate and titers after deleting native 
fermentation products are presented in Table 15. For the production of octanol and all 
other longer chain alcohols, the presence of by-products is predicted to be essential based 
on these results, which will reduce the yield of the desired alcohols.  
Table 15: Model predictions for specific growth rate, production rate and titer during production of alcohols 
using the FA biosynthesis pathway, after deleting production of native fermentation products. 
 
 
 
The simulated results using the FA biosynthesis pathway were compared to 
simulated results using the reversal of the β-oxidation cycle. Based in these simulations, 
the specific growth rates after deleting native fermentation products are predicted to be 
considerably smaller using the FA biosynthesis pathway (for butanol and hexanol), but 
the production rates are predicted to be slightly higher. The titer represents the total 
production of alcohols at the maximal specific growth rate after a period of time, and 
therefore it is a better parameter to compare both platforms. Over a period of time of 24 
hours, predicted titers using the reversal of the β-oxidation cycle are 25 and 60 times 
higher that the predicted titers using the FA biosynthesis pathway for the production of 
butanol and hexanol, respectively. These results highlight the supremacy of the reversal 
β-oxidation cycle over the FA biosynthesis pathway for the production of alcohols.   
Flux - Alcohols C-4 C-6
Specific growth rate (1/h) 0.11 0.03
Production rate (mmol C/gDW/h) 56.74 59.22
Titer 24 hr (mol C/L) 6.24 1.95
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The absence of other alcohols upon deletion of by-products using the FA 
biosynthesis pathway was unexpected, as theoretical analysis indicates that this pathway 
should produce ATP according to the following formula:  
n Glucose (4n/m) Alcohol_Cm + (
4n/m) ATP,   (88) 
where “m” is the number of carbon molecules in the product, and  n ≤ 4m. Detailed 
calculations are shown in Appendix 10.7. Therefore, for a glucose uptake rate of 15 
mmol/gCDW/h, a maximal production of alcohols is associated with production of 60/m 
molecules of ATP (with m = 4 to 18), which is greater than the ATP required for 
maintenance (ATPM = 3.15 mmol/gCDW/h). However, analysis of flux distribution 
identified that in addition to the ATPM requirement, ATP is required to maintain pH 
homeostasis, a process in which protons are transported across the membrane and energy 
is consumed under fermentative conditions (Kasimoglu et al., 1996). This was identified 
by observing a significant and essential flux through the reversible enzyme ATP synthase 
in the lcp-GEM. Since production of butanol and hexanol using the FA biosynthesis 
pathway produces more ATP than production of octanol and other longer chain alcohols, 
only production of butanol and hexanol allowed satisfying the energetic requirements for 
ATPM and proton transport. Addition of a fictitious source of ATP resulted in production 
of longer chain alcohols. For example, Figure 56 shows the predicted flux distribution 
associated with the production of octanol using the FA biosynthesis pathway, adding a 
fictitious source of ATP, blocking the synthesis of native fermentation products. This 
example shows that the main sources of cytoplasmic protons is glycolysis, the 
termination pathway, and the conversion of NADH/NADP into NAD/NADPH. The 
addition of a fictitious source of ATP to the model allows the production of all other 
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alcohols using the FA biosynthesis pathway after deleting native fermentation products, 
supporting the conclusion that the ATP requirements for cell growth and cellular 
maintenance is preventing the efficient production of longer chain alcohols. 
 
Figure 56: ATP requirements to maintain pH homeostasis (proton transport) during octanol synthesis via the 
FA biosynthesis pathway. A fictitious source of ATP was considered in the simulations.. FBA was used with 
octanol synthesis as the objective function. This figure includes the flux distribution from glucose to octanol (A), 
showing the production of protons, as well as the mechanism for proton transport across the membrane (B). 
Protons in the cytoplasm are called h[c], and protons in the periplasm are called h[p]. The overall balance for 
the production of octanol through the FA synthesis pathway is: ATP: 7.5; h[c]: 15; 'ADH: balance (A). See 
'omenclature for details (page 214). 
 
6.2.1.3 Use of the α-keto acid pathway 
 
Figure 55-C shows the predicted solution space associated with the production of 
alcohols using the α-keto acid pathway. The optimal specific growth rate for the wild-
type scenario was 0.38 h-1, and the main products were acetate (12.2 mmol/gCDW/h) and 
ethanol (11.9 mmol/gCDW/h). Production of butanol and hexanol were not found in the 
optimal solution, indicating that the native products (acetate and ethanol in this case) 
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support a higher production of biomass than production of longer chain alcohols using 
the α-keto acid pathway. The solution space using this pathway is considerably smaller 
than the solution space for the same products using the FA biosynthesis pathway, or the 
reversal β-oxidation pathway.  
Deletion of native fermentation products resulted in production of neither butanol 
nor hexanol using this pathway, indicating their requirement for pathway functioning. 
These simulations correlate well with experimental data, in which the strategies for 
production of 1-butanol include production of by-products, such as acetate (Shen & Liao, 
2008). The analysis of the theoretical maximum production yield of butanol and hexanol 
allows the identification of the necessity for other fermentative products. The overall 
balance for production of alcohols, including ATP and reducing equivalents, and using 
the pathway presented by Shen et al., and Marcheschi et al. (Marcheschi et al., 2012; 
Shen & Liao, 2008) are as follows:  
n Glucose + 2n[H] + n ATP  n butanol + n formate  (89) 
n Glucose  n/2 Hexanol + n/2 ATP + n [H] + n formate,  (90) 
where ‘n’ is the flux of glucose, ‘m’ is the number of carbons in the product, and [H] 
represents reducing equivalents (see Appendix 10.7 for details). The simulated flux 
distribution using FBA and the lcp-GEM supports these overall balances. Equation (89) 
shows that production of butanol consumes ATP, making imperative the production of an 
additional by-product that would result in an overall production of ATP. In addition, the 
consumption of reducing equivalents associated with the production of butanol requires 
the production of an additional by-product that produces reducing equivalents. Equation 
(90) shows that production of hexanol using the α-keto acid pathway produces reducing 
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equivalents and ATP. While the production of ATP would support the exclusive use of 
this pathway for cell growth, the high amount of reducing equivalents that would be 
generated would overcome the capacity to consume reducing equivalents associated with 
cell growth when using glucose as carbon source, making the production of additional 
fermentative products necessary to balance the reducing equivalents and to produce ATP 
in the case of butanol synthesis. Therefore, the in silico analysis using the lcp-GEM, as 
well as theoretical analysis using the overall pathway, indicate that production of butanol 
and hexanol using the α-keto acid pathway is less attractive than using the previously 
discussed pathways (reversal β-oxidation cycle and FA biosynthesis pathway), as 
essential production of by-products results in reducing the maximal theoretical yields.  
6.2.2 Production of alkanes 
This section shows the simulated results for the production of alkanes using the 
reversal β-oxidation cycle. In order to contrast performance, production of alkanes using 
the FA biosynthesis pathway was also simulated. In each case the solution space 
associated with each alkane was simulated allowing or deleting the synthesis of native 
fermentation products. 
6.2.2.1 Use of the reversal of the β-oxidation cycle 
The results of the predicted solution space associated with the production of 
alkanes using the reversal of the β-oxidation cycle are presented in Figure 57-A. 
Production of all alkanes is simulated by introducing a decarbonylase enzyme in the 
termination steps. Results for the production of alkanes is presented per unit on carbon 
mole basis “plus 1”, which make alkanes of all lengths comparable to each other. As with 
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the case of alcohols production, the predicted optimal solutions were not associated with 
the production of any alkane prior to deleting native fermentation products. Deletion of 
native fermentation products resulted in the production of all alkanes considered in this 
study coupled to cell growth (Figure 57-B), with an optimal growth rate equal to 0.24 h-1 
in all cases. Table 16 shows predicted production rates and titers. 
 
Figure 57: Predicted solution space for the production of alkanes using the reversal of the β-oxidation cycle (A, 
B) and the FA biosynthesis pathway (C,D). Results are shown before deleting native fermentation products (A, 
C) and after simulating the deletion of ethanol, acetate, lactate and succinate (B, D). For comparison purposes, 
all productions rates are plotted on carbon mole basis + 1. 
 
 
 
Table 16: Model predictions of specific growth rate, production rate and titer. Production of alkanes using the 
reversal of the β-oxidation cycle, after blocking synthesis of native fermentation products. 
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 To achieve redox balance the reversal β-oxidation cycle is combined with the 
conversion of PYR into AcCoA using the enzyme PFL (Table 14), which produces 
formate and not reducing equivalents. The conversion of glucose into an alkane produces 
ATP independently of the carbon chain length of the product, and the maximal theoretical 
equation for the production of alkanes is as follows (see Appendix 10.7 for details):
 n Glucose  (4n/m) Alkane_Cm-1 + 2n ATP + 4n/m formate, (91) 
  where ‘n’ is the flux of glucose, ‘m’ is the number of carbons in the product, and 
Alkane_Cm-1 is the product (example: Alkane_C7 is heptane). It is interesting to note 
that, unlike the case of alcohols productions, productions of all the alkanes coincide in the 
optimal solution (specific growth rate and production rate on carbon mole basis “plus 1”), 
which is explained by the fact that the different products are associated with the same 
protons production, and therefore there are no changes in the energetic requirements. 
Table 17 shows the flux distribution at the pyruvate node for the production of 
alkanes with different chain length. The total flux is distributed between enzymes PFOR 
and PFL, and only PFOR produces reducing equivalents (as reduced ferredoxins). The 
longer the alkane chain, the bigger the flux through PFOR and the smaller the flux 
through PFL. This is because the redox balance is achieved in the two reduction steps of 
the reversal β-oxidation pathway plus the reduction step of the termination reactions. 
Consequently, a longer chain alkane is associated with a smaller production per mole of 
product base and therefore more reducing equivalents are consumed in the cycle than in 
the termination steps. Since half of the reducing equivalents consumed in the β-oxidation 
cycle come from ferredoxins, a higher consumption of reducing equivalents requires a 
higher flux of ferredoxins to be oxidized in the reaction PFOR. When compared with the 
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pyruvate node for the production of alcohols (Table 14), fluxes through PFOR are very 
similar, and the main change is in the use of PFL instead of PDH. This is because alkanes 
are less reduced than alcohols; therefore, a lower production of reducing equivalents at 
the pyruvate node enables a redox balanced system.  
Table 17: Analysis of flux partitioning at the pyruvate node and corresponding differences in specific growth 
rate during alkane synthesis through the β-oxidation reversal. Abbreviations: PFOR (pyruvate ferredoxins 
oxidoreductase), PDH (pyruvate dehydrogenase), and PFL (pyruvate formate lyase).   
 
 
6.2.2.2 Use of the FA biosynthesis pathway 
Figure 57-C shows the predicted solution spaces associated with the production of 
alkanes using the FA biosynthesis pathway. As in the case of alcohols production, the 
simulated optimal specific growth rate is 0.38 h-1, and at the optimal solution there is no 
production of alkanes. The main products were acetate (12.2 mmol/gCDW/h) and ethanol 
(11.9 mmol/gCDW/h). Upon deletion of native fermentation products, only propane 
synthesis was predicted to be feasible and coupled to cell growth (Figure 57-D). Values 
of simulated specific growth rate, production rate and titer after deleting native 
fermentation products are presented in Table 18.  
Table 18: Model predictions of specific growth rate, production rate and titer for the synthesis of alkanes using 
the FA biosynthesis pathway, after deleting production of native fermentation products. Propane is predicted to 
be the only feasible product. 
 
 
 
 
Pyruvate Node  
(rates normalized with glucose rate) C-3 C-5 C-7 C-9 C-11 C-13 C-15 C-17
PFOR 0.91 1.20 1.34 1.43 1.49 1.53 1.56 1.59
PDH 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PFL 0.91 0.62 0.47 0.38 0.32 0.28 0.25 0.23
Alkanes
Flux - Alkanes C-3
Specific growth rate(1/h) 0.06
Production rate (mmol C/gDW/h) 43.7
Titer 24 hr (mol C/L) 2.28
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 A theoretical analysis of the production of alkanes using the FA biosynthesis 
pathway indicates that the production of ATP decreases with longer chain products, 
which explains why propane is the only product observed after simulating the deletion of 
native fermentation products. The overall equation for the maximal theoretical yield for 
the production of alkanes is as follows (see Appendix 10.7 for details): 
n Glucose  (4n/m) Alkane_Cm-1 + (4n/m)  ATP + 4n/m formate, (92) 
where ‘n’ is the flux of glucose, ‘m’ is the number of carbons in the product and 
Alkane_Cm-1 is the product (example: Alkane_C3 is propane). 
 The simulated results using the FA biosynthesis pathway were compared to 
simulated results using the reversal of the β-oxidation cycle. The predicted solution space 
associated with the production of alkanes suggests higher production rates when the 
reversal of the β-oxidation cycle is used (Figure 57), both before and after deleting native 
fermentation products.  
After deleting native fermentation products, the use of the FA biosynthesis 
pathway supports production of only propane, while the use of the reversal of the β-
oxidation cycle supports production of all alkanes that were considered in this study. For 
the production of propane, the specific growth rate after blocking the synthesis of native 
fermentation products is predicted to be considerably smaller using the FA biosynthesis 
pathway (0.06 h-1 versus 0.24 h-1), while the production rate is predicted to be slightly 
higher using the FA biosynthesis pathway (43.7 versus 39.5 mmol C/gCDW/h). Over a 
period of 24 hours, the predicted titer for propanol using the reversal of the β-oxidation 
cycle was 22 times higher than the predicted titer using the FA biosynthesis pathway, 
which highlights the supremacy of the reversed β-oxidation cycle. As in the case of 
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alcohol production, the inability of this pathway to produce longer chain alkanes is due 
the inability to satisfy ATP energetic requirements. 
6.2.3 Production of fatty acids 
The production of FAs was simulated using the reversal β-oxidation cycle 
implemented in the lcp-GEM. In order to contrast performance, the synthesis of FAs 
through the FA biosynthesis pathway was also simulated. In each case the solution space 
associated with each fatty acid was simulated in otherwise wild-type E. coli as well as a 
strain devoid of native fermentation pathways. 
6.2.3.1 Use of the reversal β-oxidation cycle 
Production of FAs was simulated using the reversal of the β-oxidation cycle, and 
the predicted solution spaces are presented in Figure 58-A. As in previous cases, the 
solutions for optimal specific growth rate were not associated with the production of any 
of the FAs included in this study. Instead, the optimal specific growth rate is associated 
with production of acetate and ethanol. When the synthesis of native fermentation 
products is blocked, the resulting solution spaces show coupling between FA production 
and the specific growth rate, making the production of FAs essential (Figure 58-B). 
Interestingly, the optimal solution is coupled to the production of 1,2-PDO in rates from 
1.56 mmol/gCDW/h (for octadecanoate production) to 5.71 mmol/gCDW/h (for butyric 
acid production). 
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Figure 58: Solution space for the synthesis of fatty acids using reversal β-oxidation cycle (A, B) and FA 
biosynthesis pathway (C, D). Results are shown for both wild-type E. coli (A, C) and an engineered strain where 
pathways for native fermentation products ethanol, acetate, lactate and succinate were eliminated (B, D). 
Table 19 shows simulated values for specific growth rate, production rate and titer 
associated with the optimal solution after the sysnthesis of native fermentation products 
was eliminated. The longer the carbons chain in the product, the higher the specific 
growth rate, the production rate, and the titer. 
Table 19: Model predictions of specific growth rate, production rate and titer. Production of FAs using the 
reversal of the β-oxidation cycle, after blocking synthesis of native fermentation products. 
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reducing equivalents. Table 14 shows that the conversion of PYR into AcCoA uses 
enzymes PFL, which does not produce reducing equivalents, and PFOR, which reduces 
ferredoxins. As in the production of alkanes, no flux goes through the enzyme PDH to 
prevent production of reducing equivalents in the form of NADH. Because the reversal of 
the β-oxidation cycle oxidizes reduced ferredoxins in the reduction of enoyl-CoA, an 
equivalent flux of ferredoxins needs to be reduced using the enzyme PFOR and, 
therefore, the only way to achieve redox-balance is through the production of a more 
reduced by-product. Simulations of the production of FAs, unlike the production of 
alcohols and alkanes, results in the production of the by-product 1,2-PDO, which acts as 
an electron sink in this process.  The overall balance to produce FAs from glucose is 
presented in Appendix 10.7, and the resulting equation is as follows: 
& Â0%!'ê =  2+¶ $e_=8 +  2& ¶ eï6 +  y+¶ 1,26 +  2+¶ I'789"  (93) 
where ‘n’ is the flux of glucose and ‘m’ is the number of carbons in the product. Equation 
93 shows that the longer the chain in the product (m), the smaller the production of 1,2-
PDO, and the greater the production of ATP. Simulated results support this analysis, as 
production of longer chain FAs after deleting native fermentation products was 
associated with a smaller production of 1,2-PDO. Less production of the by-product 1,2-
PDO and a higher production of ATP in turn support a higher production of biomass and 
of the desired product.  Thus, this analysis explains the findings presented in Figure 58-
A,B, in which production of longer chain FAs was predicted to result in higher specific 
growth rate and in higher production rates using the lcp-GEM.  
Table 16 shows the flux distribution at the pyruvate node for the production of 
FAs with different chain length. As in the case of alkanes production, the total flux is 
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distributed between enzymes PFOR and PFL, and only PFOR produces reducing 
equivalents (as reduced ferredoxins). A longer chain FA is associated with a smaller 
production per mole of product base and therefore more reducing equivalents are 
consumed in the cycle than in the termination steps, which results in a larger flux through 
PFOR and a lower flux through PFL. Since half of the reducing equivalents consumed in 
the β-oxidation cycle come from ferredoxins, a higher consumption of reducing 
equivalents requires a higher flux of ferredoxins to be oxidized in the reaction PFOR. 
When compared with the pyruvate node for the production of alkanes (Table 14), fluxes 
through PFOR and PFL are smaller due to the fact that part of the glycolytic flux is being 
directed toward the production of 1,2-PDO to achieve redox balance.  
Table 20: Analysis of flux partitioning at the pyruvate node and corresponding differences in specific growth 
rate during FA synthesis through the β-oxidation reversal. Abbreviations: PFOR (pyruvate ferredoxins 
oxidoreductase), PDH (pyruvate dehydrogenase), and PFL (pyruvate formate lyase).   
 
 
 
6.2.3.2 Use of the FA biosynthesis pathway 
 
Figure 58-C shows the predicted solution space associated with the production of 
FAs using the FA biosynthesis pathway. As in previous cases, the simulated optimal 
specific growth rate for otherwise wild type E. coli is 0.38 h-1, with acetate and ethanol as 
main products, and no production of FAs at the optimal solution. Blocking the synthesis 
of native fermentation products led to coupling between product synthesis and cell 
growth only for the case of butyric acid (Figure 58-D). Values of simulated specific 
Pyruvate Node  
(rates normalized with glucose rate) C-4 C-6 C-8 C-10 C-12 C-14 C-16 C-18
PFOR 0.77 1.07 1.23 1.34 1.41 1.46 1.50 1.53
PDH 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PFL 0.77 0.55 0.43 0.35 0.30 0.27 0.24 0.22
Fatty acids
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growth rate, production rate and titer after blocking the synthesis of native fermentation 
products are presented in Table 21.  
Table 21: Model predictions of specific growth rate, production rate and titer for production of FAs using the 
FA biosynthesis pathway after blocking synthesis of native fermentation products. Butyric acid is predicted to 
be the only feasible product. 
 
 
 
 As in the case of alcohols and alkanes production, the production of longer chain 
FA decreases production of ATP, which explains why butyric acid is the only product 
observed after simulating the deletion of native fermentation products. The overall 
equation for the maximum theoretical yield for the production of FA is as follows (see 
Appendix 10.7 for details): 
 n Glucose  (4n/m) FA_Cm + (4n/m) ATP + 8n/m formate, (94) 
where ‘n’ is the flux of glucose, ‘m’ is the number of carbons in the product and FA_Cm 
is the product (example: FA_C8 is octanoic acid). 
The performance of the FA biosynthesis pathway for the production of FAs was 
compared with the performance of the β-oxidation cycle. The predicted solution spaces 
(before blocking the synthesis of native fermentation products) show higher production 
rates when the reversal β-oxidation cycle is used (Figure 58-A,C) for most products and 
for most specific growth rates. The only exceptions are the production of butyric acid and 
hexanoic acid, whose production rates are predicted to be slightly higher in the FA 
biosynthesis pathway than in the reversal of the β-oxidation cycle in the area close to null 
growth (see solution space in Figure 58-A,C at specific growth rates less than 0.10 h-1 for 
butyric acid and less than 0.04 h-1 for hexanoic acid).  
Flux - Fatty acids C-4
Specific growth rate (1/h) 0.01
Production rate (mmol C/gDW/h) 59.74
Titer 24 hr (mol C/L) 1.59
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After blocking the synthesis of native fermentation products, the simulations 
predict that only production of butyric acid is feasible using the FA biosynthesis pathway, 
while the use of the reversal β-oxidation cycle predicts production of all FAs that were 
considered in this study. For the production of butyric acid, the specific growth rate after 
blocking the synthesis of fermentation products is predicted to be considerably smaller 
using the FA biosynthesis pathway (0.01 h-1 versus 0.12 h-1), while the production rate is 
predicted to be 33% higher using the FA biosynthesis pathway (14.9 versus 11.2 mmol 
/gCDW/h). Over a period of 24 hours, the predicted titer for propanol using the reversal 
of the β-oxidation cycle was 4 times higher than the predicted titer using the FA 
biosynthesis pathway. As in the previous cases, the inability of this pathway to produce 
longer chain alkanes is due the inability to satisfy energetic requirements. 
 
6.2.4 Comparison of engineered β-oxidation reversal using ferredoxin- and NADH-
dependent acyl-CoA dehydrogenases/trans-enoyl-CoA reductases. 
 The previous three sections of this chapter simulated the production of alcohols, 
alkanes and FAs using the reversal of the β-oxidation cycle, a platform that was 
simulated using endogenous enzymes to E. coli. Motivated by the unique constraint 
imposed on the pathway by the oxidation/reduction of ferredoxins, I decided to study the 
effect of changing the endogenous acyl-CoA dehydrogenase, a key enzyme of the 
pathway which is associated with ferredoxins (Dellomonaco et al., 2011), for an 
exogenous acyl-CoA dehydrogenase associated with NADH, such as the one from 
Euglena gracilis (Hoffmeister et al., 2005). The use of this enzyme should then release 
the constraint imposed by the ferredoxin balance. Simulation of alcohol, alkane and FA 
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synthesis using this pathway in otherwise wild-type E. coli predicted an optimal specific 
growth rate equal to 0.39 h-1, and none of the aforementiones products was synthesized in 
the optimal solution. As in previous cases, blocking the synthesis of native fermentation 
products resulted in the coupling of each of the desired products to biomass production. 
Table 22 shows a summary of results for the production of short chains and long chain 
products, for alcohols, alkanes and FAs, after blocking the synthesis of native 
fermentation products. In all cases an increase in the specific growth rate was observed 
when compared to the use of the ferredoxin-dependent acyl-CoA dehydrogenase. In the 
case of production of alcohols and alkanes, the increase in the specific growth rate is 
contrasted with a small decrease in the production rate (less than 5%), and an increase in 
all titers of 20% or more (Table 22). For the production of FAs, the use of a NADH-
dependent acyl-CoA dehydrogenase predicts an increase in the production rate of desired 
products, especially in those of shorter chain. For example, the production rate of butyric 
acid is simulated to increase from 11.2 to 13.1 mmol/gCDW/h. These increases in 
production rates, together with the increase in specific growth rate, result in an increase 
of the titer for the different products from 6 times (for octadecanoic acid) to 11 times (for 
butyric acid) (Table 22). The major contribution for the increase comes from releasing 
the restriction imposed at the redox balance level for ferredoxins, which was forcing a 
higher co-production of 1,2-PDO along with FAs, especially for short chain FAs (see 
discussion in section 6.2.3.1).   
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Table 22: Model predictions of specific growth rate, production rate and titer for production of FAs using the 
reversal of the β-oxidation cycle and a 'ADH-dependent acyl-CoA dehydrogenase after blocking synthesis of 
native fermentation products. The increase in titers with respect to the use of a ferredoxin-dependent acyl-CoA 
is presented.  
 
 
 
6.2.5 Synthesis of products with functionalized side chain 
 The previous subsections focused on simulating the production of n-alcohols, 
alkanes and FAs using the reversal β-oxidation cycle. In all cases the primer or starter 
used to initiate the cycle was an AcCoA, and the final products were obtained by adding 
one or two termination steps to acyl-CoAs of different lengths (Figure 51). In this section 
the simulations and analysis of two additional functionalities of this platform are 
presented. The first one consists of using an AcCoA as a primer and deriving the final 
products from intermediate metabolites of the reversal β-oxidation cycle other than acyl-
CoAs (i.e., β-keto acyl- CoAs, trans- β-hydroxyacyl- CoAs, and trans-d2-enoyl- CoAs). 
This strategy results in the production of alcohols, carboxylic acids, ketones and alkenes, 
as presented in the Model Implementation section (see Figure 52, page 167). The second 
functionality arises from the use of omega-hydroxylated or omega-carboxylated primers, 
as opposed to using AcCoA, and the products are produced from the hydroxylated acyl-
CoA molecule or the carboxylated acyl-CoA molecules. This second functionality results 
in the production of diols, hydroxyacids and di-carboxylic acids, depending on the 
termination pathway being used.  
Use of NADH-dependent Acyl-CoA dehydrogenase
Flux C-4 C-18 C-3 C-17 C-4 C-18
Specific growth rate (1/h) 0.32 0.32 0.28 0.31 0.24 0.30
Production rate (mmol C/gDW/h) 50.14 50.14 38.49 47.60 52.53 50.66
Titer 24 hr (mol C/L) 341.81 341.81 118.83 272.61 72.05 243.49
Fold change in titer with respect to base case 1.2 3.1 1.3 3.2 11.1 5.9
Alcohols Alkanes Fatty acids
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6.2.5.1 Products derived from intermediate metabolites of the reversed β-oxidation 
cycle 
This subsection reports the in silico predictions generated using the lcp-GEM and the 
implementation of the proper termination pathways from each of the intermediate 
metabolites of the reversal β-oxidation cycle, as explained in the section Model 
Implementation (see Figure 52, boxes 2, 3 and 4, page 167). 
The lcp-GEM was used in combination with FBA and FVA to predict the solution 
spaces associated with the production of each of the products presented in Figure 52 after 
blocking the synthesis of native fermentation products. The results of these simulations 
are presented in Figure 59, which includes products derived from β-keto acyl-CoA, trans-
β-hydroxy acyl-CoA, and trans-enoyl-CoA, a total of nine product families. Production 
of β-ketones, 3-alcohols and alkenes was plotted carbon mole basis “plus 1”, in order to 
make products of different chain length comparable and due to the loss of one carbon 
molecule in the decarbonylation step. Based on the predicted solution spaces, I classified 
these nine families into four groups (Figure 59).     
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Figure 59: Solution spaces and classification of the production of nine product families derived from 
intermediate metabolites of the reversal β-oxidation cycle. Synthesis of native fermentation products was 
blocked. Panel A correspond to the solution spaces, including classification of the nine product families into four 
groups. Panel B corresponds to the legend of panel A, including the classification of the products per family and 
per group (on the right). The nine product families were grouped according to the shape of their solution space: 
group one (blue): β-ketoacids; group 2 (orange): β-hydroxyacids, trans-2-acids and β-ketones; group 3 (yellow): 
β-ketoalcohols, 3-alcohols and alkenes; and group 4 (green): 1,3-diols and trans-2-fatty alcohols. 
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(group 2)
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(group 3)
β -ketoacids
β-ketones, 
β-hydroxyacids
trans-2-fatty acids
β -ketoalcohols, 3-
alcohols, alkenes
1,3-diols,
trans-2-fatty alcohols
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 Table 23 presents a summary of specific growth rates, production rates and titers 
in the optimal solution for short chain and long chain products of each of the nine 
families that resulted from the simulations. In accordance with results presented in Figure 
59, the products are divided into four groups according to their predicted specific growth 
rate, production rate and titer.    
Table 23: Model predictions of specific growth rates, production rates and titers for the synthesis of the nine 
product families derived from intermediate metabolites of the reversal β-oxidation cycle. Synthesis of native 
fermentation products was blocked. For each product family a short chain product (3 or 4 carbon molecules) 
and a long chain product (17 or 18 carbon molecules) are presented as they represent the behavior of each 
family. The products were classified in four categories according to their results, and four colors were used: 
group one (blue): β-ketoacids; group 2 (orange): β-hydroxyacids, trans-2-acids and β-ketones; group 3 (yellow): 
β-ketoalcohols, 3-alcohols and alkenes; and group 4 (green): 1,3-diols and trans-2-fatty alcohols. 
 
 
   
Analysis of the four groups presented in Figure 59 and Table 23 indicates that a 
common characteristic of all members of each of the four groups is that they consume the 
same amount of reducing equivalents in the reversal β-oxidation cycle plus the 
termination steps. Table 24 shows the analysis of consumption of reducing equivalents 
for the production of one molecule of product starting from the precursor AcCoA. As the 
conversion of glucose to precursor AcCoA results in production of reducing equivalents, 
the achievement of redox balance depends mainly on consumption of reducing 
equivalents in the reversal β-oxidation cycle, in the termination pathway, and in the 
Products from β-acyl-CoA β-ketobut
β-
ketoocdca
β-keto 
butanol
β-ketoocta 
decanol
acetone
hepta 
decanone
Specific growth rate(1/h) 0.03 0.18 0.24 0.24 0.12 0.21
Production rate (mmol C/gDW/h) 39.4 48.8 52.3 52.3 33.7 47.7
Titer 24 hr (mol C/L) 1.3 19.8 65.7 65.7 4.5 33.1
Products from trans-β-
hydroxyalkane-CoA
β-hydroxy 
but
β-hydroxy 
ocdca
1,3buta 
nediol
1,3octa 
decanediol
3propanol
3hepta 
decanol
Specific growth rate(1/h) 0.12 0.21 0.28 0.25 0.24 0.24
Production rate (mmol C/gDW/h) 45.0 50.5 51.4 52.3 39.2 49.4
Titer 24 hr (mol C/L) 6.0 35.1 152.7 83.2 49.2 62.0
Products from trans-2-enoyl-CoA trans-2-but
trans-2-
ocdca
trans-2-fatty-
butanol
trans-2-fatty-
octadecanol
propene
hepta 
decene
Specific growth rate(1/h) 0.12 0.21 0.28 0.25 0.24 0.24
Production rate (mmol C/gDW/h) 45.0 50.5 51.4 52.3 39.2 49.4
Titer 24 hr (mol C/L) 6.0 35.1 152.7 83.2 49.2 62.0
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potential synthesis of by-products. Simulations using the lcp-GEM identified 1,2-PDO as 
the preferred by-product to achieve redox balance in the synthesis of products from group 
1 (β-ketoacids) and group 2 (β-hydroxyacids, trans-2-acids and β-ketones). Synthesis of 
products from group 3 (β-ketoalcohols, 3-alcohols and alkenes) and group 4 (1,3-diols 
and trans-2-fatty alcohols) does not require production of by-products, and the redox 
balance is achieved by switching the use of enzymes in the pyruvate node. For example, 
for short chain products, synthesis of products from group 3 is achieved by converting 
pyruvate into AcCoA using only the enzyme PFL (no production of reducing 
equivalents), while synthesis of products from group 4 uses a combination of enzymes 
PFL and PDH (production of reducing equivalents) to convert PYR into AcCoA. Longer 
chain products combine these enzymes with the enzyme PFOR, as PFOR is essential to 
complete cycles of the reversal β-oxidation cycle. Thus, this analysis identified that 1,2-
PDO is a desired by-product to achieve redox balance in the synthesis of products from 
groups 1 and 2, and that a switch of enzymes in the pyruvate node allows achieving redox 
balance in the synthesis of products from groups 3 and 4.  
Table 24: Consumption of reducing equivalents for the synthesis of short chain products (3 or 4 carbon 
molecules) derived from intermediates of the reversal β-oxidation cycle. The classification of groups is as 
presented in Figure 59. The consumption of reducing equivalents presented in this table corresponds to those 
consumed in the reversal β-oxidation cycle and in the termination pathways. 
 
 
 
Group 1 β-ketobut  0 [H]
acetone  -2[H]
Group 2 β-hydroxybut  -2[H]
trans-2-but  -2[H]
β-ketobutanol  -4[H]
Group 3 3-propanol  -4[H]
propene  -4[H]
1,3-butanediol  -6[H]
trans-2-fatty butanol  -6[H]
Group 4
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6.2.5.2 Products derived from using hydroxylated and carboxylated primers 
The in silico predictions for the production of diols, hydroxyacids and 
dicarboxylic acids using the reversal of the β-oxidation cycle are presented in this section. 
The lcp-GEM was used to simulate the production of hydroxylated primers and 
carboxylated primers to be utilized in the reversal of the β-oxidation cycle (see subsection 
6.1.7.2 for details of the implementation of this strategy). The predicted solution spaces 
associated with the production of each of these product families are presented in Figure 
60 (diols), Figure 61 (hydroxyacids), and Figure 62 (dicarboxylic acids), and discussed 
below. 
The lcp-GEM was used to simulate production of 1,n-diols. It was found that all 
the diols considered in this study can be produced uncoupled to cell growth using the 
reversal of the β-oxidation cycle prior to blocking the synthesis of native fermentation 
products. In order to couple production of n-diols to biomass, reactions leading to the 
production of native fermentation products were deleted, and the results of these 
simulations are presented in Figure 60. Production of diols with less than 6 carbon atoms 
was not feasible after removing synthesis of native fermentation products, suggesting that 
native fermentation products are needed to achieve redox balance or to satisfy ATP 
requirements. Two distinct patterns were observed for the production of n-diols, 
depending on the chain length. Production of diols with an odd number of carbons 
follows one distinct pattern as presented in Figure 60-A, and production of diols with an 
even number of carbon molecules follows the pattern presented in Figure 60-B. The 
existence of two different patterns is due to the synthesis and use of different primers for 
the production of odd chain and even chain diols. Analysis of flux distribution allowed 
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me to identify that the production of odd chain diols is initiated by the primer 4-
hydroxybutyryl-CoA. Production of even chain diols is initiated by the primer 3-
hydroxypropionyl-CoA. For both even and odd chain diols, the longer the chain, the 
larger the predicted specific growth rate. This is a direct consequence of the ATP 
consumed in the production of the primers 4-hydroxybutyryl-CoA and 3-
hydroxypropionyl-CoA, and the fact that the longer the chain in a product, the less primer 
is required to produce the same amount of product on carbon mole basis.  
 
Figure 60: Simulated solution space for the production of (A) odd-chain length diols and (B) even-chain length 
diols. Reactions leading to the production of native fermentation products (LDH_D, PTAr, PTA2, ADH, ALDH, 
FRD2, FRD3, EX_ac(e)) were deleted. Production of diols coupled to cell growth was predicted for all the 
products with 6 or more carbon atoms. Simulations indicate that production of butanediol and pentanediol 
under present conditions is not feasible. 
 
 Production of 1,n-hydroxyacids was simulated using the lcp-GEM. As in the 
production of diols, when the synthesis of native fermentation products is allowed, the 
simulations indicate that production of all hydroxyacids considered in this study is 
feasible, although not coupled to biomass production. After the native fermentation 
products were deleted, the lcp-GEM predicted the production of hydroxyacids with 5 
carbon atoms or more coupled to cell growth, and production of other products was not 
possible (Figure 61). Analysis of flux distribution indicates that all hydroxyacids were 
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produced using a carboxylated primer (and not a hydroxylated primer). This indicated 
that cell growth coupled to production of hydroxyacids is more efficient when the flux 
goes through the pathway involving carboxylated primers, as opposed to using a pathway 
that goes through hydroxylated primers. The two different patterns that were observed, 
and that are presented in Figure 61 (panel A and B), correspond to the use of malonyl-
CoA as primer to produce hydroxyacids with an odd number of carbon molecules, and 
the use of succinyl-CoA as primer to produce hydroxyacids with an odd number of 
carbon molecules.   
 
Figure 61: Simulated solution space for the production of (A) odd-chain length hydroxyacids and (B) even-chain 
chain hydroxyacids. Reactions leading to the production of native fermentation products (LDH_D, PTAr, PTA2, 
ADH, ALDH, FRD2, FRD3, EX_ac(e)) were deleted. Production of hydroxyl acids coupled to cell growth was 
predicted for all the products with 5 or more carbon atoms. Simulations indicate that production of 4-
hydroxybutanoate under present conditions is not feasible. 
 As in the case of production of diols, the simulated optimal solution for the 
production of hydroxyacids after deleting native fermentation products predicts higher 
specific growth rate when associated with longer chain products. This is a direct 
consequence of the ATP consumed in the production of the primers malonyl-CoA and 
succinyl-CoA, and the fact that the longer the chain in the product, the less primer is 
required to produce the same amount of product per carbon atom. 
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 Finally, the lcp-GEM was used to simulate the solution spaces for the production 
of dicarboxylic acids. The model successfully simulated production of all products 
included in this study prior to deleting native fermentation products, although not coupled 
to production of biomass. Deletion of native fermentation products resulted in production 
of dicarboxylic acids with 9 or more carbon atoms coupled to cell growth. Figure 62 
shows the simulated solution spaces. Production of dicarboxylic acids with an odd 
number of carbon atoms (Panel A, left) is mediated by the primer malonyl-CoA, and 
production of dicarboxylic acids with an even number of carbon atoms (panel B, right) is 
mediated by the primer succinyl-CoA. As in the production of diols and hydroxyacids, 
production of dicarboxylic acids with longer chains is correlated with a higher specific 
growth rate at the optimal solution, a fact that is due to an smaller requirement of ATP to 
activate the smaller amount of primers of those cases.  
 
Figure 62: Simulated solution space for the production of (A) odd-chain length dicarboxylic acids and (B) even-
chain length dicarboxylic acids. Reactions leading to the production of native fermentation products (LDH_D, 
PTAr, PTA2, ADH, ALDH, FRD2, FRD3, EX_ac(e)) were deleted. Production of dicarboxylic acids coupled to 
cell growth was predicted for all the products with 9 or more carbon atoms. There was no predicted production 
of 3-dicarboxylic propionate, 4- dicarboxylic butanoate, 5- dicarboxylic pentanoate, 6- dicarboxylic hexanoate 
and 7- dicarboxylic pentanoate under present conditions. 
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6.3 Conclusions 
I have examined the metabolic capabilities of a functional reversal of the β-
oxidation cycle using mathematical modeling. By implementing this pathway in a 
genome scale model, and using Flux Balance Analysis (FBA) and Flux Variability 
Analysis (FVA), I predicted productivities associated with products with different carbon 
chain lengths. First, I studied the production of three key product families for the 
biochemical industry: n-alcohols, alkanes and FAs. In each case, I simulated the synthesis 
of products with even chain lengths ranging from 3 or 4 carbon molecules to 17 or 18 
carbon molecules. The results predict that the reversal β-oxidation cycle is capable of 
producing these products at attractive production rates and titers. Further research is 
needed on the experimental front in order to implement the strategies proposed in this 
chapter. The energy efficiency of this pathway seems to be the main factor that allowed 
obtaining significant improvement on the production of the longer chain products that 
were evaluated in this project. Further, the predictions generated by implementing the 
reversal of the β-oxidation cycle were contrasted with predictions of implemented 
alternative platforms (FA biosynthesis pathway and the α-keto acid pathway), and the 
results indicate that the use of the reversal β-oxidation cycle is significantly better than 
the evaluated alternatives in terms of production rate and titers.  
In addition, the scope of using the reversal β-oxidation cycle was extended to the 
synthesis of products with a functionalized side chain using a genome-scale model 
(GEM) adapted to produce long chain products (the "lcp-GEM"). By modifying the first 
module (primer) and/or the third module (termination), I simulated the production of a 
vast number of products, such as diols, hydroxyacids and alkanes. The products with 
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functionalized side chain were classified in 12 product families. This highlights the 
versatility of the reversal β-oxidation cycle and suggests the need for experimental 
implementation. 
While the simulations using the lcp-GEM represents a modeling analysis of the 
capabilities of E. coli using a functional of the reversal β-oxidation cycle, further steps 
will need to be taken to implement genetic manipulations that will prove these 
predictions.   
The convenience of using in silico simulations relies on the potential to  evaluate 
complex factors that have implications in the whole system rather than evaluating just a 
specific pathway. That is the case of ATP consumption/generation, redox balance, and 
other stoichiometric constraints. Finally, the use of GEM can guide the experimental 
design that will result in an optimal production of the desired product by identifying key 
reactions that need to be added, removed or modified.   
In summary, the main results and findings presented in this chapter are: 
• Modification of the GEM for E. coli to represent the synthesis of 15 
product families of different chain lengths, using the reversal β-oxidation 
cycle. To this end, a total of 400 reactions were added to the iJO1366 
model. 
• The reversal β-oxidation cycle was simulated using a system of modules, 
which allows the diversification in the synthesis of final products. 
• Simulations of optimal cell growth indicate that native fermentation 
products must be eliminated (knockout) in order to couple cell growth to 
production of desired products. To this end the following reactions were 
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eliminated: ALDH (adhE), ADH (adhE), ALDH (adhE), LDH_D (ldhA), 
PTA2 (pta), PTAr (pta), FRD2 (frdA, frdB, frdC, frdD), and FRD3 (frdA, 
frdB, frdC, frdD). In addition to these metabolic reactions, the following 
export reactions were deleted to ensure the eliminations of associated 
products: EX_ac(e) (for acetate), EX_PYR(e) (for pyruvate), and 
EX_hxa(e) (for hexanoate). 
•  Production of 1,2-PDO is an important electron sink associated with the 
synthesis of fatty acids, β-ketoacids, β-hydroxyacids, trans-2-acids and β-
ketones. 
• Identify optimal pathways for the production of long chains carboxylic 
acids, diols and hydroxyacids. These pathways include the production and 
utilization of hydroxylated and carboxylated primers from glucose. 
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7 Final remarks and future directions 
 This thesis addresses the problem of finding an economically viable alternative to 
petroleum-derived fuels and chemicals. The microbial production of biofuels and 
chemicals has become the most supported alternative to traditional fuels from petroleum 
because this alternative is renewable and environmentally friendlier than using 
petroleum-derived fuels and chemicals. However, the main drawback of using biofuels is 
the higher cost associated. While different approaches have been evaluated in recent 
years to synthesize biofuels and biochemicals, this thesis focuses in two specific 
strategies with economical potential: the fermentation of glycerol and the utilization of a 
reversal of the β-oxidation cycle.    
 In particular, the present thesis presents the modeling of the metabolic pathways 
in E. coli for the production of biofuels and chemicals using the recently experimentally 
reported glycerol fermentation and reversal β-oxidation cycle. Two platforms are very 
attractive to reduce the cost in the production of biofuels. Together with experimental 
work done by others, this study adds to the optimization of the synthesis of desired 
products. The use of mathematical models is fundamental to expand and optimize 
existing metabolic processes because mathematical tools can simulate the complexity of 
metabolic pathways resulting in a deeper understanding at a system level.  
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7.1 Summary of achievements presented in this thesis 
 The following is a summary of specific achievements of this thesis: 
Kinetic model for the fermentative metabolism of glycerol in E. coli. 
- Develop a kinetic model for the fermentative metabolism of glycerol in E. coli, 
which represents accurately the dynamic of external variables (substrate, product 
and biomass), and predicts the dynamic of concentration of internal metabolites. 
-  Use this kinetic model to determine the control structure of the pathway. This 
analysis predicted that two genes were controlling the flux through the pathway: 
glycerol dehydrogenase and di-hydroxyacetone kinase.  
- Validate the predictions of the model by experimentally overexpressing the 
enzymatic activity of glycerol dehydrogenase and di-hydroxyacetone kinase, 
resulting in an remarkable increased production rate of ethanol from 4.1 
mmol/gCDW/h to 10 mmol/gCDW/h (experiments performed by James 
Clomburg). 
Genome-scale model for the fermentative metabolism of glycerol. 
- Accurately represent glycerol fermentation in E. coli using a genome-scale model 
(modified from iJO1366 model).  
- The problem of achieving redox balance for glycerol fermentation in E. coli was 
investigated in detail, as this is a critical challenge in this process that was not 
well understood previous to this work, and which has not been addressed before 
this thesis using genome-scale models. As a result, the genome-scale model was 
carefully curated to eliminate a number of pathways that lead to non-permisive 
consumption of reducing equivalents. The resulting model supports the 
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experimental finding of ethanol and 1,2-propanediol (1,2-PDO) being essential 
for cell growth under fermentative conditions (the ethanol-1,2-PDO model). 
- Predict flux distribution and essential genes using Flux Balance Analysis (FBA). 
Elucidate a potential new optimal pathway for the incorporation of glycerol into 
the glycolytic flux linked to the ability to produce 1,2-PDO and essential 
intermediate metabolites, and propose a physiological function for genes fsaB 
(fructose aldolase) and ptsA (fused predicted PTS enzyme) based on experimental 
simulations. 
- Evaluate the addition of genetic modifications as a way to support cell growth 
linked to the synthesis of different products. These modifications need to satisfy 
cellular requirement of ATP production and redox balance achievement. Using 
the genome-scale model I identified 59 models (including the ethanol-1,2-PDO 
model) linked to the production of native and non-native products as potential 
alternatives to support cell growth under fermentative conditions. With a few 
exceptions, most of these models are new predictions with experimental 
applications in the synthesis of biofuels and chemicals.  
- Use the GEM to evaluate the synthesis of succinate, 1,2-PDO, 1,3-propanediol 
(1,3-PDO), lactate, butanol, propanol and propionic acid. I validated the model 
predictions by using pre-existing experimental data that was not used to curate the 
model. In most of these cases the solution spaces resulting from the GEM 
accurately represented the experimental data, being the only exception the 
production of lactic acid. These results corroborate the predictive capability of 
this model.  
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- Use FBA and OptKnock to propose strategies to optimize the synthesis of 1,2-
PDO, 1,3-PDO, lactate, butanol, propanol and propionic acid (or to further 
improve existent strategies). 
Genome-scale model for the reversal of the β-oxidation cycle utilizing glucose. 
- Use genome-scale modeling to represent the reversal of the β-oxidation cycle in 
E. coli to synthesize medium and long chain products from glucose (modifications 
made to the iJO1366 model).  
- Predict maximal cell growth rates and flux distribution for the production of 15 
different products family, each family with products of different length chains. 
These product families include alcohols (advanced biofuels), alkanes, and fatty 
acids, among others. Predictions of the model indicate that the production of each 
product is essential and coupled to cell growth after deleting native fermentation 
products. This results indicate that the reversal of the β-oxidation cycle is superior 
in productivities than alternative platforms that I also evaluated using genome- 
models, a finding that corroborates which has been observed experimentally.  
- Understand the main factors that affect production rates and cell growth for 
different product families and chain length. The main factors in finding an 
optimal strategy for the synthesis of desired products are 1) the ATP consumption 
of the biosynthetic pathway, which in the case of the reversal β-oxidation cycle is 
superior to other alternatives evaluated in this study, 2) the achieving of redox 
balance, and 3) stoichiometric constrains. Using the genome-scale model, I 
explain the mechanisms to achieve redox balance for all the possible products 
evaluated in this study. The use of a genome-scale model allowed the 
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identification of stoichiometric constraints, representing valuable information to 
consider in the search for optimal strategies to synthesize the desired products.  
7.2 Future directions 
A number a future directions are suggested as a result of this study, as are 
explained bellow. 
The kinetic model presented for glycerol fermentation in E. coli can be expanded 
for the production of other products, including 1,2-PDO. The inclusion of this pathway 
could be highly relevant because the enzyme glycerol dehydrogenase, which mediates 
glycerol dissimilation, also plays a role in the production of 1,2-PDO. Inclusion of 
additional reactions and/or pathways may require a re-adjustment of parameters, using 
sensitivity analysis and mathematical optimization of parameters, as is explained in this 
thesis. The model could be used to calculate the flux control coefficient of the new 
system, a process that is achieved by calculating elasticities directly from the kinetic 
expressions and which does not require additional experiments.  
In addition, the kinetic model can be modified to study the consumption of 
glycerol under different initial conditions (such as mixture of substrates, or presence of 
different metabolites) by incorporating the regulatory network. Once the model is 
expanded to include different conditions, it can be used to calculate the control structure 
of the new system, a task that builds on the kinetic model presented in this thesis, and 
which highlights the advantage of using mathematical modeling. In contrast, the control 
structure of the pathway could also be calculated by experimentally measuring 
elasticities, but in that case any modification to the system would require re-measuring 
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experimentally all the elasticities of the system because there is not building up on 
previous work.  
Another aspect that will need to be investigated is finding a more suitable kinetic 
equation for biomass production than the widely used Monod equation. In this research 
the Monod equation was used to represent cell growth, as it fit properly the cell growth. 
However, this equation assumes that cell growth is a function of external substrate 
concentration (and possible inhibitors), but it does fit well the case in which engineering 
a strain may result in an increased rate of consumption of the substrate, with an 
associated increased specific growth rate (as it was the case of glycerol fermentation after 
overexpressing the limiting enzymes). This situation will have to be addressed by re-
designing the cell kinetic growth equation. One option to do this could be to change the 
parameters of the Monod equation for functions, but then again it will need to be 
investigated which are the parameters of those functions. It seems reasonable to think that 
this new specific growth rate function will need to incorporate the rate at which ATP 
becomes available in the system, as ATP constraints certainly have an effect on cell 
growth, but other factors may need to be incorporated, such as the speed at which 
essential metabolites become available. 
The genome-scale model presented for glycerol fermentation in E. coli indicates 
that glycerol is an attractive carbon source for the synthesis of several products, and 
further experimental validation is advised. In particular, it is recommended to 
experimentally implement the strategies for the production of succinate, 1,3-PDO, 
butanol, propanol and propionic acids, as they are predicted to increase production rates. 
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Other aspects of glycerol fermentation can be investigated using mathematical 
modeling. For example, Clomburg identified that acetate plays an important role in the 
fermentation of glycerol at high concentrations of glycerol (50 g/l) in a supplemented 
medium, and the reason for that remains unknown although some hypotheses were 
suggested, including the convenience of adding acetate to the media as a means to 
consume reducing equivalents when converted to ethanol (Clomburg, 2012). If this 
theory is true, the use of mathematical models could be used to investigate this and other 
possible factors involved in this phenomenon, such as the presence of another limiting 
reactant in the medium (stoichiometric constraints) that could be preventing the achieving 
of redox balance through production of 1,2-PDO.  
The capabilities of the reversal β-oxidation cycle were explored using genome-
scale models, and the in silico analysis supports the attractiveness of this pathway for the 
production of a variety of products (including advanced biofuels), many of which have 
not been synthesized experimentally yet. Based on these results it is advised to continue 
with further experimental implementation of pathways for the synthesis of the products 
explored in this thesis using the reversal of the β-oxidation cycle, as this pathway has a 
great capability to produce a variety of products at attractive productivities. It is also 
advised to utilize this model evaluate the synthesis of other products of interest. 
Further mathematical analysis is recommended to study the reversal β-oxidation 
cycle, including the implementation of a kinetic model to elucidate the control structure 
of the pathway, and the analysis of using alternative feedstocks (such as glycerol).  
Finally, the study presented in this thesis for the mathematical modeling of the 
fermentative metabolisms of glycerol and of glucose (using the reversal of the β-
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oxidation cycle) is an important and necessary step toward the achieving of a higher goal: 
finding an ideal system for the production of fuels and chemicals that are currently 
derived from petroleum. The three mathematical models presented in this thesis are the 
first mathematical models implemented for the study of glycerol fermentation and the 
reversal β-oxidation cycle in E. coli, and the utility of these models to improve the 
production of biofuels and biochemicals and to reduce the cost associated is evident.    
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8 'omenclature 
 
 
Exponential factor (power law), kinetic parameter
(thermokinetic)
αi
Coefficient associated with the flux vi, kinetic parameter
(S-system)
Exponential factor (power law), kinetic parameter
(thermokinetic)
 Kinetic parameter (S-systems)
Concentration Metabolite i
Extracellular metabolite (lin-log)
Enzymatic activity (power law form, lin-log)
E i Enzymatic activity of i- th enzyme
Elasticity , rate vi, metabolite j
Function that depend on of metabolite concentrations C
and on a set of parameters P
 Exponential factor (S-systems)
Exponential factor (S-systems)
J Pathway; number of fluxes
Kinetic parameter (power law form, thermokinetic)
k k- th reaction
 Equilibrium constrant, reaction i
Michaelis-Menten constant, reaction i, metabolite j
Kia Kinetic constant of bi-uni-uni-uni ping-pong mechanism
Kinetic constant for biomass production
Lower admissible values for flux vi
Metabolite 
Maximum rate, reaction i
Upper admissible values for flux vi
S Stoichiometric matrix
Dilution rate
Maximum specific growth rate
v Vector of fluxes
vm Vector of meassured fluxes
vc Vector of unknown fluxes
X j Concentration Metabolite j
Intracellular metabolite (lin-log)
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[H] Reducing equivalents (ex: 2[H] = 1 NADH) 
1,2-PDO 1,2-propanediol 
1,3-PDO 1,3-propanediol 
1,3-PDODH NADH-dependant 1,3-PDO dehydrogenase 
2PG 2-phosphoglycerate 
3-HPA 3-hydroxypropionaldehyde  
3PG 3-phosphoglycerate 
5mtr 5-Methylthio-D-ribose 
ACACT3r Acetyl-CoA C-acyltransferase (hexanoyl-CoA) (reversible) 
ACALD Acetaldehyde 
AcCoA Acetyl-coenzymoA 
Acetal Acetaldehyde 
ACKr Acetate kinase 
ACL Acyl-CoA ligases 
ACP Acyl carrier protein 
ACt2rpp Acetate reversible transport via proton symport 
Actp Acetyl phosphate 
ADH Alcohols dehydrogenase 
ADH2 Alcohols dehydrogenase (S.cerevisiae) 
ADP Adenosine Diphosphate 
ALDD2y Acetaldehyde dehydrogenase NADP 
ALDH Aldehyde dehydrogenase 
ALR2 Aldose reductase (methylglyoxal) 
ALR4x Aldose reductase (HA) 
AMP Adenosine Monophosphate 
AT Acyltransferase 
AtoB Acetyl-CoA acetyltransferase 
ATP Adenosine Triphosphate 
BOF Bioamss as objective function 
CCCs Concentration control coefficients 
CO2 Carbon dioxyde 
CO2tpp Transhydrogenase periplasm 
CoA Coenzyme-A 
COBRA 
 
COnstraints Based Reconstruction and Analysis (toolbox for 
Matlab) 
DHA Dihydroxyacetone 
DHAK Dihydroxyacetone kinase 
DHAP Di-hydroxyacetone-phosphate 
D-LACtex D-lactate transport via diffusion 
e4p D-Erythrose 4-phosphate 
EI Enzyme I, PTS system, PTS system 
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EIIA Enzyme complexes II A, PTS system 
EIIBC Enzyme complexes II BC, PTS system 
ENO Enolase 
EtOH Ethanol 
F6P Fructose-6-phosphate 
F6PA Fructose 6-phosphate aldolase 2 
FA Fatty acid 
FAD Flavin adenine dinucleotide oxidized 
FadB 3-hydroxyacyl-CoA dehydrogenase 
FadM Thioesterase 
FAR fatty-acyl-CoA reductase 
FBA Flux Balance Analysis 
FBP Fructose-bi-phosphate 
FBPA Fructose bi-phosphate aldoase 
FBPA3 
 
Sedoheptulose 1,7-bisphosphate D-glyceraldehyde-3-phosphate-
lyase 
FCCs Flux control coefficients 
fd Ferredoxin (oxidized) 
fd2- Ferredoxin (reduced) 
FHL Formate-hydrogen lyase 
FORtppi Formate transporter via diffusion 
FRD2, FRD3 Fumarate reductase 
FUM Fumarase 
FVA Flux variability analysis 
G1P Glucose-1-phosphate 
G3P Glycerol-3-phosphate 
G3PD2 NADPH-dependent glycerol-3-phosphate dehydrogenase 
G6P Glucose-6-phosphate 
GAM Growth associated maintenance energy 
GAP  Glyceraldehyde-3-phosphate 
GAPD Glyceraldehyde 3-phosphate dehydrogenase 
GC-MS Gas chromatography-mass spectrometry 
GEM Genome-scale model 
GK Glycerol kinase  
GlpABC Anaerobic 3-phosphate dehydrogenase 
GlpD Aerobic 3-phosphate dehydrogenase 
GlpF Aquaglyceroporin 
GlpK ATP-dependent glycerol kinase 
glu Glutamate 
Glyc Glycerol 
glyDH NAD-dependent glycerol dehydrogenase 
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Glyc-GEM Genome-scale model for glycerol femrentation 
GLYK Glycerol kinase  
GMA-power law Power law-Generalize Mass Action 
H+, h Proton 
HA Hydroxyacetone 
HPr Histidine protein, PTS system  
ILE Isoleucine 
KIVD 2-ketoisovalerate decarboxylase 
Lald Lactaldehyde 
LALDO2x D-Lactaldehyde-NAD 1-oxidoreductase 
LCARR Lacaldehyde reductase (R-propane-1,2-diol forming) 
lcp-GEM Genome-scale model for the production of long chain products 
LDH_D D-lactate dehydrogenase 
LEU Leucine 
lin-log Linear-logarithmic 
log-linear Logarithmic-linear 
malACP Malonyl-ACP  
MCA Metabolic Control Analysis 
MDH Malate dehydrogenase 
ME2 Malate dehydrogenase NADP 
MET Metionine 
MFA Metabolic Flux Analysis 
MGSA Methylglyoxal synthase 
MOPS 4-Morpholinepropanesulfonic acid 
MOX Malate oxidase 
mql8 Menaquinol 8 
mqn8 Menaquinone 8 
NAD Nicotinamide adenine dinucleotide 
NADH Nicotinamide adenine dinucleotide - reduced 
NADP  Nicotinamide adenine dinucleotide phosphate 
NADPH Nicotinamide adenine dinucleotide phosphate - reduced 
NGAM Non-growth associated maintenance energy 
NMR Nuclear Magnetic Resonance 
OAA Oxaloacetate 
OD Optical density 
ODEs Ordinary differential equations 
PckA Phosphoenolpyruvate carboxykinase 
PDHC Pyruvate dehydrogenase complex 
PEP Phosphoenol pyruvate 
PFK (Pfl-1, Pfl-2) Phosphofructokinases 
PFL Pyruvate formate lyase 
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PFOR pyruvate ferredoxin oxidoreductase 
Pgi Phosphoglucose isomerase 
PGK Phosphoglycerate kinase 
PGL  6-phosphogluconolactonase 
PGM Phosphoglycerate mutase 
PGP 1,3-diphosphateglycerate 
PntAB Transhydrogenase periplasm 
POX Pyruvate oxidase 
PP pathway Pentose phosphate pathway 
Ppa Propionic acid 
PPC Phosphoenolpyruvate carboxylase 
PPCSCT Propanoyl-CoA: succinate CoA-transferase 
ppi Diphosphate 
PP pathway Pentose phosphate pathway 
PRO Proline 
PTA2 Phosphate acetyltransferase 
PTAr Phosphotransacetylase 
PTS Phosphotransferase system 
PYK ATP-dependent pyruvate kinase 
PYK (pykF, PykA) Pyruvate kinases 
PYR Pyruvate 
PYRtrpp Pyruvate reversible transport via proton symport 
S17BP Sedoheptulose 1,7-bisphosphate 
S7P Sedoheptulose 7-phosphate 
SBML System Biology Markup Language 
S-systems Synergistic system 
Succ Succinate 
SUCOA Succinyl-CoA 
TCA cycle Tricarboxylic acids cycle 
TES Thioesterase 
TesB Thioesterase 
THD2pp Transhydrogenase periplasm 
TPI Triose phosphate isomerase 
UQ  Ubiquinone 
UQH2 Ubiquinol 
VAL Valine 
YciA Thioesterase 
α-KG α-ketoglutarate 
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10 Appendix 
 
10.1 Matrix system for FCC 
The system of equations for the calculation of FCC in themodel for glycerol 
fermentation, as presented in Figure 28, is as follows: 
M*C=R     (95) 
 
 
 
1 1 1 1 1
0 0 0
0 0 0
0 0
M = 0 0 0
0 0 0 0
0 0 0 0 0
0 0 0 0
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0
1 1 1 1 1 1
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0
0 0 0 0
0 0 0
0   0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
233 
 
 
 
 
 
10.2 List of reactions modified in glyc-GEM 
All the modifications were implemented in the matlab function 
AC_BiomassvsProduct_GlyceroliJO1366.m. This funtion calculates optimal solutions, 
solution spaces, and evaluate the different cases that were included for the production of 
lactate, succinate, 1,2-PDO, 1,3-PDO, propanol, propionic acid and butanol.  
Table 25: List of modifications to the iJO1366 model in order to represent glycerol fermentation. The numbers 
within bracket correspond to the original value, previous to this modification. All reactions and metabolite 
abbreviations corresponds to those used in the iJO1366, with the exception of FBPA3 (originally FBA3), which 
was changes to avoid misleading with the abbreviation of flux balance analysis (FBA). 
 
Reaction 
name 
Reaction  Comments 
Lower 
bound 
Upper 
bound 
EX_26dap-
M(e) 26dap-M[e]  <=>  
no amino acids 
exchange 0 0 (1000) 
EX_5mtr(e) 5mtr[e]  <=>  
no 5mtr 
exchange  0 0 (1000) 
EX_ala-B(e) ala-B[e]  <=>  
no amino acids 
exchange 0 0 (1000) 
EX_ala-D(e) ala-D[e]  <=>  
no amino acids 
exchange 0 0 (1000) 
EX_ala-L(e) ala-L[e]  <=>  
no amino acids 
exchange 0 0 (1000) 
1
0
0
0
C = R = 0
0
0
0
0
0
0
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EX_asn-L(e) asn-L[e]  <=>  
no amino acids 
exchange 0 0 (1000) 
EX_asp-L(e) asp-L[e]  <=>  
no amino acids 
exchange 0 0 (1000) 
EX_co2(e) co2[e]  <=>  
no amino acids 
exchange 0 (-1000) 1000 
EX_cys-D(e) cys-D[e]  <=>  
no amino acids 
exchange 0 0 (1000) 
EX_cys-L(e) cys-L[e]  <=>  
no amino acids 
exchange 0 0 (1000) 
EX_fe2(e) fe2[e]  <=>  
no Fe2+ 
exchange -1000 0 (1000) 
EX_frulys(e) frulys[e]  <=>  
no amino acids 
exchange 0 0 (1000) 
EX_glc(e) glc-D[e]  <=>  
no glucose 
consumption 0 (-10) 1000 
EX_gln-L(e) gln-L[e]  <=>  
no amino acids 
exchange 0 0 (1000) 
EX_glu-L(e) glu-L[e]  <=>  
no amino acids 
exchange 0 0 (1000) 
EX_gly(e) gly[e]  <=>  
no amino acids 
exchange 0 0 (1000) 
EX_glyc(e) glyc[e]  <=>  
glycerol 
fermentation -20 1000 
EX_h2s(e) h2s[e]  <=>  
no H2S 
exchange 0 0 (1000) 
EX_his-L(e) his-L[e]  <=>  
no amino acids 
exchange 0 0 (1000) 
EX_hom-L(e) hom-L[e]  <=>  
no amino acids 
exchange 0 0 (1000) 
EX_hxa(e) hxa[e]  <=>  
no hexanoate 
exchange 0 0 (1000) 
EX_ile-L(e) ile-L[e]  <=>  
no amino acids 
exchange 0 0 (1000) 
EX_leu-L(e) leu-L[e]  <=>  
no amino acids 
exchange 0 0 (1000) 
EX_lys-L(e) lys-L[e]  <=>  
no amino acids 
exchange 0 0 (1000) 
EX_met-D(e) met-D[e]  <=>  
no amino acids 
exchange 0 0 (1000) 
EX_met-L(e) met-L[e]  <=>  
no amino acids 
exchange 0 0 (1000) 
235 
 
EX_o2(e) o2[e]  <=>  
no oxygen 
consumption 0 (-1000) 1000 
EX_orn(e) orn[e]  <=>  
no amino acids 
exchange 0 0 (1000) 
EX_phe-L(e) phe-L[e]  <=>  
no amino acids 
exchange 0 0 (1000) 
EX_pro-L(e) pro-L[e]  <=>  
no amino acids 
exchange 0 0 (1000) 
EX_ser-D(e) ser-D[e]  <=>  
no amino acids 
exchange 0 0 (1000) 
EX_ser-L(e) ser-L[e]  <=>  
no amino acids 
exchange 0 0 (1000) 
EX_spmd(e) spmd[e]  <=>  
no spirmidine 
production 0 0 (1000) 
EX_thr-L(e) thr-L[e]  <=>  
no amino acids 
exchange 0 0 (1000) 
EX_trp-L(e) trp-L[e]  <=>  
no amino acids 
exchange 0 0 (1000) 
EX_tyr-L(e) tyr-L[e]  <=>  
no amino acids 
exchange 0 0 (1000) 
EX_val-L(e) val-L[e]  <=>  
no amino acids 
exchange 0 0 (1000) 
42A12BOOXpp 
dopa[p] + h2o[p] + o2[p]  -> 
34dhpac[p] + h2o2[p] + nh4[p]  
no amino acids 
degradation 0 0 (1000) 
ADA 
adn[c] + h[c] + h2o[c]  -> ins[c] + 
nh4[c]  
no nucleotides 
degradation 0 0 (1000) 
ARGDC arg-L[c] + h[c]  -> agm[c] + co2[c]  
no amino acids 
degradation 0 0 (1000) 
ARGDCpp arg-L[p] + h[p]  -> agm[p] + co2[p]  
no amino acids 
degradation 0 0 (1000) 
ASPT asp-L[c]  -> fum[c] + nh4[c]  
no amino acids 
degradation 0 0 (1000) 
AST 
arg-L[c] + succoa[c]  -> coa[c] + 
h[c] + sucarg[c]  
no amino acids 
degradation 0 0 (1000) 
CYSDS 
cys-L[c] + h2o[c]  -> h2s[c] + 
nh4[c] + pyr[c]  
no amino acids 
degradation 0 0 (1000) 
CYTD 
cytd[c] + h[c] + h2o[c]  -> nh4[c] + 
uri[c]  
no nucleotides 
degradation 0 0 (1000) 
DAAD 
ala-D[c] + fad[c] + h2o[c]  -> 
fadh2[c] + nh4[c] + pyr[c]  
no amino acids 
degradation 0 0 (1000) 
DADA 
dad-2[c] + h[c] + h2o[c]  -> din[c] + 
nh4[c]  
no nucleotides 
degradation 0 0 (1000) 
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DCYTD 
dcyt[c] + h[c] + h2o[c]  -> duri[c] + 
nh4[c]  
no nucleotides 
degradation 0 0 (1000) 
DRPA 2dr5p[c]  -> acald[c] + g3p[c]  
no nucleotides 
degradation 0 0 (1000) 
DURIPP 
duri[c] + pi[c]  <=> 2dr1p[c] + 
ura[c]  
no nucleotides 
degradation 0 (-1000) 0 (1000) 
F6PA f6p[c]  <=> dha[c] + g3p[c]  Limit F6PA -4(-1000) 1000 
FBPA3 s17bp[c]  <=> dhap[c] + e4p[c]  no FBPA3 0 (-1000) 0 (1000) 
FHL for[c] + h[c]  -> co2[c] + h2[c]  Reverse FHL -1000 1000 
G3PD2 
glyc3p[c] + nadp[c]  <=> dhap[c] + 
h[c] + nadph[c]  
G3PD2 
irreversible -1000 0 (1000) 
GLUN 
gln-L[c] + h2o[c]  -> glu-L[c] + 
nh4[c]  
no amino acids 
degradation 0 0 (1000) 
GLYAT 
accoa[c] + gly[c]  <=> 2aobut[c] + 
coa[c]  
no amino acids 
degradation 0 (-1000) 0 (1000) 
OBTFL 
2obut[c] + coa[c]  -> for[c] + 
ppcoa[c]  
no amino acids 
degradation 0 0 (1000) 
P5CD 
1pyr5c[c] + 2 h2o[c] + nad[c]  -> 
glu-L[c] + h[c] + nadh[c]  
no amino acids 
degradation 0 0 (1000) 
PEAMNOpp 
h2o[p] + o2[p] + peamn[p]  -> 
h2o2[p] + nh4[p] + pacald[p]  
no amino acids 
degradation 0 0 (1000) 
PFK_3 
atp[c] + s7p[c]  -> adp[c] + h[c] + 
s17bp[c]  no PFK_3 0 0 (1000) 
POR5 
coa[c] + 2 flxso[c] + pyr[c]  <=> 
accoa[c] + co2[c] + 2 flxr[c] + h[c]  
no flavodoxins- 
dependent 
PYR synthase. 0 (-1000) 0 (1000) 
PPAKr 
adp[c] + ppap[c]  <=> atp[c] + 
ppa[c]  
no amino acids 
degradation 0 (-1000) 0 (1000) 
PPM2 2dr1p[c]  <=> 2dr5p[c]  
no nucleotides 
degradation 0 (-1000) 0 (1000) 
PROD2 
fad[c] + pro-L[c]  -> 1pyr5c[c] + 
fadh2[c] + h[c]  
no amino acids 
degradation 0 0 (1000) 
PUNP1 adn[c] + pi[c]  <=> ade[c] + r1p[c]  
no nucleotides 
degradation 0 (-1000) 0 (1000) 
PUNP2 
dad-2[c] + pi[c]  <=> 2dr1p[c] + 
ade[c]  
no nucleotides 
degradation 0 (-1000) 0 (1000) 
PUNP3 gsn[c] + pi[c]  <=> gua[c] + r1p[c]  
no nucleotides 
degradation 0 (-1000) 0 (1000) 
PUNP4 
dgsn[c] + pi[c]  <=> 2dr1p[c] + 
gua[c]  
no nucleotides 
degradation 0 (-1000) 0 (1000) 
PUNP5 ins[c] + pi[c]  <=> hxan[c] + r1p[c]  
no nucleotides 
degradation 0 (-1000) 0 (1000) 
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PUNP6 
din[c] + pi[c]  <=> 2dr1p[c] + 
hxan[c]  
no nucleotides 
degradation 0 (-1000) 0 (1000) 
PUNP7 pi[c] + xtsn[c]  <=> r1p[c] + xan[c]  
no nucleotides 
degradation 0 (-1000) 0 (1000) 
PYNP2r pi[c] + uri[c]  <=> r1p[c] + ura[c]  
no nucleotides 
degradation 0 (-1000) 0 (1000) 
SADH 
2 h[c] + 2 h2o[c] + sucarg[c]  -> 
co2[c] + 2 nh4[c] + sucorn[c]  
no amino acids 
degradation 0 0 (1000) 
SERD_L ser-L[c]  -> nh4[c] + pyr[c]  
no amino acids 
degradation 0 0 (1000) 
SGDS 
h2o[c] + sucglu[c]  -> glu-L[c] + 
succ[c]  
no amino acids 
degradation 0 0 (1000) 
SGSAD 
h2o[c] + nad[c] + sucgsa[c]  -> 2 
h[c] + nadh[c] + sucglu[c]  
no amino acids 
degradation 0 0 (1000) 
THRAi thr-L[c]  -> acald[c] + gly[c]  
no amino acids 
degradation 0 0 (1000) 
THRD 
nad[c] + thr-L[c]  -> 2aobut[c] + 
h[c] + nadh[c]  
no amino acids 
degradation 0 0 (1000) 
TMDPP 
pi[c] + thymd[c]  <=> 2dr1p[c] + 
thym[c]  
no nucleotides 
degradation 0 (-1000) 0 (1000) 
TRPAS2 
h2o[c] + trp-L[c]  <=> indole[c] + 
nh4[c] + pyr[c]  
no amino acids 
degradation 0 (-1000) 0 (1000) 
TYROXDApp 
h2o[p] + o2[p] + tym[p]  -> 
4hoxpacd[p] + h2o2[p] + nh4[p]  
no amino acids 
degradation 0 0 (1000) 
Add_PntAB 
nadh[c] + nadp[c] + h[p]  <=> h[c] 
+ nad[c] + nadph[c]  Add PntAB 0 1000 
* 'umbers within bracket correspond to original lower and upper bound. 
 
10.3 List of reactions modified in lcp-GEM 
I implemented all the modifications in the matlab function 
AC_BiomassvsProduct_GlucoseJO1366.m. This funtion simulates the reversal of the β-
oxidation cycle, the FA biosynthesis pathway and the α-keto acid pathway. This function 
calculates optimal solutions and solution spaces. The following table represents the 
modifications that were done in addition to those made for the glyc-GEM.  
The no flavodoxins-dependant acyl dehydrogenases were removed, as they have 
not been reported in E. coli. In contrast, these reactions have been associated with 
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ferredoxins; therefore, I added these reactions as reported previously for the functioning 
of the reversal of the β-oxidation cycle (Dellomonaco et al., 2011). 
Table 26: List of additional modifications to the iJO1366 model in order to represent synthesis of long chain 
products. The numbers within bracket correspond to the original value, previous to this modification. All 
reactions and metabolite abbreviations corresponds to those used in the iJO1366.  
 
Reaction name Reaction  Comments 
Lower 
bound 
Upper 
bound 
EX_cys-L(e) cys-L[e]  <=>  no amino acids 0 0 (1000) 
EX_dca(e) dca[e]  <=>  no production of FAs 0 0 (1000) 
EX_hdca(e) hdca[e]  <=>  no production of FAs 0 0 (1000) 
EX_ocdca(e) ocdca[e]  <=>  no production of FAs 0 0 (1000) 
EX_octa(e) octa[e]  <=>  no production of FAs 0 0 (1000) 
EX_pyr(e) pyr[e]  <=>  no production of PYR 0 0 (1000) 
EX_ttdca(e) ttdca[e]  <=>  no production of FAs 0 0 (1000) 
ACCOAC 
accoa[c] + atp[c] + 
hco3[c]  -> adp[c] + 
h[c] + malcoa[c] + 
pi[c] 
Prevent ficticious flux 
toward the FA 
biosynthesis pathway 
when analysis the 
reversed β-oxidation 
cycle 0 
0.1 
(1000) 
ACOAD1f 
btcoa[c] + fad[c]  <=> 
b2coa[c] + fadh2[c]  
no flavodoxins-
dependant acyl 
dehydrogenase 0 (-1000) 0 (1000) 
ACOAD2f 
fad[c] + hxcoa[c]  
<=> fadh2[c] + 
hx2coa[c]  
no flavodoxins-
dependant acyl 
dehydrogenase 0 (-1000) 0 (1000) 
ACOAD3f 
fad[c] + occoa[c]  
<=> fadh2[c] + 
oc2coa[c]  
no flavodoxins-
dependant acyl 
dehydrogenase 0 (-1000) 0 (1000) 
ACOAD4f 
dcacoa[c] + fad[c]  
<=> dc2coa[c] + 
fadh2[c]  
no flavodoxins-
dependant acyl 
dehydrogenase 0 (-1000) 0 (1000) 
ACOAD5f 
ddcacoa[c] + fad[c]  
<=> dd2coa[c] + 
fadh2[c]  
no flavodoxins-
dependant acyl 
dehydrogenase 0 (-1000) 0 (1000) 
ACOAD6f 
fad[c] + tdcoa[c]  <=> 
fadh2[c] + td2coa[c]  
no flavodoxins-
dependant acyl 
dehydrogenase 0 (-1000) 0 (1000) 
ACOAD7f 
fad[c] + pmtcoa[c]  
<=> fadh2[c] + 
hdd2coa[c]  
no flavodoxins-
dependant acyl 
dehydrogenase 0 (-1000) 0 (1000) 
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ACOAD8f 
fad[c] + stcoa[c]  <=> 
fadh2[c] + od2coa[c]  
no flavodoxins-
dependant acyl 
dehydrogenase 0 (-1000) 0 (1000) 
FHL 
for[c] + h[c]  -> co2[c] 
+ h2[c]  Keep original values 0 0 
G3PD2 
glyc3p[c] + nadp[c]  
<=> dhap[c] + h[c] + 
nadph[c]  Keep original values -1000 1000 
ACOAD1f_ferr 
btcoa[c] + fd_oxi  
<=> b2coa[c] + h[c] + 
fd_red  New Reaction -1000 0 (1000) 
ACOAD2f_ferr 
hxcoa[c] + fd_oxi  
<=> h[c] + hx2coa[c] 
+ fd_red  New Reaction -1000 0 (1000) 
ACOAD3f_ferr 
occoa[c] + fd_oxi  
<=> h[c] + oc2coa[c] 
+ fd_red  New Reaction -1000 0 (1000) 
ACOAD4f_ferr 
dcacoa[c] + fd_oxi  
<=> dc2coa[c] + h[c] 
+ fd_red  New Reaction -1000 0 (1000) 
ACOAD5f_ferr 
ddcacoa[c] + fd_oxi  
<=> dd2coa[c] + h[c] 
+ fd_red  New Reaction -1000 0 (1000) 
ACOAD6f_ferr 
tdcoa[c] + fd_oxi  
<=> h[c] + td2coa[c] 
+ fd_red  New Reaction -1000 0 (1000) 
ACOAD7f_ferr 
pmtcoa[c] + fd_oxi  
<=> h[c] + 
hdd2coa[c] + fd_red  New Reaction -1000 0 (1000) 
ACOAD8f_ferr 
stcoa[c] + fd_oxi  <=> 
h[c] + od2coa[c] + 
fd_red  New Reaction -1000 0 (1000) 
PFOR 
coa[c] + pyr[c] + 
fd_oxi  <=> accoa[c] 
+ co2[c] + h[c] + 
fd_red  New Reaction 0 1000 
P_butanal_ACP 
butACP[c] + h[c] + 
nadh[c]  <=> ACP[c] 
+ nad[c] + butanal[c]  New Reaction 0 0 
P_hexanal_ACP 
h[c] + hexACP[c] + 
nadh[c]  <=> ACP[c] 
+ nad[c] + hexanal[c]  New Reaction 0 0 
P_octanal_ACP 
h[c] + nadh[c] + 
ocACP[c]  <=> 
ACP[c] + nad[c] + 
octanal[c]  New Reaction 0 0 
P_decanal_ACP 
dcaACP[c] + h[c] + 
nadh[c]  <=> ACP[c] 
+ nad[c] + decanal[c]  New Reaction 0 0 
P_dodecanal_ACP 
ddcaACP[c] + h[c] + 
nadh[c]  <=> ACP[c] 
+ nad[c] + 
dodecanal[c]  New Reaction 0 0 
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P_tetradecanal_ACP 
h[c] + myrsACP[c] + 
nadh[c]  <=> ACP[c] 
+ nad[c] + 
tetradecanal[c]  New Reaction 0 0 
P_hexadecanal_ACP 
h[c] + nadh[c] + 
palmACP[c]  <=> 
ACP[c] + nad[c] + 
hexadecanal[c]  New Reaction 0 0 
P_octadecanal_ACP 
h[c] + nadh[c] + 
ocdcaACP[c]  <=> 
ACP[c] + nad[c] + 
octadecanal[c]  New Reaction 0 0 
P_butanal_CoA 
btcoa[c] + h[c] + 
nadh[c]  <=> coa[c] + 
nad[c] + butanal[c]  New Reaction 0 1000 
P_hexanal_CoA 
h[c] + hxcoa[c] + 
nadh[c]  <=> coa[c] + 
nad[c] + hexanal[c]  New Reaction 0 1000 
P_octanal_CoA 
h[c] + nadh[c] + 
occoa[c]  <=> coa[c] 
+ nad[c] + octanal[c]  New Reaction 0 1000 
P_decanal_CoA 
dcacoa[c] + h[c] + 
nadh[c]  <=> coa[c] + 
nad[c] + decanal[c]  New Reaction 0 1000 
P_dodecanal_CoA 
ddcacoa[c] + h[c] + 
nadh[c]  <=> coa[c] + 
nad[c] + dodecanal[c]  New Reaction 0 1000 
P_tetradecanal_CoA 
h[c] + nadh[c] + 
tdcoa[c]  <=> coa[c] 
+ nad[c] + 
tetradecanal[c]  New Reaction 0 1000 
P_hexadecanal_CoA 
h[c] + nadh[c] + 
pmtcoa[c]  <=> coa[c] 
+ nad[c] + 
hexadecanal[c]  New Reaction 0 1000 
P_octadecanal_CoA 
h[c] + nadh[c] + 
stcoa[c]  <=> coa[c] + 
nad[c] + 
octadecanal[c]  New Reaction 0 1000 
P_propane 
butanal[c]  <=> 
propane[c] + co[c]  New Reaction 0 1000 
P_pentane 
hexanal[c]  <=> co[c] 
+ pentane[c]  New Reaction 0 1000 
P_heptane 
octanal[c]  <=> co[c] 
+ heptane[c]  New Reaction 0 1000 
P_nonane 
decanal[c]  <=> co[c] 
+ nonane[c]  New Reaction 0 1000 
P_undecane 
dodecanal[c]  <=> 
co[c] + undecane[c]  New Reaction 0 1000 
P_tridecane 
tetradecanal[c]  <=> 
co[c] + tridecane[c]  New Reaction 0 1000 
P_pentadecane 
hexadecanal[c]  <=> 
co[c]+pentadecane[c] New Reaction 0 1000 
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P_heptadecane 
octadecanal[c]  <=> 
co[c] + 
heptadecane[c]  New Reaction 0 1000 
P_butanol 
h[c] + nadh[c] + 
butanal[c]  <=> 
nad[c] + butanol[c]  New Reaction 0 1000 
P_hexanol 
h[c] + nadh[c] + 
hexanal[c]  <=> 
nad[c] + hexanol[c]  New Reaction 0 1000 
P_octanol 
h[c] + nadh[c] + 
octanal[c]  <=> nad[c] 
+ octanol[c]  New Reaction 0 1000 
P_decanol 
h[c] + nadh[c] + 
decanal[c]  <=> 
nad[c] + decanol[c]  New Reaction 0 1000 
P_dodecanol 
h[c] + nadh[c] + 
dodecanal[c]  <=> 
nad[c] + dodecanol[c]  New Reaction 0 1000 
P_tetradecanol 
h[c] + nadh[c] + 
tetradecanal[c]  <=> 
nad[c] + 
tetradecanol[c]  New Reaction 0 1000 
P_hexadecanol 
h[c] + nadh[c] + 
hexadecanal[c]  <=> 
nad[c] + 
hexadecanol[c]  New Reaction 0 1000 
P_octadecanol 
h[c] + nadh[c] + 
octadecanal[c]  <=> 
nad[c] + 
octadecanol[c]  New Reaction 0 1000 
P_but_CoA 
btcoa[c] + h2o[c]  
<=> but[c] + coa[c] + 
h[c]  New Reaction 0 1000 
P_but_ACP 
butACP[c] + h2o[c]  
<=> ACP[c] + but[c] + 
h[c]  New Reaction 0 0 
P_hxa_ACP 
h2o[c] + hexACP[c]  
<=> ACP[c] + h[c] + 
hxa[c]  New Reaction 0 0 
P_ocdca_ACP 
h2o[c] + 
ocdcaACP[c]  <=> 
ACP[c] + h[c] + 
ocdca[c]  New Reaction 0 0 
P_octa_trans octa[c]  <=> octa[e]  New Reaction 0 1000 
P_dca_trans dca[c]  <=> dca[e]  New Reaction 0 1000 
P_ddca_trans ddca[c]  <=> ddca[e]  New Reaction 0 1000 
P_ttdca_trans ttdca[c]  <=> ttdca[e]  New Reaction 0 1000 
P_hdca_trans hdca[c]  <=> hdca[e]  New Reaction 0 1000 
P_ocdca_trans_extra 
ocdca[c]  <=> 
ocdca[e]  New Reaction 0 1000 
EX_butanol butanol[c]  <=>  New Reaction 0 1000 
EX_hexanol hexanol[c]  <=>  New Reaction 0 0 
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EX_octanol octanol[c]  <=>  New Reaction 0 0 
EX_decanol decanol[c]  <=>  New Reaction 0 0 
EX_dodecanol dodecanol[c]  <=>  New Reaction 0 0 
EX_tetradecanol tetradecanol[c]  <=>  New Reaction 0 0 
EX_hexadecanol hexadecanol[c]  <=>  New Reaction 0 0 
EX_octadecanol octadecanol[c]  <=>  New Reaction 0 0 
EX_propane propane[c]  <=>  New Reaction 0 0 
EX_pentane pentane[c]  <=>  New Reaction 0 0 
EX_heptane heptane[c]  <=>  New Reaction 0 0 
EX_nonane nonane[c]  <=>  New Reaction 0 0 
EX_undecane undecane[c]  <=>  New Reaction 0 0 
EX_tridecane tridecane[c]  <=>  New Reaction 0 0 
EX_pentadecane pentadecane[c]  <=>  New Reaction 0 0 
EX_heptadecane heptadecane[c]  <=>  New Reaction 0 0 
EX_co co[c]  <=>  New Reaction 0 1000 
P_leuA1 
2obut[c] + accoa[c] + 
h2o[c]  <=> coa[c] + 
2ethylmalate ' New Reaction 0 1000 
P_leuCD1 
2ethylmalate  <=> 
3ethylmalate ' New Reaction 0 1000 
P_3ethylmalate 
nad[c] + 3ethylmalate  
<=> co2[c] + nadh[c] 
+ 2ketovalerate  New Reaction 0 1000 
P_2ketovalerate 
2ketovalerate  <=> 
co2[c] + butanal[c]  New Reaction 0 1000 
P_leuA2 
accoa[c] + h2o[c] + 
2ketovalerate  <=> 
coa[c] + 
2propylmalate  New Reaction 0 1000 
P_leuCD2 
2propylmalate  <=> 
3propylmalate  New Reaction 0 1000 
P_3propylmalate 
nad[c] + 
3propylmalate  <=> 
co2[c] + nadh[c] + 
2ketocaproate  New Reaction 0 1000 
P_leuA3 
accoa[c] + h2o[c] + 
2ketocaproate  <=> 
coa[c] + 2butylmalate  New Reaction 0 1000 
P_leuCD3 
2butylmalate  <=> 
3butylmalate  New Reaction 0 1000 
P_3butylmalate 
nad[c] + 3butylmalate  
<=> co2[c] + nadh[c] 
+ 2ketoheptanoate  New Reaction 0 1000 
P_2ketoheptanoate 
2ketoheptanoate  
<=> co2[c] + 
hexanal[c]  New Reaction 0 1000 
* 'umbers within bracket correspond to original lower and upper bound. 
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10.4 Single gene deletion 
 The following genes were predicted to be essential to support cell growth under 
glycerol fermentative consitions. The analysis was done using the glyc-GEM. 
Table 27: List of essential genes in glycerol fermentation. 
genes 
genes genes genes genes genes genes genes genes genes genes 
accA bioB dapA fpr hisA ispU metA murE pgk pyrF thiS 
accB bioC dapB gapA hisB kdsA metB murF pheA pyrG thrB 
accC bioD dapD gldA hisC kdsB metF murG plsC ribA thrC 
accD bioF dapE glmM hisD kdsC metK murI plxH ribB thyA 
acpP bioH dapF glmS hisF leuA mgsA murJ proC ribC tmk 
acroD cdsA dfp glmU hisG leuB moaA nadA psd ribD tpiA 
aldA coaA dxr gltA hisH leuC moaC nadB pssA ribE trpA 
argA coaD dxs gltX hisI leuD moaD nadC purA ribF trpB 
argB coaE eno glyA icd lptA moaE nadD purB serA trpC 
argC cyaY fabB gmk ilvC lptB mobA nadE purC serB trpD 
argD cycA fabD guaA ilvD lptC moeA nadK purD serC trpE 
argE cysC fabG hemA ilvE lptF moeB pabA purE thiC tyrA 
argG cysD fabH hemB iscS lptG mog pabB purF thiD ubiA 
argH cysE fabI hemC ispA lpxA mraY pabC purH thiE ubiC 
aroA cysG fabZ hemD ispB lpxB msbA panB purK thiF ubiD 
aroB cysH folB hemE ispD lpxC mtn panC purL thiG ubiX 
aroC cysI folC hemG ispE lpxD murA panD purM thiH waaA 
asd cysJ folE hemH ispF lpxK murB pdxA pyrB thiI yrbG 
aspC cysN folK hemL ispG luxS murC pdxB pyrC thiL zupT 
bioA cysQ folP hemN ispH lysA murD pdxJ pyrE     
  
10.5 Diagrams of new models identified by the glyc-GEM with high predicted 
specific growth rates. 
This section presents diagrams of the 16 new models identified using the glyc-
GEM. Each of these models is predicted to enable glycerol fermentation in E. coli at 
higher specific growth rates than the optimal prediction for the wild type E. coli.  
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Figure 63: Model 1: Ethanol-Propanol. See 'omenclature for abbreviations (page 214). 
 
 
 
 
Figure 64: Model 2: Ethanol-Propanol (reversible PckA). See 'omenclature for abbreviations (page 214). 
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Figure 65: Model 3: Butanol-Propanol. See 'omenclature for abbreviations (page 214). 
 
 
Figure 66: Model 4: Butanol-Propanol (reversible PckA). See 'omenclature for abbreviations (page 214). 
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Figure 67: Model 5: Propanol-Propionate (reversible PckA). See 'omenclature for abbreviations (page 214). 
 
 
Figure 68: Model 6: Propanol-Acetate (reversible PckA). See 'omenclature for abbreviations (page 214). 
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Figure 69: Model 7:Propionate (reversible PckA)-1,2PDO (MG to lald) See 'omenclature for abbreviations 
(page 214). 
 
 
 
Figure 70: Model 8:Propionate (reversible PckA) – 1,2-PDO (glycerol to lald). See 'omenclature for 
abbreviations (page 214). 
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Figure 71: Model 9: Propionate (reversible PckA) – 1,3-PDO. See 'omenclature for abbreviations (page 214). 
 
 
 
Figure 72: Model 10: Propionate (reversible PckA) – Acetone. See 'omenclature for abbreviations (page 214). 
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Figure 73: Model 11: Ethanol - 1,2-PDO (MG to lald). See 'omenclature for abbreviations (page 214). 
 
 
 
Figure 74: Model 12: Ethanol - 1,3-PDO. See 'omenclature for abbreviations (page 214). 
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Figure 75: Model 13: Ethanol – Acetone. See 'omenclature for abbreviations (page 214). 
 
 
 
Figure 76: Model 14: Butanol - 1,2-PDO (MG to lald). See 'omenclature for abbreviations (page 214). 
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Figure 77: Model 15: Butanol - 1,3-PDO. See 'omenclature for abbreviations (page 214). 
 
 
 
Figure 78: Model 16: Butanol - Acetone. See 'omenclature for abbreviations (page 214). 
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10.6 Detail of calculations from experimental data for glycerol metabolism toward 
the synthesis of desired products.  
 The production rates and specific growth rates were obtained, calculated or 
estimated from previous experimental studies. Below is explained each calculation. 
  
1,2-PDO 
Source: Clomburg and Gonzalez, 2011. 
 The paper reports a production rate of 5.6 g/l (73.6 mmol/l). The estimated 
average biomass concentration is 1.5 OD (read from Figure 5.A), which is equivalent to 
0.51 gCDW/l (1OD = 0.34 gCDW/l). The total fermentation time is 72 hours (read from 
Figure 5.A). Thus, the average production rate is 73.6 mmol/l /0.51 gCDW/l / 72 h = 2.00 
mmol/gCDW/h. The estimated specific growth rate is zero (stationary state after 12 hours 
of cultivation). 
 
1,3-PDO 
source: Tang et al., 2009. 
 The paper reports a production rate of 104.4 g/l (1372.1 mmol/l). The estimated 
average biomass concentration is 95 OD (read from Figure 4), which is equivalent to 32.3 
gCDW/l (1OD = 0.34 gCDW/l). The total fermentation time is 30 hours. Thus, the 
average production rate is 1372.1 mmol/l /32.3 gCDW/l / 30 h = 1.42 mmol/gCDW/h. 
The average specific growth rate was calculated from Figure 4, from time 10 to 40 hours, 
which gave an average value of 0.014 h-1, with a correlation coefficient R2 = 0.62. 
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Although this number represents a poor correlation, it is still representative of the average 
specific growth rate. 
 
Succinate - microaerobic 
source: Blankschien et al., 2010. 
 The production rate was reported as 0.4 g/gCDW/h (3.45 mmol/gCDW/h). 
Specific growth rate was calculated using data from Figure 6, which gave a value of 
0.038 h-1, which a correlation coefficient R2 = 0. 91 (good correlation). 
 
Succinate - anaerobic 
source: Zhang et al., 2010. 
 The production rate was estimated by using the reported production of succinate 
(102 mmol) in a total time of 6 days (144 hours), with an associated production of 
biomass of 0.5 gCDW/l. If I assume linearity in the production of biomass, and I use the 
average biomass concentration (0.25 gCDW/l), then the production rate is estimated as 
102 mmol/0.25 gCDW/144 h = 2.8 mmol/gCDW/h.  
 
Lactatic acid 
Source: Mazumdar et al. 2010. 
 The production rate was reported as 1.25 g/gCDW/h (13.88 mmol/gCDW/h). Cell 
mass as a function of time was read from Figure 6.A, and I used data from 12 to 72 hours 
to calculate a specific growth rate equal to 0.048 h-1, which a correlation coefficient R2 = 
0. 96 (good correlation).   
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10.7 Maximal theoretical yields for long chain products 
 
Analysis of production of Alcohols using the reversal of the β-oxidation cycle 
I did the general balance for the production of alcohols using the reversal of the β-
oxidation. Figure 79 shows a simplified pathway for the maximal production rate. To 
achieve redox balance the conversion of PYR into AcCoA is split to go through the 
PFOR and the PDH. In the figure, ‘n’ is the flux of glucose, ‘m’ is the number of carbons 
in the product, and Alcohol_Cm is the product (example: Alcohols_C8 is octanol).  
 
Figure 79: Simplified diagram for the production of alcohols using the reversal of the β-oxidation cycle. This 
diagram shows production and consumption of energy (ATP) and of reducing equivalents ([H] and fd). n: flux of 
glucose, m: number of carbon molecules in product, Alcohol_Cm: product (an alcohol with m carbon 
molecules). See 'omenclature for abbreviations (page 214). 
 The achieving of redox balance for optimal production of alcohols can be 
calculated as follows: 
• $0%: ð 7 !j!0 : y+y  
• # 'I !j!0 ê: y − 1 
• Â0j!'êjê#ê: 2&2[ó] + 2&eï6 
• 6j7%9"  &'> : j I>y +  2& − j2[ó]  
•   7ê > r − ':#>9"#'& !j!0 : y+y  y − 12[ó] +  I>y  
n ATP
(2n) PEPn Glucose
(2n) ATP
(2n) 2[H]
(2n) Pyr (2n)Accoa
n PEP     n PYR
(2n-y) 2[H]
y Fd
n
[(2n)2/m ] Acyl-CoA
(m/2-1) (2n)2/m*2[H]
(m/2-1) (2n)2/m Fd
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(2n) DHAP
n ATP
[(2n)2/m ] Alcohol_Cm
(2n)2/m*4[H]
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• ï 78#&9"#'& 7 9!"#'&ê: y+y  4[ó] 
 The system is redox balance, and the solution to the system gives the following 
overall equation: 
 n Glucose (4n/m) Alcohol_Cm + 2n ATP      
Analysis of production of alkanes using the reversal of the β-oxidation cycle 
 I did the general balance for the production of alkanes using the reversal of the β-
oxidation. Figure 80 shows a simplified pathway for the maximal production rate. To 
achieve redox balance the conversion of PYR into AcCoA is split to go through the 
PFOR and the PFL. In the figure, ‘n’ is the flux of glucose, ‘m’ is the number of carbons 
in the product, and Alkane_Cm-1 is the product (example: Alkane_C7 is heptane). The 
number of cycles in the reversal β-oxidation cycle is (m/2-1). 
 
Figure 80: Simplified diagram for the production of alkanes using the reversal of the β-oxidation cycle. This 
diagram shows production and consumption of energy (ATP) and of reducing equivalents ([H] and Fd). n: flux 
of glucose, m: number of carbon molecules in product, Alkane_Cm-1: product (an alkane with m-1 carbon 
molecules). See 'omenclature for abbreviations (page 214). 
 
 The achieving of redox balance for optimal production of alkanes can be 
calculated as follows: 
• $0%: ð 7 !j!0 : y+y  
• # 'I !j!0 ê: y − 1 
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(2n) 2[H]
(2n) Pyr (2n)Accoa
n PEP     n PYR
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n
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• Â0j!'êjê#ê: 2&2[ó] + 2&eï6 
• 6j7%9"  &'> : j I>y +  2& − jI'789"   
•   7ê > r − ':#>9"#'& !j!0 : y+y  y − 12[ó] +  I>y  
• ï 78#&9"#'& 7 9!"#'&ê: y+y  2[ó] 
 The system is redox balance, and the solution to the system gives the following 
overall equation: 
 n Glucose  (4n/m) Alkane_Cm-1 + 2n ATP + 4n/m formate.  
 
 
Analysis of production of fatty acids using the reversal of the β-oxidation cycle 
 
 By performing FBA of the production of fatty acids using the reversal β-oxidation 
cycle, I found that the production of 1,2-PDO was required when I deleted other 
fermentation by-products. Figure 81 shows the overall flux distribution from glucose to a 
FA. In the figure, ‘n’ is the flux of glucose, ‘m’ is the number of carbons in the product, 
‘x’ is the flux of production of 1,2-PDO and FA_Cm is the product (example: FA_C4 is 
butyric acid). The production of 1,2-PDO is required to achieve redox balance. 
 
Figure 81: Simplified diagram for the production of FAs using the reversal of the β-oxidation cycle. This 
diagram shows production and consumption of energy (ATP) and of reducing equivalents ([H] and Fd). 
Production of 1,2-PDO is required for redox balance in this system. n: flux of glucose, m: number of carbon 
molecules in product, FA_Cm: product (a FA with m carbon molecules). See 'omenclature for abbreviations 
(page 214). 
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 The achieving of redox balance for optimal production of FAs can be calculated 
as follows: 
• $0%: ð 7 !j!0 : y+*y  
• # 'I !j!0 ê: y − 1 
• Â0j!'êjê#ê: 2& − :2[ó] + 2& − 2:eï6 
• 6j7%9"  &'> : j I>y +  2& − j − :I'789"   
•   7ê > r − ':#>9"#'& !j!0 : y+*y  y − 12[ó] +  I>y  
• 1,2 − 6 ð7'>%!"#'&: 2: 2[ó] 
 The system is redox balance, and the solution to the system gives the following 
overall equation: 
& Â0%!'ê =  2+¶ $e +  2& ¶ eï6 + y+¶ 1,26 +  2+¶ I'789"    
 
Analysis of production of butanol and hexanol using the α-keto acid pathway 
The following diagrams show the production of butanol and hexanol using the α-
keto acid pathway. Information to infer this diagram is based on published metabolic 
pathways (Marcheschi et al., 2012; Shen & Liao, 2008), and the fluxes were confirmed 
using the lcp-GEM. 
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Figure 82: Simplified diagram for the production of butanol using the α-keto acid pathway. Emphasis is in the 
requirements of ATP and the achiving of redox balance. See 'omenclature for abbreviations (page 214).  
  
The production of butanol results in the consumption of ATP and reducing equivalents, 
and thus other fermentative products are required. The overall equation that describes the 
production of butanol using this pathway is as follows: 
 n Glucose + 2n[H] + nATP  n butanol + n formate   
The production of hexanol is represented in Figure 83: 
 
Figure 83: Simplified diagram for the production of hexanol using the α-keto acid pathway. Emphasis is in the 
requirements of ATP and the achiving of redox balance . See 'omenclature for abbreviations (page 214). 
 
 Hexanol production produces ATP and reducing equivalents. The overall equation 
that describes the production of hexanol using this pathway is as follows: 
 n Glucose  n/2 hexanol + n [H] + n/2 ATP  + n formate    
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n 2obut n butanol
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n/2 2obut n/2 hexanol
n/2 formate
n AcCoA
n PEP    n PYR
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Analysis of production of Alcohols using the FA biosynthesis pathway 
I did the overall balance for the production of alcohols using the FA biosynthesis 
pathway. Figure 84 shows a simplified pathway for the maximal production rate. In the 
figure, ‘n’ is the flux of glucose, ‘m’ is the number of carbons in the product, and 
Alcohol_Cm is the product (example: Alcohols_C8 is octanol).  
 
Figure 84: Simplified diagram for the production of alcohols using the FA biosynthesis pathway. This diagram 
shows production and consumption of energy (ATP) and of reducing equivalents ([H] and fd). n: flux of glucose, 
m: number of carbon molecules in product, Alcohol_Cm: product (an alcohol with m carbon molecules). See 
'omenclature for abbreviations (page 214). 
 The achieving of redox balance for optimal production of alcohols can be 
calculated as follows: 
• $0%: ð 7 !j!0 : y+y  
• # 'I !j!0 ê: y − 1 
• Â0j!'êjê#ê: 2&2[ó] + 2&eï6 
• 6j7%9"  &'> : 2&2[ó]  
• $e #'êj&"ℎ ê#ê ð9"ℎõ9j: y+y y − 1 22[ó] − 2+  y − 1 eï6  
• ï 78#&9"#'& 7 9!"#'&ê: y+y  4[ó] 
 The system is redox balance, and the solution to the system gives the following 
overall equation: 
n ATP
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(2n) ATP
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(2n) Pyr (2n)Accoa
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 n Glucose (4n/m) Alcohol_Cm + (
4n/m) ATP      
Analysis of production of alkanes using the FA biosynthesis pathway 
 I did the overall balance for the production of alkanes using the FA biosynthesis 
pathway. Figure 85 shows a simplified pathway for the maximal production rate. In the 
figure, ‘n’ is the flux of glucose, ‘m’ is the number of carbons in the product, and 
Alkane_Cm-1 is the product (example: Alkane_C7 is heptane).  
 
Figure 85: Simplified diagram for the production of alkanes using the FA biosynthesis pathway. This diagram 
shows production and consumption of energy (ATP) and of reducing equivalents ([H] and Fd). n: flux of glucose, 
m: number of carbon molecules in product, Alkane_Cm-1: product (an alkane with m-1 carbon molecules). See 
'omenclature for abbreviations (page 214). 
 
 The achieving of redox balance for optimal production of alkanes can be 
calculated as follows: 
• $0%: ð 7 !j!0 : y+y  
• # 'I !j!0 ê: y − 1 
• Â0j!'êjê#ê: 2&2[ó] + 2&eï6 
• 6j7%9"  &'> : j2[ó] +  2& − jI'789"   
• $e #'êj&"ℎ ê#ê ð9"ℎõ9j: y+y y − 1 22[ó] − 2+  y − 1 eï6  
• ï 78#&9"#'& 7 9!"#'&ê: y+y  2[ó] 
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 The system is redox balance, and the solution to the system gives the following 
overall equation: 
 n Glucose  (4n/m) Alkane_Cm-1 + (4n/m)  ATP + 4n/m formate.  
 
 
Analysis of production of fatty acids using the FA biosynthesis pathway 
 
 Figure 86 shows the overall flux distribution to optimize production of FA from 
glucose. In the figure, ‘n’ is the flux of glucose, ‘m’ is the number of carbons in the 
product and FA_Cm is the product (example: FA_C4 is butyric acid). 
 
Figure 86: Simplified diagram for the production of FAs using the FA biosynthesis pathway. This diagram 
shows production and consumption of energy (ATP) and of reducing equivalents ([H] and Fd). Production of 
1,2-PDO is required to achieve redox balance in this system. n: flux of glucose, m: number of carbon molecules 
in product, FA_Cm: product (a FA with m carbon molecules). See 'omenclature for abbreviations (page 214). 
 The achieving of redox balance for optimal production of FAs can be calculated 
as follows: 
• $0%: ð 7 !j!0 : y+y  
• # 'I !j!0 ê: y − 1 
• Â0j!'êjê#ê: 2&2[ó] + 2&eï6 
• 6j7%9"  &'> : j2[ó] +  2& − jI'789"   
• $e #'êj&"ℎ ê#ê ð9"ℎõ9j: 2+ y − 1 22[ó] − 2+  y − 1 eï6  
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 The system is redox balance, and the solution to the system gives the following 
overall equation: 
 n Glucose  (4n/m) FA_Cm + (4n/m) ATP + 8n/m formate.  
 
10.8 Calculation of titers 
The titer can be calculating as follows: 
 ï#" 7 =  ö êð !#I#! ð7'>%!"#'& 79" ∗ g#'89êê " >"pëpv/v   
The biomass can be calculated at any time as: 
 g#'89êê " = :v ∗   Íp       
Then, assuming that x0 = 1 gCDW/L, the titer can be calculated as 
 ï#" 7 =  øë ¸ÆoùpÆ+ ¸)pÍ ∗  Íp −  1     
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10.9 Matlab function for the kinetic model  
KineticModelGlycerolFermentation_AngelaCintolesi 
% Model developed by Angela CIntolesi, 2011 
% Model developed by Angela Cintolesi as part of her Doctoral Research 
% Chemical and Biomolecular Engineering, Rice University, March 2013  
% Return a matrix Y with the optimal cell growth of each product 
  
function F = Glycerol 
global CcoA Cfdp Camp  
CcoA=0.1; Cfdp=0.2; Camp=0;  
  
global r2_max k2eq k2dha r3_max k3 d1 k4eq k5pgp k5gap k5nad k5nadh 
k6pgp k63pg k6atp k7eq r10_maxr r11_maxf Kia r12_max k2gly r4_max 
k4dhap k4gap r5_max k5eq r6_max k6eq k6adp r7_max k73pg k72pg r8_max 
k8eq k82pg k8pep Cformate e10 r10_maxf k10_pyr k10_coa k10_form 
k10_acetylcoa k11eq k11accoa k11acetal k11nad k11nadh k11coa k12eq 
k12acet k12etoh km19 mu  
d1=1;  
k2gly=56;  
k4eq=0.04; 
r4_max=68.7; 
k4dhap=2.8;  
k4gap=0.3;  
r5_max=921.6;  
k5eq=0.67; 
k5pgp=0.1; 
k5gap=0.89;  
k5nad=0.045; 
k5nadh=0.02; 
k6pgp=0.006;  
k63pg=0.17;  
k6atp=0.24;  
r6_max=3021.77; 
k6eq=1800; 
k6adp=0.18;  
r7_max=89.0497; 
k73pg=0.2; 
k72pg=0.369; 
k7eq=0.1; 
Kia=1; 
r8_max=330.448; 
k8eq=6.7; 
k82pg=0.1; 
k8pep=0.135; 
r10_maxr=656; 
Cformate = 0; 
r10_maxf=0.46*r10_maxr/1.33; 
k10_pyr=2.05; 
k10_coa=0.0068;  
k10_form=24.5;  
k10_acetylcoa=0.051;    
r11_maxf=2311; 
k11eq =1;  
k11accoa=0.007; 
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k11acetal=10; 
k11nad=0.08; 
k11nadh=0.025; 
k11coa=0.008; 
r12_max=2311; 
k12eq=12354.9; 
k12acet=5.4; 
k12etoh=2.4; 
r2_max=1.33; 
k2eq = 22.4/17.2 * 0.3/56; 
k2dha = 0.3; 
r3_max=0.72; 
k3=45/1000; 
km19=159.2; 
mu=0.04/3600; 
tf=120*3600; 
tglyc=[0; 12; 24; 36; 48; 60; 72; 84; 96; 108; 120]; %h 
glyc=[11.07; 10.50; 9.69; 8.32; 6.43; 4.05; 2.80; 1.98; 1.43; 1.07; 
0.87]*1000/92; %mM 
EtOH=[0; 0.22; 0.59; 1.20; 2.01; 3.14; 3.61; 3.90; 4.10; 4.11; 
4.24]*1000/46.07; %mM 
biomass=[0.0545; 0.59; 0.69; 0.843; 1.04; 1.34; 1.32; 1.33; 1.32; 1.29; 
1.29]*0.34; %OD 
clear t Y 
b0=0.48*0.34; 
V=[glyc(1) 1 1 1 1 1 1 1 1 1 1 0 1 EtOH(1) 4.27 0.595 1.47 0.1 b0]; % 
All values are in mM, except Biomass, in g/L 
% Values of ATP, ADP, NAD, NADH were taken from JWS, model of 
Chassagnole 
[t Y]=ode23t(@model, [0 tf], V); 
 
%%%%%%%%%%%%%%% Plot %%%%%%%%%%%%%%  
B=[t Y]; 
xlswrite('MonodMetabolitesFinal', B) 
figure (1) 
plot (t/3600, Y(:,1)/1000, '--b'); % Value in Molar 
hold on 
plot (t/3600, Y(:,19)/2, '--g'); 
hold on  
plot (t/3600, Y(:,14)/1000, '--r'); % Value in Molar 
hold on  
plot (tglyc, glyc/1000, '+b'); %MW of Glycerol is 92. Value is in Molar 
hold on  
plot (tglyc, biomass/2, '+g'); %conversion to g/l/2 
hold on 
plot (tglyc, EtOH/1000, '+r');% MW of Ethanol is 46.07. Value is in 
Molar 
xlabel ('time [h]'); 
ylabel('Glycerol [M], Biomass[g DW/L /2], EtOH [M]'); 
figure (2) 
ylabel('Metabolite [mM]'); 
xlabel('Time [h]'); 
title ({'Glyc_in (--blue), DHA (--red), DHAP (--magenta), GAP (--
green), pgp (--blak), 3pg (--cyan)'; '2pg (-*blue), PEP (-*red), PYR (-
*magenta), AcCoA (-*green), Acetahdehyde (-*black)'}) 
hold on 
plot (t/3600, Y(:,3), '--r'); 
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hold on 
plot (t/3600, Y(:,4), '--m'); 
hold on 
plot (t/3600, Y(:,5), '--g'); 
hold on 
plot (t/3600, Y(:,6), '--k'); 
hold on 
plot (t/3600, Y(:,7), '--c'); 
hold on 
plot (t/3600, Y(:,8), '--b*'); 
hold on 
plot (t/3600, Y(:,9), '--r*'); 
hold on 
plot (t/3600, Y(:,10), '--m*'); 
hold on 
plot (t/3600, Y(:,11), '--g*'); 
hold on 
plot (t/3600, Y(:,13), '--k*'); 
 
%% Elasticities and FCC  
clear t Y 
tf = 50*3600; 
%V=[g0 1 1 1 1 1 1 1 1 1 1 0 1 0 4.27 0.595 1.47 0.1 x0]; % All values 
are in mM, except Biomass, in g/L 
%Values of ATP, ADP, NAD, NADH were taken from JWS, model of 
Chassagnole 
[t Y]=ode23t(@model, [0 tf], V); 
Y(end,:) 
Y12=V(1,12); 
Y15=V(1,15); 
Y16=V(1,16); 
Y17=V(1,17); 
Y18=V(1,18); 
CcoA=0.1;  
Cfdp=0.2;  
Camp=0;  
  
% Define parameters 
Y1=sym('Y1'); 
Y2=sym('Y2'); 
Y3=sym('Y3'); 
Y4=sym('Y4'); 
Y5=sym('Y5'); 
Y6=sym('Y6'); 
Y7=sym('Y7'); 
Y8=sym('Y8'); 
Y9=sym('Y9'); 
Y10=sym('Y10'); 
Y11=sym('Y11'); 
Y13=sym('Y13'); 
Y14=sym('Y14'); 
  
% Jacobian 
f=[d1*(Y1-Y2); r2_max/k2gly*(Y2-Y3/k2eq)/(1+Y2/k2gly+Y3/k2dha); 
r3_max*(Y3/(k3+Y3)); r4_max*(Y4-Y5/k4eq)/(k4dhap*(1+Y5/k4gap)+Y4); 
r5_max*(Y5*Y17-
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Y6*Y18/k5eq)/((k5gap*(1+Y6/k5pgp)+Y5)*(k5nad*(1+Y18/k5nadh)+Y17)); 
r6_max*(Y6*Y16-
Y15*Y7/k6eq)/((k6adp*(1+Y15/k6atp)+Y16)*(k6pgp*(1+Y7/k63pg)+Y6)); 
r7_max*(Y7-Y8/k7eq)/(k73pg*(1+Y8/k72pg)+Y7); r8_max*(Y8-
Y9/k8eq)/(k82pg*(1+Y9/k8pep)+Y8); 
r10_maxf*Y10*CcoA/(Y10*CcoA+k10_pyr*CcoA+k10_coa*Y10)-
(r10_maxf)*Cformate*Y11/(Y11*Cformate+k10_form*Y11+k10_acetylcoa*Cforma
te); r11_maxf*(Y11*Y18)/(Y18*k11accoa+Y11*(Y18+k11nadh*Y13/Kia))-
r11_maxf/k11eq*Y13*Y17*CcoA/(Kia*k11nad*CcoA+k11coa*Y13*Y17+k11nad*Y13*
CcoA+k11acetal*Y17*CcoA+Y13*Y17*CcoA); r12_max/k12acet*(Y13-
Y14/k12eq)/(1+Y13/k12acet+Y14/k12etoh)]; 
x=[Y2, Y3, Y4, Y5, Y6, Y7, Y8, Y9, Y10, Y11, Y13]; 
R=jacobian (f,x); 
T = R'; 
  
% Data at 50 hrs 
sf = subs(f, {Y1, Y2, Y3, Y4, Y5, Y6, Y7, Y8, Y9, Y10, Y11, Y13, Y14}, 
{Y(end,1), Y(end,2), Y(end,3), Y(end,4), Y(end,5), Y(end,6), Y(end,7), 
Y(end,8), Y(end,9), Y(end,10), Y(end,11), Y(end,13), Y(end,14)}); 
sx=  subs(x, {Y1, Y2, Y3, Y4, Y5, Y6, Y7, Y8, Y9, Y10, Y11, Y13}, 
{Y(end,1), Y(end,2), Y(end,3), Y(end,4), Y(end,5), Y(end,6), Y(end,7), 
Y(end,8), Y(end,9), Y(end,10), Y(end,11), Y(end,13)}); 
sT = subs(T, {Y1, Y2, Y3, Y4, Y5, Y6, Y7, Y8, Y9, Y10, Y11, Y13, Y14}, 
{Y(end,1), Y(end,2), Y(end,3), Y(end,4), Y(end,5), Y(end,6), Y(end,7), 
Y(end,8), Y(end,9), Y(end,10), Y(end,11), Y(end,13), Y(end,14)}); 
xCycle=[Y(end,2) Y(end,3) Y(end,4) Y(end,5) Y(end,6) Y(end,7) Y(end,8) 
Y(end,9) Y(end,10) Y(end,11) Y(end,13)]; % {Y2, Y3, Y4, Y5, Y6, Y7, Y8, 
Y9, Y10, Y11, Y13} 
E=zeros (11, 11); 
for j=1:1:11 
    for i=1:1:11 
        E(i,j)=sx(i)/sf(j)*sT(i,j); 
    end 
end 
E 
M=zeros (11, 11); 
  
for j=1:1:11 
    M(1,j)=1; 
end 
M(2,1)=E(1,1); 
M(2,2)=E(1,2); 
M(3,2)=E(2,2); 
M(3,3)=E(2,3); 
M(9,8)=E(9,8); 
M(9,9)=E(9,9); 
M(10,9)=E(10,9); 
M(10,10)=E(10,10); 
M(11,10)=E(11,10); 
M(11,11)=E(11,11); 
for i=4:1:8 
    M(i,i-1)=E(i-1,i-1); 
    M(i,i)=E(i-1,i)-E(i,i)*xCycle(i-1)/xCycle(i); 
    M(i,i+1)=-1*E(i,i+1)*xCycle(i-1)/xCycle(i); 
end 
M(8,3)=-1*E(8,3)*xCycle(7)/xCycle(8); 
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M(8,9)=0; 
rank_of_M = rank(M) 
pseudoI=-1*eye(11,11); 
pseudoI(1,1)=1; 
pseudoI(4,5)=xCycle(3)/xCycle(4); 
pseudoI(5,6)=xCycle(4)/xCycle(5); 
pseudoI(6,7)=xCycle(5)/xCycle(6); 
pseudoI(7,8)=xCycle(6)/xCycle(7); 
pseudoI(8,9)=xCycle(7)/xCycle(8); 
CC=M\eye(11,11)*pseudoI; 
display('FCC='); 
CC(:,1) 
xlswrite ('Monod_Elasticities', E) 
xlswrite ('Monod_CC', CC) 
function dY = model (t, Y) 
dY(1) = -1*vglpf_F(Y(1), Y(2))*Y(19)*0.0022333;%Substrate. Conversion 
of units using L-cells/g-DW cells = 0.0022333 
dY(2) = 1*vglpf_F(Y(1), Y(2))-1*vglda_F(Y(2), Y(3))-vgrowth_F 
(Y(1))*Y(2); 
dY(3)= vglda_F(Y(2), Y(3))-vdhak_F(Y(3))-vgrowth_F (Y(1))*Y(3); 
dY(4)= vdhak_F(Y(3))-vtpia_F(Y(4), Y(5))-vgrowth_F (Y(1))*Y(4); 
dY(5)= vtpia_F(Y(4), Y(5))-vgapdh_F(Y(5), Y(6), Y(17), Y(18))-vgrowth_F 
(Y(1))*Y(5); 
dY(6)= vgapdh_F(Y(5), Y(6), Y(17), Y(18))-vpgk_F(Y(6), Y(7), Y(15), 
Y(16))-vgrowth_F (Y(1))*Y(6); 
dY(7)= vpgk_F(Y(6), Y(7), Y(15), Y(16))-vpgam_F(Y(7), Y(8))-vgrowth_F 
(Y(1))*Y(7); 
dY(8)= vpgam_F(Y(7), Y(8))-veno_F(Y(8), Y(9))-vgrowth_F (Y(1))*Y(8); 
dY(9)= veno_F(Y(8), Y(9))-vdhak_F(Y(3))-vgrowth_F (Y(1))*Y(9); 
dY(10)= -1*vpfl_F(Y(10), Y(11), Y(12))+vdhak_F(Y(3))-vgrowth_F 
(Y(1))*Y(10); 
dY(11)= vpfl_F(Y(10), Y(11), Y(12))-vadhe1_F(Y(11), Y(13), Y(17), 
Y(18))-vgrowth_F (Y(1))*Y(11); 
dY(12)= (vpfl_F(Y(10), Y(11), Y(12)))*Y(19)*0.0022333; %product 
dY(13)= vadhe1_F(Y(11), Y(13), Y(17), Y(18))-vadhe2_F(Y(13), Y(14))-
vgrowth_F (Y(1))*Y(13); 
dY(14)= (vadhe2_F(Y(13), Y(14)))*Y(19)*0.0022333; % Product 
dY(15)=0; 
dY(16)=0; 
dY(17)= -1*vglda_F(Y(2), Y(3))-vgapdh_F(Y(5), Y(6), Y(17), 
Y(18))+vadhe1_F(Y(11), Y(13), Y(17), Y(18))+vadhe2_F(Y(13), Y(14))-
vgrowth_F (Y(1))*Y(17); 
dY(18)= vglda_F(Y(2), Y(3))+vgapdh_F(Y(5), Y(6), Y(17), Y(18))-
vadhe1_F(Y(11), Y(13), Y(17), Y(18))-vadhe2_F(Y(13), Y(14))-vgrowth_F 
(Y(1))*Y(18); 
dY(19)= vgrowth_F (Y(1))*Y(19);%Biomass 
dY=dY'; 
  
function vglpf =vglpf_F(Y1, Y2) 
global d1 
vglpf = d1*(Y1-Y2); 
  
function vglda =vglda_F(Y2, Y3) 
global r2_max k2eq k2dha k2gly 
vglda = r2_max/k2gly*(Y2-Y3/k2eq)/(1+Y2/k2gly+Y3/k2dha); 
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function vdhak =vdhak_F(Y3) 
global r3_max k3 
vdhak = r3_max*(Y3/(k3+Y3)); 
  
function vtpia =vtpia_F(Y4, Y5) 
global k4eq r4_max k4dhap k4gap 
vtpia = r4_max*(Y4-Y5/k4eq)/(k4dhap*(1+Y5/k4gap)+Y4); 
  
function vgapdh =vgapdh_F(Y5, Y6, Y17, Y18) 
global k5gap k5pgp k5nad k5nadh r5_max k5eq 
vgapdh = r5_max*(Y5*Y17-
Y6*Y18/k5eq)/((k5gap*(1+Y6/k5pgp)+Y5)*(k5nad*(1+Y18/k5nadh)+Y17)); 
  
function vpgk =vpgk_F(Y6, Y7, Y15, Y16) 
global k6pgp k63pg k6atp r6_max k6eq k6adp 
vpgk = r6_max*(Y6*Y16-
Y15*Y7/k6eq)/((k6adp*(1+Y15/k6atp)+Y16)*(k6pgp*(1+Y7/k63pg)+Y6)); 
  
function vpgam =vpgam_F(Y7, Y8) 
global k7eq r7_max k73pg k72pg 
vpgam = r7_max*(Y7-Y8/k7eq)/(k73pg*(1+Y8/k72pg)+Y7); 
  
function veno =veno_F(Y8, Y9) 
global r8_max k8eq k82pg k8pep 
veno = r8_max*(Y8-Y9/k8eq)/(k82pg*(1+Y9/k8pep)+Y8); 
  
function vpfl =vpfl_F(Y10, Y11, Y12) 
global CcoA r10_maxr Cformate r10_maxf k10_pyr k10_coa k10_form 
k10_acetylcoa 
vpfl = r10_maxf*Y10*CcoA/(Y10*CcoA+k10_pyr*CcoA+k10_coa*Y10)-
(r10_maxr)*Cformate*Y11/(Y11*Cformate+k10_form*Y11+k10_acetylcoa*Cforma
te); 
  
function vadhe1 =vadhe1_F(Y11, Y13, Y17, Y18) 
global CcoA r11_maxf Kia k11eq k11accoa k11acetal k11nad k11nadh k11coa 
vadhe1 = r11_maxf*(Y11*Y18)/(Y18*k11accoa+Y11*(Y18+k11nadh*Y13/Kia))-
r11_maxf/k11eq*Y13*Y17*CcoA/(Kia*k11nad*CcoA+k11coa*Y13*Y17+k11nad*Y13*
CcoA+k11acetal*Y17*CcoA+Y13*Y17*CcoA); 
  
function vadhe2 =vadhe2_F(Y13, Y14) 
global r12_max k12eq k12acet k12etoh 
vadhe2 = r12_max/k12acet*(Y13-Y14/k12eq)/(1+Y13/k12acet+Y14/k12etoh); 
  
function vgrowth=vgrowth_F (Y1) 
global km19 mu  
vgrowth=mu*Y1/(km19+Y1); 
 
10.10 Matlab function for glyc-GEM 
AC_BiomassvsProduct_GlyceroliJO1366.m 
% Glycerol fermentation in E. coli as a platform for the synthesis of 
% desired products. 
% Model developed by Angela Cntolesi as part of her Doctoral Research 
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% Chemical and Biomolecular Engineering, Rice University, March 2013  
% Plot solution spaces 
%% Use the updated model iJO1366 (2011) 
  
clear all 
global SizeModel 
initCobraToolbox() 
%changeCobraSolver('glpk'); 
%% Open model 
model1=readCbModel('iJO1366'); 
biomassposition=8; 
Biomass_name='Ec_biomass_iJO1366_core_53p95M'; 
modelname='iJO1366';  
model1=changeRxnBounds(model1,{'EX_o2(e)', 'EX_glc(e)', 'EX_glyc(e)', 
'EX_co2(e)','FHL'}, [0 0 -20 0 -1000], 'l'); 
% Reverse FHL 
model1=changeRxnBounds(model1,'FHL', 1000, 'u'); 
% G3PD2 is irreversible 
model1=changeRxnBounds(model1,'G3PD2', 0, 'u'); 
%no aa degradation 
model1=changeRxnBounds(model1,{'DAAD', 'AST', 'SADH', 'SGSAD', 'SGDS', 
'ARGDC', 'ARGDCpp', 'ASPT', 'GLUN', 'P5CD', 'PROD2', 'SERD_L', 'OBTFL', 
'PPAKr', 'THRD', 'GLYAT', 'TYROXDApp', 'PEAMNOpp', 'TRPAS2', 
'CYSDS','42A12BOOXpp', 'THRAi'}, [0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0], 'u'); 
model1=changeRxnBounds(model1,{'DAAD', 'AST', 'SADH', 'SGSAD', 'SGDS', 
'ARGDC', 'ARGDCpp', 'ASPT', 'GLUN', 'P5CD', 'PROD2', 'SERD_L', 'OBTFL', 
'PPAKr', 'THRD', 'GLYAT', 'TYROXDApp', 'PEAMNOpp', 'TRPAS2', 
'CYSDS','42A12BOOXpp', 'THRAi'}, [0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0], 'l'); 
%no nucleotides degradation 
model1=changeRxnBounds(model1,{'CYTD', 'DCYTD', 'DURIPP', 'TMDPP', 
'PPM2', 'DRPA', 'ADA', 'DADA', 'PUNP1', 'PUNP4', 'PUNP2', 'PUNP3', 
'PUNP5', 'PUNP6', 'PUNP7', 'PYNP2r'}, [0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0], 'u'); 
model1=changeRxnBounds(model1,{'CYTD', 'DCYTD', 'DURIPP', 'TMDPP', 
'PPM2', 'DRPA', 'ADA', 'DADA', 'PUNP1', 'PUNP4', 'PUNP2', 'PUNP3', 
'PUNP5', 'PUNP6', 'PUNP7', 'PYNP2r'}, [0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0], 'l'); 
% export aa (direct + non escential): 
model1=changeRxnBounds(model1,{'EX_ala-B(e)', 'EX_ala-D(e)', 'EX_ala-
L(e)', 'EX_asn-L(e)', 'EX_asp-L(e)', 'EX_cys-D(e)', 'EX_cys-L(e)', 
'EX_glu-L(e)', 'EX_gln-L(e)', 'EX_gly(e)', 'EX_his-L(e)', 'EX_ile-
L(e)', 'EX_leu-L(e)', 'EX_lys-L(e)', 'EX_met-D(e)', 'EX_met-L(e)', 
'EX_phe-L(e)', 'EX_pro-L(e)', 'EX_ser-D(e)', 'EX_ser-L(e)','EX_thr-
L(e)', 'EX_trp-L(e)', 'EX_tyr-L(e)', 'EX_val-L(e)' }, [0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ], 'u'); 
model1= changeRxnBounds(model1,{'EX_26dap-M(e)','EX_frulys(e)','EX_hom-
L(e)', 'EX_orn(e)'}, [0 0 0 0 ], 'u');  
%no Fe2+ export. no H2S export 
model1=changeRxnBounds(model1,'EX_fe2(e)', 0, 'u'); 
model1=changeRxnBounds(model1,'EX_h2s(e)', 0, 'u'); 
%no POR5 export. 
model1=changeRxnBounds(model1,'POR5', 0, 'l'); 
model1=changeRxnBounds(model1,'POR5', 0, 'u'); 
%no production of 5mtr and spmd, for redox purposes 
model1=changeRxnBounds(model1,'EX_5mtr(e)', 0, 'u'); 
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model1=changeRxnBounds(model1,'EX_spmd(e)', 0, 'u'); 
%Add PntAB 
model1=addReaction(model1, 'Add_PntAB', {'nadh[c]', 'nadp[c]', 'h[p]', 
'nad[c]', 'nadph[c]', 'h[c]'}, [-1 -1 -1 1 1 1], 1, 0, 1000); 
% remove hxa as possible product 
model1=changeRxnBounds(model1,'EX_hxa(e)', 0, 'l'); 
model1=changeRxnBounds(model1,'EX_hxa(e)', 0, 'u'); 
% restrict F6PA 
model1=changeRxnBounds(model1,'F6PA', -4, 'l'); 
% no FBA3 and PFK_3 
model1=changeRxnBounds(model1,'FBA3', 0, 'l'); 
model1=changeRxnBounds(model1,'FBA3', 0, 'u'); 
model1=changeRxnBounds(model1,'PFK_3', 0, 'l'); 
model1=changeRxnBounds(model1,'PFK_3', 0, 'u'); 
  
% Study of synthesis of additional products. Case (1) correspond to E. 
coli 
% wild tyle 
display ('Add: (1)none; (2)13PDO(nadh); (3)acetone; (4)Propanol; 
(5)PPCKr; (6)Propanol+PPCKr; (7)ATP-depend DhaK; (8)13PDO(nadph); 
(9)PPCKr+ppa; '); 
K=input ('(10)Butanol (revB-oxi); (11)Propanol(12pdo); (12)D-lac: 
(13)Succ(add pyc,CO2), (14)Propanol(ppa), (15)Propanol(ppcoa), (16) 
succ(PckA,CO2)'); 
switch K  
    case 1  
    case 2        
        model1=addReaction(model1,'Add3HPA','glyc[c] -> 3HPA + 
h2o[c]');  
        model1=addReaction(model1,'Add13PDO','3HPA + h[c] + nadh[c] -> 
13PDO[c] + nad[c]'); 
        model1=addReaction(model1,'EX_13PDO','13PDO[c] ->'); 
    case 3 
        model1=addReaction(model1,'AddAcetone','glyc[c] + h[c] + 
nadh[c] -> Acetone[c] + nad[c] + 2 h2o[c]'); 
        model1=addReaction(model1,'EX_Acetone','Acetone[c] ->'); 
    case 4 
        model1=addReaction(model1,'AddPropionate','succ[c] -> ppa[c] + 
co2[c]'); 
        model1=addReaction(model1,'AddPropanol','ppa[c] + 3 h[c] + 2 
nadh[c] -> propanol[c] + 2 nad[c] + h2o[c]'); 
        model1=addReaction(model1,'EX_Propanol','propanol[c] ->'); 
    case 5 
        model1=addReaction(model1,'PPCK_r','adp[c] + co2[c] + pep[c] 
<=> atp[c] + oaa[c]'); 
        model1=changeRxnBounds(model1, 'PPCK', 0, 'u'); 
    case 6 
        model1=addReaction(model1,'PPCK_r','adp[c] + co2[c] + pep[c] 
<=> atp[c] + oaa[c]'); 
        model1=changeRxnBounds(model1, 'PPCK', 0, 'u'); 
        model1=addReaction(model1,'AddPropionate','succ[c] -> ppa[c] + 
co2[c]'); 
        model1=addReaction(model1,'AddPropanol','ppa[c] + 3 h[c] + 2 
nadh[c] -> propanol[c] + 2 nad[c] + h2o[c]'); 
        model1=addReaction(model1,'EX_Propanol','propanol[c] ->'); 
    case 7 
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        model1=addReaction(model1,'DhaKLM_Cfreundii','atp[c] + dha[c] 
<=> adp[c] + dhap[c] + h[c]'); 
         
    case 8 
        model1=addReaction(model1,'Add3HPA','glyc[c] -> 3HPA + 
h2o[c]');  
        model1=addReaction(model1,'Add13PDO','3HPA + h[c] + nadph[c] -> 
13PDO[c] + nadp[c]'); 
        model1=addReaction(model1,'EX_13PDO','13PDO[c] ->'); 
         
    case 9 
        model1=addReaction(model1,'AddTransport_ppa','ppa[c] + h[c] -> 
ppa[p] + h[p]');  
        model1=addReaction(model1,'PPCK_r','adp[c] + co2[c] + pep[c] 
<=> atp[c] + oaa[c]'); 
        model1=changeRxnBounds(model1, 'PPCK', 0, 'u'); 
    case 10 
        model1=addReaction(model1,'P_butanal_CoA',{'btcoa[c]', 
'nadh[c]', 'h[c]', 'butanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1,0,1000); 
        model1=addReaction(model1,'P_butanol',{'butanal[c]', 'nadh[c]', 
'h[c]', 'butanol[c]', 'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'EX_butanol',{'butanol[c]'},[-1],1, 
0,1000); 
        model1=changeRxnBounds(model1,'ACOAD1f', 0, 'l'); 
        model1=addReaction(model1,'ACOAD1f_nadh',{'btcoa[c]', 'nad[c]', 
'b2coa[c]', 'nadh[c]', 'h[c]'},[-1 -1 1 1 1],1,-1000,0);         
%    case 11 
%        model1=addReaction(model1,'EX_cobamamide', 'cobamamide <=>'); 
%        model1=addReaction(model1,'Add_cobamamide_ppa', '12ppd-R[e] + 
cobamamide -> h2o[c] + ppa[c]'); 
%        model1=addReaction(model1,'Add_propanal', 'ppa[c] + nadh[c] ? 
propanol[c] + nad[c]'); 
%        model1=addReaction(model1,'EX_Propanol','propanol[c] ->'); 
    case 12 
        model1=changeRxnBounds(model1,'EX_glyc(e)', -20, 'u'); 
        model1=changeRxnBounds(model1,'EX_o2(e)', -2, 'l'); 
     
    case 13 
        model1=addReaction(model1,'pyc','atp[c] + pyr[c] + hco3[c] -> 
adp[c] + pi[c] + oaa[c] + h[c]'); 
        model1=changeRxnBounds(model1,'EX_co2(e)', -1000, 'l'); 
        model1=changeRxnBounds(model1,'EX_o2(e)', -2, 'l'); 
        model1=changeRxnBounds(model1,'EX_glyc(e)', -20, 'u'); 
    
    case 14 
        model1=addReaction(model1,'PPCK_r','adp[c] + co2[c] + pep[c] 
<=> atp[c] + oaa[c]'); 
        model1=changeRxnBounds(model1, 'PPCK', 0, 'u'); 
        model1=addReaction(model1,'AddPropionate','succ[c] -> ppa[c] + 
co2[c]'); 
        %model1=addReaction(model1,'AddPropanol','ppa[c] + 3 h[c] + 2 
nadh[c] + atp[c] -> propanol[c] + 2 nad[c] + h2o[c] + amp[c] + 
ppi[c]'); %Checl this reaction! 
        model1=addReaction(model1,'AddPropanol','ppa[c] + 3 h[c] + 2 
nadh[c] -> propanol[c] + 2 nad[c] + h2o[c]'); %Check this reaction! 
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        model1=addReaction(model1,'EX_Propanol','propanol[c] ->'); 
         
    case 15 
        model1=addReaction(model1,'PPCK_r','adp[c] + co2[c] + pep[c] 
<=> atp[c] + oaa[c]'); 
        model1=changeRxnBounds(model1, 'PPCK', 0, 'u'); 
        model1=addReaction(model1,'AddPropanal1','ppcoa[c] + h[c] + 
nadh[c] -> propanal[c] + nad[c] + coa[c]'); 
        model1=addReaction(model1,'AddPropanal2','12ppd-R[c] -> 
propanal[c] + h2o[c]');  
        model1=addReaction(model1,'AddPropanol','propanal[c] + h[c] + 
nadh[c] -> propanol[c] + nad[c]');  
         
        model1=addReaction(model1,'EX_Propanol','propanol[c] ->'); 
    case 16 
        model1=addReaction(model1,'PPCK_r','adp[c] + co2[c] + pep[c] 
<=> atp[c] + oaa[c]'); 
        model1=changeRxnBounds(model1, 'PPCK', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_co2(e)', -1000, 'l'); 
end 
A= size(model1.rxns); 
SizeModel=(A(1)); 
  
%% Enter knockouts 
I= input('List of reactions to delete: '); 
%Example of inputs: {' '}, {'FBA', DHAPT'}  
SizeI=size(I); 
for p=1:1:SizeI(2) 
    RxnDelete=I(p); 
    model1=changeRxnBounds(model1, RxnDelete, 0, 'u'); 
    model1=changeRxnBounds(model1, RxnDelete, 0, 'l'); 
    if p==1 
        KnockoutReaction=RxnDelete; 
    else 
        KnockoutReaction=strcat(KnockoutReaction,',',RxnDelete); 
    end 
end 
  
%% Desired product 
prompt = {'Desired product: '}; 
%Example of input: EX_etoh(e) 
Product=inputdlg(prompt); 
model1=changeRxnBounds(model1, Product, 1000, 'u'); 
A=(model1.rxns); 
productposition=AC_findp_F(A,Product); 
model1=changeObjective(model1, Biomass_name, 1); 
solution=optimizeCbModel(model1); 
%Maximal specific growth rate 
maxbiomass =solution.f 
if solution.stat ~= 1 
    display ('The selected condition does not have any valid solution') 
    return 
end 
%Production rate of desired product at maximal specific growth rate 
Product_when_biomass_is_optimized=solution.x(productposition) 
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TitlePlot=strcat('Product versus Biomass, deletion of: ', 
KnockoutReaction); 
xlsTitle=strcat('Model_', modelname, '_', KnockoutReaction); 
model1=changeObjective(model1, Product(1), 1); 
solution=optimizeCbModel(model1); 
%Maximal production rate 
OptimeProduct=solution.x(productposition) 
%Solution space. The matrix will be storage as "Y", and it can be 
called 
%from the main screen for further analysis 
model1=changeObjective(model1, Biomass_name, 1); 
Y=zeros(101,3); 
for i=1:1:101 
    biomass1=0.01*(i-1)*maxbiomass; 
    model1=changeRxnBounds(model1, Biomass_name, biomass1, 'l'); 
    model1=changeRxnBounds(model1, Biomass_name, biomass1, 'u'); 
    [minF maxF]=fluxVariability(model1, 100,'max',{Product}, false, 
true); 
    Y(i,:)= [biomass1 minF maxF]; 
     
end 
  
model1=changeObjective(model1, Biomass_name, 1); 
model1=changeRxnBounds(model1, Biomass_name, 0, 'l'); 
model1=changeRxnBounds(model1, Biomass_name, 1000, 'u'); 
solution=optimizeCbModel(model1); 
  
%% Plot SOlution space 
figure(1) 
set(0, 'DefaultTextInterpreter', 'none') %Change set of all plots Text-
Interpreter to none, as oppose to Text (default) 
plot(Y(:,1), Y(:,2), '--b','LineWidth',2); 
hold on 
plot(Y(:,1), Y(:,3), '--b','LineWidth',2); 
xlabel('Specific Growth Rate'); 
ylabel(strcat('Product: ', Product)); 
title(TitlePlot); 
 
10.11 Matlab function to test multiple models for glycerol fermentation 
AC_BiomassvsProduct_GlyceroliJO1366_ModelTesting_Thesis 
% Glycerol fermentation in E. coli as a platform for the synthesis of 
% desired products. 
% Evaluation of multiple possible models 
% Model developed by Angela CIntolesi as part of her Doctoral Research 
% Chemical adn Biomolecular Engineering, Rice University, March 2013  
% Return a matrix Y with the optimal cell growth of each product 
  
%% Use the updated model iJO1366 (2011) 
clear all 
global SizeModel 
initCobraToolbox() 
%changeCobraSolver('glpk'); 
%% Evaluation of multiple models 
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Y=zeros(17,17); 
FigNum=1; 
for ll=1:1:15 
    for mm=1:1:ll 
P1=ll; 
        P2=mm; 
  
        clear strArray1 
clear strArray2 
model1=readCbModel('iJO1366'); 
biomassposition=8; 
Biomass_name='Ec_biomass_iJO1366_core_53p95M'; 
modelname='iJO1366'; 
model1=changeRxnBounds(model1,{'EX_o2(e)', 'EX_glc(e)', 'EX_glyc(e)', 
'EX_co2(e)','FHL'}, [0 0 -20 0 -1000], 'l'); 
%model1=changeRxnBounds(model1,'EX_glyc(e)', -20, 'u'); 
model1=changeRxnBounds(model1,'FHL', 1000, 'u'); 
model1=changeRxnBounds(model1,'G3PD2', 0, 'u'); 
%no aa degradation 
model1=changeRxnBounds(model1,{'DAAD', 'AST', 'SADH', 'SGSAD', 'SGDS', 
'ARGDC', 'ARGDCpp', 'ASPT', 'GLUN', 'P5CD', 'PROD2', 'SERD_L', 'OBTFL', 
'PPAKr', 'THRD', 'GLYAT', 'TYROXDApp', 'PEAMNOpp', 'TRPAS2', 
'CYSDS','42A12BOOXpp', 'THRAi'}, [0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0], 'u'); 
model1=changeRxnBounds(model1,{'DAAD', 'AST', 'SADH', 'SGSAD', 'SGDS', 
'ARGDC', 'ARGDCpp', 'ASPT', 'GLUN', 'P5CD', 'PROD2', 'SERD_L', 'OBTFL', 
'PPAKr', 'THRD', 'GLYAT', 'TYROXDApp', 'PEAMNOpp', 'TRPAS2', 
'CYSDS','42A12BOOXpp', 'THRAi'}, [0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0], 'l'); 
%no nucleotides degradation 
model1=changeRxnBounds(model1,{'CYTD', 'DCYTD', 'DURIPP', 'TMDPP', 
'PPM2', 'DRPA', 'ADA', 'DADA', 'PUNP1', 'PUNP4', 'PUNP2', 'PUNP3', 
'PUNP5', 'PUNP6', 'PUNP7', 'PYNP2r'}, [0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0], 'u'); 
model1=changeRxnBounds(model1,{'CYTD', 'DCYTD', 'DURIPP', 'TMDPP', 
'PPM2', 'DRPA', 'ADA', 'DADA', 'PUNP1', 'PUNP4', 'PUNP2', 'PUNP3', 
'PUNP5', 'PUNP6', 'PUNP7', 'PYNP2r'}, [0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0], 'l'); 
% export aa (direct + non escential): 
model1=changeRxnBounds(model1,{'EX_ala-B(e)', 'EX_ala-D(e)', 'EX_ala-
L(e)', 'EX_asn-L(e)', 'EX_asp-L(e)', 'EX_cys-D(e)', 'EX_cys-L(e)', 
'EX_glu-L(e)', 'EX_gln-L(e)', 'EX_gly(e)', 'EX_his-L(e)', 'EX_ile-
L(e)', 'EX_leu-L(e)', 'EX_lys-L(e)', 'EX_met-D(e)', 'EX_met-L(e)', 
'EX_phe-L(e)', 'EX_pro-L(e)', 'EX_ser-D(e)', 'EX_ser-L(e)','EX_thr-
L(e)', 'EX_trp-L(e)', 'EX_tyr-L(e)', 'EX_val-L(e)' }, [0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ], 'u'); 
model1= changeRxnBounds(model1,{'EX_26dap-M(e)','EX_frulys(e)','EX_hom-
L(e)', 'EX_orn(e)'}, [0 0 0 0 ], 'u');  
%no Fe2+ export. no H2S export 
model1=changeRxnBounds(model1,'EX_fe2(e)', 0, 'u'); 
model1=changeRxnBounds(model1,'EX_h2s(e)', 0, 'u'); 
%no POR5 export. 
model1=changeRxnBounds(model1,'POR5', 0, 'l'); 
model1=changeRxnBounds(model1,'POR5', 0, 'u'); 
%no production of 5mtr and spmd, for redox purposes 
model1=changeRxnBounds(model1,'EX_5mtr(e)', 0, 'u'); 
model1=changeRxnBounds(model1,'EX_spmd(e)', 0, 'u'); 
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%Add PntAB 
model1=addReaction(model1, 'Add_PntAB', {'nadh[c]', 'nadp[c]', 'h[p]', 
'nad[c]', 'nadph[c]', 'h[c]'}, [-1 -1 -1 1 1 1], 1, 0, 1000); 
%other products 
model1=changeRxnBounds(model1,'EX_hxa(e)', 0, 'l'); 
model1=changeRxnBounds(model1,'EX_hxa(e)', 0, 'u'); 
%F6PA 
model1=changeRxnBounds(model1,'F6PA', -4, 'l'); 
%FBA3, PFK_3 
model1=changeRxnBounds(model1,'FBA3', 0, 'l'); 
model1=changeRxnBounds(model1,'FBA3', 0, 'u'); 
model1=changeRxnBounds(model1,'PFK_3', 0, 'l'); 
model1=changeRxnBounds(model1,'PFK_3', 0, 'u'); 
  
%% Remove natural Products (except succinate, which is essential in 
small amounts) 
model1=changeRxnBounds(model1,'EX_etoh(e)', 0, 'b'); 
model1=changeRxnBounds(model1,'EX_ac(e)', 0, 'b'); 
model1=changeRxnBounds(model1,'EX_lac-D(e)', 0, 'b'); 
model1=changeRxnBounds(model1,'EX_12ppd-R(e)', 0, 'b'); 
model1=changeRxnBounds(model1,'EX_12ppd-S(e)', 0, 'b'); 
model1=changeRxnBounds(model1,'EX_succ(e)', 2, 'u'); 
model1=changeRxnBounds(model1,'EX_acald(e)', 0, 'b'); 
model1=changeRxnBounds(model1,'EX_pyr(e)', 0, 'b'); 
  
model1=changeRxnBounds(model1,'EX_4abut(e)', 0, 'b'); 
model1=changeRxnBounds(model1,'EX_lipa_cold(e)', 0, 'b'); 
model1=changeRxnBounds(model1,'EX_lipa(e)', 0, 'b'); 
model1=changeRxnBounds(model1,'EX_lipoate(e)', 0, 'b'); 
model1=changeRxnBounds(model1,'EX_enlipa(e)', 0, 'b'); 
model1=changeRxnBounds(model1,'EX_akg(e)', 0, 'b'); 
model1=changeRxnBounds(model1,'EX_acser(e)', 0, 'b'); 
model1=changeRxnBounds(model1,'EX_pyr(e)', 0, 'b'); 
model1=changeRxnBounds(model1,'EX_pyr(e)', 0, 'b'); 
model1=changeRxnBounds(model1,'EX_pyr(e)', 0, 'b'); 
 
%% Chose Product 1 
%display('Chose product 1:etoh, 2:Propanol, 3:Propanol(PckA), 4:Butoh, 
5:Propionate, 6:Propionate(pckA), 7:lactate, 8:Succ'); 
%P1=input('9:succ(PckA), 10:12PDO(LAL), 11:12PDO(AC), 12:12PDO(Glyc), 
13:13PDO, 14:Acetate, 15:Acetone, 16:Acald, 17:pyr '); 
  
switch P1 
    case 1 
        model1=changeRxnBounds(model1,'EX_etoh(e)', 1000, 'u'); 
        strArray1(1) = java.lang.String('EX_etoh(e)'); 
    case 2 
         
        model1=addReaction(model1,'AddPropanal1','ppcoa[c] + h[c] + 
nadh[c] -> propanal[c] + nad[c] + coa[c]'); 
        model1=addReaction(model1,'AddPropanal2','12ppd-R[c] -> 
propanal[c] + h2o[c]');  
        model1=addReaction(model1,'AddPropanol','propanal[c] + h[c] + 
nadh[c] -> propanol[c] + nad[c]');  
        model1=addReaction(model1,'EX_Propanol','propanol[c] ->');         
        strArray1(1) = java.lang.String('EX_Propanol'); 
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    case 3 
        model1=addReaction(model1,'PPCK_r','adp[c] + co2[c] + pep[c] 
<=> atp[c] + oaa[c]'); 
        model1=changeRxnBounds(model1, 'PPCK', 0, 'u');         
        model1=addReaction(model1,'AddPropanal1','ppcoa[c] + h[c] + 
nadh[c] -> propanal[c] + nad[c] + coa[c]'); 
        model1=addReaction(model1,'AddPropanal2','12ppd-R[c] -> 
propanal[c] + h2o[c]');  
        model1=addReaction(model1,'AddPropanol','propanal[c] + h[c] + 
nadh[c] -> propanol[c] + nad[c]');  
        model1=addReaction(model1,'EX_Propanol','propanol[c] ->'); 
        strArray1(1) = java.lang.String('EX_Propanol'); 
    case 4 
        model1=addReaction(model1,'P_butanal_CoA',{'btcoa[c]', 
'nadh[c]', 'h[c]', 'butanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1,0,1000); 
        model1=addReaction(model1,'P_butanol',{'butanal[c]', 'nadh[c]', 
'h[c]', 'butanol[c]', 'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'EX_butanol',{'butanol[c]'},[-1],1, 
0,1000); 
        model1=changeRxnBounds(model1,'ACOAD1f', 0, 'l'); 
        model1=addReaction(model1,'ACOAD1f_nadh',{'btcoa[c]', 'nad[c]', 
'b2coa[c]', 'nadh[c]', 'h[c]'},[-1 -1 1 1 1],1,-1000,0); 
        strArray1(1) = java.lang.String('EX_butanol'); 
    case 5 
        model1=addReaction(model1,'TransPropionate','ppa[c] + h[c] -> 
ppa[p] + h[p]'); 
        strArray1(1) = java.lang.String('EX_ppa(e)'); 
    case 6 
        model1=addReaction(model1,'TransPropionate','ppa[c] + h[c] -> 
ppa[p] + h[p]'); 
        model1=addReaction(model1,'PPCK_r','adp[c] + co2[c] + pep[c] 
<=> atp[c] + oaa[c]'); 
        model1=changeRxnBounds(model1, 'PPCK', 0, 'u'); 
         
        strArray1(1) = java.lang.String('EX_ppa(e)'); 
    case 7 
        model1=changeRxnBounds(model1,'EX_lac-D(e)', 1000, 'u'); 
        strArray1(1) = java.lang.String('EX_lac-D(e)'); 
    case 8 
        model1=changeRxnBounds(model1,'EX_succ(e)', 1000, 'u'); 
         model1=changeRxnBounds(model1,'EX_co2(e)', -1000, 'l'); 
        strArray1(1) = java.lang.String('EX_succ(e)'); 
    case 9 
        model1=changeRxnBounds(model1,'EX_succ(e)', 1000, 'u'); 
        model1=addReaction(model1,'PPCK_r','adp[c] + co2[c] + pep[c] 
<=> atp[c] + oaa[c]'); 
        model1=changeRxnBounds(model1, 'PPCK', 0, 'u'); 
         model1=changeRxnBounds(model1,'EX_co2(e)', -1000, 'l'); 
        strArray1(1) = java.lang.String('EX_succ(e)'); 
    case 10 
        model1=changeRxnBounds(model1,'EX_12ppd-R(e)', 1000, 'u'); 
        model1=changeRxnBounds(model1,'ALR2', 0, 'b'); 
        strArray1(1) = java.lang.String('EX_12ppd-R(e)'); 
    case 11 
        model1=changeRxnBounds(model1,'EX_12ppd-R(e)', 1000, 'u'); 
        model1=changeRxnBounds(model1,'LALDO2x', 0, 'b'); 
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        strArray1(1) = java.lang.String('EX_12ppd-R(e)'); 
    case 12 
        model1=changeRxnBounds(model1,'EX_12ppd-R(e)', 1000, 'u'); 
        model1=addReaction(model1,'AddGlyctoLald','glyc[c] + h[c] -> 
lald-D[c] + h2o[c]'); 
        strArray1(1) = java.lang.String('EX_12ppd-R(e)'); 
    case 13 
        model1=addReaction(model1,'Add13PDO','glyc[c] + h[c] + nadph[c] 
-> 13PDO[c] + nadp[c] + h2o[c]'); 
        model1=addReaction(model1,'EX_13PDO','13PDO[c] ->'); 
        strArray1(1) = java.lang.String('EX_13PDO'); 
    case 14 
        model1=changeRxnBounds(model1,'EX_ac(e)', 1000, 'u'); 
        strArray1(1) = java.lang.String('EX_ac(e)'); 
    case 15 
        model1=addReaction(model1,'AddAcetone','h[c] + nadh[c] + 
glyc[c] -> acetone[c] + nad[c] + 2 h2o[c]'); 
        model1=addReaction(model1,'EX_Acetone','acetone[c] ->'); 
        strArray1(1) = java.lang.String('EX_Acetone'); 
    case 16 
        model1=changeRxnBounds(model1,'EX_acald(e)', 1000, 'u'); 
        strArray1(1) = java.lang.String('EX_acald(e)'); 
    case 17 
        model1=changeRxnBounds(model1,'EX_pyr(e)', 1000, 'u'); 
        strArray1(1) = java.lang.String('EX_pyr(e)'); 
         
end 
Product1=cell(strArray1(1)); 
  
%% Chose Product 2 
%display('Chose product 1:etoh, 2:Propanol, 3:Propanol(PckA), 4:Butoh, 
5:Propionate, 6:Propionate(pckA), 7:lactate, 8:Succ'); 
%P2=input('9:succ(PckA), 10:12PDO(LAL), 11:12PDO(AC), 12:12PDO(Glyc), 
13:13PDO, 14:Acetate, 15:Acetone '); 
  
switch P2 
    case 1 
        model1=changeRxnBounds(model1,'EX_etoh(e)', 1000, 'u'); 
        strArray2(1) = java.lang.String('EX_etoh(e)'); 
    case 2 
        model1=addReaction(model1,'AddPropanal1','ppcoa[c] + h[c] + 
nadh[c] -> propanal[c] + nad[c] + coa[c]'); 
        model1=addReaction(model1,'AddPropanal2','12ppd-R[c] -> 
propanal[c] + h2o[c]');  
        model1=addReaction(model1,'AddPropanol','propanal[c] + h[c] + 
nadh[c] -> propanol[c] + nad[c]');  
        model1=addReaction(model1,'EX_Propanol','propanol[c] ->');         
        strArray2(1) = java.lang.String('EX_Propanol'); 
    case 3 
        model1=addReaction(model1,'PPCK_r','adp[c] + co2[c] + pep[c] 
<=> atp[c] + oaa[c]'); 
        model1=changeRxnBounds(model1, 'PPCK', 0, 'u'); 
        model1=addReaction(model1,'AddPropanal1','ppcoa[c] + h[c] + 
nadh[c] -> propanal[c] + nad[c] + coa[c]'); 
        model1=addReaction(model1,'AddPropanal2','12ppd-R[c] -> 
propanal[c] + h2o[c]');  
278 
 
        model1=addReaction(model1,'AddPropanol','propanal[c] + h[c] + 
nadh[c] -> propanol[c] + nad[c]');  
        model1=addReaction(model1,'EX_Propanol','propanol[c] ->'); 
        strArray2(1) = java.lang.String('EX_Propanol'); 
    case 4 
        model1=addReaction(model1,'P_butanal_CoA',{'btcoa[c]', 
'nadh[c]', 'h[c]', 'butanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1,0,1000); 
        model1=addReaction(model1,'P_butanol',{'butanal[c]', 'nadh[c]', 
'h[c]', 'butanol[c]', 'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'EX_butanol',{'butanol[c]'},[-1],1, 
0,1000); 
        model1=changeRxnBounds(model1,'ACOAD1f', 0, 'l'); 
        model1=addReaction(model1,'ACOAD1f_nadh',{'btcoa[c]', 'nad[c]', 
'b2coa[c]', 'nadh[c]', 'h[c]'},[-1 -1 1 1 1],1,-1000,0); 
        strArray2(1) = java.lang.String('EX_butanol'); 
    case 5 
        model1=addReaction(model1,'TransPropionate','ppa[c] + h[c] -> 
ppa[p] + h[p]'); 
        strArray2(1) = java.lang.String('EX_ppa(e)'); 
    case 6 
        model1=addReaction(model1,'TransPropionate','ppa[c] + h[c] -> 
ppa[p] + h[p]'); 
        model1=addReaction(model1,'PPCK_r','adp[c] + co2[c] + pep[c] 
<=> atp[c] + oaa[c]'); 
        model1=changeRxnBounds(model1, 'PPCK', 0, 'u'); 
         
        strArray2(1) = java.lang.String('EX_ppa(e)'); 
    case 7 
        model1=changeRxnBounds(model1,'EX_lac-D(e)', 1000, 'u'); 
        strArray2(1) = java.lang.String('EX_lac-D(e)'); 
    case 8 
        model1=changeRxnBounds(model1,'EX_succ(e)', 1000, 'u'); 
         model1=changeRxnBounds(model1,'EX_co2(e)', -1000, 'l'); 
        strArray2(1) = java.lang.String('EX_succ(e)'); 
    case 9 
        model1=changeRxnBounds(model1,'EX_succ(e)', 1000, 'u'); 
        model1=addReaction(model1,'PPCK_r','adp[c] + co2[c] + pep[c] 
<=> atp[c] + oaa[c]'); 
        model1=changeRxnBounds(model1, 'PPCK', 0, 'u'); 
         model1=changeRxnBounds(model1,'EX_co2(e)', -1000, 'l'); 
        strArray2(1) = java.lang.String('EX_succ(e)'); 
    case 10 
        model1=changeRxnBounds(model1,'EX_12ppd-R(e)', 1000, 'u'); 
        model1=changeRxnBounds(model1,'ALR2', 0, 'b'); 
        strArray2(1) = java.lang.String('EX_12ppd-R(e)'); 
    case 11 
        model1=changeRxnBounds(model1,'EX_12ppd-R(e)', 1000, 'u'); 
        model1=changeRxnBounds(model1,'LALDO2x', 0, 'b'); 
        strArray2(1) = java.lang.String('EX_12ppd-R(e)'); 
    case 12 
        model1=changeRxnBounds(model1,'EX_12ppd-R(e)', 1000, 'u'); 
        model1=addReaction(model1,'AddGlyctoLald','glyc[c] + h[c] -> 
lald-D[c] + h2o[c]'); 
        strArray2(1) = java.lang.String('EX_12ppd-R(e)'); 
    case 13 
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        model1=addReaction(model1,'Add13PDO','glyc[c] + h[c] + nadph[c] 
-> 13PDO[c] + nadp[c] + h2o[c]'); 
        model1=addReaction(model1,'EX_13PDO','13PDO[c] ->'); 
        strArray2(1) = java.lang.String('EX_13PDO'); 
    case 14 
        model1=changeRxnBounds(model1,'EX_ac(e)', 1000, 'u'); 
        strArray2(1) = java.lang.String('EX_ac(e)'); 
    case 15 
        model1=addReaction(model1,'AddAcetone','h[c] + nadh[c] + 
glyc[c] -> acetone[c] + nad[c] + 2 h2o[c]'); 
        model1=addReaction(model1,'EX_Acetone','acetone[c] ->'); 
        strArray2(1) = java.lang.String('EX_Acetone'); 
    case 16 
        model1=changeRxnBounds(model1,'EX_acald(e)', 1000, 'u'); 
        strArray2(1) = java.lang.String('EX_acald(e)'); 
    case 17 
        model1=changeRxnBounds(model1,'EX_pyr(e)', 1000, 'u'); 
        strArray2(1) = java.lang.String('EX_pyr(e)'); 
         
end 
Product2=cell(strArray2(1)); 
  
A= size(model1.rxns); 
SizeModel=(A(1)); 
  
%% Optimal solution 
solution=optimizeCbModel(model1); 
if solution.stat == 1 
    Y(ll,mm)=solution.f; 
end 
    end 
end 
  
Y 
  
10.12 Matlab function for lcp-GEM 
AC_BiomassvsProduct_GlucoseiJO1366 
% Production of long chain productsin E. coli. 
% Evaluation of the reversal B-oxidation cycle, FA biosynthesis 
pathway,and the alpha-keto acids. 
% Model developed by Angela Cintolesi as part of her Doctoral Research 
% Chemical and Biomolecular Engineering, Rice University, March 2013  
% Return a matrix Y with the optimal cell growth of each product 
  
%% Use the updated model iJO1366 (2011) 
clear all 
global SizeModel 
initCobraToolbox() 
%changeCobraSolver('glpk'); 
%% Open model 
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K=input ('Choose pathway: (1)Reverse B-oxd; (2)FA biosynthesis; 
(3)alpha ketoacids for butanol and hexanol: '); 
        model1=readCbModel('iJO1366'); 
        biomassposition=8; 
        Biomass_name='Ec_biomass_iJO1366_core_53p95M'; 
        modelname='iJO1366'; 
        %no aa degradation 
        model1=changeRxnBounds(model1,{'DAAD', 'AST', 'SADH', 'SGSAD', 
'SGDS', 'ARGDC', 'ARGDCpp', 'ASPT', 'GLUN', 'P5CD', 'PROD2', 'SERD_L', 
'OBTFL', 'PPAKr', 'THRD', 'GLYAT', 'TYROXDApp', 'PEAMNOpp', 'TRPAS2', 
'CYSDS','42A12BOOXpp', 'THRAi'}, [0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0], 'u'); 
        model1=changeRxnBounds(model1,{'DAAD', 'AST', 'SADH', 'SGSAD', 
'SGDS', 'ARGDC', 'ARGDCpp', 'ASPT', 'GLUN', 'P5CD', 'PROD2', 'SERD_L', 
'OBTFL', 'PPAKr', 'THRD', 'GLYAT', 'TYROXDApp', 'PEAMNOpp', 'TRPAS2', 
'CYSDS','42A12BOOXpp', 'THRAi'}, [0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0], 'l'); 
        %no nucleotides degradation 
        model1=changeRxnBounds(model1,{'CYTD', 'DCYTD', 'DURIPP', 
'TMDPP', 'PPM2', 'DRPA', 'ADA', 'DADA', 'PUNP1', 'PUNP4', 'PUNP2', 
'PUNP3', 'PUNP5', 'PUNP6', 'PUNP7', 'PYNP2r'}, [0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0], 'u'); 
        model1=changeRxnBounds(model1,{'CYTD', 'DCYTD', 'DURIPP', 
'TMDPP', 'PPM2', 'DRPA', 'ADA', 'DADA', 'PUNP1', 'PUNP4', 'PUNP2', 
'PUNP3', 'PUNP5', 'PUNP6', 'PUNP7', 'PYNP2r'}, [0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0], 'l'); 
        % export aa (direct + non escential): 
        model1=changeRxnBounds(model1,{'EX_ala-B(e)', 'EX_ala-D(e)', 
'EX_ala-L(e)', 'EX_asn-L(e)', 'EX_asp-L(e)', 'EX_cys-D(e)', 'EX_cys-
L(e)', 'EX_glu-L(e)', 'EX_gln-L(e)', 'EX_gly(e)', 'EX_his-L(e)', 
'EX_ile-L(e)', 'EX_leu-L(e)', 'EX_lys-L(e)', 'EX_met-D(e)', 'EX_met-
L(e)', 'EX_phe-L(e)', 'EX_pro-L(e)', 'EX_ser-D(e)', 'EX_ser-
L(e)','EX_thr-L(e)', 'EX_trp-L(e)', 'EX_tyr-L(e)', 'EX_val-L(e)' }, [0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ], 'u'); 
        model1= changeRxnBounds(model1,{'EX_26dap-
M(e)','EX_frulys(e)','EX_hom-L(e)', 'EX_orn(e)'}, [0 0 0 0 ], 'u');  
        %no Fe2+ export. no H2S export 
        model1=changeRxnBounds(model1,'EX_fe2(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_h2s(e)', 0, 'u');         
        %no POR5 export. 
        model1=changeRxnBounds(model1,'POR5', 0, 'l'); 
        model1=changeRxnBounds(model1,'POR5', 0, 'u');         
        %Add PntAB 
        model1=addReaction(model1, 'Add_PntAB', {'nadh[c]', 'nadp[c]', 
'h[p]', 'nad[c]', 'nadph[c]', 'h[c]'}, [-1 -1 -1 1 1 1], 1, 0, 1000);         
        %FBA3, PFK_3 
        model1=changeRxnBounds(model1,'FBA3', 0, 'l'); 
        model1=changeRxnBounds(model1,'FBA3', 0, 'u'); 
        model1=changeRxnBounds(model1,'PFK_3', 0, 'l'); 
        model1=changeRxnBounds(model1,'PFK_3', 0, 'u');        
        %no production of 5mtr and spmd, for redox purposes 
        model1=changeRxnBounds(model1,'EX_5mtr(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_spmd(e)', 0, 'u'); 
  
%% Modify model according to specific scenarios 
switch K  
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    case 1 % Detailed reverse B-oxidation. Production of alcohols, 
alkanes and FA (from acyl-coa)  
         
        model1=changeRxnBounds(model1,'EX_o2(e)', 0, 'l'); 
        model1=changeRxnBounds(model1,'EX_glc(e)', -15, 'l');         
        %Delete by-products 
        model1=changeRxnBounds(model1,'EX_pyr(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_acald(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_hxa(e)', 0, 'u'); 
        %restrict fA biosynthesis. ACCOC 
        model1=changeRxnBounds(model1,'ACCOAC', 0.1, 'u');                 
        %ACOAD1f are inactive in this case. 
        model1=changeRxnBounds(model1,'ACOAD1f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD1f', 0, 'u'); 
        model1=changeRxnBounds(model1,'ACOAD2f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD2f', 0, 'u'); 
        model1=changeRxnBounds(model1,'ACOAD3f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD3f', 0, 'u'); 
        model1=changeRxnBounds(model1,'ACOAD4f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD4f', 0, 'u'); 
        model1=changeRxnBounds(model1,'ACOAD5f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD5f', 0, 'u'); 
        model1=changeRxnBounds(model1,'ACOAD6f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD6f', 0, 'u'); 
        model1=changeRxnBounds(model1,'ACOAD7f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD7f', 0, 'u'); 
        model1=changeRxnBounds(model1,'ACOAD8f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD8f', 0, 'u'); 
         
        % Ferredoxins / Reversal B-oxidation cycle 
        model1=addReaction(model1,'ACOAD1f_ferr',{'btcoa[c]', 'fd_oxi', 
'b2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,-1000,0); 
        model1=addReaction(model1,'ACOAD2f_ferr',{'fd_oxi', 'hxcoa[c]', 
'hx2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,-1000,0); 
        model1=addReaction(model1,'ACOAD3f_ferr',{'fd_oxi', 'occoa[c]', 
'oc2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,-1000,0); 
        model1=addReaction(model1,'ACOAD4f_ferr',{'dcacoa[c]', 
'fd_oxi', 'dc2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,-1000,0); 
        model1=addReaction(model1,'ACOAD5f_ferr',{'ddcacoa[c]', 
'fd_oxi', 'dd2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,-1000,0); 
        model1=addReaction(model1,'ACOAD6f_ferr',{'fd_oxi', 'tdcoa[c]', 
'td2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,-1000,0); 
        model1=addReaction(model1,'ACOAD7f_ferr',{'fd_oxi', 
'pmtcoa[c]', 'hdd2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,-1000,0); 
        model1=addReaction(model1,'ACOAD8f_ferr',{'fd_oxi', 'stcoa[c]', 
'od2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,-1000,0); 
        model1=addReaction(model1,'PFOR',{'coa[c]', 'fd_oxi', 'pyr[c]', 
'accoa[c]', 'co2[c]', 'fd_red', 'h[c]'},[-1 -1 -1 1 1 1 1],1,0,1000);         
         
        %acyl-ACP --> aldehyde (butanal, hexanal, octanal, ...) %set 
al.l to 
        %zero 
        model1=addReaction(model1,'P_butanal_ACP',{'butACP[c]', 
'nadh[c]', 'h[c]', 'butanal[c]', 'nad[c]', 'ACP[c]'},[-1 -1 -1 1 1 
1],1,0,0); 
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        model1=addReaction(model1,'P_hexanal_ACP',{'hexACP[c]', 
'nadh[c]', 'h[c]', 'hexanal[c]', 'nad[c]', 'ACP[c]'},[-1 -1 -1 1 1 
1],1,0,0); 
        model1=addReaction(model1,'P_octanal_ACP',{'ocACP[c]', 
'nadh[c]', 'h[c]', 'octanal[c]', 'nad[c]', 'ACP[c]'},[-1 -1 -1 1 1 
1],1,0,0); 
        model1=addReaction(model1,'P_decanal_ACP',{'dcaACP[c]', 
'nadh[c]', 'h[c]', 'decanal[c]', 'nad[c]', 'ACP[c]'},[-1 -1 -1 1 1 
1],1,0,0); 
        model1=addReaction(model1,'P_dodecanal_ACP',{'ddcaACP[c]', 
'nadh[c]', 'h[c]', 'dodecanal[c]', 'nad[c]', 'ACP[c]'},[-1 -1 -1 1 1 
1],1,0,0); 
        model1=addReaction(model1,'P_tetradecanal_ACP',{'myrsACP[c]', 
'nadh[c]', 'h[c]', 'tetradecanal[c]', 'nad[c]', 'ACP[c]'},[-1 -1 -1 1 1 
1],1,0,0); %myristoyl-ACP 
        model1=addReaction(model1,'P_hexadecanal_ACP',{'palmACP[c]', 
'nadh[c]', 'h[c]', 'hexadecanal[c]', 'nad[c]', 'ACP[c]'},[-1 -1 -1 1 1 
1],1,0,0);         
        model1=addReaction(model1,'P_octadecanal_ACP',{'ocdcaACP[c]', 
'nadh[c]', 'h[c]', 'octadecanal[c]', 'nad[c]', 'ACP[c]'},[-1 -1 -1 1 1 
1],1,0,0);         
         
        %Reduction of acyl-coa / acyl-CoA --> aldehyde (butanal, 
hexanal, octanal, ...) 
        model1=addReaction(model1,'P_butanal_CoA',{'btcoa[c]', 
'nadh[c]', 'h[c]', 'butanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1,0,1000); 
        model1=addReaction(model1,'P_hexanal_CoA',{'hxcoa[c]', 
'nadh[c]', 'h[c]', 'hexanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1,0,1000); 
        model1=addReaction(model1,'P_octanal_CoA',{'occoa[c]', 
'nadh[c]', 'h[c]', 'octanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1,0,1000); 
        model1=addReaction(model1,'P_decanal_CoA',{'dcacoa[c]', 
'nadh[c]', 'h[c]', 'decanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1,0,1000); 
        model1=addReaction(model1,'P_dodecanal_CoA',{'ddcacoa[c]', 
'nadh[c]', 'h[c]', 'dodecanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1,0,1000); 
        model1=addReaction(model1,'P_tetradecanal_CoA',{'tdcoa[c]', 
'nadh[c]', 'h[c]', 'tetradecanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1,0,1000); 
        model1=addReaction(model1,'P_hexadecanal_CoA',{'pmtcoa[c]', 
'nadh[c]', 'h[c]', 'hexadecanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1,0,1000);         
        model1=addReaction(model1,'P_octadecanal_CoA',{'stcoa[c]', 
'nadh[c]', 'h[c]', 'octadecanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1,0,1000); 
         
        %Aldehyde decarboxilation / Production of alkanes 
        model1=addReaction(model1,'P_propane',{'butanal[c]', 
'propane[c]', 'co[c]'},[-1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_pentane',{'hexanal[c]', 
'pentane[c]','co[c]'},[-1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_heptane',{'octanal[c]', 
'heptane[c]','co[c]'},[-1 1 1],1,0,1000); 
283 
 
        model1=addReaction(model1,'P_nonane',{'decanal[c]', 
'nonane[c]','co[c]'},[-1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_undecane',{'dodecanal[c]', 
'undecane[c]', 'co[c]'},[-1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_tridecane',{'tetradecanal[c]', 
'tridecane[c]','co[c]'},[-1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_pentadecane',{'hexadecanal[c]', 
'pentadecane[c]', 'co[c]'},[-1 1 1],1,0,1000);         
        model1=addReaction(model1,'P_heptadecane',{'octadecanal[c]', 
'heptadecane[c]','co[c]'},[-1 1 1],1,0,1000); 
         
        %Alcohol production 
        model1=addReaction(model1,'P_butanol',{'butanal[c]', 'nadh[c]', 
'h[c]', 'butanol[c]', 'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_hexanol',{'hexanal[c]', 'nadh[c]', 
'h[c]', 'hexanol[c]', 'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_octanol',{'octanal[c]', 'nadh[c]', 
'h[c]', 'octanol[c]', 'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_decanol',{'decanal[c]', 'nadh[c]', 
'h[c]', 'decanol[c]', 'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_dodecanol',{'dodecanal[c]', 
'nadh[c]', 'h[c]', 'dodecanol[c]', 'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_tetradecanol',{'tetradecanal[c]', 
'nadh[c]', 'h[c]', 'tetradecanol[c]', 'nad[c]'},[-1 -1 -1 1 
1],1,0,1000); 
        model1=addReaction(model1,'P_hexadecanol',{'hexadecanal[c]', 
'nadh[c]', 'h[c]', 'hexadecanol[c]', 'nad[c]'},[-1 -1 -1 1 
1],1,0,1000); 
        model1=addReaction(model1,'P_octadecanol',{'octadecanal[c]', 
'nadh[c]', 'h[c]', 'octadecanol[c]', 'nad[c]'},[-1 -1 -1 1 
1],1,0,1000); 
         
        %acyl-coa --> fatty acids  
        model1=addReaction(model1,'P_but_CoA',{'btcoa[c]', 'h2o[c]', 
'h[c]', 'but[c]', 'coa[c]'},[-1 -1 1 1 1],1,0,1000); 
        %The rest of these reactions are already in the model: 
FACOAE60-180 
         
        %acyl-ACP --> fatty acids  
        model1=addReaction(model1,'P_but_ACP',{'butACP[c]', 'h2o[c]', 
'h[c]', 'but[c]', 'ACP[c]'},[-1 -1 1 1 1],1,0,0); 
        model1=addReaction(model1,'P_hxa_ACP',{'hexACP[c]', 'h2o[c]', 
'h[c]', 'hxa[c]', 'ACP[c]'},[-1 -1 1 1 1],1,0,0); 
        %Other reactions are already in the model (ex: FA80ACPHi) 
        model1=addReaction(model1,'P_ocdca_ACP',{'ocdcaACP[c]', 
'h2o[c]', 'h[c]', 'ocdca[c]', 'ACP[c]'},[-1 -1 1 1 1],1,0,0); 
                 
        %transport reactions to export fatty acids. All for [c] to [e] 
        %Simplified process from [c] to [p], and from [p] to [e]. 
        %because the model did not have the proper transport accross 
membrane from [p] to [e] 
        model1=addReaction(model1,'P_octa_trans',{'octa[c]', 'octa[e]', 
'h[c]', 'h[p]'},[-1 1 -1 1],1,0,1000); 
        model1=addReaction(model1,'P_dca_trans',{'dca[c]', 'dca[e]', 
'h[c]', 'h[p]'},[-1 1 -1 1],1,0,1000); 
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        model1=addReaction(model1,'P_ddca_trans',{'ddca[c]', 'ddca[e]', 
'h[c]', 'h[p]'},[-1 1 -1 1],1,0,1000); 
        model1=addReaction(model1,'P_ttdca_trans',{'ttdca[c]', 
'ttdca[e]', 'h[c]', 'h[p]'},[-1 1 -1 1],1,0,1000); 
        model1=addReaction(model1,'P_hdca_trans',{'hdca[c]', 'hdca[e]', 
'h[c]', 'h[p]'},[-1 1 -1 1],1,0,1000); 
        model1=addReaction(model1,'P_ocdca_trans_extra',{'ocdca[c]', 
'ocdca[e]', 'h[c]', 'h[p]'},[-1 1 -1 1],1,0,1000);  
       
        %Set export of existing products to zero 
        model1=changeRxnBounds(model1,'EX_but(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_hxa(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_octa(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_dca(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_ddca(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_ttdca(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_hdca(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_ocdca(e)', 0, 'u'); 
                 
        % Set export of new products to zero 
        model1=addReaction(model1,'EX_butanol',{'butanol[c]'},[-1],1, 
0,0); 
        model1=addReaction(model1,'EX_hexanol',{'hexanol[c]'},[-1],1, 
0,0); 
        model1=addReaction(model1,'EX_octanol',{'octanol[c]'},[-1 
],1,0,0); 
        model1=addReaction(model1,'EX_decanol',{'decanol[c]'},[-1],1, 
0,0); 
        model1=addReaction(model1,'EX_dodecanol',{'dodecanol[c]'},[-1 
],1,0,0); 
        
model1=addReaction(model1,'EX_tetradecanol',{'tetradecanol[c]'},[-1],1, 
0,0); 
        
model1=addReaction(model1,'EX_hexadecanol',{'hexadecanol[c]'},[-1 
],1,0,0); 
        
model1=addReaction(model1,'EX_octadecanol',{'octadecanol[c]'},[-1],1, 
0,0); 
         
        model1=addReaction(model1,'EX_propane',{'propane[c]'},[-1],1, 
0,0); 
        model1=addReaction(model1,'EX_pentane',{'pentane[c]'},[-1],1, 
0,0); 
        model1=addReaction(model1,'EX_heptane',{'heptane[c]'},[-1 
],1,0,0); 
        model1=addReaction(model1,'EX_nonane',{'nonane[c]'},[-1],1, 
0,0); 
        model1=addReaction(model1,'EX_undecane',{'undecane[c]'},[-1 
],1,0,0); 
        model1=addReaction(model1,'EX_tridecane',{'tridecane[c]'},[-
1],1, 0,0); 
        
model1=addReaction(model1,'EX_pentadecane',{'pentadecane[c]'},[-1 
],1,0,0); 
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model1=addReaction(model1,'EX_heptadecane',{'heptadecane[c]'},[-1],1, 
0,0); 
                
        model1=addReaction(model1,'EX_co',{'co[c]'},[-1 ],1,0,1000); 
         
    case 2 % (NO reverse B-oxidation). Production of alcohols, alkanes 
and FA (from acyl-ACP)          
        model1=changeRxnBounds(model1,'EX_o2(e)', 0, 'l'); 
        model1=changeRxnBounds(model1,'EX_glc(e)', -15, 'l');         
        %Delete by-products 
        model1=changeRxnBounds(model1,'EX_pyr(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_acald(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_hxa(e)', 0, 'u');                 
        %ACOAD1f are inactive in this case. 
        model1=changeRxnBounds(model1,'ACOAD1f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD1f', 0, 'u'); 
        model1=changeRxnBounds(model1,'ACOAD2f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD2f', 0, 'u'); 
        model1=changeRxnBounds(model1,'ACOAD3f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD3f', 0, 'u'); 
        model1=changeRxnBounds(model1,'ACOAD4f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD4f', 0, 'u'); 
        model1=changeRxnBounds(model1,'ACOAD5f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD5f', 0, 'u'); 
        model1=changeRxnBounds(model1,'ACOAD6f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD6f', 0, 'u'); 
        model1=changeRxnBounds(model1,'ACOAD7f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD7f', 0, 'u'); 
        model1=changeRxnBounds(model1,'ACOAD8f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD8f', 0, 'u'); 
         
        % Ferredoxins / Reversal B-oxidation cycle / inactive in this 
case 
        model1=addReaction(model1,'ACOAD1f_ferr',{'btcoa[c]', 'fd_oxi', 
'b2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,0,0); 
        model1=addReaction(model1,'ACOAD2f_ferr',{'fd_oxi', 'hxcoa[c]', 
'hx2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,0,0); 
        model1=addReaction(model1,'ACOAD3f_ferr',{'fd_oxi', 'occoa[c]', 
'oc2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,0,0); 
        model1=addReaction(model1,'ACOAD4f_ferr',{'dcacoa[c]', 
'fd_oxi', 'dc2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,0,0); 
        model1=addReaction(model1,'ACOAD5f_ferr',{'ddcacoa[c]', 
'fd_oxi', 'dd2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,0,0); 
        model1=addReaction(model1,'ACOAD6f_ferr',{'fd_oxi', 'tdcoa[c]', 
'td2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,0,0); 
        model1=addReaction(model1,'ACOAD7f_ferr',{'fd_oxi', 
'pmtcoa[c]', 'hdd2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,0,0); 
        model1=addReaction(model1,'ACOAD8f_ferr',{'fd_oxi', 'stcoa[c]', 
'od2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,0,0); 
        model1=addReaction(model1,'PFOR',{'coa[c]', 'fd_oxi', 'pyr[c]', 
'accoa[c]', 'co2[c]', 'fd_red', 'h[c]'},[-1 -1 -1 1 1 1 1],1,0,0);         
         
        %acyl-ACP --> aldehyde (butanal, hexanal, octanal, ...) %set 
al.l to 
        %zero 
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        model1=addReaction(model1,'P_butanal_ACP',{'butACP[c]', 
'nadh[c]', 'h[c]', 'butanal[c]', 'nad[c]', 'ACP[c]'},[-1 -1 -1 1 1 
1],1,0,1000); 
        model1=addReaction(model1,'P_hexanal_ACP',{'hexACP[c]', 
'nadh[c]', 'h[c]', 'hexanal[c]', 'nad[c]', 'ACP[c]'},[-1 -1 -1 1 1 
1],1,0,1000); 
        model1=addReaction(model1,'P_octanal_ACP',{'ocACP[c]', 
'nadh[c]', 'h[c]', 'octanal[c]', 'nad[c]', 'ACP[c]'},[-1 -1 -1 1 1 
1],1,0,1000); 
        model1=addReaction(model1,'P_decanal_ACP',{'dcaACP[c]', 
'nadh[c]', 'h[c]', 'decanal[c]', 'nad[c]', 'ACP[c]'},[-1 -1 -1 1 1 
1],1,0,1000); 
        model1=addReaction(model1,'P_dodecanal_ACP',{'ddcaACP[c]', 
'nadh[c]', 'h[c]', 'dodecanal[c]', 'nad[c]', 'ACP[c]'},[-1 -1 -1 1 1 
1],1,0,1000); 
        model1=addReaction(model1,'P_tetradecanal_ACP',{'myrsACP[c]', 
'nadh[c]', 'h[c]', 'tetradecanal[c]', 'nad[c]', 'ACP[c]'},[-1 -1 -1 1 1 
1],1,0,1000); %myristoyl-ACP 
        model1=addReaction(model1,'P_hexadecanal_ACP',{'palmACP[c]', 
'nadh[c]', 'h[c]', 'hexadecanal[c]', 'nad[c]', 'ACP[c]'},[-1 -1 -1 1 1 
1],1,0,1000);         
        model1=addReaction(model1,'P_octadecanal_ACP',{'ocdcaACP[c]', 
'nadh[c]', 'h[c]', 'octadecanal[c]', 'nad[c]', 'ACP[c]'},[-1 -1 -1 1 1 
1],1,0,1000);         
         
        %Reduction of acyl-coa / acyl-CoA --> aldehyde (butanal, 
hexanal, octanal, ...) 
        model1=addReaction(model1,'P_butanal_CoA',{'btcoa[c]', 
'nadh[c]', 'h[c]', 'butanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1,0,0); 
        model1=addReaction(model1,'P_hexanal_CoA',{'hxcoa[c]', 
'nadh[c]', 'h[c]', 'hexanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1,0,0); 
        model1=addReaction(model1,'P_octanal_CoA',{'occoa[c]', 
'nadh[c]', 'h[c]', 'octanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1,0,0); 
        model1=addReaction(model1,'P_decanal_CoA',{'dcacoa[c]', 
'nadh[c]', 'h[c]', 'decanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1,0,0); 
        model1=addReaction(model1,'P_dodecanal_CoA',{'ddcacoa[c]', 
'nadh[c]', 'h[c]', 'dodecanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1,0,0); 
        model1=addReaction(model1,'P_tetradecanal_CoA',{'tdcoa[c]', 
'nadh[c]', 'h[c]', 'tetradecanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1,0,0); 
        model1=addReaction(model1,'P_hexadecanal_CoA',{'pmtcoa[c]', 
'nadh[c]', 'h[c]', 'hexadecanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1,0,0);         
        model1=addReaction(model1,'P_octadecanal_CoA',{'stcoa[c]', 
'nadh[c]', 'h[c]', 'octadecanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1,0,0); 
         
        %Aldehyde decarboxilation / Production of alkanes 
        model1=addReaction(model1,'P_propane',{'butanal[c]', 
'propane[c]', 'co[c]'},[-1 1 1],1,0,1000); 
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        model1=addReaction(model1,'P_pentane',{'hexanal[c]', 
'pentane[c]','co[c]'},[-1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_heptane',{'octanal[c]', 
'heptane[c]','co[c]'},[-1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_nonane',{'decanal[c]', 
'nonane[c]','co[c]'},[-1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_undecane',{'dodecanal[c]', 
'undecane[c]', 'co[c]'},[-1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_tridecane',{'tetradecanal[c]', 
'tridecane[c]','co[c]'},[-1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_pentadecane',{'hexadecanal[c]', 
'pentadecane[c]', 'co[c]'},[-1 1 1],1,0,1000);         
        model1=addReaction(model1,'P_heptadecane',{'octadecanal[c]', 
'heptadecane[c]','co[c]'},[-1 1 1],1,0,1000); 
         
        %Alcohol production 
        model1=addReaction(model1,'P_butanol',{'butanal[c]', 'nadh[c]', 
'h[c]', 'butanol[c]', 'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_hexanol',{'hexanal[c]', 'nadh[c]', 
'h[c]', 'hexanol[c]', 'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_octanol',{'octanal[c]', 'nadh[c]', 
'h[c]', 'octanol[c]', 'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_decanol',{'decanal[c]', 'nadh[c]', 
'h[c]', 'decanol[c]', 'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_dodecanol',{'dodecanal[c]', 
'nadh[c]', 'h[c]', 'dodecanol[c]', 'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_tetradecanol',{'tetradecanal[c]', 
'nadh[c]', 'h[c]', 'tetradecanol[c]', 'nad[c]'},[-1 -1 -1 1 
1],1,0,1000); 
        model1=addReaction(model1,'P_hexadecanol',{'hexadecanal[c]', 
'nadh[c]', 'h[c]', 'hexadecanol[c]', 'nad[c]'},[-1 -1 -1 1 
1],1,0,1000); 
        model1=addReaction(model1,'P_octadecanol',{'octadecanal[c]', 
'nadh[c]', 'h[c]', 'octadecanol[c]', 'nad[c]'},[-1 -1 -1 1 
1],1,0,1000); 
                 
        %acyl-coa --> fatty acids  
        model1=addReaction(model1,'P_but_CoA',{'btcoa[c]', 'h2o[c]', 
'h[c]', 'but[c]', 'coa[c]'},[-1 -1 1 1 1],1,0,1000); 
        %The rest are already in the model: FACOAE60-180 
         
        %acyl-ACP --> fatty acids  
        model1=addReaction(model1,'P_but_ACP',{'butACP[c]', 'h2o[c]', 
'h[c]', 'but[c]', 'ACP[c]'},[-1 -1 1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_hxa_ACP',{'hexACP[c]', 'h2o[c]', 
'h[c]', 'hxa[c]', 'ACP[c]'},[-1 -1 1 1 1],1,0,1000); 
        %Other reactions are already in the model (ex: FA80ACPHi) 
        model1=addReaction(model1,'P_ocdca_ACP',{'ocdcaACP[c]', 
'h2o[c]', 'h[c]', 'ocdca[c]', 'ACP[c]'},[-1 -1 1 1 1],1,0,1000); 
         
        %transport reactions to export fatty acids. All for [c] to [e] 
        %because the model did not have the proper transport accross 
membrane form [p] to [e] 
        model1=addReaction(model1,'P_octa_trans',{'octa[c]', 'octa[e]', 
'h[c]', 'h[p]'},[-1 1 -1 1],1,0,1000); 
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        model1=addReaction(model1,'P_dca_trans',{'dca[c]', 'dca[e]', 
'h[c]', 'h[p]'},[-1 1 -1 1],1,0,1000); 
        model1=addReaction(model1,'P_ddca_trans',{'ddca[c]', 'ddca[e]', 
'h[c]', 'h[p]'},[-1 1 -1 1],1,0,1000); 
        model1=addReaction(model1,'P_ttdca_trans',{'ttdca[c]', 
'ttdca[e]', 'h[c]', 'h[p]'},[-1 1 -1 1],1,0,1000); 
        model1=addReaction(model1,'P_hdca_trans',{'hdca[c]', 'hdca[e]', 
'h[c]', 'h[p]'},[-1 1 -1 1],1,0,1000); 
        model1=addReaction(model1,'P_ocdca_trans_extra',{'ocdca[c]', 
'ocdca[e]', 'h[c]', 'h[p]'},[-1 1 -1 1],1,0,1000);  
       
        %Export of existing products to zero 
        model1=changeRxnBounds(model1,'EX_but(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_hxa(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_octa(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_dca(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_ddca(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_ttdca(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_hdca(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_ocdca(e)', 0, 'u'); 
         
        % Export of new products to zero 
        model1=addReaction(model1,'EX_butanol',{'butanol[c]'},[-1],1, 
0,0); 
        model1=addReaction(model1,'EX_hexanol',{'hexanol[c]'},[-1],1, 
0,0); 
        model1=addReaction(model1,'EX_octanol',{'octanol[c]'},[-1 
],1,0,0); 
        model1=addReaction(model1,'EX_decanol',{'decanol[c]'},[-1],1, 
0,0); 
        model1=addReaction(model1,'EX_dodecanol',{'dodecanol[c]'},[-1 
],1,0,0); 
        
model1=addReaction(model1,'EX_tetradecanol',{'tetradecanol[c]'},[-1],1, 
0,0); 
        
model1=addReaction(model1,'EX_hexadecanol',{'hexadecanol[c]'},[-1 
],1,0,0); 
        
model1=addReaction(model1,'EX_octadecanol',{'octadecanol[c]'},[-1],1, 
0,0); 
         
        model1=addReaction(model1,'EX_propane',{'propane[c]'},[-1],1, 
0,0); 
        model1=addReaction(model1,'EX_pentane',{'pentane[c]'},[-1],1, 
0,0); 
        model1=addReaction(model1,'EX_heptane',{'heptane[c]'},[-1 
],1,0,0); 
        model1=addReaction(model1,'EX_nonane',{'nonane[c]'},[-1],1, 
0,0); 
        model1=addReaction(model1,'EX_undecane',{'undecane[c]'},[-1 
],1,0,0); 
        model1=addReaction(model1,'EX_tridecane',{'tridecane[c]'},[-
1],1, 0,0); 
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model1=addReaction(model1,'EX_pentadecane',{'pentadecane[c]'},[-1 
],1,0,0); 
        
model1=addReaction(model1,'EX_heptadecane',{'heptadecane[c]'},[-1],1, 
0,0); 
                
        model1=addReaction(model1,'EX_co',{'co[c]'},[-1 ],1,0,1000); 
        
             
    case 3 % (NO reverse B-oxidation). Production of butanol and 
hexanol suing alpha elongation pathway  
         
        model1=changeRxnBounds(model1,'EX_o2(e)', 0, 'l'); 
        model1=changeRxnBounds(model1,'EX_glc(e)', -15, 'l'); 
        %Delete by-products 
        model1=changeRxnBounds(model1,'EX_pyr(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_acald(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_hxa(e)', 0, 'u'); 
  
        %ACOAD1f are inactive in this case. 
        model1=changeRxnBounds(model1,'ACOAD1f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD1f', 0, 'u'); 
        model1=changeRxnBounds(model1,'ACOAD2f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD2f', 0, 'u'); 
        model1=changeRxnBounds(model1,'ACOAD3f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD3f', 0, 'u'); 
        model1=changeRxnBounds(model1,'ACOAD4f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD4f', 0, 'u'); 
        model1=changeRxnBounds(model1,'ACOAD5f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD5f', 0, 'u'); 
        model1=changeRxnBounds(model1,'ACOAD6f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD6f', 0, 'u'); 
        model1=changeRxnBounds(model1,'ACOAD7f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD7f', 0, 'u'); 
        model1=changeRxnBounds(model1,'ACOAD8f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD8f', 0, 'u'); 
         
        % Ferredoxins / Reversal B-oxidation cycle / inactive in this 
case 
        model1=addReaction(model1,'ACOAD1f_ferr',{'btcoa[c]', 'fd_oxi', 
'b2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,0,0); 
        model1=addReaction(model1,'ACOAD2f_ferr',{'fd_oxi', 'hxcoa[c]', 
'hx2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,0,0); 
        model1=addReaction(model1,'ACOAD3f_ferr',{'fd_oxi', 'occoa[c]', 
'oc2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,0,0); 
        model1=addReaction(model1,'ACOAD4f_ferr',{'dcacoa[c]', 
'fd_oxi', 'dc2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,0,0); 
        model1=addReaction(model1,'ACOAD5f_ferr',{'ddcacoa[c]', 
'fd_oxi', 'dd2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,0,0); 
        model1=addReaction(model1,'ACOAD6f_ferr',{'fd_oxi', 'tdcoa[c]', 
'td2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,0,0); 
        model1=addReaction(model1,'ACOAD7f_ferr',{'fd_oxi', 
'pmtcoa[c]', 'hdd2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,0,0); 
        model1=addReaction(model1,'ACOAD8f_ferr',{'fd_oxi', 'stcoa[c]', 
'od2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,0,0); 
290 
 
        model1=addReaction(model1,'PFOR',{'coa[c]', 'fd_oxi', 'pyr[c]', 
'accoa[c]', 'co2[c]', 'fd_red', 'h[c]'},[-1 -1 -1 1 1 1 1],1,0,0);         
         
        %acyl-ACP --> aldehyde (butanal, hexanal, octanal, ...) %set 
al.l to 
        %zero 
        model1=addReaction(model1,'P_butanal_ACP',{'butACP[c]', 
'nadh[c]', 'h[c]', 'butanal[c]', 'nad[c]', 'ACP[c]'},[-1 -1 -1 1 1 
1],1,0,0); 
        model1=addReaction(model1,'P_hexanal_ACP',{'hexACP[c]', 
'nadh[c]', 'h[c]', 'hexanal[c]', 'nad[c]', 'ACP[c]'},[-1 -1 -1 1 1 
1],1,0,0); 
        model1=addReaction(model1,'P_octanal_ACP',{'ocACP[c]', 
'nadh[c]', 'h[c]', 'octanal[c]', 'nad[c]', 'ACP[c]'},[-1 -1 -1 1 1 
1],1,0,0); 
        model1=addReaction(model1,'P_decanal_ACP',{'dcaACP[c]', 
'nadh[c]', 'h[c]', 'decanal[c]', 'nad[c]', 'ACP[c]'},[-1 -1 -1 1 1 
1],1,0,0); 
        model1=addReaction(model1,'P_dodecanal_ACP',{'ddcaACP[c]', 
'nadh[c]', 'h[c]', 'dodecanal[c]', 'nad[c]', 'ACP[c]'},[-1 -1 -1 1 1 
1],1,0,0); 
        model1=addReaction(model1,'P_tetradecanal_ACP',{'myrsACP[c]', 
'nadh[c]', 'h[c]', 'tetradecanal[c]', 'nad[c]', 'ACP[c]'},[-1 -1 -1 1 1 
1],1,0,0); %myristoyl-ACP 
        model1=addReaction(model1,'P_hexadecanal_ACP',{'palmACP[c]', 
'nadh[c]', 'h[c]', 'hexadecanal[c]', 'nad[c]', 'ACP[c]'},[-1 -1 -1 1 1 
1],1,0,0);         
        model1=addReaction(model1,'P_octadecanal_ACP',{'ocdcaACP[c]', 
'nadh[c]', 'h[c]', 'octadecanal[c]', 'nad[c]', 'ACP[c]'},[-1 -1 -1 1 1 
1],1,0,0);         
         
        %Reduction of acyl-coa / acyl-CoA --> aldehyde (butanal, 
hexanal, octanal, ...) 
        model1=addReaction(model1,'P_butanal_CoA',{'btcoa[c]', 
'nadh[c]', 'h[c]', 'butanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1,0,0); 
        model1=addReaction(model1,'P_hexanal_CoA',{'hxcoa[c]', 
'nadh[c]', 'h[c]', 'hexanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1,0,0); 
        model1=addReaction(model1,'P_octanal_CoA',{'occoa[c]', 
'nadh[c]', 'h[c]', 'octanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1,0,0); 
        model1=addReaction(model1,'P_decanal_CoA',{'dcacoa[c]', 
'nadh[c]', 'h[c]', 'decanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1,0,0); 
        model1=addReaction(model1,'P_dodecanal_CoA',{'ddcacoa[c]', 
'nadh[c]', 'h[c]', 'dodecanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1,0,0); 
        model1=addReaction(model1,'P_tetradecanal_CoA',{'tdcoa[c]', 
'nadh[c]', 'h[c]', 'tetradecanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1,0,0); 
        model1=addReaction(model1,'P_hexadecanal_CoA',{'pmtcoa[c]', 
'nadh[c]', 'h[c]', 'hexadecanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1,0,0);         
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        model1=addReaction(model1,'P_octadecanal_CoA',{'stcoa[c]', 
'nadh[c]', 'h[c]', 'octadecanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1,0,0); 
         
        %Aldehyde decarboxilation / Production of alkanes 
        model1=addReaction(model1,'P_propane',{'butanal[c]', 
'propane[c]', 'co[c]'},[-1 1 1],1,0,0); 
        model1=addReaction(model1,'P_pentane',{'hexanal[c]', 
'pentane[c]','co[c]'},[-1 1 1],1,0,0); 
        model1=addReaction(model1,'P_heptane',{'octanal[c]', 
'heptane[c]','co[c]'},[-1 1 1],1,0,0); 
        model1=addReaction(model1,'P_nonane',{'decanal[c]', 
'nonane[c]','co[c]'},[-1 1 1],1,0,0); 
        model1=addReaction(model1,'P_undecane',{'dodecanal[c]', 
'undecane[c]', 'co[c]'},[-1 1 1],1,0,0); 
        model1=addReaction(model1,'P_tridecane',{'tetradecanal[c]', 
'tridecane[c]','co[c]'},[-1 1 1],1,0,0); 
        model1=addReaction(model1,'P_pentadecane',{'hexadecanal[c]', 
'pentadecane[c]', 'co[c]'},[-1 1 1],1,0,0);         
        model1=addReaction(model1,'P_heptadecane',{'octadecanal[c]', 
'heptadecane[c]','co[c]'},[-1 1 1],1,0,0); 
         
        %Alcohol production 
        model1=addReaction(model1,'P_butanol',{'butanal[c]', 'nadh[c]', 
'h[c]', 'butanol[c]', 'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_hexanol',{'hexanal[c]', 'nadh[c]', 
'h[c]', 'hexanol[c]', 'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_octanol',{'octanal[c]', 'nadh[c]', 
'h[c]', 'octanol[c]', 'nad[c]'},[-1 -1 -1 1 1],1,0,0); 
        model1=addReaction(model1,'P_decanol',{'decanal[c]', 'nadh[c]', 
'h[c]', 'decanol[c]', 'nad[c]'},[-1 -1 -1 1 1],1,0,0); 
        model1=addReaction(model1,'P_dodecanol',{'dodecanal[c]', 
'nadh[c]', 'h[c]', 'dodecanol[c]', 'nad[c]'},[-1 -1 -1 1 1],1,0,0); 
        model1=addReaction(model1,'P_tetradecanol',{'tetradecanal[c]', 
'nadh[c]', 'h[c]', 'tetradecanol[c]', 'nad[c]'},[-1 -1 -1 1 1],1,0,0); 
        model1=addReaction(model1,'P_hexadecanol',{'hexadecanal[c]', 
'nadh[c]', 'h[c]', 'hexadecanol[c]', 'nad[c]'},[-1 -1 -1 1 1],1,0,0); 
        model1=addReaction(model1,'P_octadecanol',{'octadecanal[c]', 
'nadh[c]', 'h[c]', 'octadecanol[c]', 'nad[c]'},[-1 -1 -1 1 1],1,0,0); 
         
         
        %acyl-coa --> fatty acids  
        model1=addReaction(model1,'P_but_CoA',{'btcoa[c]', 'h2o[c]', 
'h[c]', 'but[c]', 'coa[c]'},[-1 -1 1 1 1],1,0,0); 
        %The rest are already in the model: FACOAE60-180 
         
        %acyl-ACP --> fatty acids  
        model1=addReaction(model1,'P_but_ACP',{'butACP[c]', 'h2o[c]', 
'h[c]', 'but[c]', 'ACP[c]'},[-1 -1 1 1 1],1,0,0); 
        model1=addReaction(model1,'P_hxa_ACP',{'hexACP[c]', 'h2o[c]', 
'h[c]', 'hxa[c]', 'ACP[c]'},[-1 -1 1 1 1],1,0,0); 
        %Other reactions are already in the model (ex: FA80ACPHi) 
        model1=addReaction(model1,'P_ocdca_ACP',{'ocdcaACP[c]', 
'h2o[c]', 'h[c]', 'ocdca[c]', 'ACP[c]'},[-1 -1 1 1 1],1,0,0); 
         
        %transport reactions to export fatty acids. All for [c] to [e] 
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        %because the model did not have the proper transport accross 
membrane form [p] to [e] 
        model1=addReaction(model1,'P_octa_trans',{'octa[c]', 'octa[e]', 
'h[c]', 'h[p]'},[-1 1 -1 1],1,0,0); 
        model1=addReaction(model1,'P_dca_trans',{'dca[c]', 'dca[e]', 
'h[c]', 'h[p]'},[-1 1 -1 1],1,0,0); 
        model1=addReaction(model1,'P_ddca_trans',{'ddca[c]', 'ddca[e]', 
'h[c]', 'h[p]'},[-1 1 -1 1],1,0,0); 
        model1=addReaction(model1,'P_ttdca_trans',{'ttdca[c]', 
'ttdca[e]', 'h[c]', 'h[p]'},[-1 1 -1 1],1,0,0); 
        model1=addReaction(model1,'P_hdca_trans',{'hdca[c]', 'hdca[e]', 
'h[c]', 'h[p]'},[-1 1 -1 1],1,0,0); 
        model1=addReaction(model1,'P_ocdca_trans_extra',{'ocdca[c]', 
'ocdca[e]', 'h[c]', 'h[p]'},[-1 1 -1 1],1,0,0);  
       
        %Export of existing products to zero 
        model1=changeRxnBounds(model1,'EX_but(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_hxa(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_octa(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_dca(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_ddca(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_ttdca(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_hdca(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_ocdca(e)', 0, 'u'); 
         
        % Export of new products to zero 
        model1=addReaction(model1,'EX_butanol',{'butanol[c]'},[-1],1, 
0,0); 
        model1=addReaction(model1,'EX_hexanol',{'hexanol[c]'},[-1],1, 
0,0); 
        model1=addReaction(model1,'EX_octanol',{'octanol[c]'},[-1 
],1,0,0); 
        model1=addReaction(model1,'EX_decanol',{'decanol[c]'},[-1],1, 
0,0); 
        model1=addReaction(model1,'EX_dodecanol',{'dodecanol[c]'},[-1 
],1,0,0); 
        
model1=addReaction(model1,'EX_tetradecanol',{'tetradecanol[c]'},[-1],1, 
0,0); 
        
model1=addReaction(model1,'EX_hexadecanol',{'hexadecanol[c]'},[-1 
],1,0,0); 
        
model1=addReaction(model1,'EX_octadecanol',{'octadecanol[c]'},[-1],1, 
0,0); 
         
        model1=addReaction(model1,'EX_propane',{'propane[c]'},[-1],1, 
0,0); 
        model1=addReaction(model1,'EX_pentane',{'pentane[c]'},[-1],1, 
0,0); 
        model1=addReaction(model1,'EX_heptane',{'heptane[c]'},[-1 
],1,0,0); 
        model1=addReaction(model1,'EX_nonane',{'nonane[c]'},[-1],1, 
0,0); 
        model1=addReaction(model1,'EX_undecane',{'undecane[c]'},[-1 
],1,0,0); 
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        model1=addReaction(model1,'EX_tridecane',{'tridecane[c]'},[-
1],1, 0,0); 
        
model1=addReaction(model1,'EX_pentadecane',{'pentadecane[c]'},[-1 
],1,0,0); 
        
model1=addReaction(model1,'EX_heptadecane',{'heptadecane[c]'},[-1],1, 
0,0); 
                
        model1=addReaction(model1,'EX_co',{'co[c]'},[-1 ],1,0,1000); 
         
        %add reactions fo butanol and hexanol, using alpha-ketoacid 
        %elongation 
        model1=addReaction(model1,'P_leuA1',{'2obut[c]', 'accoa[c]', 
'h2o[c]', '2ethylmalate', 'coa[c]'},[-1 -1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_leuCD1',{'2ethylmalate', 
'3ethylmalate'},[-1 1],1,0,1000); 
        model1=addReaction(model1,'P_3ethylmalate',{'3ethylmalate', 
'nad[c]', '2ketovalerate', 'nadh[c]', 'co2[c]'},[-1 -1 1 1 
1],1,0,1000); 
        model1=addReaction(model1,'P_2ketovalerate',{'2ketovalerate', 
'butanal[c]', 'co2[c]'},[-1 1 1],1,0,1000); 
  
        model1=addReaction(model1,'P_leuA2',{'2ketovalerate', 
'accoa[c]', 'h2o[c]', '2propylmalate', 'coa[c]'},[-1 -1 -1 1 
1],1,0,1000); 
        model1=addReaction(model1,'P_leuCD2',{'2propylmalate', 
'3propylmalate'},[-1 1],1,0,1000); 
        model1=addReaction(model1,'P_3propylmalate',{'3propylmalate', 
'nad[c]', '2ketocaproate', 'nadh[c]', 'co2[c]'},[-1 -1 1 1 
1],1,0,1000); 
 %       model1=addReaction(model1,'P_2ketocaproate',{'2ketocaproate', 
'pentanal[c]', 'co2[c]'},[-1 1 1],1,0,1000); 
         
        model1=addReaction(model1,'P_leuA3',{'2ketocaproate', 
'accoa[c]', 'h2o[c]', '2butylmalate', 'coa[c]'},[-1 -1 -1 1 
1],1,0,1000); 
        model1=addReaction(model1,'P_leuCD3',{'2butylmalate', 
'3butylmalate'},[-1 1],1,0,1000); 
        model1=addReaction(model1,'P_3butylmalate',{'3butylmalate', 
'nad[c]', '2ketoheptanoate', 'nadh[c]', 'co2[c]'},[-1 -1 1 1 
1],1,0,1000); 
        
model1=addReaction(model1,'P_2ketoheptanoate',{'2ketoheptanoate', 
'hexanal[c]', 'co2[c]'},[-1 1 1],1,0,1000); 
         
end 
  
A= size(model1.rxns); 
SizeModel=(A(1)); 
%% Enter knockouts 
I= input('List of reactions to delete: '); 
  
SizeI=size(I); 
for p=1:1:SizeI(2) 
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    RxnDelete=I(p); 
    model1=changeRxnBounds(model1, RxnDelete, 0, 'u'); 
    model1=changeRxnBounds(model1, RxnDelete, 0, 'l'); 
    if p==1 
        KnockoutReaction=RxnDelete; 
    else 
        KnockoutReaction=strcat(KnockoutReaction,',',RxnDelete); 
    end 
end 
  
  
%% Desired product 
prompt = {'Desired product: '}; 
Product=inputdlg(prompt); 
model1=changeRxnBounds(model1, Product, 1000, 'u'); 
A=(model1.rxns); 
productposition=AC_findp_F(A,Product); 
  
model1=changeObjective(model1, Biomass_name, 1); 
solution=optimizeCbModel(model1); 
maxbiomass =solution.f 
if solution.stat ~= 1 
    display ('The selected condition does not have any valid solution') 
    return 
end 
Product_when_biomass_is_optimized=solution.x(productposition) 
TitlePlot=strcat('Product versus Biomass, deletion of: ', 
KnockoutReaction); 
xlsTitle=strcat('Model_', modelname, '_', KnockoutReaction); 
model1=changeObjective(model1, Biomass_name, -1); 
solution=optimizeCbModel(model1); 
minbiomass=solution.f; 
product2=solution.x(productposition); 
model1=changeObjective(model1, Product(1), 1); 
solution=optimizeCbModel(model1); 
OptimeProduct=solution.x(productposition) 
Y=zeros(101,3); 
%Y=zeros(101,7); 
for i=1:1:101 
    model1=changeRxnBounds(model1, Biomass_name, 0.01*(i-1)*maxbiomass, 
'l'); 
    % min 
    model1=changeObjective(model1, Product(1), 1); 
    maxsolution=optimizeCbModel(model1); 
    maxproduct=maxsolution.f; 
    biomass1=maxsolution.x(biomassposition); 
    %[maxminF maxmaxF]=fluxVariability(model1, 100,'max',{'ATPS4rpp'}, 
false, true); 
    %max 
    model1=changeObjective(model1, Product(1), -1);     
    minsolution=optimizeCbModel(model1); 
    minproduct=minsolution.x(productposition); 
    %[minminF minmaxF]=fluxVariability(model1, 100,'max',{'ATPS4rpp'}, 
false, true); 
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    %Y(i,:)= [biomass1 minproduct maxproduct maxminF maxmaxF minminF 
minmaxF]; 
    Y(i,:)= [biomass1 minproduct maxproduct]; 
     
end 
  
model1=changeObjective(model1, Biomass_name, 1); 
model1=changeRxnBounds(model1, Biomass_name, 0, 'l'); 
solution=optimizeCbModel(model1); 
%% Plot 
figure(1) 
set(0, 'DefaultTextInterpreter', 'none') %Change set of all plots Text-
Interpreter to none, as oppose to Text (default) 
plot(Y(:,1), Y(:,2), '--g*'); 
hold on 
plot(Y(:,1), Y(:,3), '--r*'); 
xlabel('Biomass'); 
ylabel(strcat('Product: ', Product)); 
title(TitlePlot); 
h=area(Y(:,1),Y(:,3)); 
set(h(1),'FaceColor',[1 1 0.5]) 
j=area(Y(:,1),Y(:,2)); 
set(j(1),'FaceColor',[1 1 1]) 
 
10.13 Matlab function for the synthesis of products derived from intermediate 
metabolites of the reversal β-oxidation cycle 
I added the following code to the function lcp-GEM (presented in section 10.12) 
 
AC_BiomassvsProduct_GlucoseiJO1366_DiversificationProducts 
%% 
% Termination Diversification 1: from B-ketoacyl-coa to substituted FA, 
alcohols and alkanes 
         
% Reduction of B-ketoaldehyde / B-ketoacyl-CoA --> B-ketoaldehyde (B-
keto-butanal, B-keto-hexanal, B-keto-octanal, ...) 
        model1=addReaction(model1,'P_B-ketobutanal_CoA',{'aacoa[c]', 
'nadh[c]', 'h[c]', 'B-ketobutanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 
1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-ketohexanal_CoA',{'3ohcoa[c]', 
'nadh[c]', 'h[c]', 'B-ketohexanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 
1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-ketooctanal_CoA',{'3oocoa[c]', 
'nadh[c]', 'h[c]', 'B-ketooctanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 
1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-ketodecanal_CoA',{'3odcoa[c]', 
'nadh[c]', 'h[c]', 'B-ketodecanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 
1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-
ketododecanal_CoA',{'3oddcoa[c]', 'nadh[c]', 'h[c]', 'B-
ketododecanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 1],1,0,1000); 
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        model1=addReaction(model1,'P_B-
ketotetradecanal_CoA',{'3otdcoa[c]', 'nadh[c]', 'h[c]', 'B-
ketotetradecanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-
ketohexadecanal_CoA',{'3ohdcoa[c]', 'nadh[c]', 'h[c]', 'B-
ketohexadecanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 1],1,0,1000);         
        model1=addReaction(model1,'P_B-
ketooctadecanal_CoA',{'3oodcoa[c]', 'nadh[c]', 'h[c]', 'B-
ketooctadecanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 1],1,0,1000); 
         
        %B-ketoaldehyde decarboxilation / Production of B-ketoalkanes 
        model1=addReaction(model1,'P_acetone',{'B-ketobutanal[c]', 
'acetone[c]', 'co[c]'},[-1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_2pentanone',{'B-ketohexanal[c]', 
'2pentanone[c]','co[c]'},[-1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_2heptanone',{'B-ketooctanal[c]', 
'2heptanone[c]','co[c]'},[-1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_2nonanone',{'B-ketodecanal[c]', 
'2nonanone[c]','co[c]'},[-1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_2undecanone',{'B-
ketododecanal[c]', '2undecanone[c]', 'co[c]'},[-1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_2tridecanone',{'B-
ketotetradecanal[c]', '2tridecanone[c]','co[c]'},[-1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_2pentadecanone',{'B-
ketohexadecanal[c]', '2pentadecanone[c]', 'co[c]'},[-1 1 1],1,0,1000);         
        model1=addReaction(model1,'P_2heptadecanone',{'B-
ketooctadecanal[c]', '2heptadecanone[c]','co[c]'},[-1 1 1],1,0,1000); 
         
        %B-ketoalcohol production 
        model1=addReaction(model1,'P_B-ketobutanol',{'B-
ketobutanal[c]', 'nadh[c]', 'h[c]', 'B-ketobutanol[c]', 'nad[c]'},[-1 -
1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-ketohexanol',{'B-
ketohexanal[c]', 'nadh[c]', 'h[c]', 'B-ketohexanol[c]', 'nad[c]'},[-1 -
1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-ketooctanol',{'B-
ketooctanal[c]', 'nadh[c]', 'h[c]', 'B-ketooctanol[c]', 'nad[c]'},[-1 -
1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-ketodecanol',{'B-
ketodecanal[c]', 'nadh[c]', 'h[c]', 'B-ketodecanol[c]', 'nad[c]'},[-1 -
1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-ketododecanol',{'B-
ketododecanal[c]', 'nadh[c]', 'h[c]', 'B-ketododecanol[c]', 
'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-ketotetradecanol',{'B-
ketotetradecanal[c]', 'nadh[c]', 'h[c]', 'B-ketotetradecanol[c]', 
'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-ketohexadecanol',{'B-
ketohexadecanal[c]', 'nadh[c]', 'h[c]', 'B-ketohexadecanol[c]', 
'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-ketooctadecanol',{'B-
ketooctadecanal[c]', 'nadh[c]', 'h[c]', 'B-ketooctadecanol[c]', 
'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
                 
        %acyl-coa --> fatty acids  
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        model1=addReaction(model1,'P_B-ketobut_CoA',{'aacoa[c]', 
'h2o[c]', 'h[c]', 'B-ketobut[c]', 'coa[c]'},[-1 -1 1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-ketohxa_CoA',{'3ohcoa[c]', 
'h2o[c]', 'h[c]', 'B-ketohxa[c]', 'coa[c]'},[-1 -1 1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-ketoocta_CoA',{'3oocoa[c]', 
'h2o[c]', 'h[c]', 'B-ketoocta[c]', 'coa[c]'},[-1 -1 1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-ketodca_CoA',{'3odcoa[c]', 
'h2o[c]', 'h[c]', 'B-ketodca[c]', 'coa[c]'},[-1 -1 1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-ketoddca_CoA',{'3oddcoa[c]', 
'h2o[c]', 'h[c]', 'B-ketoddca[c]', 'coa[c]'},[-1 -1 1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-ketottdca_CoA',{'3otdcoa[c]', 
'h2o[c]', 'h[c]', 'B-ketottdca[c]', 'coa[c]'},[-1 -1 1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-ketohdca_CoA',{'3ohdcoa[c]', 
'h2o[c]', 'h[c]', 'B-ketohdca[c]', 'coa[c]'},[-1 -1 1 1 1],1,0,1000);         
        model1=addReaction(model1,'P_B-ketoocdca_CoA',{'3oodcoa[c]', 
'h2o[c]', 'h[c]', 'B-ketoocdca[c]', 'coa[c]'},[-1 -1 1 1 1],1,0,1000); 
         
        
        %transport reactions to export fatty acids. All for [c] to [e] 
        %because the model did not have the proper transport accross 
membrane form [p] to [e] 
        model1=addReaction(model1,'P_B-ketobut_trans',{'B-ketobut[c]', 
'B-ketobut[e]', 'h[c]', 'h[p]'},[-1 1 -1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-ketohxa_trans',{'B-ketohxa[c]', 
'B-ketohxa[e]', 'h[c]', 'h[p]'},[-1 1 -1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-ketoocta_trans',{'B-
ketoocta[c]', 'B-ketoocta[e]', 'h[c]', 'h[p]'},[-1 1 -1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-ketodca_trans',{'B-ketodca[c]', 
'B-ketodca[e]', 'h[c]', 'h[p]'},[-1 1 -1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-ketoddca_trans',{'B-
ketoddca[c]', 'B-ketoddca[e]', 'h[c]', 'h[p]'},[-1 1 -1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-ketottdca_trans',{'B-
ketottdca[c]', 'B-ketottdca[e]', 'h[c]', 'h[p]'},[-1 1 -1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-ketohdca_trans',{'B-
ketohdca[c]', 'B-ketohdca[e]', 'h[c]', 'h[p]'},[-1 1 -1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-ketoocdca_trans_extra',{'B-
ketoocdca[c]', 'B-ketoocdca[e]', 'h[c]', 'h[p]'},[-1 1 -1 1],1,0,1000);  
       
        % Export of new products to zero 
        model1=addReaction(model1,'EX_B-ketobut', {'B-ketobut[e]'}, [-
1],1, 0,0); 
        model1=addReaction(model1,'EX_B-ketohxa',{'B-ketohxa[e]'}, [-
1],1, 0,0); 
        model1=addReaction(model1,'EX_B-ketoocta',{'B-ketoocta[e]'}, [-
1],1, 0,0); 
        model1=addReaction(model1,'EX_B-ketodca',{'B-ketodca[e]'}, [-
1],1, 0,0); 
        model1=addReaction(model1,'EX_B-ketoddca',{'B-ketoddca[e]'}, [-
1],1, 0,0); 
        model1=addReaction(model1,'EX_B-ketottdca',{'B-ketottdca[e]'}, 
[-1],1, 0,0); 
        model1=addReaction(model1,'EX_B-ketohdca',{'B-ketohdca[e]'}, [-
1],1, 0,0); 
        model1=addReaction(model1,'EX_B-ketoocdca',{'B-ketoocdca[e]'}, 
[-1],1, 0,0); 
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        model1=addReaction(model1,'EX_B-ketobutanol',{'B-
ketobutanol[c]'},[-1],1, 0,0); 
        model1=addReaction(model1,'EX_B-ketohexanol',{'B-
ketohexanol[c]'},[-1],1, 0,0); 
        model1=addReaction(model1,'EX_B-ketooctanol',{'B-
ketooctanol[c]'},[-1 ],1,0,0); 
        model1=addReaction(model1,'EX_B-ketodecanol',{'B-
ketodecanol[c]'},[-1],1, 0,0); 
        model1=addReaction(model1,'EX_B-ketododecanol',{'B-
ketododecanol[c]'},[-1 ],1,0,0); 
        model1=addReaction(model1,'EX_B-ketotetradecanol',{'B-
ketotetradecanol[c]'},[-1],1, 0,0); 
        model1=addReaction(model1,'EX_B-ketohexadecanol',{'B-
ketohexadecanol[c]'},[-1 ],1,0,0); 
        model1=addReaction(model1,'EX_B-ketooctadecanol',{'B-
ketooctadecanol[c]'},[-1],1, 0,0); 
         
        model1=addReaction(model1,'EX_acetone',{'acetone[c]'},[-1],1, 
0,0); 
        model1=addReaction(model1,'EX_2pentanone',{'2pentanone[c]'},[-
1],1, 0,0); 
        model1=addReaction(model1,'EX_2heptanone',{'2heptanone[c]'},[-1 
],1,0,0); 
        model1=addReaction(model1,'EX_2nonanone',{'2nonanone[c]'},[-
1],1, 0,0); 
        
model1=addReaction(model1,'EX_2undecanone',{'2undecanone[c]'},[-1 
],1,0,0); 
        
model1=addReaction(model1,'EX_2tridecanone',{'2tridecanone[c]'},[-1],1, 
0,0); 
        
model1=addReaction(model1,'EX_2pentadecanone',{'2pentadecanone[c]'},[-1 
],1,0,0); 
        
model1=addReaction(model1,'EX_2heptadecanone',{'2heptadecanone[c]'},[-
1],1, 0,0); 
         
        %% 
        % Termination Diversification 2: from Trans-B-hydroacyl-coa to 
substituted FA, alcohols and alkanes 
         
        % Reduction of Trans-B-hydroacyl-coa / Trans-B-hydroacyl-CoA --
> Trans-B-hydroaldehyde (Trans-B-hydro-butanal, Trans-B-hydro-hexanal, 
Trans-B-hydro-octanal, ...) 
        model1=addReaction(model1,'P_B-hydroxybutanal',{'3hbcoa[c]', 
'nadh[c]', 'h[c]', 'B-hydroxybutanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 
1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-hydroxyhexanal',{'3hhcoa[c]', 
'nadh[c]', 'h[c]', 'B-hydroxyhexanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 
1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-hydroxyoctanal',{'3hocoa[c]', 
'nadh[c]', 'h[c]', 'B-hydroxyoctanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 
1 1 1],1,0,1000); 
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        model1=addReaction(model1,'P_B-hydroxydecanal',{'3hdcoa[c]', 
'nadh[c]', 'h[c]', 'B-hydroxydecanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 
1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-hydroxydodecanal',{'3hddcoa[c]', 
'nadh[c]', 'h[c]', 'B-hydroxydodecanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 
-1 1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-
hydroxytetradecanal',{'3htdcoa[c]', 'nadh[c]', 'h[c]', 'B-
hydroxytetradecanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1,0,1000); 
        model1=addReaction(model1,'P_B-
hydroxyhexadecanal',{'3hhdcoa[c]', 'nadh[c]', 'h[c]', 'B-
hydroxyhexadecanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 1],1,0,1000);         
        model1=addReaction(model1,'P_B-
hydroxyoctadecanal',{'3hodcoa[c]', 'nadh[c]', 'h[c]', 'B-
hydroxyoctadecanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 1],1,0,1000); 
         
        %Trans-B-hydroaldehyde decarboxilation / Production of alcohols 
        model1=addReaction(model1,'P_3propanol',{'B-hydroxybutanal[c]', 
'3propanol[c]', 'co[c]'},[-1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_3pentanol',{'B-hydroxyhexanal[c]', 
'3pentanol[c]','co[c]'},[-1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_3heptanol',{'B-hydroxyoctanal[c]', 
'3heptanol[c]','co[c]'},[-1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_3nonanol',{'B-hydroxydecanal[c]', 
'3nonanol[c]','co[c]'},[-1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_3undecanol',{'B-
hydroxydodecanal[c]', '3undecanol[c]', 'co[c]'},[-1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_3tridecanol',{'B-
hydroxytetradecanal[c]', '3tridecanol[c]','co[c]'},[-1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_3pentadecanol',{'B-
hydroxyhexadecanal[c]', '3pentadecanol[c]', 'co[c]'},[-1 1 
1],1,0,1000);         
        model1=addReaction(model1,'P_3heptadecanol',{'B-
hydroxyoctadecanal[c]', '3heptadecanol[c]','co[c]'},[-1 1 1],1,0,1000); 
         
        %Trans-B-hydroalcohol production 
        model1=addReaction(model1,'P_13butanediol',{'B-
hydroxybutanal[c]', 'nadh[c]', 'h[c]', '13butanediol[c]', 'nad[c]'},[-1 
-1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_13hexanediol',{'B-
hydroxyhexanal[c]', 'nadh[c]', 'h[c]', '13hexanediol[c]', 'nad[c]'},[-1 
-1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_13octanediol',{'B-
hydroxyoctanal[c]', 'nadh[c]', 'h[c]', '13octanediol[c]', 'nad[c]'},[-1 
-1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_13decanediol',{'B-
hydroxydecanal[c]', 'nadh[c]', 'h[c]', '13decanediol[c]', 'nad[c]'},[-1 
-1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_13dodecanediol',{'B-
hydroxydodecanal[c]', 'nadh[c]', 'h[c]', '13dodecanediol[c]', 
'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_13tetradecanediol',{'B-
hydroxytetradecanal[c]', 'nadh[c]', 'h[c]', '13tetradecanediol[c]', 
'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
300 
 
        model1=addReaction(model1,'P_13hexadecanediol',{'B-
hydroxyhexadecanal[c]', 'nadh[c]', 'h[c]', '13hexadecanediol[c]', 
'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_13octadecanediol',{'B-
hydroxyoctadecanal[c]', 'nadh[c]', 'h[c]', '13octadecanediol[c]', 
'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
                 
        %Trans-B-hydroxyacyl-coa --> B-hydroxyacids  
        model1=addReaction(model1,'P_B-hydroxybut',{'3hbcoa[c]', 
'h2o[c]', 'h[c]', 'B-hydroxybut[c]', 'coa[c]'},[-1 -1 1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-hydroxyhxa',{'3hhcoa[c]', 
'h2o[c]', 'h[c]', 'B-hydroxyhxa[c]', 'coa[c]'},[-1 -1 1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-hydroxyocta',{'3hocoa[c]', 
'h2o[c]', 'h[c]', 'B-hydroxyocta[c]', 'coa[c]'},[-1 -1 1 1 
1],1,0,1000); 
        model1=addReaction(model1,'P_B-hydroxydca',{'3hdcoa[c]', 
'h2o[c]', 'h[c]', 'B-hydroxydca[c]', 'coa[c]'},[-1 -1 1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_B-hydroxyddca',{'3hddcoa[c]', 
'h2o[c]', 'h[c]', 'B-hydroxyddca[c]', 'coa[c]'},[-1 -1 1 1 
1],1,0,1000); 
        model1=addReaction(model1,'P_B-hydroxyttdca',{'3htdcoa[c]', 
'h2o[c]', 'h[c]', 'B-hydroxyttdca[c]', 'coa[c]'},[-1 -1 1 1 
1],1,0,1000); 
        model1=addReaction(model1,'P_B-hydroxyhdca',{'3hhdcoa[c]', 
'h2o[c]', 'h[c]', 'B-hydroxyhdca[c]', 'coa[c]'},[-1 -1 1 1 
1],1,0,1000);         
        model1=addReaction(model1,'P_B-hydroxyocdca',{'3hodcoa[c]', 
'h2o[c]', 'h[c]', 'B-hydroxyocdca[c]', 'coa[c]'},[-1 -1 1 1 
1],1,0,1000);         
        
        %transport reactions to export fatty acids. All for [c] to [e] 
        %because the model did not have the proper transport accross 
membrane form [p] to [e] 
        model1=addReaction(model1,'P_B-hydroxybut_trans',{'B-
hydroxybut[c]', 'B-hydroxybut[e]', 'h[c]', 'h[p]'},[-1 1 -1 
1],1,0,1000); 
        model1=addReaction(model1,'P_B-hydroxyhxa_trans',{'B-
hydroxyhxa[c]', 'B-hydroxyhxa[e]', 'h[c]', 'h[p]'},[-1 1 -1 
1],1,0,1000); 
        model1=addReaction(model1,'P_B-hydroxyocta_trans',{'B-
hydroxyocta[c]', 'B-hydroxyocta[e]', 'h[c]', 'h[p]'},[-1 1 -1 
1],1,0,1000); 
        model1=addReaction(model1,'P_B-hydroxydca_trans',{'B-
hydroxydca[c]', 'B-hydroxydca[e]', 'h[c]', 'h[p]'},[-1 1 -1 
1],1,0,1000); 
        model1=addReaction(model1,'P_B-hydroxyddca_trans',{'B-
hydroxyddca[c]', 'B-hydroxyddca[e]', 'h[c]', 'h[p]'},[-1 1 -1 
1],1,0,1000); 
        model1=addReaction(model1,'P_B-hydroxyttdca_trans',{'B-
hydroxyttdca[c]', 'B-hydroxyttdca[e]', 'h[c]', 'h[p]'},[-1 1 -1 
1],1,0,1000); 
        model1=addReaction(model1,'P_B-hydroxyhdca_trans',{'B-
hydroxyhdca[c]', 'B-hydroxyhdca[e]', 'h[c]', 'h[p]'},[-1 1 -1 
1],1,0,1000); 
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        model1=addReaction(model1,'P_B-hydroxyocdca_trans_extra',{'B-
hydroxyocdca[c]', 'B-hydroxyocdca[e]', 'h[c]', 'h[p]'},[-1 1 -1 
1],1,0,1000);  
       
        % Export of new products to zero 
        model1=addReaction(model1,'EX_B-hydroxybut', {'B-
hydroxybut[e]'}, [-1],1, 0,0); 
        model1=addReaction(model1,'EX_B-hydroxyhxa',{'B-
hydroxyhxa[e]'}, [-1],1, 0,0); 
        model1=addReaction(model1,'EX_B-hydroxyocta',{'B-
hydroxyocta[e]'}, [-1],1, 0,0); 
        model1=addReaction(model1,'EX_B-hydroxydca',{'B-
hydroxydca[e]'}, [-1],1, 0,0); 
        model1=addReaction(model1,'EX_B-hydroxyddca',{'B-
hydroxyddca[e]'}, [-1],1, 0,0); 
        model1=addReaction(model1,'EX_B-hydroxyttdca',{'B-
hydroxyttdca[e]'}, [-1],1, 0,0); 
        model1=addReaction(model1,'EX_B-hydroxyhdca',{'B-
hydroxyhdca[e]'}, [-1],1, 0,0); 
        model1=addReaction(model1,'EX_B-hydroxyocdca',{'B-
hydroxyocdca[e]'}, [-1],1, 0,0); 
         
        
model1=addReaction(model1,'EX_13butanediol',{'13butanediol[c]'},[-1],1, 
0,0); 
        
model1=addReaction(model1,'EX_13hexanediol',{'13hexanediol[c]'},[-1],1, 
0,0); 
        
model1=addReaction(model1,'EX_13octanediol',{'13octanediol[c]'},[-1 
],1,0,0); 
        
model1=addReaction(model1,'EX_13decanediol',{'13decanediol[c]'},[-1],1, 
0,0); 
        
model1=addReaction(model1,'EX_13dodecanediol',{'13dodecanediol[c]'},[-1 
],1,0,0); 
        
model1=addReaction(model1,'EX_13tetradecanediol',{'13tetradecanediol[c]
'},[-1],1, 0,0); 
        
model1=addReaction(model1,'EX_13hexadecanediol',{'13hexadecanediol[c]'}
,[-1 ],1,0,0); 
        
model1=addReaction(model1,'EX_13octadecanediol',{'13octadecanediol[c]'}
,[-1],1, 0,0); 
         
        model1=addReaction(model1,'EX_3propanol',{'3propanol[c]'},[-
1],1, 0,0); 
        model1=addReaction(model1,'EX_3pentanol',{'3pentanol[c]'},[-
1],1, 0,0); 
        model1=addReaction(model1,'EX_3heptanol',{'3heptanol[c]'},[-1 
],1,0,0); 
        model1=addReaction(model1,'EX_3nonanol',{'3nonanol[c]'},[-1],1, 
0,0); 
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        model1=addReaction(model1,'EX_3undecanol',{'3undecanol[c]'},[-1 
],1,0,0); 
        
model1=addReaction(model1,'EX_3tridecanol',{'3tridecanol[c]'},[-1],1, 
0,0); 
        
model1=addReaction(model1,'EX_3pentadecanol',{'3pentadecanol[c]'},[-1 
],1,0,0); 
        
model1=addReaction(model1,'EX_3heptadecanol',{'3heptadecanol[c]'},[-
1],1, 0,0); 
  
        %% 
        % Termination Diversification 3: from trans-enoyl-coa to 
substituted FA, alcohols and alkanes 
         
        % Reduction of trans-enoyl / trans-enoyl-CoA --> trans-
enoaldehyde 
        model1=addReaction(model1,'P_Trans-d2-eno-butanal',{'b2coa[c]', 
'nadh[c]', 'h[c]', 'Trans-d2-eno-butanal[c]', 'nad[c]', 'coa[c]'},[-1 -
1 -1 1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_Trans-d2-eno-
hexanal',{'hx2coa[c]', 'nadh[c]', 'h[c]', 'Trans-d2-eno-hexanal[c]', 
'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_Trans-d2-eno-
octanal',{'oc2coa[c]', 'nadh[c]', 'h[c]', 'Trans-d2-eno-octanal[c]', 
'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_Trans-d2-eno-
decanal',{'dc2coa[c]', 'nadh[c]', 'h[c]', 'Trans-d2-eno-decanal[c]', 
'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_Trans-d2-eno-
dodecanal',{'dd2coa[c]', 'nadh[c]', 'h[c]', 'Trans-d2-eno-
dodecanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_Trans-d2-eno-
tetradecanal',{'td2coa[c]', 'nadh[c]', 'h[c]', 'Trans-d2-eno-
tetradecanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_Trans-d2-eno-
hexadecanal',{'hdd2coa[c]', 'nadh[c]', 'h[c]', 'Trans-d2-eno-
hexadecanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 1],1,0,1000);         
        model1=addReaction(model1,'P_Trans-d2-eno-
octadecanal',{'od2coa[c]', 'nadh[c]', 'h[c]', 'Trans-d2-eno-
octadecanal[c]', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 1],1,0,1000); 
         
        %B-ketoaldehyde decarboxilation / Production of eno-alkanes 
        model1=addReaction(model1,'P_propene',{'Trans-d2-eno-
butanal[c]', 'propene[c]', 'co[c]'},[-1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_pentene',{'Trans-d2-eno-
hexanal[c]', 'pentene[c]','co[c]'},[-1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_heptene',{'Trans-d2-eno-
octanal[c]', 'heptene[c]','co[c]'},[-1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_nonene',{'Trans-d2-eno-
decanal[c]', 'nonene[c]','co[c]'},[-1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_undecene',{'Trans-d2-eno-
dodecanal[c]', 'undecene[c]', 'co[c]'},[-1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_tridecene',{'Trans-d2-eno-
tetradecanal[c]', 'tridecene[c]','co[c]'},[-1 1 1],1,0,1000); 
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        model1=addReaction(model1,'P_pentadecene',{'Trans-d2-eno-
hexadecanal[c]', 'pentadecene[c]', 'co[c]'},[-1 1 1],1,0,1000);         
        model1=addReaction(model1,'P_heptadecene',{'Trans-d2-eno-
octadecanal[c]', 'heptadecene[c]','co[c]'},[-1 1 1],1,0,1000); 
         
        %Trans-d2-alcohol production 
        model1=addReaction(model1,'P_Trans-d2-fatty-butanol',{'Trans-
d2-eno-butanal[c]', 'nadh[c]', 'h[c]', 'Trans-d2-fatty-butanol[c]', 
'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_Trans-d2-fatty-hexanol',{'Trans-
d2-eno-hexanal[c]', 'nadh[c]', 'h[c]', 'Trans-d2-fatty-hexanol[c]', 
'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_Trans-d2-fatty-octanol',{'Trans-
d2-eno-octanal[c]', 'nadh[c]', 'h[c]', 'Trans-d2-fatty-octanol[c]', 
'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_Trans-d2-fatty-decanol',{'Trans-
d2-eno-decanal[c]', 'nadh[c]', 'h[c]', 'Trans-d2-fatty-decanol[c]', 
'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_Trans-d2-fatty-dodecanol',{'Trans-
d2-eno-dodecanal[c]', 'nadh[c]', 'h[c]', 'Trans-d2-fatty-dodecanol[c]', 
'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_Trans-d2-fatty-
tetradecanol',{'Trans-d2-eno-tetradecanal[c]', 'nadh[c]', 'h[c]', 
'Trans-d2-fatty-tetradecanol[c]', 'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_Trans-d2-fatty-
hexadecanol',{'Trans-d2-eno-hexadecanal[c]', 'nadh[c]', 'h[c]', 'Trans-
d2-fatty-hexadecanol[c]', 'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_Trans-d2-fatty-
octadecanol',{'Trans-d2-eno-octadecanal[c]', 'nadh[c]', 'h[c]', 'Trans-
d2-fatty-octadecanol[c]', 'nad[c]'},[-1 -1 -1 1 1],1,0,1000); 
                 
        %Trans-d2-enoyl-coa --> Trans-d2-fatty acids  
        model1=addReaction(model1,'P_Trans-d2-but_CoA',{'b2coa[c]', 
'h2o[c]', 'h[c]', 'Trans-d2-but[c]', 'coa[c]'},[-1 -1 1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_Trans-d2-hxa_CoA',{'hx2coa[c]', 
'h2o[c]', 'h[c]', 'Trans-d2-hxa[c]', 'coa[c]'},[-1 -1 1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_Trans-d2-octa_CoA',{'oc2coa[c]', 
'h2o[c]', 'h[c]', 'Trans-d2-octa[c]', 'coa[c]'},[-1 -1 1 1 
1],1,0,1000); 
        model1=addReaction(model1,'P_Trans-d2-dca_CoA',{'dc2coa[c]', 
'h2o[c]', 'h[c]', 'Trans-d2-dca[c]', 'coa[c]'},[-1 -1 1 1 1],1,0,1000); 
        model1=addReaction(model1,'P_Trans-d2-ddca_CoA',{'dd2coa[c]', 
'h2o[c]', 'h[c]', 'Trans-d2-ddca[c]', 'coa[c]'},[-1 -1 1 1 
1],1,0,1000); 
        model1=addReaction(model1,'P_Trans-d2-ttdca_CoA',{'td2coa[c]', 
'h2o[c]', 'h[c]', 'Trans-d2-ttdca[c]', 'coa[c]'},[-1 -1 1 1 
1],1,0,1000); 
        model1=addReaction(model1,'P_Trans-d2-hdca_CoA',{'hdd2coa[c]', 
'h2o[c]', 'h[c]', 'Trans-d2-hdca[c]', 'coa[c]'},[-1 -1 1 1 
1],1,0,1000);         
        model1=addReaction(model1,'P_Trans-d2-ocdca_CoA',{'od2coa[c]', 
'h2o[c]', 'h[c]', 'Trans-d2-ocdca[c]', 'coa[c]'},[-1 -1 1 1 
1],1,0,1000); 
        
        %transport reactions to export fatty acids. All for [c] to [e] 
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        %because the model did not have the proper transport accross 
membrane form [p] to [e] 
        model1=addReaction(model1,'P_Trans-d2-but_trans',{'Trans-d2-
but[c]', 'Trans-d2-but[e]', 'h[c]', 'h[p]'},[-1 1 -1 1],1,0,1000); 
        model1=addReaction(model1,'P_Trans-d2-hxa_trans',{'Trans-d2-
hxa[c]', 'Trans-d2-hxa[e]', 'h[c]', 'h[p]'},[-1 1 -1 1],1,0,1000); 
        model1=addReaction(model1,'P_Trans-d2-octa_trans',{'Trans-d2-
octa[c]', 'Trans-d2-octa[e]', 'h[c]', 'h[p]'},[-1 1 -1 1],1,0,1000); 
        model1=addReaction(model1,'P_Trans-d2-dca_trans',{'Trans-d2-
dca[c]', 'Trans-d2-dca[e]', 'h[c]', 'h[p]'},[-1 1 -1 1],1,0,1000); 
        model1=addReaction(model1,'P_Trans-d2-ddca_trans',{'Trans-d2-
ddca[c]', 'Trans-d2-ddca[e]', 'h[c]', 'h[p]'},[-1 1 -1 1],1,0,1000); 
        model1=addReaction(model1,'P_Trans-d2-ttdca_trans',{'Trans-d2-
ttdca[c]', 'Trans-d2-ttdca[e]', 'h[c]', 'h[p]'},[-1 1 -1 1],1,0,1000); 
        model1=addReaction(model1,'P_Trans-d2-hdca_trans',{'Trans-d2-
hdca[c]', 'Trans-d2-hdca[e]', 'h[c]', 'h[p]'},[-1 1 -1 1],1,0,1000); 
        model1=addReaction(model1,'P_Trans-d2-
ocdca_trans_extra',{'Trans-d2-ocdca[c]', 'Trans-d2-ocdca[e]', 'h[c]', 
'h[p]'},[-1 1 -1 1],1,0,1000);  
       
        % Export of new products to zero 
        model1=addReaction(model1,'EX_Trans-d2-but', {'Trans-d2-
but[e]'}, [-1],1, 0,0); 
        model1=addReaction(model1,'EX_Trans-d2-hxa',{'Trans-d2-
hxa[e]'}, [-1],1, 0,0); 
        model1=addReaction(model1,'EX_Trans-d2-octa',{'Trans-d2-
octa[e]'}, [-1],1, 0,0); 
        model1=addReaction(model1,'EX_Trans-d2-dca',{'Trans-d2-
dca[e]'}, [-1],1, 0,0); 
        model1=addReaction(model1,'EX_Trans-d2-ddca',{'Trans-d2-
ddca[e]'}, [-1],1, 0,0); 
        model1=addReaction(model1,'EX_Trans-d2-ttdca',{'Trans-d2-
ttdca[e]'}, [-1],1, 0,0); 
        model1=addReaction(model1,'EX_Trans-d2-hdca',{'Trans-d2-
hdca[e]'}, [-1],1, 0,0); 
        model1=addReaction(model1,'EX_Trans-d2-ocdca',{'Trans-d2-
ocdca[e]'}, [-1],1, 0,0); 
         
        model1=addReaction(model1,'EX_Trans-d2-fatty-butanol',{'Trans-
d2-fatty-butanol[c]'},[-1],1, 0,0); 
        model1=addReaction(model1,'EX_Trans-d2-fatty-hexanol',{'Trans-
d2-fatty-hexanol[c]'},[-1],1, 0,0); 
        model1=addReaction(model1,'EX_Trans-d2-fatty-octanol',{'Trans-
d2-fatty-octanol[c]'},[-1 ],1,0,0); 
        model1=addReaction(model1,'EX_Trans-d2-fatty-decanol',{'Trans-
d2-fatty-decanol[c]'},[-1],1, 0,0); 
        model1=addReaction(model1,'EX_Trans-d2-fatty-
dodecanol',{'Trans-d2-fatty-dodecanol[c]'},[-1 ],1,0,0); 
        model1=addReaction(model1,'EX_Trans-d2-fatty-
tetradecanol',{'Trans-d2-fatty-tetradecanol[c]'},[-1],1, 0,0); 
        model1=addReaction(model1,'EX_Trans-d2-fatty-
hexadecanol',{'Trans-d2-fatty-hexadecanol[c]'},[-1 ],1,0,0); 
        model1=addReaction(model1,'EX_Trans-d2-fatty-
octadecanol',{'Trans-d2-fatty-octadecanol[c]'},[-1],1, 0,0); 
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        model1=addReaction(model1,'EX_propene',{'propene[c]'},[-1],1, 
0,0); 
        model1=addReaction(model1,'EX_pentene',{'pentene[c]'},[-1],1, 
0,0); 
        model1=addReaction(model1,'EX_heptene',{'heptene[c]'},[-1 
],1,0,0); 
        model1=addReaction(model1,'EX_nonene',{'nonene[c]'},[-1],1, 
0,0); 
        model1=addReaction(model1,'EX_undecene',{'undecene[c]'},[-1 
],1,0,0); 
        model1=addReaction(model1,'EX_tridecene',{'tridecene[c]'},[-
1],1, 0,0); 
        
model1=addReaction(model1,'EX_pentadecene',{'pentadecene[c]'},[-1 
],1,0,0); 
        
model1=addReaction(model1,'EX_heptadecene',{'heptadecene[c]'},[-1],1, 
0,0); 
  
A= size(model1.rxns); 
SizeModel=(A(1)); 
 
10.14 Matlab function for the use of hydroxylated primers for the synthesis of 
carboxyacids and diols using reversal β-oxidation cycle 
AC_BioamssvsProduct_HydroxilatedPrimer6 
% Production of diols and carboxiacids in E. coli using hydroxylated 
primers. 
% Reversal B-oxidation cycle. 
% Model developed by Angela Cintolesi as part of her Doctoral Research 
% Chemical and Biomolecular Engineering, Rice University, March 2013  
% Return a matrix Y with the optimal cell growth of each product 
  
global SizeModel 
initCobraToolbox() 
changeCobraSolver('glpk'); 
%% Open model 
        model1=readCbModel('iJO1366'); 
        biomassposition=8; 
        Biomass_name='Ec_biomass_iJO1366_core_53p95M'; 
        modelname='iJO1366'; 
        %no aa degradation 
        model1=changeRxnBounds(model1,{'DAAD', 'AST', 'SADH', 'SGSAD', 
'SGDS', 'ARGDC', 'ARGDCpp', 'ASPT', 'GLUN', 'P5CD', 'PROD2', 'SERD_L', 
'OBTFL', 'PPAKr', 'THRD', 'GLYAT', 'TYROXDApp', 'PEAMNOpp', 'TRPAS2', 
'CYSDS','42A12BOOXpp', 'THRAi'}, [0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0], 'u'); 
        model1=changeRxnBounds(model1,{'DAAD', 'AST', 'SADH', 'SGSAD', 
'SGDS', 'ARGDC', 'ARGDCpp', 'ASPT', 'GLUN', 'P5CD', 'PROD2', 'SERD_L', 
'OBTFL', 'PPAKr', 'THRD', 'GLYAT', 'TYROXDApp', 'PEAMNOpp', 'TRPAS2', 
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'CYSDS','42A12BOOXpp', 'THRAi'}, [0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0], 'l'); 
        %no nucleotides degradation 
        model1=changeRxnBounds(model1,{'CYTD', 'DCYTD', 'DURIPP', 
'TMDPP', 'PPM2', 'DRPA', 'ADA', 'DADA', 'PUNP1', 'PUNP4', 'PUNP2', 
'PUNP3', 'PUNP5', 'PUNP6', 'PUNP7', 'PYNP2r'}, [0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0], 'u'); 
        model1=changeRxnBounds(model1,{'CYTD', 'DCYTD', 'DURIPP', 
'TMDPP', 'PPM2', 'DRPA', 'ADA', 'DADA', 'PUNP1', 'PUNP4', 'PUNP2', 
'PUNP3', 'PUNP5', 'PUNP6', 'PUNP7', 'PYNP2r'}, [0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0], 'l'); 
        % export aa (direct + non escential): 
        model1=changeRxnBounds(model1,{'EX_ala-B(e)', 'EX_ala-D(e)', 
'EX_ala-L(e)', 'EX_asn-L(e)', 'EX_asp-L(e)', 'EX_cys-D(e)', 'EX_cys-
L(e)', 'EX_glu-L(e)', 'EX_gln-L(e)', 'EX_gly(e)', 'EX_his-L(e)', 
'EX_ile-L(e)', 'EX_leu-L(e)', 'EX_lys-L(e)', 'EX_met-D(e)', 'EX_met-
L(e)', 'EX_phe-L(e)', 'EX_pro-L(e)', 'EX_ser-D(e)', 'EX_ser-
L(e)','EX_thr-L(e)', 'EX_trp-L(e)', 'EX_tyr-L(e)', 'EX_val-L(e)' }, [0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ], 'u'); 
        model1= changeRxnBounds(model1,{'EX_26dap-
M(e)','EX_frulys(e)','EX_hom-L(e)', 'EX_orn(e)'}, [0 0 0 0 ], 'u');  
        %no Fe2+ export. no H2S export 
        model1=changeRxnBounds(model1,'EX_fe2(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_h2s(e)', 0, 'u');         
        %no POR5 export. 
        model1=changeRxnBounds(model1,'POR5', 0, 'l'); 
        model1=changeRxnBounds(model1,'POR5', 0, 'u');         
        %Add PntAB 
        model1=addReaction(model1, 'Add_PntAB', {'nadh[c]', 'nadp[c]', 
'h[p]', 'nad[c]', 'nadph[c]', 'h[c]'}, [-1 -1 -1 1 1 1], 1, 0, 1000);         
         
        model1=changeRxnBounds(model1,'EX_o2(e)', 0, 'l'); 
        model1=changeRxnBounds(model1,'EX_glc(e)', -15, 'l'); 
        %Delete by-products 
        model1=changeRxnBounds(model1,'EX_pyr(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_acald(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_hxa(e)', 0, 'u'); 
        %FBA3, PFK_3 
        model1=changeRxnBounds(model1,'FBA3', 0, 'l'); 
        model1=changeRxnBounds(model1,'FBA3', 0, 'u'); 
        model1=changeRxnBounds(model1,'PFK_3', 0, 'l'); 
        model1=changeRxnBounds(model1,'PFK_3', 0, 'u'); 
        %no production of 5mtr and spmd, for redox purposes 
        model1=changeRxnBounds(model1,'EX_5mtr(e)', 0, 'u'); 
        model1=changeRxnBounds(model1,'EX_spmd(e)', 0, 'u'); 
        %ACOAD1f are inactive in this case. 
        model1=changeRxnBounds(model1,'ACOAD1f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD1f', 0, 'u'); 
        model1=changeRxnBounds(model1,'ACOAD2f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD2f', 0, 'u'); 
        model1=changeRxnBounds(model1,'ACOAD3f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD3f', 0, 'u'); 
        model1=changeRxnBounds(model1,'ACOAD4f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD4f', 0, 'u'); 
        model1=changeRxnBounds(model1,'ACOAD5f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD5f', 0, 'u'); 
        model1=changeRxnBounds(model1,'ACOAD6f', 0, 'l'); 
307 
 
        model1=changeRxnBounds(model1,'ACOAD6f', 0, 'u'); 
        model1=changeRxnBounds(model1,'ACOAD7f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD7f', 0, 'u'); 
        model1=changeRxnBounds(model1,'ACOAD8f', 0, 'l'); 
        model1=changeRxnBounds(model1,'ACOAD8f', 0, 'u'); 
         
         
model1=addReaction(model1,'PFOR',{'coa[c]', 'fd_oxi', 'pyr[c]', 
'accoa[c]', 'co2[c]', 'fd_red', 'h[c]'},[-1 -1 -1 1 1 1 1],1,0,1000); 
%% Production of Diols, hydroxylated acids, and bi-acids 
%Export acids 
model1=addReaction(model1,'EX_hydroxyacetate',{ 'hydroxyacetate[e]'},[-
1],1, 0,0); 
model1=addReaction(model1,'EX_hydroxypropionate',{ 
'hydroxypropionate[e]'},[-1],1, 0,0); 
model1=addReaction(model1,'EX_hydroxybutyrate',{ 'ghb[e]'},[-1],1, 
0,0); % already in the model, as gamma-hydroxybutyrycacid (ghb) 
%Transport 
model1=addReaction(model1,'TR_hydroxyacetate','hydroxyacetate[e] + h[p] 
-> hydroxyacetate[c] + h[c]'); 
model1=addReaction(model1,'TR_hydroxypropionate','hydroxypropionate[e] 
+ h[p] -> hydroxypropionate[c] + h[c]');% This is as r8: 3-
hydroxypropionate 
model1=addReaction(model1,'TR_hydroxybutyrate','ghb[e] + h[p] -> ghb[c] 
+ h[c]'); %ghb[c] is gamma-hydroxybutyrycacid 
%activation: 
model1=addReaction(model1,'P_hydroxyacetylCoA','hydroxyacetate[c] + 
atp[c] + coa[c] -> hydroxyacetyl-CoA + amp[c] + ppi[c]'); 
model1=addReaction(model1,'P_3hydroxypropionylCoA','hydroxypropionate[c
] + atp[c] + coa[c] -> 3-hydroxypropionyl-CoA + amp[c] + ppi[c]'); 
model1=addReaction(model1,'P_4hydroxybutyrylCoA','ghb[c] + atp[c] + 
coa[c] -> 4hydroxybutyryl-CoA + amp[c] + ppi[c]'); 
%initiation 
model1=addReaction(model1,'P_4hydroxyacetoacetylCoA',{ 'hydroxyacetyl-
CoA', 'accoa[c]', '4-hydroxy-acetoacetyl-CoA', 'coa[c]'},[-1 -1 1 1],1, 
0,1000); 
model1=addReaction(model1,'P_5hyxdroxypentanoylCoA',{'3-
hydroxypropionyl-CoA', 'accoa[c]', '5-hydroxy-3-Oxopentanoyl-CoA', 
'coa[c]'},[-1 -1 1 1],1, 0,1000); 
model1=addReaction(model1,'P_6hyxdroxyhexanoylCoA',{'4hydroxybutyryl-
CoA', 'accoa[c]', '6-hydroxy-3-Oxohexanoyl-CoA', 'coa[c]'},[-1 -1 1 
1],1, 0,1000); 
% 
%Export acids 
model1=addReaction(model1,'EX_oxalate',{ 'oxa[e]'},[-1],1, 0,0); 
%oxa[c] is part of the model. I add it as source 
model1=addReaction(model1,'EX_malonate',{ 'malonate[e]'},[-1],1, 0,0); 
%Transport 
model1=addReaction(model1,'TR_oxalate','oxa[e] + h[p] -> oxa[c] + 
h[c]');%oxa[c] is part of the model.  
model1=addReaction(model1,'TR_malonate','malonate[e] + h[p] -> 
malonate[c] + h[c]'); 
% Transport of succ is already part of the model, and it uses 2 protons  
  
%activation 
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model1=addReaction(model1,'P_oxalylCoA','oxa[c] + atp[c] + coa[c] -> 
oxalcoa[c] + amp[c] + ppi[c]');%oxalyl-CoA already in the model 
model1=addReaction(model1,'P_malonylCoA','malonate[c] + atp[c] + coa[c] 
-> malcoa[c] + amp[c] + ppi[c]');%malonyl-coa = malcoa 
model1=addReaction(model1,'P_succinylCoA','succ[c] + atp[c] + coa[c] -> 
succoa[c] + amp[c] + ppi[c]');% Already in the model (succinyl-
coa=succoa). There is a close reaction in the model, that only uses one 
P group. 
  
%initiation 
model1=addReaction(model1,'P_3oxosuccinylCoA',{ 'oxalcoa[c]', 
'accoa[c]', '3oxosuccinyl-CoA', 'coa[c]'},[-1 -1 1 1],1, 0,1000); 
model1=addReaction(model1,'P_3oxoglutarylCoA',{'malcoa[c]', 'accoa[c]', 
'3oxoglutaryl-CoA', 'coa[c]'},[-1 -1 1 1],1, 0,1000); 
model1=addReaction(model1,'P_3oxoadipylCoA',{'succoa[c]', 'accoa[c]', 
'oxadpcoa[c]', 'coa[c]'},[-1 -1 1 1],1, 0,1000);%3oxoadipyl-CoA = 
oxadpcoa[c] already in model 
%--------------------- 
%Primers 1, 2, and 3: 4-hydroxyacetoacetyl-coa, 5-hydroxy3oxopentanoyl-
coa, 
%and 6hydroxy3oxohexanoyl-coa 
%3-hydroxyacyl-CoA dehydrogenase (Adapted from HACDxi in B-oxidation 
cycle): 
model1=addReaction(model1,'PA_1', {'4-hydroxy-acetoacetyl-CoA', 
'nadh[c]', 'h[c]', '3,4-dihydroxybutanoyl-CoA', 'nad[c]'},[-1 -1 -1 1 
1],1, 0,1000); 
model1=addReaction(model1,'PA_2', {'5-hydroxy-3-Oxopentanoyl-CoA', 
'nadh[c]', 'h[c]', '3,5-dihydroxypentanoyl-CoA', 'nad[c]'},[-1 -1 -1 1 
1],1, 0,1000); 
model1=addReaction(model1,'PA_3', {'6-hydroxy-3-Oxohexanoyl-CoA', 
'nadh[c]', 'h[c]', '3,6-dihydroxyhexanoyl-CoA', 'nad[c]'},[-1 -1 -1 1 
1],1, 0,1000); 
model1=addReaction(model1,'PA_4', {'7-hydroxy-3-Oxoheptanoyl-CoA', 
'nadh[c]', 'h[c]', '3,7-dihydroxyheptanoyl-CoA', 'nad[c]'},[-1 -1 -1 1 
1],1, 0,1000); 
model1=addReaction(model1,'PA_5', {'8-hydroxy-3-Oxooctanoyl-CoA', 
'nadh[c]', 'h[c]', '3,8-dihydroxyoctanoyl-CoA', 'nad[c]'},[-1 -1 -1 1 
1],1, 0,1000); 
model1=addReaction(model1,'PA_6', {'9-hydroxy-3-Oxononanoyl-CoA', 
'nadh[c]', 'h[c]', '3,9-dihydroxynonanoyl-CoA', 'nad[c]'},[-1 -1 -1 1 
1],1, 0,1000); 
model1=addReaction(model1,'PA_7', {'10-hydroxy-3-Oxodecanoyl-CoA', 
'nadh[c]', 'h[c]', '3,10-dihydroxydecanoyl-CoA', 'nad[c]'},[-1 -1 -1 1 
1],1, 0,1000); 
model1=addReaction(model1,'PA_8', {'11-hydroxy-3-Oxoundecanoyl-CoA', 
'nadh[c]', 'h[c]', '3,11-dihydroxyundecanoyl-CoA', 'nad[c]'},[-1 -1 -1 
1 1],1, 0,1000); 
model1=addReaction(model1,'PA_9', {'12-hydroxy-3-Oxododecanoyl-CoA', 
'nadh[c]', 'h[c]', '3,12-dihydroxydodecanoyl-CoA', 'nad[c]'},[-1 -1 -1 
1 1],1, 0,1000); 
model1=addReaction(model1,'PA_10', {'13-hydroxy-3-Oxotridecanoyl-CoA', 
'nadh[c]', 'h[c]', '3,13-dihydroxytridecanoyl-CoA', 'nad[c]'},[-1 -1 -1 
1 1],1, 0,1000); 
model1=addReaction(model1,'PA_11', {'14-hydroxy-3-Oxotetradecanoyl-
CoA', 'nadh[c]', 'h[c]', '3,14-dihydroxytetradecanoyl-CoA', 
'nad[c]'},[-1 -1 -1 1 1],1, 0,1000); 
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model1=addReaction(model1,'PA_12', {'15-hydroxy-3-Oxopentadecanoyl-
CoA', 'nadh[c]', 'h[c]', '3,15-dihydroxypentadecanoyl-CoA', 
'nad[c]'},[-1 -1 -1 1 1],1, 0,1000); 
model1=addReaction(model1,'PA_13', {'16-hydroxy-3-Oxohexadecanoyl-CoA', 
'nadh[c]', 'h[c]', '3,16-dihydroxyhexadecanoyl-CoA', 'nad[c]'},[-1 -1 -
1 1 1],1, 0,1000); 
model1=addReaction(model1,'PA_14', {'17-hydroxy-3-Oxoheptadecanoyl-
CoA', 'nadh[c]', 'h[c]', '3,17-dihydroxyheptadecanoyl-CoA', 
'nad[c]'},[-1 -1 -1 1 1],1, 0,1000); 
model1=addReaction(model1,'PA_15', {'18-hydroxy-3-Oxooctadecanoyl-CoA', 
'nadh[c]', 'h[c]', '3,18-dihydroxyoctadecanoyl-CoA', 'nad[c]'},[-1 -1 -
1 1 1],1, 0,1000); 
%3-hydroxyacyl-CoA dehydratase (Adapted from ECOAHx in B-oxidation 
cycle): 
model1=addReaction(model1,'PB_1', {'3,4-dihydroxybutanoyl-CoA', '4-
hydroxy-crotonyl-CoA', 'h2o[c]'},[-1 1 1],1, 0,1000);  
model1=addReaction(model1,'PB_2', {'3,5-dihydroxypentanoyl-CoA', '5-
hydroxy-trans-pen-2-enoyl-CoA', 'h2o[c]'},[-1 1 1],1, 0,1000);   
model1=addReaction(model1,'PB_3', {'3,6-dihydroxyhexanoyl-CoA', '6-
hydroxy-trans-hex-2-enoyl-CoA', 'h2o[c]'},[-1 1 1],1, 0,1000);   
model1=addReaction(model1,'PB_4', {'3,7-dihydroxyheptanoyl-CoA', '7-
hydroxy-trans-hep-2-enoyl-CoA', 'h2o[c]'},[-1 1 1],1, 0,1000);   
model1=addReaction(model1,'PB_5', {'3,8-dihydroxyoctanoyl-CoA', '8-
hydroxy-trans-oct-2-enoyl-CoA', 'h2o[c]'},[-1 1 1],1, 0,1000);   
model1=addReaction(model1,'PB_6', {'3,9-dihydroxynonanoyl-CoA', '9-
hydroxy-trans-non-2-enoyl-CoA', 'h2o[c]'},[-1 1 1],1, 0,1000);   
model1=addReaction(model1,'PB_7', {'3,10-dihydroxydecanoyl-CoA', '10-
hydroxy-trans-dec-2-enoyl-CoA', 'h2o[c]'},[-1 1 1],1, 0,1000);   
model1=addReaction(model1,'PB_8', {'3,11-dihydroxyundecanoyl-CoA', '11-
hydroxy-trans-undec-2-enoyl-CoA', 'h2o[c]'},[-1 1 1],1, 0,1000);   
model1=addReaction(model1,'PB_9', {'3,12-dihydroxydodecanoyl-CoA', '12-
hydroxy-trans-dodec-2-enoyl-CoA', 'h2o[c]'},[-1 1 1],1, 0,1000);   
model1=addReaction(model1,'PB_10', {'3,13-dihydroxytridecanoyl-CoA', 
'13-hydroxy-trans-tridec-2-enoyl-CoA', 'h2o[c]'},[-1 1 1],1, 0,1000);   
model1=addReaction(model1,'PB_11', {'3,14-dihydroxytetradecanoyl-CoA', 
'14-hydroxy-trans-tetradec-2-enoyl-CoA', 'h2o[c]'},[-1 1 1],1, 0,1000);   
model1=addReaction(model1,'PB_12', {'3,15-dihydroxypentadecanoyl-CoA', 
'15-hydroxy-trans-pentadec-2-enoyl-CoA', 'h2o[c]'},[-1 1 1],1, 0,1000);   
model1=addReaction(model1,'PB_13', {'3,16-dihydroxyhexadecanoyl-CoA', 
'16-hydroxy-trans-hexadec-2-enoyl-CoA', 'h2o[c]'},[-1 1 1],1, 0,1000);   
model1=addReaction(model1,'PB_14', {'3,17-dihydroxyheptadecanoyl-CoA', 
'17-hydroxy-trans-heptadec-2-enoyl-CoA', 'h2o[c]'},[-1 1 1],1, 0,1000);   
model1=addReaction(model1,'PB_15', {'3,18-dihydroxyoctadecanoyl-CoA', 
'18-hydroxy-trans-octadec-2-enoyl-CoA', 'h2o[c]'},[-1 1 1],1, 0,1000);   
%acyl-CoA dehydrogenase (Adapted from ACOADxf_ferr in reversal B-
oxidation cycle) 
model1=addReaction(model1,'PC_1', {'4-hydroxy-crotonyl-CoA', 'fd_red', 
'h[c]', '4hydroxybutyryl-CoA', 'fd_oxi'},[-1 -1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PC_2', {'5-hydroxy-trans-pen-2-enoyl-CoA', 
'fd_red', 'h[c]', '5-hydroxy-pentanoyl-coa', 'fd_oxi'},[-1 -1 -1 1 
1],1, 0,1000);  
model1=addReaction(model1,'PC_3', {'6-hydroxy-trans-hex-2-enoyl-CoA', 
'fd_red', 'h[c]', '6-hydroxy-hexanoyl-coa', 'fd_oxi'},[-1 -1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PC_4', {'7-hydroxy-trans-hep-2-enoyl-CoA', 
'fd_red', 'h[c]', '7-hydroxy-heptanoyl-coa', 'fd_oxi'},[-1 -1 -1 1 
1],1, 0,1000);  
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model1=addReaction(model1,'PC_5', {'8-hydroxy-trans-oct-2-enoyl-CoA', 
'fd_red', 'h[c]', '8-hydroxy-octanoyl-coa', 'fd_oxi'},[-1 -1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PC_6', {'9-hydroxy-trans-non-2-enoyl-CoA', 
'fd_red', 'h[c]', '9-hydroxy-nonanoyl-coa', 'fd_oxi'},[-1 -1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PC_7', {'10-hydroxy-trans-dec-2-enoyl-CoA', 
'fd_red', 'h[c]', '10-hydroxy-decanoyl-coa', 'fd_oxi'},[-1 -1 -1 1 
1],1, 0,1000);  
model1=addReaction(model1,'PC_8', {'11-hydroxy-trans-undec-2-enoyl-
CoA', 'fd_red', 'h[c]', '11-hydroxy-undecanoyl-coa', 'fd_oxi'},[-1 -1 -
1 1 1],1, 0,1000);  
model1=addReaction(model1,'PC_9', {'12-hydroxy-trans-dodec-2-enoyl-
CoA', 'fd_red', 'h[c]', '12-hydroxy-dodecanoyl-coa', 'fd_oxi'},[-1 -1 -
1 1 1],1, 0,1000);  
model1=addReaction(model1,'PC_10', {'13-hydroxy-trans-tridec-2-enoyl-
CoA', 'fd_red', 'h[c]', '13-hydroxy-tridecanoyl-coa', 'fd_oxi'},[-1 -1 
-1 1 1],1, 0,1000);  
model1=addReaction(model1,'PC_11', {'14-hydroxy-trans-tetradec-2-enoyl-
CoA', 'fd_red', 'h[c]', '14-hydroxy-tetradecanoyl-coa', 'fd_oxi'},[-1 -
1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PC_12', {'15-hydroxy-trans-pentadec-2-enoyl-
CoA', 'fd_red', 'h[c]', '15-hydroxy-pentadecanoyl-coa', 'fd_oxi'},[-1 -
1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PC_13', {'16-hydroxy-trans-hexadec-2-enoyl-
CoA', 'fd_red', 'h[c]', '16-hydroxy-palmitoyl-coa', 'fd_oxi'},[-1 -1 -1 
1 1],1, 0,1000);  
model1=addReaction(model1,'PC_14', {'17-hydroxy-trans-heptadec-2-enoyl-
CoA', 'fd_red', 'h[c]', '17-hydroxy-heptadecanoyl-coa', 'fd_oxi'},[-1 -
1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PC_15', {'18-hydroxy-trans-octadec-2-enoyl-
CoA', 'fd_red', 'h[c]', '18-hydroxy-stearoyl-coa', 'fd_oxi'},[-1 -1 -1 
1 1],1, 0,1000);  
%3-ketoacyl-CoA thiolase (Adapted from KATx in reversal B-oxidation 
cycle) 
model1=addReaction(model1,'PD_1', {'4hydroxybutyryl-CoA', 'accoa[c]', 
'6-hydroxy-3-Oxohexanoyl-CoA', 'coa[c]'},[-1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PD_2', {'5-hydroxy-pentanoyl-coa', 
'accoa[c]', '7-hydroxy-3-Oxoheptanoyl-CoA', 'coa[c]'},[-1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PD_3', {'6-hydroxy-hexanoyl-coa', 
'accoa[c]', '8-hydroxy-3-Oxooctanoyl-CoA', 'coa[c]'},[-1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PD_4', {'7-hydroxy-heptanoyl-coa', 
'accoa[c]', '9-hydroxy-3-Oxononanoyl-CoA', 'coa[c]'},[-1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PD_5', {'8-hydroxy-octanoyl-coa', 
'accoa[c]', '10-hydroxy-3-Oxodecanoyl-CoA', 'coa[c]'},[-1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PD_6', {'9-hydroxy-nonanoyl-coa', 
'accoa[c]', '11-hydroxy-3-Oxoundecanoyl-CoA', 'coa[c]'},[-1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PD_7', {'10-hydroxy-decanoyl-coa', 
'accoa[c]', '12-hydroxy-3-Oxododecanoyl-CoA', 'coa[c]'},[-1 -1 1 1],1, 
0,1000);  
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model1=addReaction(model1,'PD_8', {'11-hydroxy-undecanoyl-coa', 
'accoa[c]', '13-hydroxy-3-Oxotridecanoyl-CoA', 'coa[c]'},[-1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PD_9', {'12-hydroxy-dodecanoyl-coa', 
'accoa[c]', '14-hydroxy-3-Oxotetradecanoyl-CoA', 'coa[c]'},[-1 -1 1 
1],1, 0,1000);  
model1=addReaction(model1,'PD_10', {'13-hydroxy-tridecanoyl-coa', 
'accoa[c]', '15-hydroxy-3-Oxopentadecanoyl-CoA', 'coa[c]'},[-1 -1 1 
1],1, 0,1000);  
model1=addReaction(model1,'PD_11', {'14-hydroxy-tetradecanoyl-coa', 
'accoa[c]', '16-hydroxy-3-Oxohexadecanoyl-CoA', 'coa[c]'},[-1 -1 1 
1],1, 0,1000);  
model1=addReaction(model1,'PD_12', {'15-hydroxy-pentadecanoyl-coa', 
'accoa[c]', '17-hydroxy-3-Oxoheptadecanoyl-CoA', 'coa[c]'},[-1 -1 1 
1],1, 0,1000);  
model1=addReaction(model1,'PD_13', {'16-hydroxy-palmitoyl-coa', 
'accoa[c]', '18-hydroxy-3-Oxooctadecanoyl-CoA', 'coa[c]'},[-1 -1 1 
1],1, 0,1000);  
%Termination I (Alcohol). Reduction of acyl-CoA 
model1=addReaction(model1,'PE_1', {'4hydroxybutyryl-CoA', 'nadh[c]', 
'h[c]', '4-hydroxy-butyraldehyde', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1, 0,1000);  
model1=addReaction(model1,'PE_2', {'5-hydroxy-pentanoyl-coa', 
'nadh[c]', 'h[c]', '5-hydroxy-pentanaldehyde', 'nad[c]', 'coa[c]'},[-1 
-1 -1 1 1 1],1, 0,1000);  
model1=addReaction(model1,'PE_3', {'6-hydroxy-hexanoyl-coa', 'nadh[c]', 
'h[c]', '6-hydroxy-hexanaldehyde', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1, 0,1000);  
model1=addReaction(model1,'PE_4', {'7-hydroxy-heptanoyl-coa', 
'nadh[c]', 'h[c]', '7-hydroxy-heptanaldehyde', 'nad[c]', 'coa[c]'},[-1 
-1 -1 1 1 1],1, 0,1000);  
model1=addReaction(model1,'PE_5', {'8-hydroxy-octanoyl-coa', 'nadh[c]', 
'h[c]', '8-hydroxy-octanaldehyde', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1, 0,1000);  
model1=addReaction(model1,'PE_6', {'9-hydroxy-nonanoyl-coa', 'nadh[c]', 
'h[c]', '9-hydroxy-nonaldehyde', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 
1],1, 0,1000);  
model1=addReaction(model1,'PE_7', {'10-hydroxy-decanoyl-coa', 
'nadh[c]', 'h[c]', '10-hydroxy-decanaldehyde', 'nad[c]', 'coa[c]'},[-1 
-1 -1 1 1 1],1, 0,1000);  
model1=addReaction(model1,'PE_8', {'11-hydroxy-undecanoyl-coa', 
'nadh[c]', 'h[c]', '11-hydroxy-undecanaldehyde', 'nad[c]', 'coa[c]'},[-
1 -1 -1 1 1 1],1, 0,1000);  
model1=addReaction(model1,'PE_9', {'12-hydroxy-dodecanoyl-coa', 
'nadh[c]', 'h[c]', '12-hydroxy-dodecanaldehyde', 'nad[c]', 'coa[c]'},[-
1 -1 -1 1 1 1],1, 0,1000);  
model1=addReaction(model1,'PE_10', {'13-hydroxy-tridecanoyl-coa', 
'nadh[c]', 'h[c]', '13-hydroxy-tridecanaldehyde', 'nad[c]', 
'coa[c]'},[-1 -1 -1 1 1 1],1, 0,1000);  
model1=addReaction(model1,'PE_11', {'14-hydroxy-tetradecanoyl-coa', 
'nadh[c]', 'h[c]', '14-hydroxy-tetradecanaldehyde', 'nad[c]', 
'coa[c]'},[-1 -1 -1 1 1 1],1, 0,1000);  
model1=addReaction(model1,'PE_12', {'15-hydroxy-pentadecanoyl-coa', 
'nadh[c]', 'h[c]', '15-hydroxy-pentadecanaldehyde', 'nad[c]', 
'coa[c]'},[-1 -1 -1 1 1 1],1, 0,1000);  
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model1=addReaction(model1,'PE_13', {'16-hydroxy-palmitoyl-coa', 
'nadh[c]', 'h[c]', '16-hydroxy-hexadecanaldehyde', 'nad[c]', 
'coa[c]'},[-1 -1 -1 1 1 1],1, 0,1000);  
model1=addReaction(model1,'PE_14', {'17-hydroxy-heptadecanoyl-coa', 
'nadh[c]', 'h[c]', '17-hydroxy-heptadecanaldehyde', 'nad[c]', 
'coa[c]'},[-1 -1 -1 1 1 1],1, 0,1000);  
model1=addReaction(model1,'PE_15', {'18-hydroxy-stearoyl-coa', 
'nadh[c]', 'h[c]', '18-hydroxy-octadecanaldehyde', 'nad[c]', 
'coa[c]'},[-1 -1 -1 1 1 1],1, 0,1000);  
%Termination I (Alcohol). Reduction of aldehyde  
model1=addReaction(model1,'PF_1', {'4-hydroxy-butyraldehyde', 
'nadh[c]', 'h[c]', '1,4 butanediol', 'nad[c]'},[-1 -1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PF_2', {'5-hydroxy-pentanaldehyde', 
'nadh[c]', 'h[c]', '1,5 pentanediol', 'nad[c]'},[-1 -1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PF_3', {'6-hydroxy-hexanaldehyde', 
'nadh[c]', 'h[c]', '1,6 hexanediol', 'nad[c]'},[-1 -1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PF_4', {'7-hydroxy-heptanaldehyde', 
'nadh[c]', 'h[c]', '1,7 heptanediol', 'nad[c]'},[-1 -1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PF_5', {'8-hydroxy-octanaldehyde', 
'nadh[c]', 'h[c]', '1,8 octanediol', 'nad[c]'},[-1 -1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PF_6', {'9-hydroxy-nonaldehyde', 'nadh[c]', 
'h[c]', '1,9 nonanediol', 'nad[c]'},[-1 -1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PF_7', {'10-hydroxy-decanaldehyde', 
'nadh[c]', 'h[c]', '1,10 decanediol', 'nad[c]'},[-1 -1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PF_8', {'11-hydroxy-undecanaldehyde', 
'nadh[c]', 'h[c]', '1,11 undecanediol', 'nad[c]'},[-1 -1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PF_9', {'12-hydroxy-dodecanaldehyde', 
'nadh[c]', 'h[c]', '1,12 dodecanediol', 'nad[c]'},[-1 -1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PF_10', {'13-hydroxy-tridecanaldehyde', 
'nadh[c]', 'h[c]', '1,13 tridecanediol', 'nad[c]'},[-1 -1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PF_11', {'14-hydroxy-tetradecanaldehyde', 
'nadh[c]', 'h[c]', '1,14 tetradecanediol', 'nad[c]'},[-1 -1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PF_12', {'15-hydroxy-pentadecanaldehyde', 
'nadh[c]', 'h[c]', '1,15 pentadecanediol', 'nad[c]'},[-1 -1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PF_13', {'16-hydroxy-hexadecanaldehyde', 
'nadh[c]', 'h[c]', '1,16 hexadecanediol', 'nad[c]'},[-1 -1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PF_14', {'17-hydroxy-heptadecanaldehyde', 
'nadh[c]', 'h[c]', '1,17 heptadecanediol', 'nad[c]'},[-1 -1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PF_15', {'18-hydroxy-octadecanaldehyde', 
'nadh[c]', 'h[c]', '1,18 octadecanediol', 'nad[c]'},[-1 -1 -1 1 1],1, 
0,1000);  
%Export (Diols) 
model1=addReaction(model1,'EX_butanediol', {'1,4 butanediol'},[-1],1, 
0,0);  
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model1=addReaction(model1,'EX_pentanediol', {'1,5 pentanediol'},[-1],1, 
0,0);  
model1=addReaction(model1,'EX_hexanediol', {'1,6 hexanediol'},[-1],1, 
0,0);  
model1=addReaction(model1,'EX_heptanediol', {'1,7 heptanediol'},[-1],1, 
0,0);  
model1=addReaction(model1,'EX_octanediol', {'1,8 octanediol'},[-1],1, 
0,0);  
model1=addReaction(model1,'EX_nonanediol', {'1,9 nonanediol'},[-1],1, 
0,0);  
model1=addReaction(model1,'EX_decanediol', {'1,10 decanediol'},[-1],1, 
0,0);  
model1=addReaction(model1,'EX_undecanediol', {'1,11 undecanediol'},[-
1],1, 0,0);  
model1=addReaction(model1,'EX_dodecanediol', {'1,12 dodecanediol'},[-
1],1, 0,0);  
model1=addReaction(model1,'EX_tridecanediol', {'1,13 tridecanediol'},[-
1],1, 0,0);  
model1=addReaction(model1,'EX_tetradecanediol', {'1,14 
tetradecanediol'},[-1],1, 0,0);  
model1=addReaction(model1,'EX_pentadecanediol', {'1,15 
pentadecanediol'},[-1],1, 0,0);   
model1=addReaction(model1,'EX_hexadecanediol', {'1,16 
hexadecanediol'},[-1],1, 0,0);  
model1=addReaction(model1,'EX_heptadecanediol', {'1,17 
heptadecanediol'},[-1],1, 0,0);   
model1=addReaction(model1,'EX_octadecanediol', {'1,18 
octadecanediol'},[-1],1, 0,0);  
%Termination II (Acid). 
model1=addReaction(model1,'PG_1', {'4hydroxybutyryl-CoA', 'h2o[c]', 
'4hydroxybutanoicacid' 'coa[c]'},[-1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PG_2', {'5-hydroxy-pentanoyl-coa', 'h2o[c]', 
'5hydroxypentanoicacid', 'coa[c]'},[-1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PG_3', {'6-hydroxy-hexanoyl-coa', 'h2o[c]', 
'6hydroxyhexanoicacid', 'coa[c]'},[-1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PG_4', {'7-hydroxy-heptanoyl-coa', 'h2o[c]', 
'7hydroxyheptanoicacid', 'coa[c]'},[-1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PG_5', {'8-hydroxy-octanoyl-coa', 'h2o[c]', 
'8hydroxyoctanoicacid', 'coa[c]'},[-1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PG_6', {'9-hydroxy-nonanoyl-coa', 'h2o[c]', 
'9hydroxynonanoicacid', 'coa[c]'},[-1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PG_7', {'10-hydroxy-decanoyl-coa', 'h2o[c]', 
'10hydroxydecanoicacid', 'coa[c]'},[-1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PG_8', {'11-hydroxy-undecanoyl-coa', 
'h2o[c]', '11hydroxyundecanoicacid', 'coa[c]'},[-1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PG_9', {'12-hydroxy-dodecanoyl-coa', 
'h2o[c]', '12hydroxydodecanoicacid', 'coa[c]'},[-1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PG_10', {'13-hydroxy-tridecanoyl-coa', 
'h2o[c]', '13hydroxytridecanoicacid', 'coa[c]'},[-1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PG_11', {'14-hydroxy-tetradecanoyl-coa', 
'h2o[c]', '14hydroxytetradecanoicacid', 'coa[c]'},[-1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PG_12', {'15-hydroxy-pentadecanoyl-coa', 
'h2o[c]', '15hydroxypentadecanoicacid', 'coa[c]'},[-1 -1 1 1],1, 
0,1000);  
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model1=addReaction(model1,'PG_13', {'16-hydroxy-palmitoyl-coa', 
'h2o[c]', '16hydroxyhexadecanoicacid', 'coa[c]'},[-1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PG_14', {'17-hydroxy-heptadecanoyl-coa', 
'h2o[c]', '17hydroxyheptadecanoicacid', 'coa[c]'},[-1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PG_15', {'18-hydroxy-stearoyl-coa', 
'h2o[c]', '18hydroxyoctadecanoicacid', 'coa[c]'},[-1 -1 1 1],1, 
0,1000);  
%Export (hydroxyacids) 
model1=addReaction(model1,'EX_4hydroxybutanoicacid', 
{'4hydroxybutanoicacid'},[-1],1, 0,0);  
model1=addReaction(model1,'EX_5hydroxypentanoicacid', 
{'5hydroxypentanoicacid'},[-1],1, 0,0);  
model1=addReaction(model1,'EX_6hydroxyhexanoicacid', 
{'6hydroxyhexanoicacid'},[-1],1, 0,0);  
model1=addReaction(model1,'EX_7hydroxyheptanoicacid', 
{'7hydroxyheptanoicacid'},[-1],1, 0,0);  
model1=addReaction(model1,'EX_8hydroxyoctanoicacid', 
{'8hydroxyoctanoicacid'},[-1],1, 0,0);  
model1=addReaction(model1,'EX_9hydroxynonanoicacid', 
{'9hydroxynonanoicacid'},[-1],1, 0,0);  
model1=addReaction(model1,'EX_10hydroxydecanoicacid', 
{'10hydroxydecanoicacid'},[-1],1, 0,0); 
model1=addReaction(model1,'EX_11hydroxyundecanoicacid', 
{'11hydroxyundecanoicacid'},[-1],1, 0,0);  
model1=addReaction(model1,'EX_12hydroxydodecanoicacid', 
{'12hydroxydodecanoicacid'},[-1],1, 0,0);  
model1=addReaction(model1,'EX_13hydroxytridecanoicacid', 
{'13hydroxytridecanoicacid'},[-1],1, 0,0);  
model1=addReaction(model1,'EX_14hydroxytetradecanoicacid', 
{'14hydroxytetradecanoicacid'},[-1],1, 0,0); 
model1=addReaction(model1,'EX_15hydroxypentadecanoicacid', 
{'15hydroxypentadecanoicacid'},[-1],1, 0,0);  
model1=addReaction(model1,'EX_16hydroxyhexadecanoicacid', 
{'16hydroxyhexadecanoicacid'},[-1],1, 0,0);  
model1=addReaction(model1,'EX_17hydroxyheptadecanoicacid', 
{'17hydroxyheptadecanoicacid'},[-1],1, 0,0); 
model1=addReaction(model1,'EX_18hydroxyoctadecanoicacid', 
{'18hydroxyoctadecanoicacid'},[-1],1, 0,0);   
%% Primer 4 and 6. This section uses generic names for intermediate 
metabolites for simplification.  
%oxalate   ->-> 3-oxosuccinyl-coa(Adapted from HACDxi in B-oxidation 
cycle)/ 
%succinate ->-> oxadpcoa[c](Adapted from HACDxi in B-oxidation cycle): 
model1=addReaction(model1,'PH_1', {'3oxosuccinyl-CoA', 'nadh[c]', 
'h[c]', '3oxosuccinyl-CoA_HACDxi', 'nad[c]'},[-1 -1 -1 1 1],1, 0,1000); 
model1=addReaction(model1,'PH_2', {'oxadpcoa[c]', 'nadh[c]', 'h[c]', 
'oxadpcoa_HACDxi', 'nad[c]'},[-1 -1 -1 1 1],1, 0,1000); 
model1=addReaction(model1,'PH_3', {'5carboxypentanoyl-CoA_KATx', 
'nadh[c]', 'h[c]', '5carboxypentanoyl-CoA_HACDxi', 'nad[c]'},[-1 -1 -1 
1 1],1, 0,1000); 
model1=addReaction(model1,'PH_4', {'7carboxyheptanoyl-CoA_KATx', 
'nadh[c]', 'h[c]', '7carboxyheptanoyl-CoA_HACDxi', 'nad[c]'},[-1 -1 -1 
1 1],1, 0,1000); 
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model1=addReaction(model1,'PH_5', {'9carboxynonanoyl-CoA_KATx', 
'nadh[c]', 'h[c]', '9carboxynonanoyl-CoA_HACDxi', 'nad[c]'},[-1 -1 -1 1 
1],1, 0,1000); 
model1=addReaction(model1,'PH_6', {'11carboxyundecanoyl-CoA_KATx', 
'nadh[c]', 'h[c]', '11carboxyundecanoyl-CoA_HACDxi', 'nad[c]'},[-1 -1 -
1 1 1],1, 0,1000); 
model1=addReaction(model1,'PH_7', {'13carboxytridecanoyl-CoA_KATx', 
'nadh[c]', 'h[c]', '13carboxytridecanoyl-CoA_HACDxi', 'nad[c]'},[-1 -1 
-1 1 1],1, 0,1000); 
model1=addReaction(model1,'PH_8', {'15carboxypentadecanoyl-CoA_KATx', 
'nadh[c]', 'h[c]', '15carboxypentadecanoyl-CoA_HACDxi', 'nad[c]'},[-1 -
1 -1 1 1],1, 0,1000); 
%3-hydroxyacyl-CoA dehydratase (Adapted from ECOAHx in B-oxidation 
cycle). Use generic names adding the name of the enzyme that is 
modifying 
%the molecule:  
model1=addReaction(model1,'PI_1', {'3oxosuccinyl-CoA_HACDxi', 
'3oxosuccinyl-CoA_ECOAHi', 'h2o[c]'},[-1 1 1],1, 0,1000);  
model1=addReaction(model1,'PI_2', {'oxadpcoa_HACDxi', 
'oxadpcoa_ECOAHi', 'h2o[c]'},[-1 1 1],1, 0,1000);   
model1=addReaction(model1,'PI_3', {'5carboxypentanoyl-CoA_HACDxi', 
'5carboxypentanoyl-CoA_ECOAHi', 'h2o[c]'},[-1 1 1],1, 0,1000);   
model1=addReaction(model1,'PI_4', {'7carboxyheptanoyl-CoA_HACDxi', 
'7carboxyheptanoyl-CoA_ECOAHi', 'h2o[c]'},[-1 1 1],1, 0,1000);   
model1=addReaction(model1,'PI_5', {'9carboxynonanoyl-CoA_HACDxi', 
'9carboxynonanoyl-CoA_ECOAHi', 'h2o[c]'},[-1 1 1],1, 0,1000);   
model1=addReaction(model1,'PI_6', {'11carboxyundecanoyl-CoA_HACDxi', 
'11carboxyundecanoyl-CoA_ECOAHi', 'h2o[c]'},[-1 1 1],1, 0,1000); 
model1=addReaction(model1,'PI_7', {'13carboxytridecanoyl-CoA_HACDxi', 
'13carboxytridecanoyl-CoA_ECOAHi', 'h2o[c]'},[-1 1 1],1, 0,1000); 
model1=addReaction(model1,'PI_8', {'15carboxypentadecanoyl-CoA_HACDxi', 
'15carboxypentadecanoyl-CoA_ECOAHi', 'h2o[c]'},[-1 1 1],1, 0,1000);   
  
%acyl-CoA dehydrogenase (Adapted from ACOADxf_ferr in reversal B-
oxidation 
%cycle). Use generic names adding the name of the enzyme that is 
modifying 
%the molecule 
model1=addReaction(model1,'PJ_1', {'3oxosuccinyl-CoA_ECOAHi', 'fd_red', 
'h[c]', 'succoa[c]', 'fd_oxi'},[-1 -1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PJ_2', {'oxadpcoa_ECOAHi', 'fd_red', 'h[c]', 
'5carboxypentanoyl-CoA', 'fd_oxi'},[-1 -1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PJ_3', {'5carboxypentanoyl-CoA_ECOAHi', 
'fd_red', 'h[c]', '7carboxyheptanoyl-CoA', 'fd_oxi'},[-1 -1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PJ_4', {'7carboxyheptanoyl-CoA_ECOAHi', 
'fd_red', 'h[c]', '9carboxynonanoyl-CoA', 'fd_oxi'},[-1 -1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PJ_5', {'9carboxynonanoyl-CoA_ECOAHi', 
'fd_red', 'h[c]', '11carboxyundecanoyl-CoA', 'fd_oxi'},[-1 -1 -1 1 
1],1, 0,1000);  
model1=addReaction(model1,'PJ_6', {'11carboxyundecanoyl-CoA_ECOAHi', 
'fd_red', 'h[c]', '13carboxytridecanoyl-CoA', 'fd_oxi'},[-1 -1 -1 1 
1],1, 0,1000);  
model1=addReaction(model1,'PJ_7', {'13carboxytridecanoyl-CoA_ECOAHi', 
'fd_red', 'h[c]', '15carboxypentadecanoyl-CoA', 'fd_oxi'},[-1 -1 -1 1 
1],1, 0,1000);  
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model1=addReaction(model1,'PJ_8', {'15carboxypentadecanoyl-CoA_ECOAHi', 
'fd_red', 'h[c]', '17carboxyheptadecanoyl-CoA', 'fd_oxi'},[-1 -1 -1 1 
1],1, 0,1000);  
  
%3-ketoacyl-CoA thiolase (Adapted from KATx in reversal B-oxidation 
cycle). 
%Use generic names adding the name of the enzyme that is modifying 
%the molecule 
model1=addReaction(model1,'PK_1', {'succoa[c]', 'accoa[c]', 
'3carboxypropanoyl-CoA_KATx', 'coa[c]'},[-1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PK_2', {'5carboxypentanoyl-CoA', 'accoa[c]', 
'5carboxypentanoyl-CoA_KATx', 'coa[c]'},[-1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PK_3', {'7carboxyheptanoyl-CoA', 'accoa[c]', 
'7carboxyheptanoyl-CoA_KATx', 'coa[c]'},[-1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PK_4', {'9carboxynonanoyl-CoA', 'accoa[c]', 
'9carboxynonanoyl-CoA_KATx', 'coa[c]'},[-1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PK_5', {'11carboxyundecanoyl-CoA', 
'accoa[c]', '11carboxyundecanoyl-CoA_KATx', 'coa[c]'},[-1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PK_6', {'13carboxytridecanoyl-CoA', 
'accoa[c]', '13carboxytridecanoyl-CoA_KATx', 'coa[c]'},[-1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PK_7', {'15carboxypentadecanoyl-CoA', 
'accoa[c]', '15carboxypentadecanoyl-CoA_KATx', 'coa[c]'},[-1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PK_8', {'17carboxyheptadecanoyl-CoA', 
'accoa[c]', '17carboxyheptadecanoyl-CoA_KATx', 'coa[c]'},[-1 -1 1 1],1, 
0,1000);  
%Termination I (Alcohol). Reduction of acyl-CoA 
model1=addReaction(model1,'PL_1', {'succoa[c]', 'nadh[c]', 'h[c]', 
'4oxobutanoicacid', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 1],1, 0,1000);  
model1=addReaction(model1,'PL_2', {'5carboxypentanoyl-CoA', 'nadh[c]', 
'h[c]', '6oxohexanoicacid', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PL_3', {'7carboxyheptanoyl-CoA', 'nadh[c]', 
'h[c]', '8oxooctanoicacid', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PL_4', {'9carboxynonanoyl-CoA', 'nadh[c]', 
'h[c]', '10oxodecanoicacid', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PL_5', {'11carboxyundecanoyl-CoA', 
'nadh[c]', 'h[c]', '12oxododecanoicacid', 'nad[c]', 'coa[c]'},[-1 -1 -1 
1 1 1],1, 0,1000);  
model1=addReaction(model1,'PL_6', {'13carboxytridecanoyl-CoA', 
'nadh[c]', 'h[c]', '14oxotetradecanoicacid', 'nad[c]', 'coa[c]'},[-1 -1 
-1 1 1 1],1, 0,1000);  
model1=addReaction(model1,'PL_7', {'15carboxypentadecanoyl-CoA', 
'nadh[c]', 'h[c]', '16oxohexadecanoicacid', 'nad[c]', 'coa[c]'},[-1 -1 
-1 1 1 1],1, 0,1000);  
model1=addReaction(model1,'PL_8', {'17carboxyheptadecanoyl-CoA', 
'nadh[c]', 'h[c]', '18oxooctadecanoicacid', 'nad[c]', 'coa[c]'},[-1 -1 
-1 1 1 1],1, 0,1000);  
%Termination I (Alcohol). Reduction of aldehyde  
model1=addReaction(model1,'PM_1', {'4oxobutanoicacid', 'nadh[c]', 
'h[c]', '4hydroxybutanoicacid', 'nad[c]'},[-1 -1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PM_2', {'6oxohexanoicacid', 'nadh[c]', 
'h[c]', '6hydroxyhexanoicacid', 'nad[c]'},[-1 -1 -1 1 1],1, 0,1000);  
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model1=addReaction(model1,'PM_3', {'8oxooctanoicacid', 'nadh[c]', 
'h[c]', '8hydroxyoctanoicacid', 'nad[c]'},[-1 -1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PM_4', {'10oxodecanoicacid', 'nadh[c]', 
'h[c]', '10hydroxydecanoicacid', 'nad[c]'},[-1 -1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PM_5', {'12oxododecanoicacid', 'nadh[c]', 
'h[c]', '12hydroxydodecanoicacid', 'nad[c]'},[-1 -1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PM_6', {'14oxotetradecanoicacid', 'nadh[c]', 
'h[c]', '14hydroxytetradecanoicacid', 'nad[c]'},[-1 -1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PM_7', {'16oxohexadecanoicacid', 'nadh[c]', 
'h[c]', '16hydroxyhexadecanoicacid', 'nad[c]'},[-1 -1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PM_8', {'18oxooctadecanoicacid', 'nadh[c]', 
'h[c]', '18hydroxyoctadecanoicacid', 'nad[c]'},[-1 -1 -1 1 1],1, 
0,1000);  
%Export Hydroxyacids --> already in the model 
%Termination II (Acid). 
model1=addReaction(model1,'PN_1', {'succoa[c]', 'h2o[c]', 
'3carboxypropanoate', 'h[c]', 'coa[c]'},[-1 -1 1 1 1],1, 0,1000);  
model1=addReaction(model1,'PN_2', {'5carboxypentanoyl-CoA', 'h2o[c]', 
'5carboxypentanoate', 'h[c]', 'coa[c]'},[-1 -1 1 1 1],1, 0,1000);  
model1=addReaction(model1,'PN_3', {'7carboxyheptanoyl-CoA', 'h2o[c]', 
'7carboxyheptanoate', 'h[c]', 'coa[c]'},[-1 -1 1 1 1],1, 0,1000);  
model1=addReaction(model1,'PN_4', {'9carboxynonanoyl-CoA', 'h2o[c]', 
'9carboxynonanoate', 'h[c]', 'coa[c]'},[-1 -1 1 1 1],1, 0,1000);  
model1=addReaction(model1,'PN_5', {'11carboxyundecanoyl-CoA', 'h2o[c]', 
'11carboxyundecanoate', 'h[c]', 'coa[c]'},[-1 -1 1 1 1],1, 0,1000);  
model1=addReaction(model1,'PN_6', {'13carboxytridecanoyl-CoA', 
'h2o[c]', '13carboxytridecanoate', 'h[c]', 'coa[c]'},[-1 -1 1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PN_7', {'15carboxypentadecanoyl-CoA', 
'h2o[c]', '15carboxypentadecanoate', 'h[c]', 'coa[c]'},[-1 -1 1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PN_8', {'17carboxyheptadecanoyl-CoA', 
'h2o[c]', '17carboxyheptadecanoate', 'h[c]', 'coa[c]'},[-1 -1 1 1 1],1, 
0,1000);  
%Export Reactions (hydroxylated acid) 
model1=addReaction(model1,'EX_3carboxypropanoate', 
{'3carboxypropanoate'},[-1 ],1, 0,0);  
model1=addReaction(model1,'EX_5carboxypentanoate', 
{'5carboxypentanoate'},[-1 ],1, 0,0);  
model1=addReaction(model1,'EX_7carboxyheptanoate', 
{'7carboxyheptanoate'},[-1 ],1, 0,0);  
model1=addReaction(model1,'EX_9carboxynonanoate', 
{'9carboxynonanoate'},[-1 ],1, 0,0);  
model1=addReaction(model1,'EX_11carboxyundecanoate', 
{'11carboxyundecanoate'},[-1 ],1, 0,0);  
model1=addReaction(model1,'EX_13carboxytridecanoate', 
{'13carboxytridecanoate'},[-1 ],1, 0,0);  
model1=addReaction(model1,'EX_15carboxypentadecanoate', 
{'15carboxypentadecanoate'},[-1 ],1, 0,0);  
model1=addReaction(model1,'EX_17carboxyheptadecanoate', 
{'17carboxyheptadecanoate'},[-1 ],1, 0,0); 
%% Primer 5: Malonate/3-oxoglutaryl-coa(Adapted from HACDxi in B-
oxidation cycle): 
model1=addReaction(model1,'PHH_1', {'3oxoglutaryl-CoA', 'nadh[c]', 
'h[c]', '3oxoglutaryl-CoA_HACDxi', 'nad[c]'},[-1 -1 -1 1 1],1, 0,1000); 
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model1=addReaction(model1,'PHH_2', {'4carboxybutanoyl-CoA_KATx', 
'nadh[c]', 'h[c]', '4carboxybutanoyl-CoA_HACDxi', 'nad[c]'},[-1 -1 -1 1 
1],1, 0,1000); 
model1=addReaction(model1,'PHH_3', {'6carboxyhexanoyl-CoA_KATx', 
'nadh[c]', 'h[c]', '6carboxyhexanoyl-CoA_HACDxi', 'nad[c]'},[-1 -1 -1 1 
1],1, 0,1000); 
model1=addReaction(model1,'PHH_4', {'8carboxyoctanoyl-CoA_KATx', 
'nadh[c]', 'h[c]', '8carboxyoctanoyl-CoA_HACDxi', 'nad[c]'},[-1 -1 -1 1 
1],1, 0,1000); 
model1=addReaction(model1,'PHH_5', {'10carboxydecanoyl-CoA_KATx', 
'nadh[c]', 'h[c]', '10carboxydecanoyl-CoA_HACDxi', 'nad[c]'},[-1 -1 -1 
1 1],1, 0,1000); 
model1=addReaction(model1,'PHH_6', {'12carboxydodecanoyl-CoA_KATx', 
'nadh[c]', 'h[c]', '12carboxydodecanoyl-CoA_HACDxi', 'nad[c]'},[-1 -1 -
1 1 1],1, 0,1000); 
model1=addReaction(model1,'PHH_7', {'14carboxytetradecanoyl-CoA_KATx', 
'nadh[c]', 'h[c]', '14carboxytetradecanoyl-CoA_HACDxi', 'nad[c]'},[-1 -
1 -1 1 1],1, 0,1000); 
model1=addReaction(model1,'PHH_8', {'16carboxyhexadecanoyl-CoA_KATx', 
'nadh[c]', 'h[c]', '16carboxyhexadecanoyl-CoA_HACDxi', 'nad[c]'},[-1 -1 
-1 1 1],1, 0,1000); 
%3-hydroxyacyl-CoA dehydratase (Adapted from ECOAHx in B-oxidation 
cycle). Use generic names adding the name of the enzyme that is 
modifying 
%the molecule: 
model1=addReaction(model1,'PII_1', {'3oxoglutaryl-CoA_HACDxi', 
'3oxoglutaryl-CoA_ECOAHi', 'h2o[c]'},[-1 1 1],1, 0,1000);  
model1=addReaction(model1,'PII_2', {'4carboxybutanoyl-CoA_HACDxi', 
'4carboxybutanoyl-CoA_ECOAHi', 'h2o[c]'},[-1 1 1],1, 0,1000);   
model1=addReaction(model1,'PII_3', {'6carboxyhexanoyl-CoA_HACDxi', 
'6carboxyhexanoyl-CoA_ECOAHi', 'h2o[c]'},[-1 1 1],1, 0,1000);   
model1=addReaction(model1,'PII_4', {'8carboxyoctanoyl-CoA_HACDxi', 
'8carboxyoctanoyl-CoA_ECOAHi', 'h2o[c]'},[-1 1 1],1, 0,1000);   
model1=addReaction(model1,'PII_5', {'10carboxydecanoyl-CoA_HACDxi', 
'10carboxydecanoyl-CoA_ECOAHi', 'h2o[c]'},[-1 1 1],1, 0,1000);   
model1=addReaction(model1,'PII_6', {'12carboxydodecanoyl-CoA_HACDxi', 
'12carboxydodecanoyl-CoA_ECOAHi', 'h2o[c]'},[-1 1 1],1, 0,1000); 
model1=addReaction(model1,'PII_7', {'14carboxytetradecanoyl-
CoA_HACDxi', '14carboxytetradecanoyl-CoA_ECOAHi', 'h2o[c]'},[-1 1 1],1, 
0,1000); 
model1=addReaction(model1,'PII_8', {'16carboxyhexadecanoyl-CoA_HACDxi', 
'16carboxyhexadecanoyl-CoA_ECOAHi', 'h2o[c]'},[-1 1 1],1, 0,1000);   
%acyl-CoA dehydrogenase (Adapted from ACOADxf_ferr in reversal B-
oxidation 
%cycle). Use generic names adding the name of the enzyme that is 
modifying 
%the molecule 
model1=addReaction(model1,'PJJ_1', {'3oxoglutaryl-CoA_ECOAHi', 
'fd_red', 'h[c]', '4carboxybutanoyl-CoA', 'fd_oxi'},[-1 -1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PJJ_2', {'4carboxybutanoyl-CoA_ECOAHi', 
'fd_red', 'h[c]', '6carboxyhexanoyl-CoA', 'fd_oxi'},[-1 -1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PJJ_3', {'6carboxyhexanoyl-CoA_ECOAHi', 
'fd_red', 'h[c]', '8carboxyoctanoyl-CoA', 'fd_oxi'},[-1 -1 -1 1 1],1, 
0,1000);  
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model1=addReaction(model1,'PJJ_4', {'8carboxyoctanoyl-CoA_ECOAHi', 
'fd_red', 'h[c]', '10carboxydecanoyl-CoA', 'fd_oxi'},[-1 -1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PJJ_5', {'10carboxydecanoyl-CoA_ECOAHi', 
'fd_red', 'h[c]', '12carboxydodecanoyl-CoA', 'fd_oxi'},[-1 -1 -1 1 
1],1, 0,1000);  
model1=addReaction(model1,'PJJ_6', {'12carboxydodecanoyl-CoA_ECOAHi', 
'fd_red', 'h[c]', '14carboxytetradecanoyl-CoA', 'fd_oxi'},[-1 -1 -1 1 
1],1, 0,1000);  
model1=addReaction(model1,'PJJ_7', {'14carboxytetradecanoyl-
CoA_ECOAHi', 'fd_red', 'h[c]', '16carboxyhexadecanoyl-CoA', 
'fd_oxi'},[-1 -1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PJJ_8', {'16carboxyhexadecanoyl_ECOAHi', 
'fd_red', 'h[c]', '18carboxyoctadecanoyl-CoA', 'fd_oxi'},[-1 -1 -1 1 
1],1, 0,1000);  
%3-ketoacyl-CoA thiolase (Adapted from KATx in reversal B-oxidation 
cycle). 
%Use generic names adding the name of the enzyme that is modifying 
%the molecule 
model1=addReaction(model1,'PKK_1', {'4carboxybutanoyl-CoA', 'accoa[c]', 
'4carboxybutanoyl-CoA_KATx', 'coa[c]'},[-1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PKK_2', {'6carboxyhexanoyl-CoA', 'accoa[c]', 
'6carboxyhexanoyl-CoA_KATx', 'coa[c]'},[-1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PKK_3', {'8carboxyoctanoyl-CoA', 'accoa[c]', 
'8carboxyoctanoyl-CoA_KATx', 'coa[c]'},[-1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PKK_4', {'10carboxydecanoyl-CoA', 
'accoa[c]', '10carboxydecanoyl-CoA_KATx', 'coa[c]'},[-1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PKK_5', {'12carboxydodecanoyl-CoA', 
'accoa[c]', '12carboxydodecanoyl-CoA_KATx', 'coa[c]'},[-1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PKK_6', {'14carboxytetradecanoyl-CoA', 
'accoa[c]', '14carboxytetradecanoyl-CoA_KATx', 'coa[c]'},[-1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PKK_7', {'16carboxyhexadecanoyl-CoA', 
'accoa[c]', '16carboxyhexadecanoyl-CoA_KATx', 'coa[c]'},[-1 -1 1 1],1, 
0,1000);  
%Termination I (Alcohol). Reduction of acyl-CoA 
model1=addReaction(model1,'PLL_1', {'4carboxybutanoyl-CoA', 'nadh[c]', 
'h[c]', '5oxopentanoicacid', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PLL_2', {'6carboxyhexanoyl-CoA', 'nadh[c]', 
'h[c]', '7oxoheptanoicacid', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PLL_3', {'8carboxyoctanoyl-CoA', 'nadh[c]', 
'h[c]', '9oxononanoicacid', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PLL_4', {'10carboxydecanoyl-CoA', 'nadh[c]', 
'h[c]', '11oxoundecanoicacid', 'nad[c]', 'coa[c]'},[-1 -1 -1 1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PLL_5', {'12carboxydodecanoyl-CoA', 
'nadh[c]', 'h[c]', '13oxotridecanoicacid', 'nad[c]', 'coa[c]'},[-1 -1 -
1 1 1 1],1, 0,1000);  
model1=addReaction(model1,'PLL_6', {'14carboxytetradecanoyl-CoA', 
'nadh[c]', 'h[c]', '15oxopentadecanoicacid', 'nad[c]', 'coa[c]'},[-1 -1 
-1 1 1 1],1, 0,1000);  
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model1=addReaction(model1,'PLL_7', {'16carboxyhexadecanoyl-CoA', 
'nadh[c]', 'h[c]', '17oxoheptadecanoicacid', 'nad[c]', 'coa[c]'},[-1 -1 
-1 1 1 1],1, 0,1000);  
%Termination I (Alcohol). Reduction of aldehyde  
model1=addReaction(model1,'PMM_1', {'5oxopentanoicacid', 'nadh[c]', 
'h[c]', '5hydroxypentanoicacid', 'nad[c]'},[-1 -1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PMM_2', {'7oxoheptanoicacid', 'nadh[c]', 
'h[c]', '7hydroxyheptanoicacid', 'nad[c]'},[-1 -1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PMM_3', {'9oxononanoicacid', 'nadh[c]', 
'h[c]', '9hydroxynonanoicacid', 'nad[c]'},[-1 -1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PMM_4', {'11oxoundecanoicacid', 'nadh[c]', 
'h[c]', '11hydroxyundecanoicacid', 'nad[c]'},[-1 -1 -1 1 1],1, 0,1000);  
model1=addReaction(model1,'PMM_5', {'13oxotridecanoicacid', 'nadh[c]', 
'h[c]', '13hydroxytridecanoicacid', 'nad[c]'},[-1 -1 -1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PMM_6', {'15oxopentadecanoicacid', 
'nadh[c]', 'h[c]', '15hydroxypentadecanoicacid', 'nad[c]'},[-1 -1 -1 1 
1],1, 0,1000);  
model1=addReaction(model1,'PMM_7', {'17oxoheptadecanoicacid', 
'nadh[c]', 'h[c]', '17hydroxyheptadecanoicacid', 'nad[c]'},[-1 -1 -1 1 
1],1, 0,1000);  
%Export hydroxyacids --> Already in the model 
%Termination II (Acid). 
model1=addReaction(model1,'PNN_1', {'4carboxybutanoyl-CoA', 'h2o[c]', 
'4carboxybutanoate', 'h[c]', 'coa[c]'},[-1 -1 1 1 1],1, 0,1000);  
model1=addReaction(model1,'PNN_2', {'6carboxyhexanoyl-CoA', 'h2o[c]', 
'6carboxyhexanoate', 'h[c]', 'coa[c]'},[-1 -1 1 1 1],1, 0,1000);  
model1=addReaction(model1,'PNN_3', {'8carboxyoctanoyl-CoA', 'h2o[c]', 
'8carboxyoctanoate', 'h[c]', 'coa[c]'},[-1 -1 1 1 1],1, 0,1000);  
model1=addReaction(model1,'PNN_4', {'10carboxydecanoyl-CoA', 'h2o[c]', 
'10carboxydecanoate', 'h[c]', 'coa[c]'},[-1 -1 1 1 1],1, 0,1000);  
model1=addReaction(model1,'PNN_5', {'12carboxydodecanoyl-CoA', 
'h2o[c]', '12carboxydodecanoate', 'h[c]', 'coa[c]'},[-1 -1 1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PNN_6', {'14carboxytetradecanoyl-CoA', 
'h2o[c]', '14carboxytetradecanoate', 'h[c]', 'coa[c]'},[-1 -1 1 1 1],1, 
0,1000);  
model1=addReaction(model1,'PNN_7', {'16carboxyhexadecanoyl-CoA', 
'h2o[c]', '16carboxyhexadecanoate', 'h[c]', 'coa[c]'},[-1 -1 1 1 1],1, 
0,1000);  
%Export Reactions (hydroxylated acid) 
model1=addReaction(model1,'EX_4carboxybutanoate', 
{'4carboxybutanoate'},[-1 ],1, 0,0);  
model1=addReaction(model1,'EX_6carboxyhexanoate', 
{'6carboxyhexanoate'},[-1 ],1, 0,0);  
model1=addReaction(model1,'EX_8carboxyoctanoate', 
{'8carboxyoctanoate'},[-1 ],1, 0,0);  
model1=addReaction(model1,'EX_10carboxydecanoate', 
{'10carboxydecanoate'},[-1 ],1, 0,0);  
model1=addReaction(model1,'EX_12carboxydodecanoate', 
{'12carboxydodecanoate'},[-1 ],1, 0,0);  
model1=addReaction(model1,'EX_14carboxytetradecanoate', 
{'14carboxytetradecanoate'},[-1 ],1, 0,0);  
model1=addReaction(model1,'EX_16carboxyhexadecanoate', 
{'16carboxyhexadecanoate'},[-1 ],1, 0,0);  
model1=addReaction(model1,'EX_18carboxyoctadecanoate', 
{'18carboxyoctadecanoate'},[-1 ],1, 0,0); 
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%% Add reactions to produce missing internal primers 
%(Fig 4, reaction 12)  
model1=addReaction(model1,'P_Fig4_r12', {'malcoa[c]', 'nadph[c]', 
'h[c]', 'Malonate-semialdehyde', 'coa[c]', 'nadp[c]'},[-1 -1 -1 1 1 
1],1, 0,1000);   
%(Fig 4, reaction 13)  
model1=addReaction(model1,'P_Fig4_r_13', {'Malonate-semialdehyde', 
'nadph[c]', 'h[c]', '3-hydroxypropionate', 'nadp[c]'},[-1 -1 -1 1 1],1, 
0,1000);   
%(Fig 4, reaction 8)  
model1=addReaction(model1,'P_Fig4_r_8', {'3-hydroxypropionate', 
'coa[c]', 'atp[c]', '3-hydroxypropionyl-CoA', 'ppi[c]', 'amp[c]'},[-1 -
1 -1 1 1 1],1, 0,1000);   
%(Fig 4, reaction 6)  
model1=addReaction(model1,'P_Fig4_r_6', {'glyc[c]', '3-
hydroxypropionaldehyde', 'h2o[c]'},[-1 1 1],1, 0,1000);   
%(Fig 4, reaction 7)  
model1=addReaction(model1,'P_Fig4_r_7', {'3-hydroxypropionaldehyde', 
'nad[c]', 'h2o[c]', '3-hydroxypropionate', 'nadh[c]', 'h[c]'},[-1 -1 -1 
1 1 2 ],1, 0,1000);   
% Ferredoxins / Reversal B-oxidation cycle / inactive in this case 
        model1=addReaction(model1,'ACOAD1f_ferr',{'btcoa[c]', 'fd_oxi', 
'b2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,0,0); 
        model1=addReaction(model1,'ACOAD2f_ferr',{'fd_oxi', 'hxcoa[c]', 
'hx2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,0,0); 
        model1=addReaction(model1,'ACOAD3f_ferr',{'fd_oxi', 'occoa[c]', 
'oc2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,0,0); 
        model1=addReaction(model1,'ACOAD4f_ferr',{'dcacoa[c]', 
'fd_oxi', 'dc2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,0,0); 
        model1=addReaction(model1,'ACOAD5f_ferr',{'ddcacoa[c]', 
'fd_oxi', 'dd2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,0,0); 
        model1=addReaction(model1,'ACOAD6f_ferr',{'fd_oxi', 'tdcoa[c]', 
'td2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,0,0); 
        model1=addReaction(model1,'ACOAD7f_ferr',{'fd_oxi', 
'pmtcoa[c]', 'hdd2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,0,0); 
        model1=addReaction(model1,'ACOAD8f_ferr',{'fd_oxi', 'stcoa[c]', 
'od2coa[c]', 'fd_red', 'h[c]'},[-1 -1 1 1 1],1,0,0); 
        model1=addReaction(model1,'PFOR',{'coa[c]', 'fd_oxi', 'pyr[c]', 
'accoa[c]', 'co2[c]', 'fd_red', 'h[c]'},[-1 -1 -1 1 1 1 1],1,0,0);        
  
%% 
A= size(model1.rxns); 
SizeModel=(A(1)); 
%% Enter knockouts 
I= input('List of reactions to delete: '); 
  
SizeI=size(I); 
for p=1:1:SizeI(2) 
    RxnDelete=I(p); 
    model1=changeRxnBounds(model1, RxnDelete, 0, 'u'); 
    model1=changeRxnBounds(model1, RxnDelete, 0, 'l'); 
    if p==1 
        KnockoutReaction=RxnDelete; 
    else 
        KnockoutReaction=strcat(KnockoutReaction,',',RxnDelete); 
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    end 
end 
  
  
%% Desired primer and product 
prompt = {'Desired primer: '}; 
Primer=inputdlg(prompt); 
model1=changeRxnBounds(model1, Primer, -15, 'l'); 
prompt = {'Desired product: '}; 
Product=inputdlg(prompt); 
model1=changeRxnBounds(model1, Product, 1000, 'u'); 
A=(model1.rxns); 
productposition=AC_findp_F(A,Product); 
model1=changeObjective(model1, Biomass_name, 1); 
solution=optimizeCbModel(model1); 
maxbiomass =solution.f 
if solution.stat ~= 1 
    display ('The selected condition does not have any valid solution') 
    return 
end 
Product_when_biomass_is_optimized=solution.x(productposition) 
TitlePlot=strcat('Product versus Biomass, deletion of: ', 
KnockoutReaction); 
xlsTitle=strcat('Model_', modelname, '_', KnockoutReaction); 
model1=changeObjective(model1, Biomass_name, -1); 
solution=optimizeCbModel(model1); 
minbiomass=solution.f; 
product2=solution.x(productposition); 
model1=changeObjective(model1, Product(1), 1); 
solution=optimizeCbModel(model1); 
OptimeProduct=solution.x(productposition) 
Y=zeros(101,3); 
%Y=zeros(101,7); 
for i=1:1:101 
    model1=changeRxnBounds(model1, Biomass_name, 0.01*(i-1)*maxbiomass, 
'l'); 
    % min 
    model1=changeObjective(model1, Product(1), 1); 
    maxsolution=optimizeCbModel(model1); 
    maxproduct=maxsolution.f; 
    biomass1=maxsolution.x(biomassposition); 
    model1=changeObjective(model1, Product(1), -1);     
    minsolution=optimizeCbModel(model1); 
    minproduct=minsolution.x(productposition); 
    Y(i,:)= [biomass1 minproduct maxproduct]; 
     
end 
  
model1=changeObjective(model1, Biomass_name, 1); 
model1=changeRxnBounds(model1, Biomass_name, 0, 'l'); 
solution=optimizeCbModel(model1); 
%% Plot 
figure(1) 
set(0, 'DefaultTextInterpreter', 'none') %Change set of all plots Text-
Interpreter to none, as oppose to Text (default) 
plot(Y(:,1), Y(:,2), '--g*'); 
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hold on 
plot(Y(:,1), Y(:,3), '--r*'); 
xlabel('Biomass'); 
ylabel(strcat('Product: ', Product)); 
title(TitlePlot); 
h=area(Y(:,1),Y(:,3)); 
set(h(1),'FaceColor',[1 1 0.5]) 
j=area(Y(:,1),Y(:,2)); 
set(j(1),'FaceColor',[1 1 1]) 
 
 
 
 
 
